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Increasing	   global	   demand	   for	   food	   is	   a	   major	   issue	   facing	   modern	   day	   agriculture.	   For	  
crops	   such	   as	   wheat	   and	   rice,	   where	   the	   seed	   constitutes	   the	   harvestable	   yield,	   the	  
engineering	  of	  larger	  seeds	  provides	  a	  possible	  strategy	  for	  yield	  improvement.	  A	  detailed	  
understanding	  of	  the	  growth	  of	  plant	  organs	  in	  general	  is	  paramount	  if	  such	  advances	  are	  
to	  be	  made.	  Utilising	  previously	  characterised	  regulators	  of	  plant	  organ	  growth,	  this	  thesis	  
explores	  the	  molecular	  mechanisms	  involved	  in	  the	  setting	  of	  final	  organ	  size.	  	  	  	  
This	  thesis	  capitalises	  on	  previous	  studies	  that	  have	  identified	  DA1	  as	  a	  negative	  regulator	  
of	  organ	  growth;	   it	  explores	   the	   role	  of	   the	  DA1	  protein	  and	   investigates	   its	   interactions	  
with	  other	  proteins.	   In	  vitro	  studies	   reveal	   that	  DA1	   forms	  homo-­‐	  and	  hetero-­‐multimeric	  
complexes	  with	  its	  sister	  protein	  DAR1	  and	   in	  vitro	  and	  in	  yeast	  assays	  reveal	  interactions	  
between	  DA1	  and	  the	  transcription	   factor	  TCP15	  and	  the	  growth-­‐regulating	  receptor-­‐like	  
kinase	  TMK4.	  
In	   addition,	   biochemical	   assays	   described	   in	   this	   thesis	   identify	   an	   active	   ubiquitin	  
interacting	   motif	   (UIM)	   in	   the	   N-­‐terminal	   region	   of	   DA1	   and	   an	   ubiquitin-­‐activated	  
metallopeptidase	  in	  its	  C-­‐terminal	  region.	  Further	  studies	  reveal	  that,	  in	  addition	  to	  being	  
activated	  by	   the	  RING	  E3	   ligases	  EOD1/BB	  and	  DA2,	   the	  DA1	  peptidase	   is	  active	   towards	  
both	   EOD1/BB	   and	   DA2.	   In	   vitro	   and	   in	   vivo	   studies	   demonstrate	   that	   DA1	   cleaves	   a	  
peptide	  fragment	  from	  the	  N-­‐terminus	  of	  EOD1	  and	  the	  C-­‐terminus	  of	  DA2.	  	  
Finally,	   this	   thesis	   reports	   two	   genetic	   screens	   carried	   out	   in	   two	   separate	   Arabidopsis	  
mapping	   populations	   in	   order	   to	   identify	   novel	   regulators	   of	   organ	   growth.	   Analyses	   of	  
petal	   and	   seed	   phenotypes	   in	   the	  MAGIC	   RIL-­‐type	   population	   and	   in	   a	   natural	   Swedish	  
population	  identify	  novel	  and	  a	  priori	  candidate	  genes	  for	  further	  characterisation.	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Chapter	  1	  -­‐	  Introduction	  
	  
1.1	  -­‐	  Population	  growth	  and	  food	  production	  
Global	   food	  production	   is	  constantly	  under	  pressure	   to	  keep	  up	  with	  demand	   from	  a	   rapidly	  
growing	  population.	  Over	   the	  course	  of	  human	  history,	  events	   such	  as	   the	  mechanisation	  of	  
farming	   during	   the	   agricultural	   revolution	   of	   the	   17th-­‐18th	   century,	   and	   more	   recently	   the	  
Green	  Revolution	  of	  the	  1960s,	  have	  generated	  huge	  advances	  in	  productivity.	  The	  significant	  
improvements	   in	   irrigation,	   cultivars,	   fertilisers,	   and	   pesticides	   of	   the	   green	   revolution	   have	  
allowed	  agriculture	  to	  sustain	  the	  huge	  population	  increase	  of	  the	  last	  40	  years	  (Mitchell	  and	  
Sheehy,	  2006).	  However,	  despite	   these	  advances,	   yield	   increases	  of	   key	   crops	  –	   such	  as	   rice	  
and	  wheat–	  have	  begun	  to	  plateau	  (Cassman,	  1999),	  with	  yield	  potentials	  (the	  yield	  achieved	  
under	   optimal	   conditions,	   free	   of	   pathogens	   and	   pests)	   failing	   to	   improve	   over	   the	   past	   30	  
years	  (Mitchell	  and	  Sheehy,	  2006).	  The	  stagnation	  of	  the	  yield-­‐potential	  increase	  suggests	  that	  
increasing	  crop	  productivity	  is	  paramount	  if	  the	  projected	  population	  growth	  is	  to	  be	  sustained.	  
For	  key	   food	  crops	   such	  as	  wheat,	   rice	  and	  maize,	  and	  potential	   fuel	   crops	   such	  as	  oilseeds,	  
where	  the	  seed	  constitutes	  the	  harvestable	  yield,	   the	  engineering	  of	   increased	  seed	  size	  and	  
seed	  number	  has	  significant	  potential	  benefits	  for	  food	  production	  and	  food	  security.	  
1.2	  –	  Organ	  formation	  in	  plants	  
1.2.1	  –	  Plant	  organs	  display	  determinate	  growth	  characteristics	  
Unlike	  animals,	  plants	  are	  unable	  to	  change	  location	  in	  response	  to	  environmental	  fluctuations	  
and	   as	   a	   consequence	   have	   evolved	   a	   high	   degree	   of	   developmental	   plasticity	   to	  maximise	  
fitness	  in	  different	  environments.	  Despite	  this	  plasticity,	  and	  the	  indeterminate	  nature	  of	  their	  
vegetative	   growth,	   organs	   such	   as	   seeds,	   petals	   and	   leaves	   are	   determinate	   in	   their	  
development.	  That	  is	  to	  say	  that	  they	  have	  a	  pre-­‐determined	  size	  and	  shape.	  This	  is	  shown	  by	  
the	  uniformity	  of	  final	  size	  and	  morphology	  of	  organs	  within	  species,	  compared	  to	  that	  found	  
between	  species	  and	  between	  different	  varieties.	  In	  animal	  systems,	  organ	  development	  is	  also	  
determinate	  and	  although	  growth	  of	  simple	  organs,	  such	  as	  the	  Drosophila	  early	  embryo,	  can	  
be	   regulated	   by	   cell-­‐counting	  mechanisms	   (Edgar	   et	   al.,	   1994),	   complex	   organs	   such	   as	   the	  
Drosophila	  wing	  are	  thought	  to	  be	  regulated	  by	  	  ‘size	  checkpoints’	  that	  detect	  total	  organ	  size	  
rather	  than	  cell	  number	  (Dong	  et	  al.,	  2007).	  Current	  theories	  to	  explain	  how	  this	  determinate	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development	   is	   achieved	   will	   be	   discussed	   in	   detail	   in	   section	   1.5;	   however	   the	   following	  
sections	  will	  focus	  on	  the	  developmental	  processes	  that	  underpin	  organ	  growth.	  
It	   is	   important	   to	   note	   that,	   despite	   considerable	   similarities,	   the	   developmental	   processes	  
governing	  the	  growth	  of	  petals	  and	  leaves	  differ	  markedly	  from	  that	  of	  seeds.	  Therefore,	  in	  the	  
interest	   of	   clarity	   the	   bulk	   of	   general	   discussion	   of	   ‘organ	   development’	   in	   this	   section	   will	  
refer	   to	   that	   of	   petals	   and	   leaves,	   and	   a	   separate	   section	   (section	   1.4)	   will	   describe	   seed-­‐
specific	  regulatory	  processes.	  	  
1.2.2	  –	  Organ	  initiation	  and	  identity	  
Shoot	  organs	  are	   initiated	   from	   the	  periphery	  of	   the	   shoot	  apical	  meristem	   (SAM)	   (Fig.	   1.1),	  
and	   the	   cells	   committed	   to	   form	   these	  organ	  primordia	   are	   then	   replenished	  by	   a	   stem	  cell	  
population	  in	  the	  central	  zone	  of	  the	  SAM	  (reviewed	  in	  (Sablowski,	  2011)).	  The	  maintenance	  of	  
this	   stem	  cell	  population	   in	   the	  central	   zone	   is	  promoted	  by	   the	  homeodomain	   transcription	  
factor	  WUSCHEL	   (WUS),	  which	   is	  expressed	   in	   the	   subjacent	  organising	  centre	   (Mayer	  et	  al.,	  
1998).	   WUS	   exists	   in	   a	   regulatory	   negative	   feedback	   loop	   with	   the	   CLAVATA	   1,	   (CLV1),	  
CLAVATA	   2	   (CLV2)	   and	  CLAVATA	   3	   (CLV3),	  which	   acts	   to	   define	   the	   size	   and	   position	   of	   the	  
stem	  cell	  population	   (Schoof	  et	  al.,	  2000,	  Bleckmann	  et	  al.,	  2010).	   In	   this	   loop,	  CLV3,	  a	  small	  
peptide	   ligand	   expressed	   by	   stem	   cells,	   activates	   the	   receptor-­‐proteins	   CLV1,	   CLV2	   and	  
CORYNE	  (CRN),	  which	   in	  turn	  act	   to	  repress	  WUS	  and	  thereby	  repress	  stem-­‐cell	   identity	   (Fig.	  
1.1)	  (Bleckmann	  et	  al.,	  2010,	  Schoof	  et	  al.,	  2000).	  	  
The	  pluripotent	  stem	  cells	  of	  the	  apical	  meristem	  express	  Class	  I	  KNOTTED1-­‐LIKE	  HOMEOBOX	  
(KNOX)	  genes	   including	  SHOOTMERISTEMLESS	   (STM)	   in	  Arabidopsis	  and	  KNOTTED	  1	   (KN1)	   in	  
Maize	  (Jackson	  et	  al.,	  1994,	  Smith	  et	  al.,	  1992,	  Long	  et	  al.,	  1996).	  Non-­‐pluripotent	  cells	  within	  
the	   shoot	   apical	   meristem	   do	   not	   express	   the	   KNOX	   genes	   and	   KNOX	   genes	   are	   therefore	  
considered	  to	  be	  markers,	  and	  possibly	  determinants	  of	  stem	  cell	  identity	  (Jackson	  et	  al.,	  1994,	  
Smith	   et	   al.,	   1992,	   Long	   et	   al.,	   1996).	   Cells	   recruited	   into	   initiating	   organ	   primordia	   have	   a	  
determinate	  fate	  and	  therefore	  stem-­‐cell	  identity	  cues	  are	  repressed	  prior	  to	  organ	  initiation.	  
This	  is	  illustrated	  by	  the	  observation	  that	  leaf	  initiation	  from	  the	  Arabidopsis	  SAM	  is	  promoted	  
by	  the	  repression	  of	  the	  KNOX	  gene	  BREVIPEDICELLUS	  (BP)	  (Hay	  et	  al.,	  2006).	  BP	  expression	  in	  
the	  lateral	  regions	  of	  the	  SAM	  is	  repressed	  by	  auxin	  (Scanlon,	  2003,	  Hay	  et	  al.,	  2006)	  as	  well	  as	  
the	  Arabidopsis	  MYB	  transcription	  factor	  ASYMMETRIC	  LEAF	  1	  (AS1)	  and	  the	  LATERAL	  ORGAN	  
BOUNDARIES	  family	  member	  ASYMMETRIC	  LEAVES	  2	  (AS2)	  (Guo	  et	  al.,	  2008,	  Hay	  et	  al.,	  2006).	  
In	  fact,	  the	  exact	  location	  of	  organ	  initiation	  from	  the	  meristem	  can	  be	  defined	  by	  auxin	  levels,	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with	  auxin	  maxima	  observed	  to	  form	  at	  the	  precise	  site	  of	  organ	  primordium	  formation,	  and	  
with	   evidence	   that	   exogenous	   application	   of	   auxin	   is	   sufficient	   to	   promote	   ectopic	   organ	  




















Figure	  1.1	  –	  Leaf	  initiation	  from	  the	  shoot	  apical	  meristem	  
(A)	   A	   stem	   cell	   population	   is	   maintained	   at	   the	   tip	   of	   the	   shoot	   apical	   meristem	   (SAM)	   by	   a	  
feedback	  loop	  between	  WUS	  and	  CLV1,	  CLV2,	  CLV3	  and	  CRN.	  WUS	  is	  expressed	  in	  the	  organising	  
centre	   (brown	   shading)	   and	   promotes	   CLV3	   activity	   in	   the	   stem	   cell	   population	   (grey	   shading),	  
which	  is	  perceived	  by	  CLV1,	  CLV2	  and	  CRN,	  whose	  expression	  domain	  is	  marked	  by	  green	  shading.	  
CLV1,	   CLV2	   and	   CRN	   activity	   represses	   WUS.	   (B)	   Organ	   primordium	   formation	   in	   Arabidopsis.	  
Founder	   cells	   on	   the	   flank	   of	   the	   SAM	   switch	   from	   an	   indeterminate	   growth	   programme	   to	   a	  
determinate	  fate,	  and	  subsequently	  develop	  into	  organ	  primordia.	  (A)	  Adapted	  from	  Sablowski	  et	  




The	   repression	   of	   KNOX	   genes	   in	   cells	   that	   go	   on	   to	   form	   organ	   primordia	   is	   thought	   to	  
represent	  a	  switch	  from	  indeterminate	  to	  determinate	  growth	  programmes	  (Moon	  and	  Hake,	  
2011).	  The	   formation	  and	   initiation	  of	  organ	  primordia	  also	   results	   in	  a	  change	   in	   identity	  of	  
founder	   cells;	   from	   a	   meristem	   identity	   to	   an	   organ-­‐specific	   identity	   (e.g.	   petal,	   sepal,	   leaf	  
precursors).	  For	  example,	  the	  switch	  in	  cell-­‐identity	  that	  occurs	  during	  sepal	  initiation	  results	  in	  
changes	   in	   cell	   proliferation	   rate,	   cell	   volume	   changes,	   heterogeneity	   in	   cell	   volumes,	   and	  
growth	  isotropy	  (Schiessl	  et	  al.,	  2012).	  These	  changes	  are	  in	  part	  mediated	  by	  the	  transcription	  
factor	  JAGGED	  (JAG)	   (Schiessl	  et	  al.,	  2012).	  Whereas	  the	  growth	  of	  wild-­‐type	  sepal	  primordia	  
differs	  from	  that	  of	  the	  meristem	  in	  many	  ways	  (mentioned	  above),	   jag-­‐1	  sepal	  primordia	  do	  
not	   (Schiessl	   et	   al.,	   2012);	   suggesting	   that	   JAG	   is	   required	   for	   the	   timely	   establishment	   of	  
proper	  primordium	  identity	  (and	  therefore	  for	  appropriate	  primordium	  development).	  
Furthermore,	  as	  with	  plant	  growth	  in	  general,	  rather	  than	  being	  controlled	  by	  the	  autonomous	  
allocation	   of	   individual	   cellular	   identities,	   shoot	   organ	   development	   is	   controlled	   by	   the	  
interaction	   of	   different	   regions	   in	   relation	   to	   one	   another.	   This	   is	   highlighted	   by	   the	  
Arabidopsis	  floral-­‐identity	  triple	  mutant	  -­‐	  apetala2	  (ap2)	  apetala3	  (ap3)	  agamous	  (ag),	  which	  
results	  in	  the	  conversion	  of	  floral	  organs	  to	  leaf-­‐like	  organs	  (Bowman	  et	  al.,	  1991).	  The	  absence	  
of	   the	  respective	   floral	   identity	  genes	   in	   these	  plants	   results	   in	  a	   loss	  of	   floral	   identity	   in	   the	  
floral	  organs	  and	  their	  consequent	  reversion	  to	  ‘leaf-­‐like’	  organs	  (Bowman	  et	  al.,	  1991).	  While	  
these	   modified	   floral	   organs	   display	   many	   leaf-­‐like	   characteristics,	   such	   as	   their	   overall	  
morphology,	   they	   remain	   a	   similar	   size	   to	   organs	   of	   the	   perianth	   (Bowman	   et	   al.,	   1991),	  
illustrating	  that	  the	  organ-­‐intrinsic	  leaf-­‐identity	  cues	  that	  result	  in	  a	  canonical	  leaf	  morphology	  
interact	  with	  the	  meristem	  signals	  that	  dictate	  final	  organ	  size.	  	  
1.2.3	  –	  Organ	  polarity	  
Following	  initiation	  from	  the	  meristem,	  leaf	  development	  occurs	  on	  three	  polar	  axes	  (Fig.	  1.2);	  
proximal-­‐distal,	  adaxial-­‐abaxial	  and	  medial-­‐lateral	   (Moon	  and	  Hake,	  2011),	   the	  establishment	  
of	  all	  of	  which	  are	  necessary	  for	  wild-­‐type	  leaf	  form	  and	  function.	  	  
In	  the	  mature	  leaf,	  adaxial	  (dorsal)	  tissues	  are	  often	  distinct	  from	  abaxial	  (ventral)	  tissues,	  and	  
it	  is	  therefore	  important	  for	  adaxial-­‐abaxial	  polarity	  to	  be	  accurately	  defined.	  For	  example,	  the	  
C4	   grass,	   Paspalum	   dilatatum	   has	   a	   greater	   stomatal	   density	   and	   higher	   rates	   of	   CO2	  
assimilation	   in	   its	   abaxial	   surface	   relative	   to	   the	   adaxial	   surface	   (Soares	   et	   al.,	   2008).	  
Maintenance	   of	   adaxial-­‐abaxial	   polarity	   is	   determined	   by	   the	   antagonistic	   interaction	   of	  
adaxially-­‐expressed	  adaxial-­‐identity	  promoting	  genes,	  and	  abaxially-­‐expressed	  abaxial-­‐identity	  
promoting	  genes.	  Adaxial-­‐identity	  promoting	  genes	  include	  AS1,	  AS2	  and	  the	  Class	  III	  HOMEO-­‐
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DOMAIN	  LEUCINE	  ZIPPER	  (HD-­‐ZIPIII)	  family	  (Fu	  et	  al.,	  2007,	  Lin	  et	  al.,	  2003,	  Emery	  et	  al.,	  2003)	  
and	   abaxial-­‐identity	   promoting	   genes	   include	   members	   of	   the	   KANADI	   (KAN)	   (Eshed	   et	   al.,	  
2001,	   Kerstetter	   et	   al.,	   2001)	   and	   YABBY	   (YAB)	   gene	   families	   (Eshed	   et	   al.,	   2004).	   The	  
antagonistic	  interaction	  between	  these	  two	  groups	  of	  genes	  serves	  to	  restrict	  their	  expression	  
to	  their	  respective	  compartments	  and	  thereby	  define	  an	  adaxial-­‐abaxial	  boundary	  (reviewed	  in	  







In	   simple	   leaves	   the	   proximal-­‐distal	   axis	   determines	   the	   blade-­‐petiole	   (in	   dicots)	   and	   blade-­‐
sheath	   (in	  monocots)	   organisation.	   The	   de-­‐repression	   of	   KNOX	   genes	   in	   the	   petioles	   of	   the	  
blade	  on	  petiole	  (bop)	  mutant	  results	  in	  ectopic	  leaf	  blade	  tissue	  developing	  on	  the	  petiole	  (Ha	  
et	  al.,	  2004,	  Norberg	  et	  al.,	  2005).	  While	  KNOX	  genes	  are	  not	  normally	  expressed	  in	  developing	  
simple	  leaves,	  their	  expression	  is	  required	  for	  the	  lobed	  shape	  of	  compound	  leaves	  (Efroni	  et	  
al.,	  2010).	  Indeed	  a	  correlation	  has	  been	  observed	  between	  the	  expression	  of	  KNOX	  genes	  and	  
leaf	  complexity	  in	  such	  plants	  (Bharathan	  et	  al.,	  2002,	  Hareven	  et	  al.,	  1996)	  (reviewed	  in	  Efroni	  
Figure	  1.2	  –	  Organ	  polarity	  in	  the	  leaf	  
A	  schematic	  illustrating	  the	  three	  planes	  of	  polarity	  in	  the	  developing	  organ,	  using	  the	  leaf	  as	  an	  
example.	  The	  proximal-­‐distal	  axis	   runs	  along	   the	   length	  of	   the	   leaf,	   from	  petiole	   to	   leaf	   tip;	   the	  
medial-­‐lateral	   axis	   runs	   perpendicular	   to	   the	   proximal-­‐distal	   axis,	   across	   the	   leaf	   blade;	   the	  
adaxial-­‐abaxial	   axis	   runs	   perpendicular	   to	   both	  medial-­‐lateral	   and	   proximal-­‐distal	   axes,	   through	  




et	   al.,	   2010),	   and	   ectopic	   expression	   of	   maize	   KN1	   has	   been	   shown	   to	   generate	   super-­‐
compound	  leaves	  in	  tomato	  (Hareven	  et	  al.,	  1996).	  
Because	   the	  modifications	   to	   leaf	   shape	   along	   the	  medial-­‐lateral	   axis	   often	  occur	   in	   concert	  
with	  modification	   along	   the	  proximal-­‐distal	   axis,	   it	   is	   perhaps	  more	  useful	   to	   consider	   these	  
axes	  as	  interacting	  elements	  of	  overall	  leaf	  shape.	  Indeed,	  aspect	  ratio	  (length:width)	  has	  been	  
used	  as	  a	  metric	  for	  measuring	  the	  shape	  of	  both	  Arabidopsis	  leaves	  (Kieffer	  et	  al.,	  2011)	  and	  
petals	  (Abraham	  et	  al.,	  2013)	  in	  recent	  publications.	  
While	  aberrations	   in	  adaxial-­‐abaxial	  polarity	  can	  result	   from	  mis-­‐expression	  of	   tissue-­‐identity	  
genes,	  aberrations	   in	  organ	  shape	  result	   from	  the	  mis-­‐regulation	  of	  the	  two	  driving	  forces	  of	  
organ	  growth:	  cell	  proliferation	  and	  cell	  expansion	  (see	  section	  1.3).	  Following	  initiation	  from	  
the	   meristem,	   organ	   growth	   is	   driven	   by	   a	   phase	   of	   cell	   proliferation	   –	   during	   which	   cells	  
mitotically	  divide	  and	  increase	  in	  number	  –	  and	  then	  a	  phase	  of	  cell	  expansion,	  wherein	  cells	  
exit	  mitosis	  and	  increase	  in	  volume	  (described	  in	  detail	  in	  section	  1.3).	  The	  tissue	  specific	  mis-­‐
regulation	  of	  cell	  proliferation	  and	  cell	  expansion	  along	  medial-­‐lateral	  and	  proximal-­‐distal	  axes	  
can	  affect	  overall	  organ	  shape.	  	  
As	  discussed	  in	  detail	  in	  section	  1.3,	  cell	  proliferation	  in	  the	  developing	  organ	  is	  though	  to	  be	  
terminated	   by	   a	   basipetal	   cell-­‐cycle	   arrest	   front,	   which	   causes	   cells	   to	   exit	   mitosis	   and	  
commence	   cell	   expansion	   (Nath	   et	   al.,	   2003).	   Mutants	   in	   the	   Antirrhinum	   TCP	   family	  
transcription	   factor	   CINCINNATA	   (CIN)	  have	   an	   altered	   pattern	   of	   cell-­‐cycle	   arrest,	  whereby,	  
compared	   to	  wild-­‐type	   leaves,	   the	  marginal	   tissue	   grows	   for	   longer	   (Nath	   et	   al.,	   2003).	   This	  
increase	  in	  growth	  in	  the	  leaf	  margins,	  results	  in	  wider	  leaves	  with	  a	  negative	  curvature	  (2003,	  
Nath	  et	  al.,	  2003).	  
Members	  of	  the	  Arabidopsis	  TCP	  family	  of	  transcription	  factors	  have	  also	  been	  shown	  to	  affect	  
leaf	   shape.	  Mutations	   in	   the	  Class	   I	  TCPs,	   TCP14	  and	  TCP15,	   despite	  having	  a	  wild-­‐type	   final	  
leaf	  size,	  have	  been	  shown	  (using	  a	  principal	  component	  analysis)	  to	  have	  significantly	  altered	  
shape	  components	   (Kieffer	  et	  al.,	  2011).	  These	   include	  an	  altered	  aspect	   ratio	  component	  of	  
leaf	   shape;	   revealing	   that	   in	   the	   tcp14/15	  mutants	   there	   is	  a	  mis-­‐regulation	  of	  growth	  along	  
the	  proximal-­‐distal	   axis	   relative	   to	  growth	  along	   the	  medial-­‐lateral	   axis	   (Kieffer	  et	   al.,	   2011).	  
More	   severe	   TCP-­‐related	   leaf-­‐shape	   phenotypes	   can	   be	   seen	   in	   JAW-­‐D	   plants,	   which	   over-­‐
express	   miR319a	   (a	   micro-­‐RNA	   that	   down-­‐regulates	   TCP2,	   TCP3,	   TCP4,	   TCP10,	   and	   TCP24)	  
(Palatnik	   et	   al.,	   2003).	   Leaves	   of	   JAW-­‐D	   plants	   have	   significantly	   altered	   shape,	   with	   a	  










Figure	  1.3	  –	  Growth	  phases	  during	  organ	  development	  
Overlapping	   stages	   of	   cell	   proliferation,	   meristemoid	   division	   and	   cell	   expansion	   shown	   at	   the	  
cellular,	  leaf	  and	  rosette	  level.	  Proliferating	  cells	  are	  represented	  as	  green	  cells,	  post-­‐mitotic	  cells	  
are	   shown	   in	   yellow	   and	   meristemoid	   cells	   are	   shown	   in	   orange.	   In	   the	   early	   stages	   of	   leaf	  
development	  the	  majority	  of	  cells	  are	  mitotically	  active	  and	  proliferate	  rapidly.	  This	  is	  followed	  by	  
mitotic	  arrest	  and	  the	  transition	  from	  cell	  proliferation	  to	  cell	  expansion,	  such	  that	  eventually	  all	  
cells	   are	   in	   the	   expansive	   phase.	   Overlapping	   the	   transition	   from	   cell	   proliferation	   to	   cell	  
expansion	  is	  a	  phase	  of	  prolonged	  meristemoid	  division,	  which	  appears	  to	  persist	  after	  the	  onset	  




1.3	  –	  Organ	  growth	  is	  a	  multi-­‐phase	  process	  
Leaf	  and	  petal	  growth	  can	  be	  generalised	  into	  two	  key	  cellular	  processes	  that	  occur	  in	  phases;	  
an	  initial	  period	  of	  cell	  proliferation,	  followed	  by	  a	  period	  cell	  expansion	  (Fig.	  1.3)	  (Johnson	  and	  
Lenhard,	  2011,	  Horiguchi	  et	  al.,	  2006a,	  Bögre	  et	  al.,	  2008).	  	  Following	  initiation	  from	  the	  SAM,	  
cells	  in	  the	  organ	  primordium	  divide	  during	  a	  period	  of	  cell	  proliferation,	  wherein	  rapid	  mitotic	  
divisions	   result	   in	  an	   increase	   in	   cell	  number	   (Johnson	  and	  Lenhard,	  2011).	  This	  proliferative	  
phase	   of	   growth	   is	   terminated	   by	   a	   basipetal	   front	   of	   cell-­‐cycle	   arrest	   (Nath	   et	   al.,	   2003,	  
Donnelly	  et	  al.,	  1999)	  that	  causes	  cells	  to	  exit	  the	  mitotic	  cell-­‐cycle	  and	  initiate	  a	  phase	  of	  cell	  
expansion	  (Melaragno	  et	  al.,	  1993).	  In	  some	  organs	  –	  such	  as	  leaves	  –	  mitotic	  exit	  is	  concurrent	  
with	  entry	  to	  the	  endocycle	  (see	  Box	  1.2)	  and	  subsequent	  endoreduplication.	  	  
The	  following	  sections	  (1.3.1	  –	  1.3.4)	  describe	  in	  detail	  the	  importance	  of	  organ	  initiation,	  cell	  
proliferation,	  cell	  expansion,	  and	  the	  transitory	  growth	  phase	  in	  establishing	  final	  organ	  size.	  
1.3.1	  –	  Primordial	  formation	  from	  the	  shoot	  apical	  meristem	  	  
Organs	  such	  as	  leaves	  and	  petals	  are	  formed	  from	  primordia	  that	  initiate	  from	  the	  shoot	  SAM	  
(see	   section	  1.2.2).	  When	  cell	  proliferation	   is	  accelerated	   in	   the	  SAM,	   such	  as	   caused	  by	   the	  
overexpression	  of	  Arabidopsis	  CDC27a	  (a	  subunit	  of	  the	  Anaphase	  Promoting	  Complex	  (APC))	  
in	  tobacco,	  the	  L1	  zone	  forms	  with	  a	  larger	  complement	  of	  smaller	  cells	  (Rojas	  et	  al.,	  2009).	  As	  
a	  consequence,	  more	   (smaller)	  cells	  are	  recruited	   into	  the	   initiating	  organ	  primordia	  and	  the	  
resulting	  mature	  leaf	  is	  significantly	   larger	  than	  the	  wild-­‐type	  (Rojas	  et	  al.,	  2009).	   In	  addition,	  
the	  exogenous	  application	  of	  auxin	  (dissolved	  in	  lanolin)	  to	  pin1	  mutant	  SAMs	  has	  been	  shown	  
to	  be	  sufficient	  to	  induce	  ectopic	  organ	  initiation	  (Reinhardt	  et	  al.,	  2003).	  Interestingly,	  larger	  
droplets	  of	  lanolin	  resulted	  in	  the	  initiation	  of	  larger	  organ	  primordia	  from	  the	  SAM	  (Reinhardt	  
et	  al.,	  2003).	  	  
These	  data	   suggest	   that	  an	   increase	   in	   the	  number	  primordium	   founder	   cells	   can	   lead	   to	  an	  
increase	  in	  overall	  organ	  size.	  This	  is	  consistent	  with	  observations	  that	  the	  struwwelpeter	  (swp)	  
mutant	   in	   Arabidopsis,	   has	   reduced	   leaf	   area	   and	   cell	   number	   from	   the	   earliest	   stages	   of	  
development	  (Autran	  et	  al.,	  2002).	  The	  reduction	  in	  final	  leaf	  size	  and	  cell	  number	  is	  therefore	  
possibly	  due	   to	   fewer	   cells	  being	   recruited	   into	   the	   initiating	   leaf	  primordium	   (Autran	  et	   al.,	  
2002).	  	  
In	  addition	  to	  the	  influence	  of	  the	  size	  of	  the	  organ	  primordium,	  the	  rate	  of	  primordia	  initiation	  
may	  also	  have	  an	  impact	  on	  final	  organ	  size.	  This	  has	  been	  observed	  with	  klu	  mutants,	  which	  
show	   an	   interaction	   between	   an	   accelerated	   plastochron	   and	   a	   reduced	   final	   organ	   size	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(Anastasiou	   et	   al.,	   2007),	   as	   well	   as	   in	   rice	   pla1	   (plastochron	   1)	   mutants,	   which	   have	   an	  
increased	  plastochron	  and	  smaller	  leaves	  (Miyoshi	  et	  al.,	  2004).	  
1.3.2	  –	  Cell	  proliferation	  
The	   proliferative	   stage	   of	   organ	   growth	   occurs	   early	   in	   the	   development	   of	   the	   organ	  
(Andriankaja	  et	  al.,	  2012),	  and	   is	  responsible	  for	  determining	  the	  population	  of	  cells	  that	  will	  
enter	   the	  expansive	  phase.	  As	   the	  expansive	  phase	  contributes	   to	   the	  majority	  of	  organ	  size	  
increase,	  the	  rate	  and	  duration	  of	  cell	  proliferation	  in	  young	  organ	  primordia	  can	  significantly	  
influence	  final	  organ	  size.	  The	  rate	  of	  cell	  proliferation	  refers	  to	  the	  average	  number	  of	  mitotic	  
cycles	   per	   unit	   time	   during	   the	   proliferative	   phase;	   with	   an	   elevated	   proliferation	   rate	  
generating	   a	   larger	   population	   of	   cells	   in	   a	   fixed	   time	   interval.	   The	   proliferative	   phase	  
commences	  when	   primordia	   initiate	   from	   the	   SAM	   and	   it	   is	   terminated	  when	   cells	   exit	   the	  
mitotic	  cell	  cycle.	  The	  duration	  of	  cell	  proliferation	  therefore	  refers	  to	  the	  average	  duration	  of	  
mitotic	  activity	  within	  the	  developing	  organ.	  
Many	   genes	   have	   been	   shown	   to	   influence	   cell	   proliferation	   during	   organ	   formation;	   these	  
include	   genes	   that	   affect	   the	   rate	   of	   cell	   proliferation	   as	   well	   as	   genes	   that	   influence	   the	  
duration	   of	   cell	   proliferation	   (reviewed	   in	   (Breuninger	   and	   Lenhard,	   2010)).	   Genes	   that	  
influence	  the	  rate	  of	  cell	  proliferation	  include	  the	  GIF1/2/3	  (GRF-­‐interacting	  factor)	  triplet.	  The	  
gif1/2/3	  triple	  mutant	  has	  a	  reduction	  in	  final	  leaf	  size,	  which	  is	  concurrent	  with	  a	  reduction	  in	  
cell	  number	  (Lee	  et	  al.,	  2009).	  Kinematic	  analysis	  of	  growth	  revealed	  that	  this	  reduction	  in	  cell	  
number	  is	  due	  to	  a	  reduction	  in	  cell-­‐proliferation	  rate	  rather	  than	  a	  temporal	  mis-­‐regulation	  of	  
proliferation	   initiation	  and	  termination	  (Lee	  et	  al.,	  2009).	  Arabidopsis	  GIF	  proteins	  have	  been	  
shown	  to	  directly	  physically	   interact	  with	  the	  GROWTH-­‐REGULATING	  FACTOR	  (GRF)	   family	  of	  
proteins,	  a	  relationship	  that	  is	  thought	  to	  reflect	  the	  fact	  that	  GRFs	  and	  GIFs	  are	  transcriptional	  
coactivators	  (Horiguchi	  et	  al.,	  2005,	  Kim	  et	  al.,	  2003).	  Similarly	  to	  the	  gif1/2/3	  triple	  knockout	  
(Lee	   et	   al.,	   2009),	   the	  grf5	   single	  mutant	   and	   the	  grf1/grf2/grf3	   triple	  mutant	   have	   smaller	  
leaves	  with	  fewer	  cells	  (Horiguchi	  et	  al.,	  2005,	  Kim	  et	  al.,	  2003,	  Kim	  and	  Kende,	  2004).	  Based	  
on	  the	  observed	  interactions	  between	  GRFs	  and	  GIFs	  (Horiguchi	  et	  al.,	  2005,	  Kim	  et	  al.,	  2003,	  
Kim	   and	   Kende,	   2004),	   this	   reduction	   in	   leaf	   size	   is	   expected	   to	   be	   a	   consequence	   of	   a	  
reduction	  in	  the	  rate	  of	  cell	  proliferation	  during	  leaf	  development.	  
A	  similar	  effect	   is	  seen	  with	  sleepy1	   (sly1)	  mutant	  plants,	  which	  are	  defective	   in	  an	  F-­‐BOX	  E3	  
ligase	   subunit	   (see	   section	   1.7.4	   for	   details).	   In	   sly1	   plants,	   leaf	   area	   is	   also	   reduced	   as	  
consequence	  of	  a	  reduction	  in	  cell	  proliferation	  rate	  (McGinnis	  et	  al.,	  2003,	  Achard	  et	  al.,	  2009).	  
The	  molecular	  basis	  of	  this	  phenotype	  is	  discussed	  in	  more	  detail	  in	  section	  1.5.1.	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In	   contrast	   to	   influencing	   the	   rate	   of	   cell	   proliferation,	   three	   genes,	   all	   with	   links	   to	   the	  
ubiquitin	  system,	  have	  been	  shown	  to	  negatively	  influence	  the	  duration	  of	  cell	  proliferation	  (Li	  
et	  al.,	  2008,	  Xia,	  2013,	  Disch	  et	  al.,	  2006).	  Loss	  of	   function	  mutations	   in	  two	  RING	  E3	   ligases,	  
BB/EOD1	   and	  DA2,	   result	   in	   an	   increase	   in	   leaf	   area	  as	   a	   consequence	  of	   an	   increase	   in	   cell	  
number	   (Disch	   et	   al.,	   2006,	   Xia,	   2013).	   Kinematic	   analysis	   of	   leaf	   growth	   in	   these	   mutants	  
reveals	  that	  the	  cell-­‐proliferation	  rate	  is	  not	  increased;	  instead	  the	  duration	  of	  the	  proliferative	  
phase	  of	  organ	  growth	  is	  increased	  (Disch	  et	  al.,	  2006,	  Xia,	  2013).	  E3	  ligases	  are	  involved	  in	  the	  
post-­‐translational	  modification	  of	  substrate	  proteins	  with	  ubiquitin	   (see	  section	  1.7.4),	  which	  
can	  act	  as	  both	  an	  enhancing	  and	  a	   repressive	  signal	   (Mallery	  et	  al.,	  2002,	  Fang	  et	  al.,	  2000,	  
Stevenson	  et	   al.,	   2007).	   It	   is	   possible	   that	  DA2	   and	  EOD1	   repress	   organ	   growth	   through	   the	  
ubiquitin-­‐directed	   proteolysis	   of	   factors	   that	   promote	   cell	   proliferation,	   or	   through	   the	  
ubiquitin-­‐dependent	  activation	  of	  factors	  that	  promote	  cell	  expansion.	  
A	  similar	  phenotype	   is	  also	  seen	  with	  the	  dominant	  negative	  da1-­‐1	  allele	  of	  DA1,	  encoding	  a	  
UIM	   (ubiquitin	   interaction	   motif)-­‐containing	   peptidase.	   da1-­‐1	   plants	   have	   enlarged	   leaves,	  
petals	  and	  seeds	  as	  a	  consequence	  of	  an	  extended	  duration	  of	  cell	  proliferation	  (Li	  et	  al.,	  2008).	  
In	  the	  case	  of	  da1-­‐1,	  cells	  in	  the	  developing	  leaf	  were	  mitotically	  active	  for	  almost	  50%	  longer	  
than	   in	   wild-­‐type	   plants,	   resulting	   in	   a	   increased	   number	   of	   cells	   leading	   into	   the	   phase	   of	  
expansive	  cell	  growth	  (Li	  et	  al.,	  2008).	  	  
Although	   EOD1	   and	   DA2	   do	   not	   genetically	   interact,	   recent	   data	   has	   revealed	   a	   genetic	  
interaction	  between	  DA1	  and	  both	  E3	   ligases;	  EOD1	  and	  DA2	   (Li	  et	  al.,	  2008,	  Xia,	  2013).	  This	  
interaction,	  and	  the	  link	  to	  the	  ubiquitin	  system	  held	  by	  all	  three	  genes,	  presents	  the	  possibility	  
that	  all	  these	  genes	  might	  influence	  cell	  proliferation	  through	  the	  same	  mechanism.	  	  
In	  contrast	  to	  the	  negative	  effect	  on	  the	  duration	  of	  proliferation	  exhibited	  by	  DA1,	  EOD1	  and	  
DA2;	   KLUH	   (KLU)	   –	   a	   cytochrome	   P450	   –	   has	   been	   revealed	   as	   a	   positive	   regulator	   of	   the	  
duration	   of	   cell	   proliferation	   in	   developing	   organs	   (Anastasiou	   et	   al.,	   2007).	   Klu-­‐2	   knockout	  
plants	  display	  reduced	  leaf,	  sepal	  and	  petal	  area	  (Anastasiou	  et	  al.,	  2007),	  and	  a	  reduction	  in	  
final	   seed	   size	   (Adamski	   et	   al.,	   2009).	   The	   reduction	   in	   lateral	   organ	   area	   does	   not	   coincide	  
with	   a	   reduction	   in	   cell	   size	   or	   cell	   proliferation	   rate,	   instead	   cells	   in	   klu-­‐2	   organs	   have	   a	  
reduced	   duration	   of	   cell	   proliferation	   during	   organ	   growth	   (Anastasiou	   et	   al.,	   2007).	  
Interestingly,	   in	   KLU/klu-­‐2	   chimeric	   plants	   KLU	   appears	   to	   function	   non-­‐cell-­‐autonomously;	  
influencing	  the	  development	  of	  neighbouring	  klu-­‐2	  tissues	   in	  chimeric	  organs	  and	  influencing	  
klu-­‐2	   organs	   in	   chimeric	   inflorescences	   (Eriksson	   et	   al.,	   2010).	   These	   observations	   are	  
reminiscent	  of	  data	   from	  the	  study	  of	   the	  developing	  Drosophila	  wing	  disc,	  which	  reveal	   the	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coordinated	   growth	   of	   adjacent	   cell	   populations.	   In	   these	   studies,	   targeted	   inhibition	   of	  
growth	  in	  the	  anterior	  or	  posterior	  territory	  of	  the	  Drosophila	  wing	  disc	  resulted	  in	  a	  non-­‐cell-­‐
autonomous	   reduction	   in	  cell	  proliferation	   in	   the	  adjacent,	  unaffected	   territory	   (Mesquita	  et	  
al.,	  2010).	  This	  coordinated	  reduction	  in	  cell	  proliferation	  across	  the	  entire	  organ	  results	  in	  the	  
formation	  of	  well-­‐proportioned	  wings	  despite	  growth	  inhibition	  in	  only	  one	  territory	  (Mesquita	  
et	   al.,	   2010).	   This	   is	   similar	   to	   the	   coordinated,	   well-­‐proportioned	   morphology	   observed	   in	  
KLU/klu-­‐2	   chimeric	   petals,	   which	   occurs	   despite	   the	   absence	   of	   KLU	   in	   one	   petal	   region	  
(Eriksson	   et	   al.,	   2010).	   These	   data	   suggest	   that	   KLU	   might	   influence	   organ	   growth	   via	   a	  
diffusible	  signal	  molecule	  (Eriksson	  et	  al.,	  2010,	  Kazama	  et	  al.,	  2010);	  this	  is	  discussed	  in	  detail	  
in	  section	  1.5.2.	  
Evidence	   that	   the	  basipetal	  arrest	   front	   (responsible	   for	   triggering	  exit	   from	  the	  proliferative	  
phase)	  persists	  at	  a	  fixed	  distance	  from	  the	  leaf	  blade	  base	  (Kazama	  et	  al.,	  2010)	  suggests	  that,	  
as	  well	   as	   the	   regulation	  of	   rate	   and	  duration	   of	   cell	   proliferation,	   regulation	  of	   the	  area	   of	  
mitotic	   competence	   within	   the	   developing	   leaf	   might	   also	   determine	   final	   organ	   size.	   For	  
example,	  an	  enlarged	  proliferative	  region	  in	  the	  developing	  leaves	  of	  the	  spatula	  (spt)	  mutant	  
is	   thought	   to	   contribute	   to	  an	   increase	   in	   final	   leaf	   size	   (Ichihashi	   et	   al.,	   2010).	   In	   spt	   leaves	  
(deficient	  in	  the	  SPT	  bHLH	  transcription	  factor),	  an	  increase	  in	  cell	  number	  with	  no	  change	  in	  
cell	  size	  suggests	  that	  mis-­‐regulation	  of	  cell	  proliferation	  is	  responsible	  for	  the	  larger	  final	  leaf	  
size	  (Ichihashi	  et	  al.,	  2010).	  The	  fact	  that	  a	  size	  difference	  is	  only	  visible	  five	  days	  after	  sowing	  
(DAS),	  and	  not	  at	  3	  DAS	  (during	  the	  proliferative	  phase),	  suggests	  that	  the	  rate	  of	  proliferation	  
is	   in	   fact	   not	   altered	   (Ichihashi	   et	   al.,	   2010).	   Despite	   the	   lack	   of	   direct	   evidence	   that	   the	  
duration	   of	   proliferation	   is	   unaffected,	   evidence	   that	   the	   proliferative	   region	   of	   the	   leaf	   is	  
larger	   in	   spt	   plants	   supports	   the	   idea	   that	   SPT	   could	   influence	   the	   spatial	   regulation	   of	  
proliferative	   competence	   within	   the	   developing	   leaf.	   Based	   on	   this	   data,	   there	   are	   two	  
potential	  mechanisms	  of	  action	  of	   the	  spt	  mutant.	  Firstly,	  SPT	  could	   influence	  the	  range	  of	  a	  
purported	   diffusible	   growth	   signal,	   thereby	   extending	   the	   influence	   of	   a	   pro-­‐proliferation	  
factor.	  Alternatively,	  it	  could	  adjust	  the	  sensitivity	  of	  all	  cells	  in	  the	  leaf	  to	  such	  a	  growth	  factor,	  
and	   therefore	   alter	   the	   growth	   factor’s	   active	   range	   (a	   more	   detailed	   discussion	   of	   these	  
concepts	  is	  presented	  in	  section	  1.5).	  	  
As	  well	  as	  the	  uniform	  regulation	  of	  cell	  proliferation	  across	  the	  entire	  organ,	  some	  genes	  have	  
been	  revealed	  to	  control	  cell	  proliferation	   in	  a	   tissue-­‐specific	  manner.	  For	  example,	   the	  zinc-­‐
finger	  transcription	  factor,	  JAG,	  which	  has	  narrower	  and	  shorter	  petals	  and	  sepals	   than	  wild-­‐
type	  plants,	  affects	  the	  duration	  of	  cell	  proliferation	  of	  certain,	  specific	  petal	  tissues	  (Dinneny	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et	   al.,	   2004,	   Ohno	   et	   al.,	   2004).	   JAG	   appears	   to	   promote	   petal	   growth	   by	   maintaining	   the	  
mitotic	   competence	   of	   the	   distal	   regions	   of	   the	   petal	   (Dinneny	   et	   al.,	   2004),	   revealing	   a	  
differential	  regulation	  of	  cell	  proliferation	  along	  the	  proximal-­‐distal	  axis.	   In	  a	  similar	  way,	  the	  
Antirrhinum	  CIN	  gene	  appears	  to	  regulate	  the	  duration	  of	  cell	  proliferation	  along	  the	  medial-­‐
lateral	  axis,	  with	  leaf	  margins	  proliferating	  for	  longer	  in	  cin	  mutants	  (2003).	  Leaves	  of	  cin	  plants	  
are	  larger	  than	  the	  wild-­‐type	  and,	  like	  jag	  petals,	  have	  an	  aberrant	  morphology	  (2003,	  Dinneny	  
et	   al.,	   2004,	   Ohno	   et	   al.,	   2004),	   revealing	   a	   role	   for	   tissue-­‐specific	   regulation	   of	   cell	  
proliferation	  in	  the	  patterning	  of	  organs.	  	  	  
Additional	   tissue-­‐specific	   regulation	  of	   cell	  proliferation	   in	   the	  developing	  organ	  can	  be	  seen	  
for	  meristemoid	   cells,	   which	   are	   guard	   cell	   precursors	   (Fig.	   1.3).	  Meristemoid	   cells	   typically	  
undergo	   one	   to	   three	   rounds	   of	   asymmetric	   division	   before	   forming	   the	   guard	  mother	   cell	  
(GMC),	   which	   then	   undergoes	   one	   further	   symmetric	   division	   to	   form	   two	   guard	   cells	  
(Peterson	   et	   al.,	   2010).	   This	  means	   that	   a	   single	  meristemoid	   cell	   can	   generate	   up	   to	   three	  
pavement	   cells	   and	   two	   guard	   cells,	   and	   their	   population	   therefore	   makes	   a	   significant	  
contribution	  to	  overall	  leaf	  size.	  Importantly,	  regulation	  of	  meristemoid	  division	  appears	  to	  be	  
largely	  independent	  of	  the	  mechanisms	  controlling	  pavement	  cell	  proliferation	  (Andriankaja	  et	  
al.,	   2012),	   and	   therefore	   it	   is	   perhaps	   appropriate	   to	   consider	   meristemoid	   division	   as	   a	  
separate	  growth	  phase.	  	  
Only	  one	  example	  of	  the	  mis-­‐regulation	  of	  meristemoid	  cell	  division	  is	  known	  for	  Arabidopsis:	  
PEAPOD	  (PPD).	  The	  ppd	   loss-­‐of-­‐function	  mutant	  has	   increased	  leaf	   lamina	  size	  and	  generates	  
curved	   leaves	   due	   to	   increased	   proliferation	   within	   the	   leaf	   blade	   (White,	   2006).	   However,	  
unlike	   the	  da1-­‐1	  mutant	   or	   the	  gif1/2/3	   triple	  mutant	   (Lee	   et	   al.,	   2009,	   Li	   et	   al.,	   2008),	   the	  
observed	  increase	  in	  proliferation	  is	  not	  a	  consequence	  of	  a	  general	   increase	  in	  proliferation,	  
but	  specifically	  a	  mis-­‐regulation	  of	  meristemoid	  cell	  proliferation.	  
It	  is	  noteworthy	  that	  the	  absence	  of	  meristemoid	  cells	  in	  petals	  makes	  the	  petal	  a	  considerably	  
simpler	  organ	  for	  the	  study	  of	  growth	  and	  development.	  
1.3.3	  –	  Cell	  expansion	  
During	   organ	   growth,	   cell	   expansion	   occurs	   through	   either	   an	   endoreduplication-­‐correlated	  
mechanism,	   or	   an	   endoreduplication-­‐independent	   mechanism.	   	   In	   the	   former	   system,	   cells	  
enter	   a	   modified	   cell-­‐cycle	   called	   the	   endocycle	   (see	   Box	   1.2),	   and	   every	   endocycle	   is	  
accompanied	  by	  a	  concurrent	  increase	  in	  cell	  volume.	  The	  latter	  system	  involves	  cell	  expansion	  
that	  is	  independent	  of	  the	  endocycle,	  and	  is	  primarily	  dependent	  on	  biophysical	  expansion.	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1.3.3.1	  –	  Endoreduplication-­‐correlated	  cell	  expansion	  
Analysis	   of	   cell	   types	   from	  many	   different	   organisms	   -­‐	   from	   endoreduplicated	   plant	   cells	   to	  
multi-­‐nucleate	   somatic	   syncytia	   in	   Caenorhabditis	   elegans	   –	   reveals	   a	   positive	   correlation	  
between	   cell	   size	   and	   ploidy,	   with	   larger	   cells	   having	   an	   increased	   DNA	   content	   (Sugimoto-­‐
Shirasu	   and	   Roberts,	   2003,	   Flemming	   et	   al.,	   2000,	   Nagl,	   1976).	   The	   molecular	   basis	   of	   this	  
correlation	  is	  not	  well	  understood	  (Sugimoto-­‐Shirasu	  and	  Roberts,	  2003),	  however	  it	  is	  possible	  
that	  high	  ploidy	  is	  simply	  a	  requirement	  of	  increased	  cell	  size.	  It	  has	  been	  suggested	  that	  cell	  
division	   is	  a	  consequence	  of	  organ	  growth	  rather	  than	  a	  cause;	   i.e.	  a	  high	  density	  of	  nuclei	   is	  
needed	  to	  provide	  “information”	  (RNA	  and	  proteins)	  over	  suitable	  distances	  to	  the	  developing	  
organ	  (Mizukami,	  2001).	  Based	  on	  this	  logic,	  it	  would	  follow	  that	  endoreduplication	  would	  be	  
necessary	   to	  sustain	   large	  cell	   sizes.	  This	   is	   supported	  by	  observations	   in	  crop	  plants	  such	  as	  
wheat	  and	  sugarcane,	   in	  which	  genome	  duplication	  events	  are	  associated	  with	   increased	  cell	  
size.	  	  
The	  endocycle	   (the	   cell-­‐cycle	   that	  drives	   endoreduplication)	   is	   a	  modified	   cell-­‐cycle	   in	  which	  
DNA	  replication	  is	  un-­‐coupled	  from	  cytokinesis	  (see	  Box	  1.2).	  For	  this	  reason,	  regulation	  of	  cell	  
expansion	   can	   also	   occur	   at	   the	   level	   of	   the	   cell-­‐cycle.	   For	   example,	   a	  mutation	   in	   RPT2a,	   a	  
subunit	  of	  the	  26S	  proteasome	  regulatory	  particle,	  has	  been	  shown	  to	  increase	  final	  leaf	  size	  as	  
a	   result	   of	   increased	   cell	   expansion	   and	   endoreplication	   (Sonoda	   et	   al.,	   2009).	   The	   26S	  
proteasome	   plays	   a	   key	   role	   in	   the	   cell-­‐cycle	   by	   rapidly	   degrading	   cell-­‐cycle	   regulators	   and	  
ensuring	   a	   unidirectional	   progression	   through	   the	   cycle	   (see	   section	   1.6	   for	   a	   detailed	  
discussion	   of	   the	   cell-­‐cycle).	   rpt2a	   mutants	   show	   elevated	   expression	   of	   G1-­‐	   and	   S-­‐phase	  
specific	  factors	  and	  an	  uncoupling	  of	  the	  G2/M	  transition	  (see	  section	  1.6),	  both	  of	  which	  act	  
to	  promote	  endoreplication	  (Sonoda	  et	  al.,	  2009).	  Additional	  genes,	  such	  as	  ARL	  (ARGOS-­‐LIKE)	  
and	   ZINC	   FINGER	   HOMEODOMAIN5	   (ZHD5),	   have	   been	   shown	   to	   increase	   leaf	   size	   by	  
influencing	   cell	   expansion	   (Hu	   et	   al.,	   2006,	   Hong	   et	   al.,	   2011).	   However,	   in	   these	   examples	  
there	  is	  no	  clear	  causative	  link	  to	  the	  mis-­‐regulation	  of	  the	  cell-­‐cycle.	  
1.3.3.1	  –	  Biophysical	  regulation	  of	  cell	  expansion	  
The	   cell	   wall	   of	   plants	   exerts	   major	   constraints	   on	   cell	   expansion,	   and	   emerging	   evidence	  
shows	   that	   there	   is	  a	  complex	   interplay	  between	   the	  constraint	  of	  cell	  expansion	  by	   the	  cell	  
wall,	  and	  genes	  that	  control	  cell	  size.	  	  
A	   striking	   example	   of	   this	   is	   the	   transparent	   testa	   glabra	   2	   (ttg2)	  mutation,	  which	   causes	   a	  
biophysical	  constraint	   in	  one	  tissue	  type	  that	  results	   in	  an	  overall	  reduction	  in	  the	  size	  of	  the	  
entire	   organ	   (Garcia	   et	   al.,	   2005).	   TTG2	   is	   a	   seed-­‐coat	   expressed	   gene	   that	   is	   thought	   to	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influence	   seed	   size	   through	   the	   integument-­‐mediated	   physical	   restriction	   of	   endosperm	  
growth	  (Garcia	  et	  al.,	  2005).	  TTG2	  is	  discussed	  in	  more	  detail	  in	  section	  1.4.	  In	  addition	  to	  this	  
example,	  which	  documents	  the	  physical	  restriction	  of	  whole	  organs,	  there	  are	  also	  examples	  of	  
physical	  constraints	  acting	  on	   individual	  cells.	  These	   forces,	  which	   influence	  cells	  of	   the	  SAM	  
and	  the	  developing	   leaf	  primordium,	  have	  been	  shown	  to	  affect	  both	   leaf	   initiation	  and	  final	  
size.	   In	   tomato,	   the	   exogenous	   application	   of	   expansin	   –	   a	   cell	   wall	   loosening	   protein	  
(Sampedro	  and	  Cosgrove,	  2005)	  –	  to	  the	  SAM	  causes	  ectopic	  primordia	  formation	  (Fleming	  et	  
al.,	  1999,	  Fleming	  et	  al.,	  1997).	  This	  is	  thought	  to	  occur	  through	  the	  loosening	  of	  the	  L1	  layer	  of	  
the	  SAM,	  relaxing	   its	  physical	  constraint	  to	  the	  over-­‐proliferation	  of	  subjacent	  cell	   layers	  and	  
allowing	  de	  novo	  leaf	  primordia	  to	  develop	  (Kessler	  and	  Sinha,	  2004).	  In	  support	  of	  this	  work	  is	  
data	   demonstrating	   that,	   in	   addition	   to	   the	   exogenous	   application	   of	   expansins,	   the	   over-­‐
expression	  of	  EXPANSIN	  10	   (EXP10)	   in	  Arabidopsis	   is	   sufficient	   to	   increase	   leaf	   size	   (Cho	  and	  
Cosgrove,	  2000).	  	  
Work	  has	   also	   revealed	   that	   changes	   in	   the	  methyl-­‐ester	   status	   of	   pectin	   polysaccharides	   in	  
the	  cell	  walls	  of	  the	  SAM	  contributes	  to	  organ	  primordia	  formation	  and	  phyllotaxis	  (Peaucelle	  
et	   al.,	   2008).	   This	   is	   thought	   to	   be	   due	   to	   the	   increased	   tissue	   elasticity	   that	   accompanies	  
demethylesterification	   (Peaucelle	  et	  al.,	  2011),	  and	  supports	  predictions	  that	  elastic	  domains	  
in	  the	  SAM	  form	  mechanical	  signals	  that	  promote	  organ	   initiation	   	   (Kierzkowski	  et	  al.,	  2012).	  
This	   regulatory	   effect	   of	   the	   SAM	   on	   overall	   plant	   growth	   can	   be	   seen	   through	   the	  
manipulation	  of	  the	  SAM	  in	  brassinosteroid	  insensitive1	  (bri1)	  plants,	  which	  exhibit	  a	  dwarfed	  
phenotype	  as	  a	  consequence	  of	  defects	  in	  cell	  expansion	  (Clouse	  et	  al.,	  1996).	  Over-­‐expression	  
of	  BRI1	  in	  the	  L1	  layer	  of	  the	  SAM	  of	  bri1	  plants	  is	  sufficient	  to	  completely	  rescue	  the	  dwarfed	  
phenotype	  (Savaldi-­‐Goldstein	  et	  al.,	  2007).	  In	  addition,	  targeted	  depletion	  of	  brassinosteroids	  
in	  the	  L1	  layer	  of	  wild-­‐type	  plants	  is	  sufficient	  to	  generate	  a	  dwarfed	  phenotype,	  revealing	  that	  
the	  SAM	  epidermis	  is	  able	  to	  both	  promote	  and	  restrict	  plant	  shoot	  growth	  (Savaldi-­‐Goldstein	  
et	  al.,	  2007).	  
Finally,	   there	   is	   also	   evidence	   that	   cortical	  microtubule	   dynamics	   control	   organ	   growth	   and	  
development	  through	  a	  biophysical	  mechanism.	  The	  observation	  that	  the	  long	  and	  narrow	  leaf	  
phenotype	  of	  the	  angustifolia	  (an)	  mutant	  is	  due	  to	  the	  promotion	  of	  cell-­‐expansion	  along	  the	  
apical-­‐basal	  axis,	   and	   that	   this	   is	   concurrent	  with	  altered	  cortical	  microtubule	  arrangements,	  
suggests	   that	   the	  regulation	  of	  microtubules	  at	   the	  cellular	   level	  may	   influence	  overall	  organ	  
size	  (Kim	  et	  al.,	  2002).	  This	  link	  between	  individual	  cell	  growth	  and	  whole-­‐organ	  development	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is	   important,	  as	   it	  demonstrates	   that	  cell-­‐autonomous	  mechanisms	  can	  provide	  considerable	  
control	  of	  overall	  growth	  (see	  section	  1.5).	  
1.3.4.	  –	  The	  transition	  phase:	  controlling	  the	  ‘stock’	  of	  cells	  entering	  expansion	  
For	  organs	  that	  undergo	  endocycle-­‐correlated	  cell	  expansion,	  organ	  growth	  can	  be	  simplified	  
into	  an	  initial	  phase	  of	  cell	  proliferation	  followed	  by	  a	  phase	  of	  endocycle-­‐driven	  cell	  expansion.	  
While	  these	  phases	  may	  overlap	  at	  the	  whole-­‐organ	   level	   (i.e.	  at	  a	  specific	   time	  point	  during	  
organ	   formation	   some	   cells	   will	   be	   cycling	   through	   the	  mitotic	   cell	   cycle	   and	   others	  will	   be	  
cycling	   through	   the	   endocycle),	   individual	   cells	   can	   only	   either	   be	   mitotically	   cycling	   or	  
endocycling.	   As	   a	   consequence,	   cells	   undergo	   a	   decision-­‐making	   process,	   with	   some	   factors	  
influencing	   them	   to	   remain	   proliferating,	   and	  others	   promoting	   the	   switch	   to	   the	   endocycle	  
(see	  section	  1.6	  for	  detailed	  review	  of	  this	  topic).	  	  
Genes	   such	   as	   DA1,	   EOD1,	   DA2,	   and	   KLU	   (Disch	   et	   al.,	   2006,	   Li	   et	   al.,	   2008,	   Xia,	   2013,	  
Anastasiou	  et	  al.,	  2007)	  control	  the	  temporal	  dynamics	  of	  this	  decision	  and	  thereby	  alter	  the	  
timing	  of	  the	  switch	  to	  cell	  expansion.	  DA1	  and	  EOD1	  for	  example,	  both	  promote	  the	  onset	  of	  
cell	  expansion,	  and	  cells	  in	  which	  these	  genes	  are	  absent	  take	  longer	  to	  execute	  the	  decision	  to	  
enter	   the	  expansive	  phase	   (Li	  et	  al.,	  2008,	  Disch	  et	  al.,	  2006).	  Conversely,	  genes	  such	  as	  KLU	  
and	  CYCD3	   appear	   to	   negatively	   regulate	   the	   onset	   of	   cell	   expansion	   (Adamski	   et	   al.,	   2009,	  
Anastasiou	   et	   al.,	   2007,	   Dewitte	   et	   al.,	   2007).	   This	   reveals	   the	   existence	   of	   antagonistic	  
signalling	  pathways,	  which	  possibly	  influence	  cell	  proliferation	  through	  the	  decision-­‐making	  of	  
individual	  cells	  (to	  divide	  or	  to	  expand)	  during	  organ	  growth.	  	  
As	   discussed	   in	   section	   1.3.2,	   the	   Antirrhinum	   CIN	   gene	   is	   also	   thought	   to	   increase	   the	  
sensitivity	  of	  cells	  to	  the	  basipetal	  arrest	  front	  (Nath	  et	  al.,	  2003).	  However	  in	  this	  example,	  the	  
effect	  is	  enhanced	  only	  in	  the	  leaf	  margins	  where	  CIN	   is	  most	  strongly	  expressed	  (Nath	  et	  al.,	  
2003),	   further	   highlighting	   the	   importance	   of	   cell-­‐autonomous	   factors	   during	   the	   transition	  
phase.	  
Conversely,	   genes	   such	   as	   SPT	   regulate	   the	   spatial	   dynamics	   of	   the	   transition	   from	   cell	  
proliferation	  to	  cell	  expansion;	   influencing	  the	  distance	  of	  the	  arrest	  front	  from	  the	  leaf	  base	  
during	  the	  arrest	  front	  pausing	  phase	  (Ichihashi	  et	  al.,	  2010,	  Andriankaja	  et	  al.,	  2012,	  Kazama	  
et	  al.,	  2010).	  The	   re-­‐location	  of	   the	  arrest	   front	   in	   the	  spt	  mutant	   could	  be	  due	   to	  either	  an	  
extension	   of	   the	   field	   of	   a	  mobile	   growth	   signal	   (see	   section	   1.5.2	   for	   a	   discussion),	   or	   the	  
increased	   sensitivity	   of	   leaf	   cells	   to	   this	   signal.	   In	   both	   models,	   the	   balance	   of	   factors	  
influencing	   proliferation	   and	   expansion	   would	   be	   influenced	   in	   the	   direction	   of	   cell	  
proliferation	  (along	  the	  apical-­‐basal	  axis),	  and	  thus	  result	  in	  an	  enlarged	  proliferative	  region.	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Typically,	   genes	   such	   as	  DA1	   and	  EOD1	   (Li	   et	   al.,	   2008,	  Disch	   et	   al.,	   2006)	   –	  whose	  mutants	  
result	   in	   enlarged	   organs	   –	   are	   considered	   to	   be	  negative	   regulators	   of	   the	   duration	   of	   cell	  
proliferation.	  However	  as	  this	  section	  highlights,	  ultimately,	  it	  is	  the	  molecular	  decision-­‐making	  
of	  individual	  cells	  that	  will	  determine	  final	  organ	  size	  and	  therefore	  it	  is	  perhaps	  more	  accurate	  
to	  consider	  these	  genes	  as	  promoters	  of	  the	  transition	  to	  expansion,	   thereby	  considering	  the	  








1.4	  –	  Seed	  growth	  
Seed	  development	  requires	  the	  integration	  of	  three	  genetically	  distinct	  tissues,	  all	  of	  which	  are	  
not	   found	   in	   other	   aerial	   organs	   (Fig.	   1.4).	   All	   angiosperms	   undergo	   double	   fertilisation,	  
whereby	   two	  sperm	  cells	  enter	   the	  embryo	   sac,	  with	  one	   fertilising	   the	  haploid	  egg	  cell	   and	  
one	   fertilising	   the	  homodiploid	   central	   cell	   (Berger	   et	   al.,	   2008).	   This	   results	   in	   the	   fertilised	  
seed	  consisting	  of	   three	  genetically	  distinct	   components	   (see	  Box	  1.1);	   the	  embryo	   (2N),	   the	  
endosperm	   (3N)	   and	   the	   seed	   coat	   -­‐	   derived	   from	   the	  ovule	   integuments	   (2N).	  Due	   to	   their	  
intricate	   inter-­‐dependence,	   the	  growth	  of	  all	   three	   tissues	   is	   tightly	   coordinated	  during	   seed	  
Figure	  1.4	  –	  The	  mature	  Arabidopsis	  female	  gametophyte	  and	  the	  developing	  seed	  
(A)	  The	  embryo	  sac	  contains	  one	  homodiploid	  central	  cell,	  one	  haploid	  egg	  cell,	  and	  two	  haploid	  
synergid	   cells.	   (B,C)	   The	   Arabidopsis	   gametophyte	   prior	   to	   fertilisation	   (B)	   and	   the	   developing	  
seed	   (C).	  Maternal	   tissues	   are	   labelled	   in	   gold,	   diploid	   zygotic	   tissues	   are	   labelled	   in	   green	   and	  
triploid	   zygotic	   tissues	   in	   yellow.	   Before	   and	   after	   fertilisation	   the	  maternal	   sporophytic	   tissue	  
(either	   the	   integuments	   (B)	   or	   the	   seed	   coat	   (C))	   is	   intimately	   associated	   with	   the	  
gametophytically	  derived	   tissue	  of	   the	   central	   cell	   and	  egg	   cell,	  which	  becomes	   the	  endosperm	  




development.	   For	   example,	   the	   developing	   embryo	   relies	   on	   the	   provision	   of	   nutrients	   and	  
support	  from	  the	  endosperm	  (Hirner	  et	  al.,	  1998,	  Lopes	  and	  Larkins,	  1993),	  and	  the	  endosperm	  
in	   turn	   depends	   on	   the	   accurate	   development	   of,	   and	   nutrient	   flow	   from	   the	   integuments	  
(Garcia	  et	  al.,	  2005,	  Lopes	  and	  Larkins,	  1993).	  This	   interdependence	  can	  be	  seen	  through	  the	  
highly	  complex	  developmental	  regulation	  in	  the	  seed,	  whereby	  changes	  in	  an	  individual	  tissue	  
can	  have	  pleiotropic	  effects	  on	  the	  other	  tissues,	  as	  well	  as	  on	  seed	  size	  in	  general.	  	  
	  
	  	  	  
	  
Maternal	  regulation	  of	  seed	  development	  can	  occur	  in	  different	  ways.	  One	  such	  mechanism	  is	  
the	   maternal	   regulation	   of	   seed	   nutrition,	   which	   occurs	   through	   the	   chalazal	   tissue.	  
Impairment	   to	   this	   tissue	   (the	   site	   of	   nutrient	   transport)	   in	   the	   Seg	   1,	   3,	   6,	   and	   7	   barley	  
mutants	  has	  been	  shown	  to	  significantly	  reduce	  overall	  seed	  size	  (Felker	  et	  al.,	  1985).	  Maternal	  
regulation	  of	   seed	  development	   can	  also	  occur	  via	   the	   integuments,	   as	   illustrated	  by	   ttg2;	   a	  
mutation	   in	   an	   integument-­‐expressed	   proanthocyanin	   synthesis	   gene.	   ttg2	   plants	   produce	  
smaller	   and	   rounder	   seeds	   as	   a	   direct	   consequence	   of	   reduced	   cell	   elongation	   in	   the	  
integuments	   (Garcia	   et	   al.,	   2005).	   In	   these	   seeds,	   through	   either	   biophysical	   constraint,	   or	  
through	  proanthocyanin-­‐mediated	  poisoning	  of	   the	  endosperm,	   the	   ttg2	   integuments	   act	   to	  
restrict	  endosperm	  growth,	  thereby	  reducing	  final	  seed	  size	  (Garcia	  et	  al.,	  2005).	  	  Furthermore,	  
and	  highlighting	  the	  intricate	  relationship	  between	  all	  genetic	  compartments	  within	  the	  seed,	  
this	  reduction	  in	  endosperm	  restricts	  embryo	  growth	  (Garcia	  et	  al.,	  2005).	  	  
BOX	  1.1	  –	  Genetic	  composition	  of	  the	  seed	  
Sporophyte	  and	  gametophyte	  
The	  Arabidopsis	  female	  gametophyte;	  the	  embryo	  sac,	  contains	  two	  synergid	  cells,	  one	  haploid	  egg	  cell,	  and	  
a	  homodiploid	  central	  cell.	  It	  exists	  in	  intimate	  contact	  with	  the	  sporophytic	  tissue	  of	  the	  seed	  coat,	  which	  is	  
derived	  from	  the	  maternal	  ovule	  integuments	  (Chaudhury	  et	  al.,	  1998).	  
Maternal	  and	  zygotic	  
The	   partition	   between	  maternal	   and	   zygotic	   tissue	   is	   not	   as	   distinctive	   as	   the	   sporophyte	   –	   gametophyte	  
split.	  Zygotic	  tissue	  is	  that	  derived	  from	  the	  fertilised	  egg	  cell;	  the	  embryo	  (2N),	  and	  from	  the	  fertilised	  central	  
cell;	  the	  endosperm(3N)	  (Berger	  et	  al.,	  2008).	  The	  only	  true	  maternal	  tissue	  is	  the	  sporophytic	  tissue	  of	  the	  
seed	   coat	   (2N),	   however,	   maternal	   gametophytic	   regulation	   also	   exists.	   This	   is	   from	  maternally	   inherited	  
alleles	  that	  act	  through	  the	  gametophytic	  tissue,	  even	  after	  the	  fertilisation	  events	  (Grossniklaus	  et	  al.,	  2001).	  




Conversely,	   gametophytic	   regulation	   of	   sporophytic	   tissues	   can	   also	   occur.	   Autonomous	  
endosperm	  proliferation	  in	  the	  gametophytic	  multicopy	  suppressor	  of	  ira	  (msi1)	  mutant,	  leads	  
to	  the	  enlargement	  and	  partial	  differentiation	  of	  the	  integuments	  (Ingouff	  et	  al.,	  2006).	  It	  is	  not	  
clear	  whether	  this	  gametophytic	  effect	  on	  integument	  development	  is	  of	  a	  biophysical	  nature	  
or	   due	   to	   cross	   talk	   between	   the	   two	   compartments,	   however	   it	   clearly	   shows	   that	   the	  
development	   of	   the	   endosperm	   and	   the	   integuments	   are	   intricately	   linked.	   One	   further	  
example	  is	  the	  sporophytic	  recessive	  haiku	  (iku)	  mutation	  (Garcia	  et	  al.,	  2003),	  which,	  like	  msi1,	  
reduces	  integument	  development	  through	  a	  reduction	  in	  endosperm	  growth.	  However,	  unlike	  
the	  msi1	   allele,	   the	   iku	   allele	   is	   zygotically	   expressed.	   This	   demonstrates	   that	  partitioning	  of	  
the	  developing	  seed	  into	  the	  gametophyte	  and	  the	  sporophyte,	  or	  maternal	  and	  zygotic	  tissue,	  
is	   probably	   not	   sufficient	   to	   understand	   the	   complexities,	   coordination,	   and	   compartmental	  
cross-­‐talk	  involved	  in	  seed	  development.	  	  
1.5	  –	  Coordinating	  cell	  division	  and	  expansion	  during	  organ	  growth	  
1.5.1	  –	  Hormonal	  regulation	  of	  organ	  growth	  
Auxin,	  brassinosteroids,	  gibberellic	  acid	  and	  cytokinins	  are	  long-­‐range	  signalling	  molecules	  that	  
have	  widespread	  effects	  in	  plant	  development	  and	  play	  a	  key	  role	  in	  regulating	  organ	  growth	  
(Johnson	   and	   Lenhard,	   2011).	   As	   small	   signalling	   molecules,	   they	   have	   the	   potential	   to	  
coordinate	  the	  activities	  of	  large	  populations	  of	  cells	  throughout	  the	  developing	  plant,	  and	  as	  a	  
consequence	   aberrations	   in	   synthesis,	   perception	   and	   degradation	   of	   phytohormones	   often	  
results	  in	  systemic	  phenotypes.	  	  	  
Auxins	  have	  been	   shown	   to	   influence	  both	   cell	   expansion	  and	   cell	   proliferation	   (Chen	  et	   al.,	  
2001),	   and	   to	   be	   involved	   in	   regulating	   many	   developmental	   processes,	   including	   embryo	  
development,	   organ	   initiation,	   leaf	   vascular	   development	   and	   patterning,	   and	   root	   growth	  
(reviewed	   in	  Teale	  et	  al	  2006).	  Auxins	  appear	   to	   influence	   leaf	  expansion	  via	   changes	   to	   the	  
cell	  wall	   and	   the	  plasma	  membrane	   (Overvoorde	  et	   al.,	   2005,	   Teale	  et	   al.,	   2006),	   suggesting	  
that	   auxin-­‐dependent	   cell	   expansion	   changes	  are	  due	   to	  biophysical	   effects.	  Auxin-­‐mediated	  
regulation	  of	   cell	   proliferation,	   however,	   is	   less	  well	   understood,	   although	   there	   is	   evidence	  
that	   auxin	   regulates	   the	  expression	  of	   several	   cell-­‐cycle	   genes	   (reviewed	   in	   (Vanneste	  et	   al.,	  
2005)).	  
The	   effect	   of	   auxin	   on	   cell	   expansion	   in	   leaves	   can	   be	   seen	   by	   over-­‐expressing	   Arabidopsis	  
AUXIN	  BINDING	  PROTEIN1	  (ABP1)	  in	  tobacco.	  Over-­‐expression	  of	  ABP1	  is	  sufficient	  to	  promote	  
cell	   expansion,	   and	   generates	   leaves	   with	   larger	   cells	   (Jones	   et	   al.,	   1998).	   In	   addition,	   the	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auxin-­‐inducible	   gene,	   ARGOS	   has	   been	   revealed	   as	   a	   negative	   regulator	   of	   organ	   growth.	  
Unlike	  for	  ABP1,	  ARGOS	  over-­‐expression	  primarily	  affects	  cell	  number;	  generating	  larger	  leaves	  
with	   more	   cells	   (Hu	   et	   al.,	   2003).	   This	   suggests	   that	   ARGOS	   promotes	   either	   the	   rate	   or	  
duration	   of	   cell	   proliferation	   in	   developing	   organs.	   Interestingly	  ARGOS	   appears	   to	   function	  
upstream	  of	  ANT	   and	  CYCD3,	   and	   its	   over-­‐expression	   results	   in	   the	   prolonged	   expression	  of	  
ANT	  and	  CYCD3	  (Hu	  et	  al.,	  2003).	  The	  role	  of	  CYCD3	  in	  the	  maintenance	  of	  the	  mitotic	  cell	  cycle	  
(Dewitte	   et	   al.,	   2007)	   suggests	   that	   perhaps	  ARGOS	   influences	   organ	   growth	   via	   the	   auxin-­‐
dependent	  promotion	  of	  the	  duration	  of	  cell	  proliferation.	  
A	   related	   gene,	   ARGOS-­‐LIKE	   (ARL)	   also	   affects	   organ	   growth,	   but	   in	   response	   to	  
brassinosteroids.	   ARL	   is	   up-­‐regulated	   by	   brassinosteroids,	   and	   demonstrates	   a	   role	   for	  
brassinosteroids	   in	   the	   setting	   of	   final	   organ	   size.	   Over-­‐expression	   of	   ARL	   results	   in	   larger	  
leaves	   and	   cotyledons,	   a	   phenotype	   that	   is	   largely	   due	   to	   an	   increase	   in	   cell	   size;	   indicating	  
that	  ARL	  promotes	   cell	   expansion	   in	   the	   developing	   leaf	   (Hu	   et	   al.,	   2006).	   	   Brassinosteroids	  
have	   also	   been	   shown	   to	   affect	   organ	   development	   as	   part	   of	   systemic	   changes	   to	   cell	  
expansion	   rates.	   The	   bri	   (brassinosteroid	   insensitive1)	   and	   the	   dwf4	   (dwarf4)	   mutants	   have	  
severe	   dwarfed	   phenotypes	   with	   smaller	   leaves,	   that	   are	   thicker	   and	   curled	   in	   bri1	   plants	  
(Clouse	   et	   al.,	   1996,	   Azpiroz	   et	   al.,	   1998).	   Both	   BRI1	   and	  DWF4	   reduce	   organ	   size	   through	  
reduced	  cell	  expansion	  rates,	  an	  effect	  that	  can	  be	  reversed	  in	  bri1	  plants	  by	  expressing	  wild-­‐
type	   BRI1	   in	   the	   L1	   layer	   of	   the	   SAM	   (Savaldi-­‐Goldstein	   et	   al.,	   2007),	   which	   suggests	   that	  
brassinosteroids	  might	   regulate	  organ	  size	  exclusively	   through	  altered	  expansion	  rates	   in	   the	  
SAM.	  
Much	  like	  in	  the	  case	  of	  auxin,	  cytokinins	  influence	  a	  wide	  variety	  of	  plant	  responses	  including	  
the	   pathogen	   response,	   apical	   dominance,	   organ	   development	   and	   vascular	   development	  
(reviewed	  in	  Choi	  and	  Hwang	  (2007)).	  The	  effect	  of	  cytokinins	  on	  organ	  growth	  can	  be	  seen	  in	  
the	  ahk2/ahk3/ahk4	  mutant,	  which	  is	  defective	  for	  three	  cytokinin	  receptors.	  This	  mutant	  has	  
fewer	   leaves,	  which	  are	  smaller	  than	  wild-­‐type	   leaves	  due	  to	  a	  reduction	   in	  cell	  number	  (cell	  
area	   is	   the	   same	   as	   the	   wild-­‐type),	   indicating	   that	   cytokinins	   promote	   leaf	   growth	   via	   an	  
increase	  in	  cell	  proliferation	  (Higuchi	  et	  al.,	  2004,	  Nishimura	  et	  al.,	  2004).	  This	  is	  supported	  by	  
the	  observation	   that	  disruption	  of	  cytokinin	  metabolism	  has	  also	  been	  shown	  to	  affect	  petal	  
growth.	   Knock-­‐down	   of	   two	   cytokinin	   oxidase/dehydrogenase	   (CKX)	   genes,	   CKX3	   and	   CHX5	  
(responsible	   for	   catalysing	   the	  degradation	  of	   cytokinins)	   results	   in	   an	   increase	   in	  petal	   area	  
(Bartrina	  et	  al.,	  2011).	  The	  increase	  in	  petal	  area	  is	  a	  consequence	  of	  an	  increased	  number	  of	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wild-­‐type	  sized	  cells,	  revealing	  that	  the	  large	  organ	  phenotype	  is	  achieved	  through	  promotion	  
of	  cell	  proliferation	  in	  the	  developing	  petal	  (Bartrina	  et	  al.,	  2011).	  	  
The	   role	   of	   gibberellins	   in	   organ	   growth	   and	   development	   was	   revealed	   through	   the	  
identification	  of	  the	  DELLA	  proteins	  (Koornneef	  and	  Van	  der	  Veen,	  1980),	  which	  are	  negative	  
regulators	  of	  gibberellin-­‐dependent	  growth	  promotion	  (Hauvermale	  et	  al.,	  2012,	  Davière	  and	  
Achard,	  2013,	  Dixit,	  2013).	  DELLA	  knockout	  mutations	  increase	  leaf	  area	  through	  an	  increase	  in	  
cell	  number,	  which	  is	  a	  consequence	  of	  elevated	  cell	  expansion	  and	  proliferation	  rates	  (Achard	  
et	  al.,	  2009).	  As	  with	  brassinosteroids,	  constitutively	  desensitising	  plants	  to	  gibberellins	  results	  
in	   a	   systemic	   dwarf	   phenotype	   (Peng	   et	   al.,	   1997).	   DELLAs	   are	   destabilised	   by	   ubiquitin-­‐
directed,	   proteasome-­‐mediated	   degradation	   (Alvey	   and	   Harberd,	   2005),	   and	   knockdown	   of	  
SLY1,	  an	  F-­‐BOX	  subunit	  of	  the	  SCF	  E3	  ubiquitin	  ligase	  (McGinnis	  et	  al.,	  2003)	  (see	  section	  1.7.4	  
and	  5.1.1)	  leads	  to	  a	  reduced	  leaf	  area	  as	  a	  result	  of	  decreased	  cell	  proliferation	  (Achard	  et	  al.,	  
2009).	   Interestingly,	   gibberellins	   have	   also	   been	   shown	   to	   affect	   cell	   expansion,	   with	  
overexpression	   of	   the	   gibberellin	   biosynthetic	   gene,	   GIBBERELLIN	   20-­‐OXIDASE1	   (GA20OX)	  
increasing	  leaf	  area	  through	  increased	  cell	  size	  and	  cell	  number	  (Gonzalez	  et	  al.,	  2010).	  
Abscisic	   acid	   (ABA)	   is	   less	   well	   characterised	   as	   a	   regulator	   of	   growth	   and	   development,	  
however	  there	  is	  evidence	  that	  it	  might	  regulate	  organ	  growth	  through	  DA1	  and	  DAR1	  (Li	  et	  al.,	  
2008).	  DA1	  expression	  is	  induced	  by	  ABA	  and	  da1-­‐1	  seedlings	  are	  partially	  insensitive	  to	  ABA-­‐
inhibition,	  indicating	  that	  ABA	  might	  be	  involved	  in	  regulating	  the	  duration	  of	  cell	  proliferation	  
in	  the	  developing	  organ	  (Li	  et	  al.,	  2008).	  
1.5.2	  –	  Evidence	  for	  additional	  long-­‐range	  growth	  factors	  in	  organ	  development	  
The	   type	   of	   spatial	   coordination	   revealed	   by	   the	   compensation	   mechanism	   (described	   in	  
section	  1.5.3)	  may	  be	  due	  to	  a	  diffusible,	  threshold-­‐dependent,	  long-­‐range	  growth-­‐signal	  such	  
as	   Drosophila	  WINGLESS	   (WG),	   which	   is	   involved	   in	   coordinating	  Drosophila	   embryogenesis	  
(Zecca	  et	  al.,	  1996).	  In	  this	  system,	  a	  gradient	  of	  WG	  accumulates	  in	  cells	  surrounding	  the	  WG-­‐
expressing	   cells,	   and	   cells	   in	   this	   field	   respond	   quantitatively;	   resulting	   in	   the	   differential	  
expression	   of	   additional	   growth	   factors	   (Zecca	   et	   al.,	   1996).	   Interestingly,	   the	   study	   of	   a	  
cytochrome	   p450	   enzyme	   encoded	   by	   the	   KLU	   gene	   has	   provided	   evidence	   for	   a	   similar	  
diffusible	  signal	  in	  the	  regulation	  of	  Arabidopsis	  floral	  development.	  At	  the	  single	  organ	  level	  –	  
in	  the	  regulation	  of	  petals	  –	  KLU	   functions	  in	  a	  non-­‐cell	  autonomous	  manner	  (Adamski	  et	  al.,	  
2009,	  Anastasiou	  et	   al.,	   2007);	  with	   the	  KLU	  genotype	  able	   to	   influence	   the	  development	  of	  
adjacent	  klu-­‐2	  tissues.	  Further	  work	  with	  KLU/klu-­‐2	  chimeric	   inflorescences	  has	  revealed	  that	  
KLU	   has	   an	   effect	   beyond	   individual	   flowers	   and	   can	   influence	   the	   development	   of	   klu-­‐2	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flowers	  in	  the	  same	  inflorescence	  (Eriksson	  et	  al.,	  2010).	  KLU	  cytochrome	  P450	  is	  a	  member	  of	  
a	   large	   superfamily	   of	   genes	   involved	   the	   oxidation	   of	   many	   diverse	   substrates	   including	  
steroids	  and	  fatty	  acids	  (Pinot	  and	  Beisson,	  2011);	  suggesting	  that	  KLU	  may	  be	  involved	  in	  the	  
synthesis	   or	   modification	   of	   a	   lipid	   or	   steroidal	   signal	   molecule.	   Indeed,	   in	   animal	   systems	  
cytochrome	   P450s	   are	   involved	   in	   the	  modification	   of	   retinoic	   acid	   (vitamin	   A),	   which	   is	   an	  
important	  morphogen	  during	  vertebrate	  embryonic	  development	   (Nebert	  and	  Russell,	  2002).	  
Taken	  together,	  these	  data	  suggest	  that	  targets	  of	  KLU	  may	  be	  diffusible	  signalling	  molecules	  
involved	  in	  the	  coordination	  of	  cell	  proliferation	  in	  lateral	  organ	  growth.	  There	  is	  strong	  data	  to	  
support	  the	  role	  of	  a	  KLU-­‐dependent	  signal	  in	  the	  long	  distance	  coordination	  of	  organ	  growth	  
(Adamski	   et	   al.,	   2009,	   Anastasiou	   et	   al.,	   2007,	   Eriksson	   et	   al.,	   2010),	   however	   there	   is	   little	  
direct	  evidence	  that	  a	  similar	  diffusible	  signal	  is	  responsible	  for	  coordinating	  the	  arrest	  front	  in	  
developing	  organs	  (see	  section	  1.5.5).	  	  
1.5.3	  –	  A	  compensation	  mechanism	  regulates	  final	  organ	  size	  
Sections	   1.3.1	   and	   1.3.2	   describe	   genes	   that	  mis-­‐regulate	   cell	   proliferation	   or	   cell-­‐expansion	  
and	  in	  doing	  so	  alter	  final	  organ	  size.	  Interestingly,	  there	  are	  also	  genes	  that	  mis-­‐regulate	  cell	  
proliferation	  and	  cell	  expansion	  without	  influencing	  overall	  organ	  size.	  These	  genes	  reveal	  the	  
phenomenon	  of	  compensation,	  which	  is	  the	  ability	  of	  the	  developing	  organ	  to	  compensate	  for	  
fluctuations	   in	   cell	   number	  with	   changes	   cell	   size	   (and	  vice	   versa);	   such	   that	   final	   organ	   size	  
remains	  constant.	  For	  example,	  as	  discussed	   in	  section	  1.3.2	  and	   in	  a	   similar	   fashion	   to	  KLU,	  
CYCLIND3;1-­‐3	  are	  thought	  to	  positively	  regulate	  the	  duration	  of	  cell	  proliferation	  in	  developing	  
organs	   (Dewitte	  et	  al.,	  2007).	  However,	  whereas	   the	  reduction	   in	  cell	  number	   in	  klu-­‐2	  petals	  
results	   in	  an	  over-­‐all	   reduction	   in	  petal	  size,	   the	  reduction	   in	  cell	  number	   in	  cycd3;1-­‐3	   leaves	  
does	  not	  affect	  leaf	  area	  (Dewitte	  et	  al.,	  2007).	  This	  is	  due	  to	  a	  compensatory	  increase	  in	  cell	  
expansion	   in	   cycd3;1-­‐3	   leaves	   that	   results	   in	   cells	   that	   are	   considerably	   larger	   that	   the	  wild	  
type	  (Dewitte	  et	  al.,	  2007).	  A	  similar	  compensatory	  effect	  can	  be	  seen	  when	  Arabidopsis	  AUXIN	  
BINDING-­‐PROTEIN	  1(ABP1)	  –	   involved	  in	  the	  promotion	  of	  auxin-­‐mediated	  cell-­‐expansion	  –	  is	  
over-­‐expressed	   in	   tobacco	   (Jones	   et	   al.,	   1998).	   In	   this	   case,	   despite	   an	   increase	   in	   cell	   area,	  
there	  is	  an	  apparent	  reduction	  in	  cell	  number	  that	  causes	  the	  leaves	  to	  remain	  morphologically	  
identical	   to	   the	   wild-­‐type	   (Jones	   et	   al.,	   1998).	   This	   compensation	   effect	   suggests	   that	  
developing	   organs	   possess	   an	   intrinsic	   ‘measure’	   of	   organ	   size,	   and,	   that	   throughout	   their	  
growth	  they	  are	  able	  to	  access	  this	  pre-­‐determined	  spatial	  information	  that	  sets	  the	  final	  size.	  	  
Investigation	  of	  the	  compensation	  mechanism	  by	  Ferjani	  et	  al	   (2007)	  revealed	  that	  there	  are	  
three	   distinct	   routes	   by	   which	   the	   developing	   leaf	   can	   compensate	   for	   a	   reduction	   in	   cell	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proliferation.	   The	   first	   route	   involves	   the	   initiation	   of	   cell	   expansion	   during	   the	   proliferative	  
phase,	  as	  seen	  in	  KRP2	  overexpressing	  lines	  (Ferjani	  et	  al.,	  2007).	  The	  second	  and	  third	  routes	  
involve	  post-­‐mitotic	  compensation,	  where	  enhanced	  cell	  expansion	  follows	  the	  termination	  of	  
the	  proliferative	  phase	   (Ferjani	  et	   al.,	   2007).	  One	   route	  –	   that	  utilised	  by	   fugu2-­‐1	  mutants	  –	  
involves	  an	  elevated	  rate	  of	  post-­‐mitotic	  cell	  expansion,	  and	  the	  other	  route	  –	  that	  utilised	  by	  
fugu5	  mutants	   –	   involves	   an	   elevated	  duration	   of	   post	  mitotic	   cell	   expansion	   (Ferjani	   et	   al.,	  
2007).	  
1.5.4	  –	  Models	  to	  explain	  the	  compensatory	  mechanism	  
A	   non-­‐cell-­‐autonomous	  model	   provides	   one	   explanation	   of	   why	   certain	  mutations	   affecting	  
cell	   proliferation	   are	   compensated,	   and	   why	   others	   lead	   to	   a	   change	   in	   final	   organ	   size.	   It	  
predicts	  that	  there	  are	  two	  classes	  of	  genes	  involved	  in	  organ	  size	  regulation;	  those	  involved	  in	  
spatial	   sensing	   (signal	   propagation,	   transduction	   and	   perception),	   and	   those	   that	   operate	  
outside	  of	  the	  sensing	  mechanism	  -­‐	  involved	  in	  performing	  core	  cellular	  activities	  only	  (such	  as	  
cell	  expansion	  and	  cell	  proliferation)	  (Fig.	  1.5).	  	  
In	   this	  scenario	  genes	   involved	   in	   these	  core	   cellular	  processes	  would	  be	   independent	  of	   the	  
sensing	  mechanism	  and	  therefore	  any	  aberrant	  growth	  that	  resulted	  from	  mutations	  in	  these	  
core	  genes	  would	  be	  detected	  and	  compensated.	  Conversely,	  mutations	  in	  components	  of	  the	  
sensing	  mechanism	  would	  have	  effects	   that	   cannot	  be	   compensated,	   because	   the	  detection	  
and	  response	  mechanisms	  would	  themselves	  be	  aberrant.	  This	  can	  be	  explored	  by	  comparison	  
of	  the	  effect	  of	  da1-­‐1	  and	  cycd3;1-­‐3	  mutations.	  Both	  of	  these	  mutations	  alter	  the	  duration	  of	  
cell	  proliferation	  during	  organ	  formation,	  but	  only	  the	  cycd3;1-­‐3	  mutant	  is	  compensated	  (Li	  et	  
al.,	  2008,	  Dewitte	  et	  al.,	  2007).	   	  CYCD3;1-­‐3	  are	  key	  cell-­‐cycle	  genes	  responsible	  for	  negatively	  
regulating	   the	   switch	   from	   the	  mitotic	   cell-­‐cycle	   to	   the	   endocycle	   (Dewitte	   et	   al.,	   2007).	   In	  
cycd3;3	  mutants,	  the	  absence	  of	  the	  negative	  influence	  of	  the	  CYCLIND3	  genes	  causes	  cells	  to	  
be	  released	  early	  from	  the	  proliferative	  phase.	  However,	  perhaps	  because	  cycd3;3	  cells	  are	  still	  
able	   to	   accurately	   sense	   their	   position	   in	   the	   developing	   organ,	   development	   is	   adjusted	  
according	   to	   the	   still	   correct	   spatial	   cues	   (resulting	   in	   increased	   expansion),	   and	   the	   pre-­‐
determined	  final	  organ	  size	  is	  achieved.	  	  
The	  da1-­‐1	   large	  organ	  phenotype	  suggests	   that	  da1-­‐1	  cells	  have	  an	   increased	  sensitivity	   to	  a	  
potential	  proliferation-­‐promoting	  signal.	  This	  would	  lead	  to	  proliferation	  at	  lower	  signal	  levels,	  
therefore	  a	   later	  exit	   from	  the	  proliferative	  phase	  and	  consequently	  an	   increased	  organ	  size.	  












da1-­‐1	  developing	  organ	  would	  be	  unable	  to	  detect	  the	  aberrant	  growth	  that	  results	  from	  the	  
da1-­‐1	  mutation.	  As	  a	  consequence,	  the	  developing	  organ	  would	  not	  undergo	  a	  compensatory	  
reduction	  in	  cell	  expansion.	  	  
This	   model	   predicts	   that	   genes	   with	   non-­‐compensated	   mutations	   (such	   as	   DA1,	   BB/EOD1,	  
KLUH	  and	  SPT	  (Li	  et	  al.,	  2008,	  Disch	  et	  al.,	  2006,	  Anastasiou	  et	  al.,	  2007,	  Ichihashi	  et	  al.,	  2010))	  
are	   likely	  to	  be	   involved	   in	  responding	  to	  or	  regulating	  the	  size-­‐sensing	  mechanism,	  and	  that	  
genes	  that	  are	  compensated	  (such	  as	  CYCD3;1-­‐3,	  and	  CYCD2;1	  (Qi	  and	  John,	  2007,	  Dewitte	  et	  
al.,	   2007))	   are	   involved	   in	   core	   developmental	   processes	   downstream	   of	   the	   sensing	  
mechanism.	  
	  
Figure	  1.5	  –	  A	  model	  to	  explain	  the	  compensation	  effect	  
This	  model	  predicts	  that	  there	  are	  two	  groups	  of	  genes	  involved	  in	  organ	  growth:	  genes	  involved	  
in	  a	  size-­‐sensing	  mechanism	  and	  genes	  involved	  in	  downstream	  core	  growth	  processes.	  It	  predicts	  
that	  spatial	  cues	  are	  received	  and	  transduced	  by	  a	  sensing	  machinery	  that	  in	  turn	  influences	  the	  
activity	  of	  down-­‐stream	  core	  growth	  drivers	  (which	  indirectly	  or	  directly	  influence	  organ	  growth).	  
The	   model	   predicts	   that	   while	   mutation	   of	   core	   growth	   drivers	   might	   affect	   organ	   growth,	  
accurate	  perception	  of	  aberrant	  growth	  by	  an	  intact	  size	  sensing	  mechanism	  would	  buffer	  against	  
developmental	   abnormalities.	  Conversely,	   this	  model	  predicts	   that	  growth-­‐altering	  mutations	   in	  
elements	   of	   the	   size	   sensing	   machinery	   might	   also	   render	   the	   organ	   unable	   to	   perceive	   the	  





1.5.5	  –	  Coordination	  of	  growth	  at	  the	  organ	  level	  
Evidence	   of	   a	   compensation	   mechanism	   in	   the	   setting	   of	   final	   organ	   size	   (section	   1.5.3)	  
suggests	  that	  throughout	  organ	  development,	  constituent	  cells	  can	  map	  their	  position	  relative	  
to	   the	   other	   cells	   in	   the	   organ.	   This	   allows	   cells	   to	   alter	   their	   growth	   such	   that	   a	   pre-­‐
determined	   final	   organ	   size	   can	   be	   reached.	   This	   positional	   mapping	   could	   be	   achieved	  
through	   one	   of	   two	   systems:	   a	   non-­‐cell-­‐autonomous	   signal	   ‘field’	   that	   generates	   spatial	  
information	   to	   constituent	   cells,	   or	   a	   cell-­‐autonomous	   system	   in	  which	   individual	  progenitor	  
cells	  have	  a	  fixed	  growth	  potential	  such	  that	  they	  divide	  a	  certain	  number	  of	  times	  and	  then	  
expand	   to	   a	   fixed	   size	   (Fig.	   1.6).	   It	   is	   also	   possible	   that	   a	   combination	   of	   both	  mechanisms	  
function	  during	  organ	  formation.	  	  
The	  cell-­‐autonomous	  model	   (Fig.	  1.6a)	   is	  based	  on	  observations	  that	   the	  growth	  potential	  of	  
certain	  structures	  can	  be	  pre-­‐determined	  by	  pre-­‐loading	  with	  a	  fixed	  amount	  of	  growth	  factor.	  
The	  maternal	  provision	  of	  CYCLINB	  mRNA	  to	  the	  Drosophila	  early	  embryo	  is	  one	  such	  example	  
(Edgar	  et	  al.,	  1994).	  The	  Drosophila	  early	  embryo	  is	  preloaded	  with	  a	  pool	  of	  maternal	  CYCLIN	  
B,	  which	  acts	  as	  a	  regulator	  of	  nuclear	  proliferation	  (Edgar	  et	  al.,	  1994).	  CYCLIN	  B	  is	  degraded	  
on	  the	  mitotic	  spindle	  and	  therefore	  levels	  fall	  with	  every	  nuclear	  division.	  This	  means	  that	  the	  
maternal	  ‘loading’	  of	  the	  embryo	  is	  able	  to	  pre-­‐determine	  exactly	  how	  many	  nuclear	  divisions	  
will	   occur	   regardless	   of	   their	   frequency;	   allowing	   the	   developing	   embryo	   to	   compensate	   for	  
any	  changes	  in	  the	  rate	  of	  cell	  division	  (Edgar	  et	  al.,	  1994)	  In	  this	  model,	  if	  nuclear	  division	  rate	  
was	  accelerated,	  although	  more	  nuclear	  divisions	  could	  occur	  per	  unit	  time,	  the	  growth	  factor	  
would	   run	   out	   after	   the	   pre-­‐determined	   number	   of	   divisions	   and	   nuclear	   division	  would	   be	  
halted.	   It	   is	   tempting	   to	   speculate	   that	   this	  model	   extends	   to	   cellularised	  organs.	   	   In	   such	   a	  
system,	  initial	  progenitor	  cells	  might	  be	  ‘loaded’	  with	  a	  cell-­‐autonomous	  signal	  that	  accurately	  
regulates	  proliferation	  in	  a	  similar	  mitosis-­‐dependent	  way	  to	  establish	  an	  intrinsic	  measure	  of	  
organ	  size.	  	  	  
Examples	   of	   an	   alternative	   (non-­‐cell-­‐autonomous)	   model	   (Fig.	   1.6b)	   can	   also	   be	   found	   in	  
animal	   systems.	   In	   Drosophila,	   a	   gradient	   of	   either	   the	   mRNA	   or	   the	   protein	   of	   the	  
transcription	   factor	   BICOID,	   defines	   spatial	   boundaries	   in	   the	   developing	   embryo	   (Lipshitz,	  
2009),	   and	   it	   is	   thought	   that	   a	   similar	   system	   might	   be	   responsible	   for	   coordinating	   the	  
proliferation	   arrest	   front	   in	   Arabidopsis	   lateral	   organs	   (Lenhard,	   2012).	   Evidence	   that	   the	  
arrest	   front	   is	   held	   at	   a	   fixed	   distance	   from	   the	   base	   of	   the	   leaf	   (Andriankaja	   et	   al.,	   2012,	  
Kazama	  et	  al.,	  2010)	  suggests	  that	  a	  proliferation	  promoting	  signal	  field,	  originating	  from	  the	  
41	  
leaf	  base,	  may	  be	  responsible	  for	  maintaining	  mitotic	  competence	  and	  cell	  proliferation.	  Such	  
a	  morphogen,	  emitted	   from	  the	   leaf	  base,	  would	  promote	  cell	  proliferation	   in	   the	   leaf	  basal	  
region	  only,	  as	  a	  consequence	  of	   its	  purported	  threshold-­‐dependent	  activity	  (Lenhard,	  2012).	  
In	   more	   distal	   regions,	   where	   the	   morphogen	   concentration	   is	   reduced,	   cells	   would	   be	  
released	   from	   mitosis	   (Lenhard,	   2012).	   This	   proposed	   mechanism	   predicts	   that	   cell	  
proliferation	  drives	  cells	  in	  the	  organ	  out	  of	  the	  morphogen	  field	  and	  thereby	  causes	  their	  exit	  










Examples	  of	  pro-­‐proliferative	  diffusible	  signals	  regulating	  organ	  growth	  exist	  in	  animal	  systems.	  
These	   include	   DECAPENTAPLEGIC	   (DPP),	   which	   is	   a	   diffusible	   long-­‐range	   signal	   involved	   in	  
Figure	  1.6	  –	  Cell-­‐autonomous	  and	  non-­‐cell-­‐autonomous	  coordination	  of	  organ	  growth	  
(A)	  The	  cell-­‐autonomous	  model	  of	  organ	  growth	  involves	  the	  pre-­‐loading	  of	  progenitor	  cells	  with	  a	  
fixed	  degree	  of	  growth	  potential.	   In	   this	  example,	   the	  cells	   (white	   squares)	  are	  pre-­‐loaded	  with	  
growth	   factor	   (red	   stars;	   each	   star	   conferring	   the	   ability	   to	   divide	   once),	   and	  when	   no	   growth	  
factor	  remains,	  cell	  division	  is	  arrested.	  (B)	  Non-­‐cell-­‐autonomous	  growth	  regulation	  via	  a	  diffusible	  
growth	  signal.	  In	  this	  example,	  a	  cell-­‐proliferation-­‐promoting	  growth	  factor	  is	  expressed	  from	  the	  
base	   of	   the	   organ.	   Cells	   located	   within	   this	   signal	   field	   (green	   shading)	   are	   stimulated	   to	  
proliferate	   (denoted	  by	   ‘P’),	  whereas	   cells	   outside	   the	   signal	   field	   cease	  proliferation	  and	  begin	  
cell	  expansion	  (denoted	  by	  ‘E’).	  In	  this	  model,	  as	  cells	  divide	  they	  are	  mechanically	  forced	  out	  of	  





drosophila	  wing	  disc	  growth	  and	  patterning,	  and	  whose	  gradient	  has	  been	  shown	  to	  influence	  
cell	   proliferation	   (Rogulja	   et	   al.,	   2008,	   Lecuit	   et	   al.,	   1996,	   Rogulja	   and	   Irvine,	   2005).	   One	  
response	   to	  DPP	   signalling,	   is	   the	  phosphorylation	  of	   the	   transcription	   factor,	  MAD,	   to	   form	  
MADPhos,	   which	   then	   influences	   downstream	   targets	   in	   a	   concentration-­‐dependent	   manner	  
(Rogulja	  et	  al.,	  2008).	  Cells	   that	  cannot	   respond	   to	  DPP	  signalling	  do	  not	  proliferate	  and	  die,	  
and	   those	   that	   show	   over-­‐sensitivity	   to	   DPP	   over-­‐proliferate	   (Burke	   and	   Basler,	   1996,	  
Capdevila	  and	  Guerrero,	  1994).	  DPP	  signalling	  has	  been	  tentatively	  linked	  (Rogulja	  et	  al.,	  2008)	  	  
to	  another	  pathway,	  the	  hippo	  pathway,	  that	  is	  thought	  to	  be	  a	  size-­‐checkpoint	  for	  wing	  disc	  
development	   (Zhao	  et	   al.,	   2010,	   Pan,	   2007,	  Dong	  et	   al.,	   2007).	   The	  Hippo	  pathway	   (the	   Yap	  
pathway	   in	  mammals)	   is	   a	   kinase	   cascade	  of	  negative	   growth	   regulators	   that	   is	   activated	  by	  
high	   cell	   density	   and	   results	   in	   the	   repression	   of	   cell	   proliferation	   and	   the	   promotion	   of	  
apoptosis	  (Zhao	  et	  al.,	  2010).	  The	  signalling	  molecules	  responsible	  for	  activating	  the	  Hippo-­‐Yap	  
pathway	   are	   not	   yet	   known.	   However	   the	   activated	   pathway	   results	   in	   the	   phosphorylation	  
and	  inactivation	  of	  YORKIE,	  which	  is	  a	  promoter	  of	  cell	  proliferation	  and	  cell	  survival	  (Zhao	  et	  
al.,	   2010,	   Pan,	   2007).	   Interference	  with	   the	   Hippo-­‐pathway	   results	   in	   over-­‐proliferation	   and	  
tumourogenesis	   (Dong	   et	   al.,	   2007),	   which	   is	   perhaps	   reminiscent	   of	   interference	   with	   the	  	  
DA1,	  EOD1,	   and	  DA2	   pathways;	   all	   of	  which	   result	   in	  over-­‐proliferation	  and	  enlarged	  organs	  
(Xia,	  2013,	  Li	  et	  al.,	  2008,	  Disch	  et	  al.,	  2006).	  
	  
BOX	  1.2	  –	  The	  cell	  cycle	  and	  its	  regulation	  during	  development	  
	  
	  
The	  mitotic	  cell	  cycle	  is	  a	  highly-­‐regulated,	  unidirectional	  progression	  through	  a	  series	  of	  stages	  
required	  for	  cell	  growth	  and	  division.	  G1	  phase	  -­‐	  	  when	  much	  of	  the	  cell	  machinery	  is	  replicated,	  S	  
phase-­‐	  when	  genetic	  material	  is	  replicated,	  G2-­‐	  a	  proof-­‐reading	  stage	  involving	  the	  double-­‐checking	  
of	  replicated	  DNA,	  M-­‐phase	  –	  mitosis,	  followed	  by	  cytokinesis.	  	  
	  
	  
The	  endocycle	  is	  a	  modified	  cell	  cycle	  with	  mitosis	  and	  cytokinesis	  absent.	  The	  cycle	  consists	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




The	  syncytial	  cell	  cycle	  is	  modified	  such	  that	  there	  are	  no	  growth	  phases	  or	  cytokinesis.	  This	  allows	  




1.6	  –	  Organ	  growth	  and	  the	  cell-­‐cycle	  
As	  discussed	   in	  section	  1.3,	  organ	  growth	   is	  driven	  by	  a	  combination	  of	  cell	  proliferation	  and	  
cell	   expansion.	   Cell	   proliferation	   and	   endoreduplication-­‐dependent	   cell	   expansion	   are	   both	  
processes	  that	  have	  the	  cell	  cycle	  as	  their	  core.	  In	  the	  leaf,	  proliferating	  cells	  progress	  through	  
the	  mitotic	  cell-­‐cycle	  and	  expanding	  cells	  can	  progress	  through	  the	  endocycle,	  a	  modified	  cell-­‐
cycle	  where	  mitosis	   and	   cytokinesis	   are	   absent	   (see	   Box	   1.2).	   In	   both	   cases,	   the	   number	   of	  
cycles	   can	   affect	   the	   final	   size	   of	   the	   organ,	   and	   therefore	   mis-­‐regulation	   of	   the	   rate	   or	  
duration	  of	  either	  the	  mitotic	  cell-­‐cycle	  or	  the	  endocycle	  may	  influence	  final	  organ	  size.	  	  
1.6.1	  –	  The	  cell-­‐cycle:	  a	  brief	  overview	  
1.6.1.1	  –	  The	  Mitotic	  cell-­‐cycle	  
The	  cell-­‐cycle	  is	  a	  cyclical,	  unidirectional	  progression	  through	  different	  growth	  stages.	  Mitotic	  
cells	  progress	  through	  a	  DNA	  synthesis	  phase	  (S-­‐phase),	  which	  is	  preceded	  and	  proceeded	  by	  
two	  gap	  phases	  (G1-­‐	  and	  G2-­‐phase	  respectively).	  G1-­‐phase	  is	  required	  for	  the	  replication	  of	  cell	  
machinery	   in	   preparation	   for	   the	   DNA	   synthesis	   of	   S-­‐phase,	   and	   G2-­‐phase	   is	   required	   for	  
checking	  and	  proof-­‐reading	  the	  DNA	  after	  replication.	  Following	  the	  completion	  of	  G1,	  S	  and	  
G2,	   cells	   then	   progress	   through	   the	   mitotic	   phase	   (M-­‐phase),	   where	   cells	   divide	   through	  
cytokinesis.	  Cell-­‐cycle	  checkpoints	  exist	  at	   the	  boundaries	  between	  these	  different	  phases	   to	  
ensure	  that	  the	  preceding	  phases	  have	  been	  completed	  and	  that	  there	  is	  no	  premature	  entry	  
into	   the	   next	   phase.	   Importantly,	   these	   checkpoints	   are	   unidirectional	   (i.e.	   cells	   can	   only	  
progress	   in	   one	   direction),	   which	   ensures	   that	   cells	   progress	   through	   the	   cell-­‐cycle	   in	   the	  
correct	  order.	  
The	   accurate	   and	   timely	   progression	   of	   the	   cell-­‐cycle	   is	   mediated	   by	   a	   family	   of	  
serine/threonine	  kinases,	  the	  CYCLIN	  DEPENDENT	  KINASES	  (CDKs),	  and	  their	  CYCLIN	  subunits,	  
which	  are	  required	  for	  CDK	  activity	  (van	  den	  Heuvel,	  2005).	  The	  regulation	  of	  CDKs	  is	  tight	  and	  
multi-­‐layered,	   and	   includes	   phosphorylation	   events	   (both	   activating	   and	   repressive),	   strict	  
control	  of	  protein	  expression	  and	  degradation,	  and	  regulation	  by	  CDK	  inhibitors	  (CKIs)	  (Dewitte	  
and	  Murray,	  2003).	  Five	  classes	  of	  CDK	  (termed	  CDKA-­‐E)	  (Joubes	  et	  al.,	  2000),	  and	  five	  classes	  
of	  cyclin	  (termed	  CYCLIN	  A,	  B,	  C,	  D	  and	  H)	  have	  been	  identified	  in	  plants	  (Dewitte	  and	  Murray,	  
2003).	   Cyclins,	   so	   named	   due	   to	   their	   periodic	   cyclical	   expression	   patterns,	   are	   the	   chief	  
regulatory	  influence	  on	  CDKs,	  and	  individual	  cyclins	  have	  roles	  at	  specific	  cell-­‐cycle	  checkpoints.	  
For	   example,	   A-­‐type	   cyclins	   regulate	   S-­‐phase	   progression,	   B-­‐type	   cyclins	   regulate	   the	   G2/M	  
transition,	  and	  D-­‐type	  cyclins	  regulate	  the	  G1/S	  transition	  (Dewitte	  and	  Murray,	  2003).	  Unlike	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A-­‐	   and	   B-­‐type	   cyclins,	   D-­‐type	   cyclins	   do	   not	   have	   a	   cyclical	   pattern	   of	   abundance,	   and	   are	  
thought	   to	  be	  controlled	  by	  higher-­‐order	   signalling	   in	   the	   regulation	  of	   cell	  division	   (Dewitte	  
and	  Murray,	   2003).	   There	   are	   seven	   identified	   Arabidopsis	   CDK	   inhibitors	  with	   homology	   to	  
animal	   CKIs;	   these	   are	   termed	   ICK/KRP	   proteins	   (INHIBITOR	   OF	   CDK/KIP-­‐RELATED	   PROTEIN)	  
and	   they	   inhibit	   CDK	   activity	   through	   their	   binding	   to	   CDK-­‐CYCLIN	   complexes	   (Dewitte	   and	  
Murray,	  2003,	  De	  Veylder	  et	  al.,	  2001).	  Four	  CKIs	  have	  also	  been	  characterised	  in	  Arabidopsis	  
belonging	  to	  the	  SIAMESE	  (SIM)	  and	  SIAMESE-­‐RELATED	  (SMR)	  protein	  families	  (Churchman	  et	  
al.,	  2006).	  
Cell-­‐cycle	  unidirectionality	   is	  maintained	  by	  ubiquitin-­‐mediated	  degradation	  of	   cyclins,	  which	  
ensures	   that	   once	   a	   checkpoint	   is	   passed,	   components	   required	   for	   the	   previous	   stage	   are	  
destroyed	   (Dewitte	   and	   Murray,	   2003).	   A-­‐	   and	   B-­‐type	   cyclins	   are	   directed	   for	   destruction	  
through	  ubiquitination	  by	   the	  Anaphase	  Promoting	  Complex	   (APC),	   and	  D-­‐type	   cyclins	  by	  an	  
SCF-­‐type	  E3	  ligase,	  (Dewitte	  and	  Murray,	  2003).	  In	  addition	  to	  cyclins,	  CDK	  inhibitors	  are	  also	  
regulated	  by	  ubiquitin-­‐dependent	  proteolysis;	  thereby	  de-­‐repressing	  the	  respective	  CDK	  (King	  
et	  al.,	  1996).	  
1.6.1.2	  –	  Cell-­‐cycle	  variations	  
Excluding	  the	  meiotic	  cell	  cycle	  –	  where	  S-­‐phase	  is	  followed	  by	  a	  modified	  M-­‐phase,	  with	  two	  
rounds	   of	   chromosome	   segregation	   (van	   den	   Heuvel,	   2005)	   –	   there	   are	   two	   significant	  
variations	  of	  the	  mitotic	  cell	  cycle;	  the	  endocycle	  and	  the	  syncytial	  cell-­‐cycle.	  
Cells	   in	   the	   syncytial	   cell-­‐cycle	   rapidly	   cycle	   between	   S-­‐phase	   and	   a	  modified	  M-­‐phase	   that	  
lacks	  cytokinesis.	  The	  absence	  of	  G1	  and	  G2	  permits	   rapid	  cycling,	  and	  the	   lack	  of	  cytokinesis	  
results	  in	  syncytial	  growth	  to	  produce	  multiple	  nuclei	  dividing	  without	  cellularisation.	  	  The	  lack	  
of	  G1	  and	  G2	  means	  that	  syncytial	  tissues	  are	  highly	  dependent	  on	  the	  extracellular	  provision	  of	  
DNA	   and	   protein,	   and	   their	   development	   is	   often	   governed	   by	   the	   nucleo-­‐cytoplasmic	   ratio	  
(Edgar	   et	   al.,	   1986,	   Edgar	   and	   Datar,	   1996).	   In	   plants	   the	   early	   stages	   of	   endosperm	  
development	  involves	  the	  syncytial	  cell	  cycle.	  
The	  endocycle	  consists	  of	  an	  S-­‐phase	  followed	  by	  a	  single	  G-­‐phase	  and	  no	  mitosis,	  resulting	  in	  
a	  doubling	  of	  ploidy	  level	  with	  each	  cycle	  (van	  den	  Heuvel,	  2005).	  Down-­‐regulation	  of	  the	  M-­‐
phase	  components,	  CYCA1,	  CYCA2,	  CYCBs	  and	  CDKB	  have	  been	  reported	   in	  endocycling	  cells	  
(Dewitte	  and	  Murray,	  2003).	  Work	  has	  also	   implicated	  CYCD3;1-­‐3	   in	   the	  maintenance	  of	   the	  
mitotic	   cell	   cycle	   (Dewitte	   et	   al.,	   2007),	   suggesting	   that	   CYCD3	   acts	   as	   a	  mitotic	   cyclin	   that	  
drives	   cells	   from	  G2	   to	  M,	   rather	   than	  allowing	   them	   to	  exit	   (to	   the	  endocycle)	   from	  G2	  –	   S-­‐
phase	   (Dewitte	   et	   al.,	   2007).	   Interestingly	   elevated	   levels	   of	   CYCD3	   have	   been	   identified	   in	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endoreduplicating	  tomato	  tissues	  (Joubes	  and	  Chevalier,	  2000)	  ,	  suggesting	  that	  CYCD3	  may	  be	  
a	  general	  promoter	  of	  all	  cell	  cycles	  (mitotic	  and	  endocycles)	  as	  a	  consequence	  of	  a	  promotion	  
of	  the	  G1/S-­‐phase	  transition	  (Dewitte	  et	  al.,	  2007).	  	  
1.6.2	  –	  Regulating	  cell	  proliferation	  via	  the	  mitotic	  cell-­‐cycle	  
As	  described	  in	  section	  1.5.1,	  quadruple	  DELLA	  knockout	  plants	  exhibit	  an	  increased	  leaf	  area	  
due	  to	  an	  increased	  rate	  of	  cell	  proliferation	  (Achard	  et	  al.,	  2009).	  Further	  investigation	  of	  this	  
phenotype	  revealed	  that	  DELLAs	  promote	  the	  expression	  of	  several	  CKIs;	  KRP2,	  SIM1,	  SMR1,	  
SMR2	   (Achard	  et	  al.,	  2009).	  As	  CKIs	  negatively	   regulate	   the	  progression	  of	   the	  cell-­‐cycle,	   the	  
absence	  of	  DELLA	  activity	   in	   the	  quadruple	  DELLA	  knockout	   is	   therefore	   thought	   to	  drive	  an	  
increase	   cell-­‐proliferation	   through	   a	   de-­‐repression	   CKI-­‐mediated	   cell-­‐cycle	   inhibition.	   Over-­‐
expression	  of	  the	  APC	  subunits,	  CDC27a	  and	  APC10	  has	  also	  been	  shown	  to	  increase	  the	  rate	  
of	  cell	  proliferation	  in	  the	  developing	   leaf	  (Rojas	  et	  al.,	  2009,	  Eloy	  et	  al.,	  2011).	  As	  the	  APC	  is	  
required	  for	  mitotic	  progression,	  an	  increase	  in	  APC	  activity	  (through	  increased	  abundance	  of	  
its	  subunits),	  leads	  to	  an	  elevated	  mitotic	  rate.	  
As	   well	   as	   explaining	   observed	   increases	   in	   proliferation	   rate	   during	   organ	   growth,	  
manipulation	   of	   the	   cell-­‐cycle	  machinery	   has	   also	   been	   shown	   to	   affect	   the	  duration	   of	   cell	  
proliferation	   during	   organ	   formation.	   As	   described	   in	   section	   1.5.4,	   cyc3;1-­‐3	   triple	   knockout	  
leaves	  and	  petals	  have	  a	  reduced	  duration	  of	  cell	  proliferation	  (Dewitte	  et	  al.,	  2007).	  This	  has	  
led	  to	  a	  suggestion	  that	  CYCLIN	  D3s	  act	  as	  gatekeeper	  proteins,	  promoting	  the	  maintenance	  of	  
the	   mitotic	   cell-­‐cycle	   and	   blocking	   entrance	   into	   the	   endocycle	   (Dewitte	   et	   al.,	   2007).	  
Consistent	   with	   this	   is	   the	   observation	   that	   the	   large	   organ-­‐size	   phenotype	   of	   plants	   over-­‐
expressing	  AINTEGUMENTA	   (ANT),	   is	   associated	  with	   increased	  CYCD3	   expression	   (Mizukami	  
and	  Fischer,	  2000).	  Over-­‐expression	  of	  ANT	  –	  an	  AP2-­‐domain	  transcription	  factor	  –	  results	   in	  
enlarged	  leaves	  with	  more	  cells,	  and	  conversely	  ant	  mutant	  leaves	  are	  smaller	  and	  have	  fewer	  
cell	   (Mizukami	   and	   Fischer,	   2000).	  ANT	   over-­‐expression	   causes	   an	   increased	  duration	  of	   cell	  
proliferation,	   which	   is	   consistent	   with	   the	   observed	   increase	   in	   CYCD3	   expression,	   further	  
supporting	  a	  role	  for	  CYCD3	  in	  the	  maintenance	  of	  mitotic	  competence	  (Mizukami	  and	  Fischer,	  
2000).	  
1.6.3	  –	  Regulating	  cell	  expansion	  via	  the	  endocycle	  
As	   discussed	   in	   section	   1.3.3,	   some	   mechanisms	   of	   cell	   expansion	   are	   accompanied	   by	  
endoreduplication	   (Sugimoto-­‐Shirasu	   and	   Roberts,	   2003).	   It	   is	   therefore	   possible	   that	  
regulation	  of	  the	  switch	  to,	  and	  the	  persistence	  of	  the	  endocycle	  will	  have	  a	  significant	  impact	  
on	  cell	  expansion	  in	  developing	  organs.	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The	  switch	  from	  the	  mitotic	  cell-­‐cycle	  to	  the	  endocycle	  may	  be	  governed	  by	  the	  antagonistic	  
influences	  of	  factors	  that	  promote	  mitosis	  and	  endocycling	  respectively.	  Because	  exit	  from	  the	  
mitotic	  cell	  cycle	  is	  a	  pre-­‐requisite	  for	  entry	  to	  the	  endocycle,	  cell	  cycle	  regulators	  described	  in	  
section	  1.6.2	  that	  influence	  the	  duration	  of	  cell	  proliferation	  are	  also	  likely	  to	  be	  important	  in	  
determining	   the	   onset	   of	   the	   endocycle.	   The	   blurring	   of	   the	   boundaries	   between	   what	   is	  
negative	  regulation	  of	   the	  mitotic	  cell-­‐cycle	  and	  promotion	  of	   the	  endocycle	   (and	  vice	  versa)	  
has	   made	   studies	   in	   this	   area	   difficult.	   For	   example,	   three	   recent	   papers	   disagree	   as	   to	  
whether	   the	   class	   I	   TCP,	   TCP15,	   is	   involved	   in	   the	   regulation	   of	   cell	   proliferation	   or	   cell	  
expansion	   (Kieffer	   et	   al.,	   2011,	   Li	   et	   al.,	   2012,	   Uberti-­‐Manassero	   et	   al.,	   2012).	   Using	  
quantitative	  imaging,	  Kieffer	  et	  al	  report	  that	  TCP15	  influences	  the	  expansion	  of	  the	  leaf	  blade	  
as	  a	  consequence	  of	  repressed	  cell	  proliferation	  in	  the	  developing	  leaf	  epidermis.	  Conversely,	  
Li	  et	  al	  (2012)	  suggest	  that	  TCP15	  represses	  endoreduplication	  in	  trichomes	  and	  cotyledon	  cells.	  
This	  disagreement	   is	  consistent	  with	  the	  apparent	  context-­‐dependent	  role	  of	  the	  class	   I	  TCPs	  
(Kieffer	   et	   al.,	   2011,	   Li	   et	   al.,	   2012,	   Uberti-­‐Manassero	   et	   al.,	   2012),	   however	   it	   also	   likely	  
reflects	   the	  coupled	  nature	  of	   the	  mitotic	  cell-­‐cycle	  and	  the	  endocycle.	  The	  mitotic	  cell-­‐cycle	  
and	  the	  endocycle	  both	  have	  G-­‐	  and	  S-­‐phases,	  and	  therefore	  factors	  that	  can	  promote	  either	  
of	   these	   shared	   phases	   might	   enhance	   both	   types	   of	   cell-­‐cycle.	   It	   is	   also	   worthwhile	  
considering	   that	   TCP15-­‐dependent	   growth	   factors	   are	   likely	   only	   a	   subset	   of	   the	   total	  
population	  of	  growth	  factors	  that	  influence	  the	  cell-­‐cycle.	  As	  such,	  the	  precise	  effect	  of	  altered	  
TCP15	   expression	   is	   likely	   to	   be	   dependent	   on	   the	   background	   (in	   terms	   of	   cell-­‐cycle	  
regulation)	   of	   each	   treatment	   and	   tissue.	   Indeed,	   Li	   et	   al	   (2012)	   only	   reported	   six	   cell-­‐cycle	  
regulators	  differentially	  regulated	  by	  TCP15	  (Li	  et	  al.,	  2012).	  	  	  
Knockout	   of	   RPT2a,	   a	   26S	   proteasome	   regulatory	   subunit	   (see	   section	   1.3.3),	   increases	   the	  
duration	  of	  cell	  expansion	  and,	  as	  a	  consequence,	  increases	  leaf	  size	  through	  an	  increase	  in	  cell	  
size	  (Sonoda	  et	  al.,	  2009).	  Further	  investigation	  of	  this	  mutant	  revealed	  that	  the	  G1	  regulator,	  
CYCD3;1	   and	   the	   S-­‐phase	   regulators,	   CDC6b,	   CDT1a,	   CDT1b,	   HISH4	   and	   CYCA3;1,	   were	   up-­‐
regulated	   in	   rpt2a-­‐2	   mutants	   (Sonoda	   et	   al.,	   2009).	   The	   number	   of	   cells	   in	   rpt2a-­‐2	   leaves	  
remains	  similar	  to	  the	  wild-­‐type	  throughout	  development,	  suggesting	  that	  the	  increase	  in	  cell	  
size	   is	   a	   consequence	   of	   enhanced	   endocycling	   (rate	   or	   duration),	   but	   not	   due	   to	   a	  
consequence	  of	  early	  mitotic	  exit	  (Sonoda	  et	  al.,	  2009).	  As	  the	  endocycle	  consists	  only	  of	  a	  G-­‐
phase	   and	   an	   S-­‐phase,	   up-­‐regulation	   of	   these	   G1-­‐	   and	   S-­‐phase	   specific	   factors	   reflects	   the	  
increased	  persistence	  and/or	  up-­‐regulation	  of	  the	  endocycle.	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Recent	   work	   has	   pointed	   to	   chloroplast	   retrograde	   signalling	   promoting	   the	   onset	   of	   cell	  
expansion	   in	   the	   developing	   leaf	   (Andriankaja	   et	   al.,	   2012).	   This	   work	   showed	   that	   genes	  
involved	   in	  chloroplast	  differentiation	  were	  up-­‐regulated	  prior	   to	  the	  appearance	  of	   the	  cell-­‐
cycle	  arrest	  front,	  and	  that	  chemical	   inhibition	  of	  chloroplast	  differentiation	  blocked	  the	  cell-­‐
cycle	  arrest	  front	  (Andriankaja	  et	  al.,	  2012).	  Chloroplast	  retrograde	  signalling	  in	  cultures	  of	  the	  
red	   algae,	   Cyanidioschyzon	   merolae	   activates	   CDKA	   and	   thereby	   initiates	   nuclear	   DNA	  
replication	   (Kobayashi	   et	   al.,	   2009).	   The	   reliance	   of	   nuclear	   DNA	   replication	   on	   chloroplast	  
differentiation	  shown	  by	  these	  studies	  may	  reflect	  a	  requirement	  for	  active	  plastids	  during	  S-­‐
phase.	   The	   inhibition	  of	   cell	   proliferation	  by	   chloroplast	  differentiation	   can	  be	  uncoupled	  by	  
the	   addition	   of	   CDK	   inhibitors	   (aphidicolin	   or	   nalidixic	   acid),	   which	   permits	   chloroplast	  
differentiation	   without	   subsequent	   nuclear	   DNA	   replication	   (Kobayashi	   et	   al.,	   2009).	  
Arabidopsis	  CDKA	  levels	  are	  elevated	  in	  G1-­‐	  and	  S-­‐phase	  (Dewitte	  and	  Murray,	  2003)	  and	  thus	  
the	   up-­‐regulation	   of	   CDKA	   in	   response	   to	   retrograde	   signalling	   is	   reminiscent	   of	   the	   up-­‐
regulation	  of	  other	  G1-­‐	  and	  S-­‐phase	  specific	  factors	  in	  the	  rpt2a-­‐2	  mutant,	  which	  has	  increased	  
endocycling	  and	  larger	  leaves	  (Sonoda	  et	  al.,	  2009).	  
1.7	  –	  The	  ubiquitin	  system	  
The	   characterisation	   of	   the	   E3	   ligases,	   DA2,	   EOD1	   and	   SLY	   as	  bona	   fide	   regulators	   of	   organ	  
growth	   (McGinnis	   et	   al.,	   2003,	   Disch	   et	   al.,	   2006,	   Xia,	   2013),	   as	  well	   as	   the	   identification	   of	  
other	  members	   of	   the	   ubiquitin	   pathway	   as	   growth	   regulators	   (Li	   et	   al.,	   2008,	   Rojas	   et	   al.,	  
2009),	  suggests	  that	  ubiquitination	  probably	  plays	  a	  key	  role	  in	  regulating	  organ	  growth,	  as	  in	  
most	   other	   biological	   processes.	   Furthermore,	   the	   importance	   of	   ubiquitin-­‐dependent	  
proteolysis	   in	  the	  cell-­‐cycle,	  a	  centrally	   important	  process	  at	  the	  heart	  of	  organ	  development	  
(section	   1.6),	   further	   stresses	   the	   significance	   of	   ubiquitination	   in	   the	   establishment	   of	   final	  
organ	  size.	  
Ubiquitination	   is	   a	   reversible	   post-­‐translation	   modification	   akin	   to	   phosphorylation,	   which	  
involves	  the	  ligation	  of	  ubiquitin	  (a	  short	  peptide	  molecule)	  to	  lysine	  residues	  on	  the	  surface	  of	  
substrate	  proteins	   (Hershko	  and	  Ciechanover,	   1998).	   The	   ligation	  mechanism	   is	   a	   three-­‐step	  
enzymatic	   process	   involving	   three	   classes	   of	   enzyme:	   E1-­‐activating	   enzymes,	   E2-­‐conjugating	  
enzymes	  and	  E3-­‐ligases	  (Fig.	  1.7).	  The	  ligation	  of	  ubiquitin	  can	  occur	  in	  variety	  of	  forms,	  from	  
single	  mono-­‐ubiquitin	  molecules,	   to	   long-­‐chain	  poly-­‐ubiquitin	  molecules	   (Woelk	   et	   al.,	   2006,	  
Mallery	   et	   al.,	   2002,	   Disch	   et	   al.,	   2006,	   Petroski	   and	   Deshaies,	   2003).	   Moreover,	   the	   inter-­‐
molecular	   couplings	   and	   lengths	   of	   these	   chains	   can	   impart	   different	   signals,	   ranging	   from	  
enhancing	   modifications	   to	   labels	   for	   destruction	   (Mallery	   et	   al.,	   2002,	   Fang	   et	   al.,	   2000,	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Stevenson	   et	   al.,	   2007).	   The	   following	   section	   describes	   the	   ubiquitination	   cascade	   and	   key	  
enzymatic	   steps,	   and	  explores	   the	   roles	  played	  by	   these	  enzymes	   in	   the	   regulation	  of	   organ	  
growth.	  Importantly,	  this	  section	  leverages	  the	  wealth	  of	  knowledge	  present	  in	  metazoan	  and	  
yeast	   ubiquitin-­‐biology,	   and	   uses	   it	   to	   improve	   our	   understanding	   of	   the	   hitherto	   less	  
advanced	  field	  of	  plant	  ubiquitin-­‐biology.	  Ubiquitination	  has	  a	  centrally	  important	  role	  in	  cell-­‐
cycle	   regulation	   (Hershko	   and	   Ciechanover,	   1998),	   which	   is	   a	   process	   at	   the	   core	   of	   both	  
cancer	  progression	  in	  animals	  (Vermeulen	  et	  al.,	  2003,	  Hartwell	  and	  Kastan,	  1994)	  and	  organ	  
growth	  in	  plants	  (Inzé	  and	  De	  Veylder,	  2006,	  Beemster	  et	  al.,	  2003).	  	  
1.7.1	  –	  Ubiquitin:	  a	  small	  peptide	  with	  multiple	  signalling	  roles	  
Ubiquitin	   is	  a	  highly	  conserved	  76	  amino	  acid	  protein,	  whose	  structure	   is	  100%	  conserved	   in	  
higher	  plants	  and	  differs	  by	  only	  three	  residues	  from	  animal	  ubiquitin	  (Callis	  et	  al.,	  1995).	  It	  is	  
expressed	  as	  an	   inactive	  precursor,	  as	  either	  an	  ubiquitin	  polymer,	  or	  fused	  to	  other	  peptide	  
sequences	  (Wiborg	  et	  al.,	  1985,	  Ozkaynak	  et	  al.,	  1987,	  Callis	  et	  al.,	  1995).	  Ubiquitin	  oligomers	  
are	   formed	   through	   the	   creation	   of	   an	   isopeptide	   linkage	   between	   a	   C-­‐terminal	   glycine	   of	  
ubiquitin	   (Gly76)	  and	  a	   lysine	   residue	  on	   the	   substrate	  protein	   (Pickart	  and	  Fushman,	  2004).	  
These	  can	  be	  single	  mono-­‐ubiquitin	  moieties,	  such	  as	  those	  involved	  in	  the	  regulation	  of	  EPS15	  
(Woelk	  et	  al.,	  2006).	  They	  can	  also	  be	  long	  chain	  poly-­‐ubiquitin	  signals,	  such	  as	  those	  seen	  on	  
BRCA2	  and	  MDM2	  in	  animals	  and	  EOD1	  and	  DA2	  in	  Arabidopsis	  (Mallery	  et	  al.,	  2002,	  Disch	  et	  
al.,	  2006,	  Xia,	  2013,	  Fang	  et	  al.,	  2000).	  
Poly-­‐ubiquitin	   chains	   can	   be	   formed	   through	   two	   distinct	   processes;	   an	   isopeptide	   linkage	  
between	   the	   C-­‐terminal	   Gly76	   and	   a	   lysine	   residue	   on	   the	   preceding	   ubiquitin	   (Pickart	   and	  
Fushman,	   2004),	   or	   through	   head-­‐to-­‐tail	   ‘linear’	   chains	   where	   the	   N-­‐terminal	   Met1	   is	  
conjugated	   to	  Gly76	   through	  a	  peptide	   linkage	   (Kirisako	  et	  al.,	  2006).	  There	  are	   seven	   lysine	  
residues	   on	  ubiquitin	   (K6,	   K11,	   K27,	   K29,	   K31,	   K48	   and	  K63),	   therefore	   seven	  possible	   (non-­‐
linear)	  poly-­‐ubiquitin	  architectures	  are	  available.	  All	  seven	  linkages	  have	  been	  identified	  in	  vivo	  
in	  yeast	  (Peng	  et	  al.,	  2003),	  and	  all	  but	  K6	  and	  K27	  have	  been	  identified	  in	  Arabidopsis	  (Saracco	  
et	   al.,	   2009).	   The	   different	   linkages	   are	   thought	   to	   confer	   different	   signals	   to	   the	   substrate	  
protein,	   with	   K48	   linked	   chains	   generally	   associated	   with	   signalling	   proteasome-­‐mediated	  
degradation	  (Jacobson	  et	  al.,	  2009),	  and	  other	  linkages	  thought	  to	  have	  a	  variety	  of	  functions	  
including	   enzyme	   activation	   (Mallery	   et	   al.,	   2002,	   Woelk	   et	   al.,	   2006).	   The	   structure	   and	  



















Figure	  1.7	  –	  The	  ubiquitin	  cascade	  
An	   illustration	  of	   the	  ubiquitin	   cascade,	  using	   the	  HECT	   family	  of	   E3	   ligases	  as	  an	  example.	   The	  
ubiquitin	   cascade	   is	   initiated	   by	   an	   ATP	   consuming	   reaction	   in	  which	   the	   E1	   activating	   enzyme	  
forms	  a	  thioester	  bond	  with	  the	  C-­‐terminal	  glycine	  of	  ubiquitin,	  this	  is	  followed	  by	  transfer	  of	  the	  
E1	   conjugated	  ubiquitin	  molecule	   to	   the	   active	   site	  of	   the	   E2	   conjugating	   enzyme.	   The	   E2	   then	  
transfers	   the	   ubiquitin	   molecule	   to	   the	   E3,	   which	   ligates	   it	   to	   the	   substrate	   protein,	   via	   an	  
isopeptide	   linkage	  between	   the	  C-­‐terminal	  Gly76	  and	  a	   lysine	   residue	  on	   the	   substrate	  protein.	  
Poly-­‐ubiquitin	  chains	  are	  formed	  through	  the	  ligation	  of	  ubiquitin	  molecules	  onto	  lysine	  residues	  
on	   additional	   ubiquitin	   molecules.	   Non	   HECT-­‐family	   E3	   ligases	   do	   not	   form	   a	   covalent	  
intermediate	   with	   the	   ubiquitin	   molecule;	   instead	   they	   cooperate	   with	   the	   E2	   to	   ligate	   the	  




1.7.2	  –	  E1	  activating	  enzymes:	  ATP-­‐dependent	  ubiquitin	  activation	  
As	  described	  above,	  the	  mechanism	  of	  ligating	  an	  ubiquitin	  molecule	  to	  its	  substrate	  is	  a	  three-­‐
step	  process	   involving	   three	   classes	  of	  enzyme	   (Fig.	   1.7).	   The	   first	   step	   in	   this	  process	   is	   the	  
conjugation	   of	   free	   ubiquitin	   to	   the	   E1	   activating	   enzyme	   in	   an	   ATP-­‐consuming	   step.	   This	  
reaction,	   via	   an	   ubiquitin-­‐adenylate	   intermediate,	   results	   in	   the	   formation	   of	   a	   high	   energy	  
thiolester	  linkage	  between	  the	  ubiquitin	  and	  a	  catalytic	  cysteine	  residue	  on	  the	  E1	  (Hatfield	  et	  
al.,	  1997,	  Hershko	  and	  Ciechanover,	  1998).	  	  
The	  Arabidopsis	  genome	  encodes	  two	  E1	  genes	  (UBA1	  and	  UBA2)	  (Hatfield	  et	  al.,	  1997),	  one	  of	  
which	   has	   been	   shown	   to	   play	   a	   role	   in	   plant	   innate	   immunity	   and	   to	   have	   an	   organ-­‐size	  
phenotype	  in	  certain	  genetic	  backgrounds	  (Goritschnig	  et	  al.,	  2007).	  A	  15bp	  deletion	  in	  the	  C-­‐
terminal	  region	  of	  Arabidopsis	  UBA1	  (named	  mos5	  (modifier	  of	  snc1	  5))	  was	  able	  to	  rescue	  the	  
dwarf	  phenotype	  of	  the	  npr1-­‐1	  snc1	  double	  mutant,	  which	  has	  constitutively	  activated	  defence	  
responses	   (Goritschnig	   et	   al.,	   2007).	   Reduced	   plant	   growth	   is	   a	   characteristic	   	   defence	  
response	   and	   can	   be	   seen	   in	   various	   assays	   for	   pathogen	   challenge	   (Gómez‐Gómez	   et	   al.,	  
1999,	  Gómez-­‐Gómez	  and	  Boller,	  2000,	  Zipfel	  et	  al.,	  2006).	  This	  highlights	  an	  overlap	  between	  
plant	  development	  and	   the	  pathogen	  response,	  which	   is	   supported	  by	  observations	   that	   the	  
well	   characterised	   growth	   regulator,	  TCP14	   (Kieffer	   et	   al.,	   2011)	   is	   also	   a	   central	   hub	   in	   the	  
plant	   immune	   system	   network	   (Mukhtar	   et	   al.,	   2011).	   Therefore,	   in	   addition	   to	   the	  mos5	  
phenotype	   implicating	  UBA1	   in	   the	   defence	   response,	   it	  may	   reveal	   a	   potential	   link	   to	   core	  
developmental	  growth	  control.	  
1.7.3	  –	  E2	  conjugating	  enzymes:	  transferring	  ubiquitin	  to	  substrates	  
After	  activation	  of	  the	  ubiquitin	  monomer,	  the	  E1-­‐thiolester-­‐bound	  ubiquitin	  is	  transferred	  to	  
a	  thiol	  group	  on	  the	  active	  site	  cysteine	  of	  the	  E2	  enzyme.	  In	  spite	  of	  there	  being	  only	  two	  E1	  
enzymes	  in	  Arabidopsis,	  the	  fact	  that	  only	  UBA1	  has	  a	  pathogen	  response	  phenotype,	  suggests	  
that	   there	   may	   be	   some	   degree	   of	   selectivity	   in	   its	   downstream	   interactions	   with	   E2s	  
(Goritschnig	  et	  al.,	  2007).	  	  Indeed,	  data	  from	  animal	  systems	  demonstrates	  that	  the	  Human	  E1s,	  
UBA1	  and	  UBE6,	  have	  different	  E2	  binding	  preferences	  (Jin	  et	  al.,	  2007).	  This	  idea	  that	  the	  E1-­‐
E2	  interaction	  is	  to	  some	  extent	  specific,	   is	  supported	  by	  observations	  that	  UBA1	  binds	  to	  E2	  
enzymes	  with	  a	  greater	  affinity	  when	  it	  is	  ubiquitinated	  (Haas	  et	  al.,	  1988,	  Ye	  and	  Rape,	  2009).	  
This	  in	  turn	  suggests	  that	  the	  thiolester-­‐ubiquitin	  status	  of	  the	  E1	  might	  serve	  to	  recruit	  the	  E2	  
to	   the	   E1	   (Ye	   and	   Rape,	   2009).	   Perhaps	   in	   a	   similar	   fashion	   to	   the	   proposed	   recruitment	   of	  
UIM-­‐containing	  proteins	  by	  E3-­‐bound	  ubiquitin,	  in	  the	  process	  of	  coupled	  mono-­‐ubiquitination	  
(Woelk	  et	  al.,	  2006).	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The	   E2	   conjugating	   step	   is	   the	   second	   tier	   of	   the	   ubiquitin	   cascade	   and	   E2	   enzymes	   have	   a	  
significant	   influence	  on	  target	  protein	  specificity.	  This	   is	  reflected	  in	  the	  increased	  number	  of	  
E2s	   (relative	   to	   E1s);	   analysis	   of	   the	   Arabidopsis	   genome	   sequence	   predicted	   37	   E2s	   in	   12	  
subfamilies	  (Vierstra,	  1996,	  Sadanandom	  et	  al.,	  2012).	  E2	  conjugating	  enzymes	  are	  responsible	  
for	   catalysing	   the	   transfer	   of	   ubiquitin	   to	   the	   substrate	   proteins,	   and	   E3	   enzymes,	   although	  
often	  necessary,	  are	  typically	  only	  required	  to	  coordinate	  the	  E2-­‐substrate	  interaction.	  Indeed,	  
although	  most	  E2s	  appear	  to	  be	  inactive	  without	  an	  E3,	  the	  Arabidopsis	  E2s,	  UBCE,	  UBC2	  and	  
UBC8	  have	   all	   been	   shown	   to	   ubiquitinate	   substrates	   in	   vitro	   in	   the	   absence	   of	   E3	   enzymes	  
(Wiborg	  et	  al.,	  2008).	  	  
In	  animal	  systems,	  E2	  enzymes	  have	  been	  shown	  to	  influence	  cell	  proliferation	  rate	  and	  cancer	  
progression.	  Over-­‐expression	  of	  the	  human	  E2,	  UBCH10,	  the	  expression	  of	  which	  is	  elevated	  in	  
many	  primary	  tumours,	  results	  in	  an	  increase	  in	  cell	  proliferation	  (Okamoto	  et	  al.,	  2003).	  This	  
increase	   in	   cell	   proliferation	   is	   likely	   to	   be	   a	   direct	   consequence	   of	   UBCH10	   being	   the	  
preferential	   binding	   partner	   of	   the	   APC	   E3	   ligase	   (Summers	   et	   al.,	   2008),	   and	   therefore	   its	  
over-­‐expression	   is	   likely	   to	   lead	   to	   accelerated	   mitotic	   cell-­‐cycling.	   Indeed	   UBCH10	   over-­‐
expression	  was	  shown	  to	  be	  sufficient	  to	  promote	  APC-­‐mediated	  degradation	  of	  securin,	  a	  key	  
anaphase	  inhibitor	  (Pellman	  and	  Christman,	  2001,	  Summers	  et	  al.,	  2008).	  
1.7.4	  –	  E3	  ligases:	  coordinating	  and	  specifying	  the	  ligation	  of	  ubiquitin	  to	  substrates	  
E3	   ligase	   enzymes	   are	   responsible	   for	   the	   final	   step	   of	   the	   ubiquitin	   cascade,	   where	   they	  
coordinate	   the	   E2-­‐mediated	   ligation	   of	   ubiquitin	   to	   the	   target	   protein.	   Due	   to	   their	   role	   in	  
specifying	  the	  ligation	  of	  ubiquitin,	  there	  are	  large	  numbers	  of	  E3	  genes;	  for	  example	  there	  are	  
1415	   predicted	   in	   Arabidopsis	   (Mazzucotelli	   et	   al.,	   2006).	   E3	   ligases	   are	   unified	   by	   their	  
biochemical	   function	   and	   not	   their	   structure	   or	   sequence.	   Whereas	   all	   E3	   ligases	   act	   to	  
facilitate	   the	   ligation	   of	   E2-­‐ubiquitin	   to	   the	   relevant	   target	   protein,	   their	   group	   as	   a	   whole	  
contains	   both	   monomeric	   and	   multimeric	   proteins	   of	   varying	   sequence	   divergence	  
(Mazzucotelli	  et	  al.,	  2006).	  	  
Despite	  their	  functional	  conservation,	  E3	  ligases	  are	  an	  extremely	  diverse	  group	  of	  enzymes.	  In	  
terms	   of	   structure,	   there	   are	   two	   groups	   of	   E3	   ligase;	   monomeric	   E3s,	   where	   E2-­‐binding	  
domains	   and	   substrate	   binding	   domains	   are	   on	   the	   same	   polypeptide,	   and	  multimeric	   E3s.	  
Multimeric	  E3s	  consist	  of	  an	  E2-­‐interacting	  module,	  and	  a	  target-­‐specifying	  module	  joined	  by	  a	  
CUL	  (CULLIN)	  or	  CUL-­‐like	  protein;	  (Mazzucotelli	  et	  al.,	  2006)	  (Fig.	  5.1).	  	  
E3	  ligases	  can	  also	  be	  split	   into	  two	  groups	  based	  on	  their	  E2-­‐binding	  domains,	  characterised	  
by	  the	  presence	  of	  either	  a	  HECT	   (Homology	  to	  E6-­‐AP	  C-­‐Terminus)	  domain	  or	  a	  RING	  (Really	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Interesting	   New	   Gene)/U-­‐box	   domain.	   All	   HECT	   E3s,	   including	   UPL3	   (UBIQUITIN	   PROTEIN	  
LIGASE	  3)	   -­‐	   a	   regulator	  of	   trichome	  development	   (Downes	  et	  al.,	  2003),	   are	  monomeric	  E3s;	  
whereas	   RING	   E3s	   exist	   as	   both	   monomeric	   E3s	   and	   as	   subunits	   in	   multimeric	   modular	   E3	  
complexes	   (Mazzucotelli	  et	  al.,	  2006).	  Some	  RING	  E3s,	   such	  as	  EOD1	   (Disch	  et	  al.,	  2006)	  and	  
the	  negative	  regulator	  of	  ABA	  signalling	  KEG	  (KEEP	  ON	  GOING)	  (Stone	  et	  al.,	  2006),	  as	  well	  as	  
the	  closely	  related	  PLANT	  U-­‐BOX	  (PUB)	  E3s,	   including	  PUB12	  and	  PUB13	  (Lu	  et	  al.,	  2011),	  are	  
single	   polypeptide	   E3s.	   Whereas	   the	   RING	   protein	   atRBX1	   (RING	   BOX	   PROTEIN1),	   the	  
knockdown	   of	   which	   causes	   severe	   developmental	   phenotypes	   such	   as	   poorly	   developed	  
leaves	   and	   loss	   of	   apical	   dominance	   (Lechner	   et	   al.,	   2002),	   is	   part	   of	   a	  multimeric	   E3	   ligase.	  
RBX1	  is	  the	  E2-­‐binding	  subunit	  of	  SCF	  (SKP1-­‐CULLIN-­‐F-­‐BOX),	  CUL3-­‐BTB/POZ	  (CULLIN-­‐3	  –	  BRIC-­‐
A-­‐BRAC,	   TRAMTRACK	   and	   BROAD	   COMPLEX/POX	   VIRUS	   and	   ZINC	   FINGER),	   and	   CUL4-­‐DDB1	  
(UV-­‐DAMAGED	  DNA-­‐BINDING	  PROTEIN1)	  E3	   ligases;	  henceforth	  termed	  the	  cullin-­‐ring	   ligases	  
(CRLs)	  (Mazzucotelli	  et	  al.,	  2006).	  All	  E3	  ligases,	  except	  HECT	  E3s,	  simply	  act	  to	  coordinate	  the	  
ligation	  of	  the	  E2-­‐conjugated	  ubiquitin	  to	  the	  substrate,	  without	  themselves	  covalently	  binding	  
the	   ubiquitin.	   HECT	   E3	   ligases,	   however,	   form	   a	   thioester	   intermediate	   with	   the	   ubiquitin	  
molecule	  before	  ligation	  to	  the	  substrate.	  
As	   discussed	   in	   section	   1.7.4,	   the	   activity	   of	   the	   human	   APC,	   a	   multimeric	   E3	   ligase,	   can	  
influence	   the	   rate	   of	   cell	   proliferation	   through	   manipulating	   the	   spindle	   checkpoint	   arrest	  
(Okamoto	   et	   al.,	   2003,	   Summers	   et	   al.,	   2008).	   This	   is	   consistent	   with	   evidence	   that	   over-­‐
expression	   of	   Arabidopsis	   CDC27a	   (an	   APC	   subunit)	   in	   tobacco	   is	   sufficient	   to	   increase	   cell	  
proliferation	   in	   the	   SAM	   (see	   section	   1.3.1)	   (Rojas	   et	   al.,	   2009).	   The	  Arabidopsis	   APC	   has	   at	  
least	   11	   subunits	   (Capron	   et	   al.,	   2003,	   Gieffers	   et	   al.,	   2001)	   and	   a	   multitude	   of	   interacting	  
proteins	  (Fülöp	  et	  al.,	  2005),	  presenting	  multiple	  possibilities	  for	  manipulating	  cell-­‐proliferation	  
rate.	   The	   molecular	   basis	   of	   the	   CDC27a	   overexpression-­‐dependent	   increase	   in	   cell	  
proliferation	   is	   thought	   to	  be	  an	   increase	   in	  APC-­‐mediated	  ubiquitin-­‐directed	  degradation	  of	  
mitotic	   cyclins	   (Irniger	  et	   al.,	   1995),	   anaphase	   inhibitors	   (Pellman	  and	  Christman,	  2001),	   and	  
regulators	  of	  DNA	  replication	  (Capron	  et	  al.,	  2003),	  which	  together	  accelerate	  the	  exit	  from	  M-­‐
phase	  and	  increase	  the	  rate	  of	  cell	  proliferation.	  
Another	  example	  relating	  ubiquitination	  to	  growth	  in	  Arabidopsis	  is	  that	  of	  the	  F-­‐BOX	  protein	  
SLY1	  (see	  section	  1.5.1).	  Its	  knockdown	  causes	  reduction	  in	  leaf	  area	  through	  a	  decrease	  in	  cell	  
proliferation	  rate	  (McGinnis	  et	  al.,	  2003,	  Dill	  et	  al.,	  2004).	  Unlike	  the	  APC,	  the	  targets	  of	  SLY1	  
are	  not	  at	  the	  level	  of	  the	  cell-­‐cycle,	  instead	  they	  are	  DELLA	  proteins	  (Dill	  et	  al.,	  2004),	  which	  
are	  negative	  regulators	  of	  gibberellin-­‐dependent	  growth	  promotion	  (Hauvermale	  et	  al.,	  2012,	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Davière	   and	   Achard,	   2013,	   Dixit,	   2013).	   This	   indicates	   that	   E3	   ligases	   mediate	   multiple	  
processes	  that	  influence	  growth.	  	  
Knockout	  mutations	  of	  two	  E3	  ligases,	  EOD1/BB	  and	  DA2	  (Disch	  et	  al.,	  2006,	  Xia,	  2013),	  have	  
large-­‐organ	  phenotypes,	  which	  are	  caused	  by	  a	  prolonged	  duration	  of	  cell	  proliferation	  during	  
organ	  formation.	  Despite	  their	  well-­‐characterised	  organ	  size	  phenotypes,	  little	  is	  known	  about	  
their	  targets.	  As	  discussed	  in	  section	  1.5.4,	  the	  observation	  that	  mutations	  in	  these	  genes	  are	  
not	   compensated	   for	   by	   decreased	   cell	   expansion	   might	   suggest	   that	   their	   substrates	   are	  
involved	  in	  spatial	  sensing	  during	  organ	  growth.	  
As	   well	   as	   those	   E3	   ligases	   that	   have	   well	   characterised	   organ-­‐size	   phenotypes	   (already	  
discussed	  in	  this	  section),	  there	  are	  also	  E3	  ligases	  and	  complex	  components	  that	  are	  involved	  
in	  pathways	  linking	  organ	  growth	  and	  development.	  These	  include	  the	  RING	  E3	  ligase,	  KEEP	  ON	  
GOING	  (KEG),	  which	  is	  a	  negative	  regulator	  of	  ABA	  signalling	  (Stone	  et	  al.,	  2006)	  and	  the	  F-­‐BOX	  
proteins	   EBF1	   and	   EBF2	   (EIN3-­‐BINDING	   F-­‐BOX),	   which	   promote	   growth	   via	   repression	   of	  
ethylene	   action	   (Gagne	   et	   al.,	   2004);	   both	   of	   which	   are	   linked	   to	   phytohormone	   growth	  
responses.	   The	   F-­‐BOX	   protein,	   UFO	   (UNUSUAL	   FLORAL	  ORGANS)	   is	   a	   regulator	   of	  meristem	  
development	  and	  floral	  organ	  identity	  in	  Arabidopsis	  (Levin	  and	  Meyerowitz,	  1995),	  and	  due	  to	  
the	   intimate	  relationship	  between	  organ	  size,	  shape	  and	   identity	  (discussed	   in	  section	  1.2.2),	  
its	  activities	  are	  also	  relevant	  to	  organ	  development	  in	  general.	  
Studies	  of	  cancer	  cell	  biology	  are	  much	  more	  advanced	  that	  those	  of	  plant	  development,	  and	  
as	   a	   consequence	   have	   identified	   many	   E3	   ligases	   involved	   in	   the	   regulation	   of	   cell	  
proliferation	  (Nakayama	  and	  Nakayama,	  2006).	  Despite	  significant	  differences	  between	  cancer	  
progression	  and	  the	  establishment	  of	  final	  organ	  size	  in	  plants,	  because	  they	  share	  the	  process	  
of	   cell	   proliferation,	   some	   degree	   of	   comparison	   is	   likely	   to	   be	   fruitful.	   Furthermore,	   as	  
regulation	  of	  the	  cell-­‐cycle	  is	  centrally	  important	  for	  cell-­‐proliferation	  control	  in	  both	  systems,	  
understanding	   the	   involvement	   of	   E3	   ligases	   in	   the	   regulation	   of	   the	   cell-­‐cycle	   in	   cancer	  
progression	  may	  shed	  valuable	  light	  on	  the	  role	  of	  ubiquitination	  in	  the	  control	  of	  final	  organ	  
size.	  
The	  F-­‐BOX	  protein	  SKP2	  is	  an	  oncogenic	  E3	  ligase	  subunit	  in	  humans,	  and	  has	  been	  shown	  to	  
promote	  cell	  proliferation	  by	  targeting	  several	  CKIs	  for	  proteolytic	  degradation	  (Nakayama	  and	  
Nakayama,	   2006).	   Although	   there	   are	   thought	   to	   be	   many	   targets	   of	   SKP2	   (Nakayama	   and	  
Nakayama,	  2006),	  its	  primary	  target	  is	  considered	  to	  be	  p27	  (Sutterlüty	  et	  al.,	  1999),	  which	  is	  a	  
CKI	   involved	   in	   negatively	   regulating	   the	   G1-­‐S-­‐phase	   transition	   and	   whose	   over-­‐expression	  
represses	   cell	   proliferation	   (Vlach	   et	   al.,	   1996).	   Conversely,	   the	   F-­‐BOX	   E3	   subunit	   FBW7	   is	   a	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tumour	   suppressor	   and	   acts	   to	   restrict	   cell	   proliferation	   through	   the	   negative	   regulation	   of	  
cell-­‐cycle	  promoters	  including	  CYCLIN	  E	  (Nakayama	  and	  Nakayama,	  2006,	  Tetzlaff	  et	  al.,	  2004).	  
CYCLIN	   E	   is	   a	   promoter	   of	   the	   G1-­‐S-­‐phase	   transition	   and	   therefore	   its	   ubiquitin-­‐directed	  
degradation,	   mediated	   by	   FBW7,	   is	   thought	   to	   repress	   cell-­‐cycling	   (Tetzlaff	   et	   al.,	   2004,	  
Nakayama	  and	  Nakayama,	  2006).	  
These	  examples	  from	  mammalian	  cancer	  biology	  demonstrate	  the	  potential	  roles	  played	  by	  E3	  
ligases	   in	  the	  promotion	  and	  repression	  of	  cell	  proliferation	  through	  direct	  regulation	  of	  cell-­‐
cycle	   promoters	   and	   repressors.	   Despite	   the	   fact	   that	   some	  mammalian	   E3	   ligases	   and	   cell-­‐
cycle	   regulators	   do	   not	   have	   homologs	   in	   higher	   plants,	   the	   overall	   close	   similarities	   in	   the	  
regulation	  of	  cell	  cycle	  progression,	  such	  as	  the	  common	  functions	  of	  proliferation	  promoting	  
cyclins	  and	  repressive	  CKIs	  (Dewitte	  and	  Murray,	  2003),	  indicates	  that	  exploring	  these	  systems	  
may	  lead	  to	  the	  identification	  of	  new	  E3	  ligases.	  
1.7.6	  –	  Ubiquitin-­‐like	  proteins	  also	  modulate	  protein	  function	  
In	  addition	  to	  ubiquitin,	  many	  organisms	  including	  higher	  plants	  encode	  ubiquitin-­‐like	  proteins	  
(UBLs).	  Although	  their	  sequences	  are	  relatively	  diverse,	  with	  sequence	  similarity	  ranging	  from	  
~50%	  	  (RUB	  (RELATED	  TO	  UBIQUITIN))	  to	  ~20%	  (mammalian	  AUT7)	  (Jentsch	  and	  Pyrowolakis,	  
2000,	  Schwartz	  and	  Hochstrasser,	  2003),	  all	  UBLs	   share	  a	   similar	   tertiary	   structure	  known	  as	  
the	   ubiquitin	   fold	   (Miura	   and	   Hasegawa,	   2010,	   Hochstrasser,	   2009).	   All	   UBLs	   are	   also	  
conjugated	   in	   to	   their	   substrate	   in	  a	   similar	  way	   to	  ubiquitin;	   through	  an	  ɛ-­‐amido	   linkage	  or	  
isopeptide	  bond	  between	  the	  C-­‐terminal	  glycine	  of	  the	  UBL	  and	  a	  lysine	  on	  the	  target	  protein	  
(Miura	  and	  Hasegawa,	  2010,	  Kerscher	  et	  al.,	  2006).	  In	  addition,	  all	  UBL	  conjugation	  pathways	  
also	  involve	  E1-­‐like,	  E2-­‐like	  and	  E3-­‐like	  proteins	  in	  a	  conjugation	  cascade.	  	  
The	  UBL,	  HUB1,	  which	  is	  involved	  in	  yeast	  cell	  polarisation	  (Dittmar	  et	  al.,	  2002),	  and	  which	  has	  
also	   been	   identified	   in	   Arabidopsis	   (Downes	   and	   Vierstra,	   2005),	   has	   a	   relatively	   poorly	  
understood	   conjugation	   cascade.	   SUMO	   (SMALL	   UBIQUITIN-­‐RELATED	   MODIFIER)	   and	   RUB	  
have	   been	   relatively	   well	   characterised	   in	   animals	   and	   plants	   and	   use	   hetero-­‐dimeric	   E1	  
complexes	   and	   specialist	   E2-­‐conjugating	   enzymes	   (Miura	   and	   Hasegawa,	   2010).	   SUMO	   and	  
RUB	   are	   activated	   by	   the	   hetero-­‐dimeric	   E1	   complexes	   SAE1-­‐SAE2	   (Castaño-­‐Miquel	   et	   al.,	  
2013)	  and	  AXR1-­‐ECR1/AXL1-­‐ECR1	  (Hotton	  et	  al.,	  2011)	  respectively.	  In	  addition	  SUMO	  and	  RUB	  
utilise	   the	  specialised	  E2-­‐conjugating	  enzymes	  SCE1	  and	  RCE1	  respectively	   (Dharmasiri	  et	  al.,	  
2007,	  Miura	  and	  Hasegawa,	  2010,	  Jentsch	  and	  Pyrowolakis,	  2000).	  Specialist	  E3-­‐ligase	  enzymes	  
are	   also	   required	   for	   ligating	  UBLs;	   SIZ1	  and	  HPY2	  are	   involved	   in	   sumoylation	   (Ishida	  et	   al.,	  
2009,	  Miura	  et	  al.,	  2010)	  and	  RBX1/ROC	  in	  rubylation	  (Miura	  and	  Hasegawa,	  2010).	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Although	   rubylation	   and	   sumoylation	   are	   the	   best-­‐studied	   processes	   in	   plant	   UBL	   biology,	  
rubylation	  appears	   to	  be	  a	   significantly	  more	   restricted	  process	  as	   its	  only	  known	  substrates	  
are	   the	   cullin	   subunits	  of	  multimeric	   E3	   ligases	   (Miura	  and	  Hasegawa,	  2010).	  Here	   it	  plays	  a	  
significant	   role	   in	   the	   regulation	   of	  multimeric	   E3	   activity	   and	   specificity	   (Duda	   et	   al.,	   2008,	  
Merlet	  et	  al.,	  2009).	  This	   is	  discussed	  in	  more	  detail	   in	  section	  5.1.2.	  In	  contrast,	  sumoylation	  
has	   been	   shown	   to	   be	   involved	   in	   a	   variety	   of	   biological	   processes	   including	   phytohormone	  
signalling,	   cold-­‐tolerance,	   meiosis,	   DNA	   damage	   responses	   and	   chloroplast	   development	  
(Miura	   et	   al.,	   2007,	   Budhiraja	   et	   al.,	   2009,	  Miura	   et	   al.,	   2009,	  Miura	   and	   Hasegawa,	   2010).	  
Furthermore,	   sumoylation	   plays	   a	   role	   in	   regulating	   the	   transition	   from	   cell-­‐proliferation	   to	  
cell-­‐expansion,	   with	   the	   SUMO	   E3	   ligase	   HIGH	   PLOIDY	   2	   (HPY2)	   characterised	   as	   a	   negative	  
regulator	  of	   the	  endocycle	   in	  Arabidopsis	   (Ishida	  et	  al.,	   2009).	   This	   study	   revealed	   that	  hpy2	  
mutants	  suffer	  premature	  mitotic	  exit	  and,	  as	  a	  consequence,	  have	  a	  dwarfed	  phenotype	  with	  
defective	  meristems	   (Ishida	  et	   al.,	   2009).	   In	   addition,	   the	  SUMO	  E3	   ligase	  SIZ1	   is	   involved	   in	  
regulating	  the	  salicylic-­‐acid-­‐mediated	  growth	  response,	  with	  siz1	  mutants	  exhibiting	  a	  dwarfed	  
phenotype	  (Miura	  et	  al.,	  2010).	  This	  phenotype	  includes	  a	  reduced	  leaf	  area	  and	  reduced	  root	  
biomass,	  as	  a	  consequence	  of	  altered	  cell	  proliferation	  and	  cell	  expansion	  respectively	  (Miura	  
et	  al.,	  2010).	  
	  
This	   chapter	   has	   reviewed	   the	   current	   state	   of	   knowledge	   surrounding	   the	   processes	  
governing	  organ	  formation	  and	  the	  setting	  of	  organ	  size	  in	  animals	  and	  plants.	  It	  has	  focused	  
on	  the	  contribution	  made	  by	  cell	  proliferation	  and	  cell	  expansion	  in	  the	  developing	  organ,	  and	  
detailed	   the	   identities	   and	   mechanisms	   of	   action	   of	   the	   key	   regulators	   of	   these	   processes.	  
Drawing	  on	  studies	  from	  animal	  systems,	  this	  chapter	  has	  explored	  possible	  models	  to	  explain	  
the	   apparent	   size-­‐checkpoint	   system	   that	   is	   evidenced	   by	   the	   presence	   of	   a	   compensation	  
mechanism	  in	  plant	  organ	  development.	  It	  has	  also	  focused	  on	  the	  role	  played	  by	  the	  cell	  cycle	  
in	  the	  regulation	  of	  organ	  size,	  and	  in	  particular	  on	  how	  modification	  of	  the	  cell	  cycle	  can	  drive	  
changes	  in	  the	  rate	  and	  duration	  of	  both	  cell	  proliferation	  and	  cell	  expansion.	  The	  importance	  
of	  the	  process	  of	  ubiquitination	  in	  the	  cell-­‐cycle	  and	  other	  organ-­‐growth	  regulatory	  pathways	  
has	   also	  been	  explored	  and	   the	  enzymatic	  processes	  underpinning	  ubiquitination	  have	  been	  
discussed	  in	  detail.	  	  
This	   thesis	   focuses	  on	   the	   role	  played	  by	  DA1	   in	   the	   regulation	  of	  organ	   size	   in	  Arabidopsis.	  
Chapter	  3,	  the	  first	  results	  chapter,	   focuses	  on	  the	  structure	  of	  the	  DA1	  protein	  and	  the	  role	  
played	  by	   its	   individual	  domains	   in	  DA1	  biochemistry	  and	  DA1-­‐dependent	  growth	  regulation.	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Chapter	  4	  explores	  the	  DA1	  interactome	  through	  a	  yeast-­‐2-­‐hybrid	  screen	  and	  seeks	  to	  link	  DA1	  
to	  upstream	  signalling	  events	  as	  well	  as	  to	  downstream	  regulation	  of	  the	  cell-­‐cycle.	  Chapter	  5	  
looks	  in	  detail	  at	  the	  DA1-­‐EOD1	  and	  DA1-­‐DA2	  interactions	  and	  explores	  the	  role	  played	  by	  DA1	  
in	   the	   regulation	   of	   growth	   through	   the	   Arabidopsis	   ubiquitin	   system.	   Complementing	   the	  
function	  analysis	  of	  DA1	  in	  Chapters	  3-­‐5,	  Chapter	  6	  describes	  two	  large	  scale	  genetic	  analyses	  
conducted	   to	   screen	   for	   novel	   regulators	   of	   organ	   growth	   in	   Arabidopsis,	   as	   well	   as	   to	  





Chapter	  2	  -­‐	  Materials	  and	  Methods	  
	  
2.1	  –	  Reagents	  
General	   reagents	  used	   in	   this	   thesis	  were	  purchased	  from	  Merk	  Chemicals	  Ltd.	   (Nottingham,	  
UK),	   Sigma-­‐Aldrich	   Company	   Ltd.	   (Gillingham	   UK),	   Melford	   Laboratories	   Ltd.	   (Ipswich,	   UK),	  
New	  England	  Biolabs	  UK	  Ltd.	  (Herts,	  UK),	  Qiagen	  Ltd.	  (Manchester,	  UK),	  Bio-­‐Rad	  Laboratories	  
Ltd.	   (Herts,	  UK),	  and	  Santa	  Cruz	  Biotechnology	   Inc.	   (Texas,	  USA).	  Reagents	  used	   for	  ubiquitin	  
biochemistry	  were	  obtained	  from	  Boston	  Biochem	  Inc.	  (Massachusetts,	  USA).	  	  
2.2	  –	  Recombinant	  DNA	  work	  
Some	  constructs	  described	  in	  this	  thesis	  were	  made	  by	  Neil	  McKenzie	  (Bevan	  Lab).	  
2.2.1	  –	  Agarose	  gel	  electrophoresis	  	  
0.8%	  or	  1%	  agarose	  gels	  were	  made	  by	  dissolving	  agarose	  in	  1x	  TRIS-­‐acetate-­‐EDTA	  (TAE).	  The	  
agarose	  was	  mixed	  with	  TAE	  and	  heated	  in	  a	  microwave	  oven	  until	  boiling	  and	  dissolution	  of	  
the	  agarose.	  The	  solution	  was	  cooled	  at	   room	  temperature	  before	  being	  mixed	  with	  0.005%	  
(v/v)	  ethidium	  bromide	  and	  poured	  into	  a	  custom	  gel	  tray.	  The	  gel	  was	  then	  left	  to	  set	  at	  room	  
temperature.	  When	   set,	   the	   gel	  was	   placed	   in	   a	   custom	   gel	   tank	   and	   immersed	   in	   1%	   TAE.	  
Samples	   were	   mixed	   with	   10X	   DNA	   loading	   buffer	   (0.25%	   (w/v)	   Bromophenol	   Blue,	   0.01%	  
(w/v)	   SDS	   ,	   4%	   (w/v)	   glycerol,	   and	  0.5	  mM	  EDTA)	  and	   loaded	   in	  either	  10μl	  or	  20μl	   aliquots	  
onto	  the	  gel.	  Samples	  were	  run	  in	  parallel	  with	  3μl	  of	  1Kb	  DNA	  Ladder	  (New	  England	  BioLabs)	  
at	  80-­‐150V.	  Gels	  were	  analysed	  using	  an	  AlphaImager	  EP	  gel	  analyser	  (Alpha	  Innotech,	  USA).	  
2.2.2	  –	  PCR	  amplification	  of	  DNA	  
All	  PCR	  protocols	  used	  dNTP	  solutions	  made	  from	  a	  100mM	  dNTP	  stock	  solution	  consisting	  of	  
dATP,	   dGTP,	   dCTP,	   dTTP	   (Promega	   U1240).	   PCRs	   were	   carried	   out	   in	   either	   individual	   PCR	  
tubes	   (4titude	  4TI-­‐0790),	   strips	   of	   eight	   PCR	   tubes	   (4titude	   	   4TI-­‐0780)	   or	   96	  well	   PCR	  plates	  
(Fisher	  Scientific	  11757533),	  and	  were	  run	  using	  the	  PTC200	  PCR	  machine	  (MJ	  Research).	  
2.2.2.1	  –	  High	  fidelity	  PCR	  amplification	  of	  DNA	  
High	   fidelity	  PCR	  was	  used	   to	   amplify	   cDNA	   in	   the	   cloning	  of	  whole	   gene	   coding	   sequences.	  
The	  cDNA	  used	  in	  this	  thesis	  was	  kindly	  provided	  by	  Mathilde	  Seguela.	  This	  protocol	  uses	  the	  
Phusion®	   High-­‐Fidelity	   DNA	   Polymerase	   kit	   from	  New	   England	   BioLabs	   Ltd	   (M0530S).	   It	   is	   a	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‘Hot-­‐Start’	  protocol	  and	  requires	  the	  addition	  of	  Phusion®	  High-­‐Fidelity	  DNA	  Polymerase	  once	  





2.2.2.2	  –	  Colony	  PCR	  
This	  PCR	  protocol	  was	  used	  to	  assay	  for	  successful	  transformation	  of	  Escherichia	  coli	  (E.	  coli).	  	  
Using	  a	  10μl	  pipette	  tip,	  1μl	  of	  either	   liquid	  culture	  or	  plated	  culture	  was	  added	  to	  each	  PCR	  
tube.	  PCR	  tubes	  were	  then	  vortex	  for	  10	  seconds	  and	  loaded	  into	  the	  PCR	  machine.	  
	   	   	  
	   	  
Reagent	   Volume	  (μl)	   STEP	   Temperature	  
Time	  
(minutes)	  
Ultra-­‐pure	  Water	   15	   1	   98°C	   3	  
10X	  PCR	  Buffer	  (Qiagen	  201203)	   2	   2	   98°C	   0.5	  
Forward	  Primer	   0.4	   3	   55°C	   0.5	  
Reverse	  Primer	   0.4	   4	   72°C	   2	  
dNTPs	  (10mM)	   0.4	   	  	   	  29x	  repeats	  	  of	  steps	  2-­‐4	   	  
Taq	  Polymerase	  (Qiagen	  201203)	   0.8	   5	   72°C	   5	   	  
Template	  DNA	   1	  
	  
	   	  
TOTAL	   20	  
	  
	   	  
Table	  2.2	  –	  Colony	  PCR	  protocol	   	   	   	   	  
	  
	   	   	  
	   	  
Reagent	   Volume	  (μl)	   STEP	   Temperature	  
Time	  
(minutes)	  
Ultra-­‐pure	  Water	   34	   1	   98°C	   3	  
Phusion®	  HF	  Buffer	   10	   2	   98°C	   0.5	  
dNTPs	  (10mM)	   1	   3	   60°C	   0.5	  
Forward	  Primer	   2	   4	   72°C	   1	  
Reverse	  Primer	   2	  
	  
	  30x	  repeats	  	  of	  steps	  2-­‐4	   	  
Template	  DNA	   0.5	   5	   72°C	   5	  
Phusion®	   High-­‐Fidelity	   DNA	  
Polymerase	   0.5	  
	  
	   	  
TOTAL	   50	  
	  
	   	  
Table	  2.1	  –	  High	  Fidelity	  PCR	  protocol	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2.2.2.3	  –	  YeastAmp	  PCR	  
This	  PCR	  protocol	  was	  used	  to	  amplify	  DNA	  from	  yeast	  miniprep	  products.	  
	   	   	  
	   	  
Reagent	   Volume	  (μl)	   STEP	   Temperature	  
Time	  
(minutes)	  
Ultra-­‐pure	  Water	   36.25	   1	   94°C	   3	  
10X	   PCR	   Buffer	   (Invitrogen	  
18067-­‐017)	   5	   2	   94°C	   0.5	  
MgCl	  (50mM)	   1.5	   3	   56°C	   0.5	  
Forward	  Primer	   2.5	   4	   72°C	   2	  
Reverse	  Primer	   2.5	   	  	   	  30x	  repeats	  	  of	  steps	  2-­‐4	   	  
dNTPs	  (10mM)	   1	   5	   72°C	   5	  
TaqPolymerase(Invitrogen	  10342)	   0.25	  
	  
	   	  
TOTAL	   50	  
	  
	   	  
Table	  2.3	  –	  YeastAmp	  PCR	  protocol	   	   	   	   	  
	  
2.2.2.4	  –	  Sequencing	  PCR	  reaction	  
DNA	  was	  submitted	   to	  The	  Genome	  Analysis	  Centre	   (Norwich,	  UK)	   for	   sequencing	  as	   ‘ready-­‐
reactions’.	   Prior	   to	   submission,	   the	   sequencing	   sample	   was	   prepared	   using	   the	   PCR	   based	  
BigDye®	   Terminator	   v3.1	   Cycle	   Sequencing	   Kit	   from	   Invitrogen	   (Invitrogen	   28002870).	  
Sequencing	  data	  was	  analysed	  using	  the	  VectorNTI	  contigExpress	  software	  (Invitrogen	  A14470).	  
	   	   	  
	   	  
Reagent	   Volume	  (μl)	   STEP	   Temperature	  
Time	  
(minutes)	  
Template	  DNA	   1	   1	   96°C	   0.5	  
Primer	   0.32	   2	   50°C	   0.25	  
BigDye	   1	   3	   60°C	   4	  
Ultrapure	  water	   6.18	   	  	  
	  30x	   repeats	   	   of	   steps	  
2-­‐4	  
	  
TOTAL	   50	   5	   14°C	   5	   	  
Table	  2.4	  –	  Sequencing	  PCR	  protocol	   	   	   	   	  
	  
2.2.2.5	  –	  Site-­‐directed	  mutagenesis	  of	  DNA	  
This	  technique	  was	  used	  for	  the	  site-­‐directed	  mutagenesis	  of	  the	  DA1	  peptidase	  domain.	  It	  was	  
carried	  out	  using	  Primers	  for	  the	  3’	  and	  5’	  termini	  of	  DA1	  as	  well	  as	  mutagenic	  primers	  for	  the	  
peptidase	  domain	  (see	  section	  2.2.8).	  	  
Two	  first-­‐step	  PCRs	  were	  carried	  out	  using	  the	  high-­‐fidelity	  PCR	  documented	  in	  section	  2.2.2.1;	  
the	   first	   containing	   the	  DA1	  5’	   forward	  primer	  and	   the	   reverse	  peptidase	  mutagenic	  primer,	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and	   the	   second	  containing	   the	   forward	  peptidase	  mutagenic	  primer	  and	   the	  DA1	  3’terminus	  
reverse	   primer.	   PCR	   products	   from	   each	   reaction	   were	   purified	   using	   the	   PCR	   purification	  
technique	   described	   in	   section	   2.3.3.2.	   A	   second	   high	   fidelity	   PCR	   reaction	   was	   carried	   out	  
using	  the	  products	  of	  both	  first-­‐step	  PCRs	  and	  the	  DA1	  5’	  forward	  and	  3’	  reverse	  primers.	  
2.2.2.5	  –	  Genotyping	  of	  transgenic	  plants	  
Using	  genomic	  DNA	  extracted	  from	  the	  appropriate	  plants	  (section	  2.2.3.4)	  and	  the	  Colony	  PCR	  
protocol	  (2.2.2.2).	  PCRs	  using	  the	  T-­‐DNA	  border	  primer	  (BP)	  and	  the	  right	  genomic	  primer	  (RP)	  
were	  used	  to	  detect	  the	  T-­‐DNA	  insert,	  whereas	  PCRs	  using	  the	  left	  genomic	  primer	  (LP)	  and	  RP	  
were	  used	   to	   confirm	  no	   insertion.	  Homozygotes	   for	   the	  T-­‐DNA	   insertion	   contained	  a	  BP-­‐RP	  
PCR	  fragment	  only,	  heterozygotes	  contained	  both	  BP-­‐RP	  and	  LP-­‐RP	  PCR	  fragments,	  and	  wild-­‐
type	  plants	  contained	  only	  LP-­‐RP	  PCR	  fragments.	  
A	  similar	  technique	  was	  used	  to	  detect	  binary	  vector	  insertions	  in	  genomic	  DNA.	  
2.2.3	  –	  DNA	  Purification	  
2.2.3.1	  –	  DNA	  extraction	  from	  E.coli	  
Miniprep	   DNA	   extraction	   from	   E.	   coli	   was	   carried	   out	   using	   the	   Qiagen	   Spin	   Miniprep	   Kit	  
(Qiagen	  27104),	  according	  to	  the	  manufacturer’s	  instructions.	  Samples	  were	  eluted	  in	  30μl	  of	  
Qiagen	  Buffer	  EB.	  
Large	  quantities	  of	  DNA	  were	  extracted	  from	  E.	  coli	  using	  the	  Qiagen	  Plasmid	  Maxi	  Kit	  (Qiagen	  
12162),	   according	   to	   the	   manufacturer’s	   instructions.	   The	   DNA	   pellet	   was	   resuspended	   in	  
200μl	  in	  1x	  ultrapure	  water.	  
2.2.3.2	  –	  DNA	  extraction	  from	  PCR	  solutions	  and	  agarose	  gels	  
DNA	   was	   extracted	   from	   completed	   PCR	   reactions	   using	   the	   QIAquick	   PCR	   Purification	   Kit	  
(Qiagen	   28104),	   according	   to	   the	   manufacturer’s	   instructions.	   Samples	   were	   eluted	   in	   30μl	  
Qiagen	  Buffer	  EB.	  	  
Specific	  DNA	  fragments	  were	  extracted	  from	  completed	  PCR	  reactions	  and	  restriction	  digests	  
using	   the	   QIAquick	   Gel	   Extraction	   Kit	   (Qiagen	   Ltd	   28704),	   according	   to	   the	   manufacturer’s	  
instructions.	  Samples	  were	  eluted	  in	  30μl	  Qiagen	  Buffer	  EB.	  
2.2.3.3	  –	  DNA	  extraction	  from	  yeast	  
	  DNA	  was	  extracted	  from	  yeast	  using	  the	  Qiagen	  Spin	  Miniprep	  Kit	   (Qiagen	  Ltd	  27104)	  and	  a	  
modified	  protocol.	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1.5ml	  of	  an	  overnight	  yeast	  culture	  (see	  section	  2.7)	  was	  pelleted	  at	  600x	  g	  for	  2	  minutes	  and	  
the	   supernatant	   discarded.	   250μl	   Qiagen	   Buffer	   P1	   (RNAase	   added)	   was	   mixed	   with	   3μl	  
Zymolase	  (Zymo	  Research	  E1004)	  and	  added	  to	  the	  pelleted	  yeast.	  The	  pellet	  was	  resuspended	  
and	  incubated	  at	  37	  °C	  for	  one	  hour.	  Following	  incubation,	  the	  remainder	  or	  the	  Qiagen	  Spin	  
Miniprep	   Kit	   manufacturer’s	   protocol	   was	   followed	   (beginning	   with	   the	   addition	   of	   250μl	  
Qiagen	  Buffer	  P2).	  Samples	  were	  eluted	  in	  30μl	  Qiagen	  Buffer	  EB.	  
2.2.3.4	  –	  DNA	  extraction	  from	  plants	  	  
A	   single	   leaf	  was	  placed	   in	   a	   1.5ml	   eppendorf	   tube	  and	  ground	  with	   a	  disposable	   grinder	   in	  
150μl	   REB	   buffer	   (50mM	   TRIS-­‐HCL	   pH8,	   25mM	   EDTA,	   250mM	  NaCl,	   0.5%	   (w/v)	   SDS).	   150μl	  
Phenol:Chlorophorm:Isoamyl	   alcohol	   (Sigma-­‐Aldrich	   P3803)	   was	   added	   to	   each	   tube	   and	  
vortexed	  for	  10	  seconds,	  before	  centrifuging	  for	  5minutes	  at	  16	  000x	  g.	  130μl	  of	  the	  aqueous	  
phase	   was	   then	   transferred	   to	   a	   clean	   1.5ml	   eppendorf	   tube,	   where	   the	   addition	   110μl	   of	  
isopropanol	  was	   followed	  by	   centrifuging	   for	  30	  minutes	  at	  16	  000x	  g.	   The	   supernatant	  was	  
discarded,	  the	  pellet	  was	  washed	  with	  50μl	  70%	  ethanol,	  and	  the	  tube	  was	  centrifuged	  for	  a	  
further	  minute	  at	  16	  000x	  g.	  The	  ethanol	  supernatant	  was	  discarded	  and	  the	  pellet	  was	  left	  to	  
dry	  at	  room	  temperature	  for	  one	  hour,	  before	  being	  resuspended	  in	  50μl	  of	  ultrapure	  water.	  
2.2.4	  –	  Subcloning	  	  
2.2.4.1	  –	  Restriction	  digestion	  of	  DNA	  
Restriction	  digests	  were	   carried	  out	  using	   restriction	  endonuclease	  enzymes	  purchased	   from	  
New	   England	   BioLabs	   (BamHI	   (R3136T/M),	   XhoI	   (R0146M),	  NotI	   (R3189M),	   SalI	   (R3138T/M),	  
NdeI	   (R0111S),	   NheI	   (R0131S),	   EcoRI	   (R0101S))	   using	   the	   appropriate,	   designated	   buffers.	  
Restriction	   digests	   were	   carried	   out	   in	   a	   20μl	   reaction	   volumes	   containing	   1μl	   restriction	  
endonuclease,	  2μl	  manufacturer’s	   reaction	  buffer	   and	  made	  up	   to	  20μl	  with	   sample	  DNA	  or	  
ultrapure	  water.	  Restriction	  digests	  were	  carried	  out	  for	  two	  hours	  at	  37°C.	  
2.2.4.2	  –	  DNA	  ligation	  
DNA	   ligations	  were	  carried	  out	  using	  the	  LigaFast	  Rapid	  DNA	  Ligation	  System	  from	  Promega.	  
Reactions	  were	  carried	  out	  in	  a	  volume	  of	  10μl,	  including	  5μl	  2x	  LigaFast	  Rapid	  Ligation	  Buffer	  
(Promega	  C671A)	  and	  1μl	  T4	  DNA	   ligase	   (Promega	  M1801).	  The	  amount	  of	  vector	  and	   insert	  
DNA	  was	  calculated	  using	  the	  following	  formula	  (from	  Promega)	  and	  the	  reaction	  volume	  was	  






ngof	  vector	  x	  size	  of	  insert	  (kb)	  
Size	  of	  vector	  (kb)
Insert
x	  	  ratio	  of	  
vector




2.2.4.3	  –Klenow	  reaction	  
The	   Klenow	   polymerase	   reaction	   was	   used	   to	   blunt	   5’	   overhangs	   (created	   from	   restriction	  
digestion),	   prior	   to	   ligation.	   The	   DNA	   Polymerase	   I,	   Large	   (Klenow)	   Fragment	   kit	   from	   New	  
England	  BioLabs	  Ltd	  (M0210S)	  was	  used	  for	  this	  work.	  A	  20μl	  reaction	  was	  used	  containing	  1-­‐
4μg	  template	  DNA,	  2μl	  NEBuffer	  2,	  0.8μl	  1mM	  dNTPs	  (see	  section	  2.2.2),	  1μl	  DNA	  Polymerase	  I,	  
Large	   (Klenow)	   Fragment	   and	   nuclease-­‐free	   water.	   The	   reaction	   was	   run	   for	   30	  minutes	   at	  
room	  temperature.	  
2.2.5	  –	  Transforming	  bacteria	  
2.2.5.1	  –	  Bacterial	  strains	  
Subcloning	   efficiency	   DH5α	   competent	   E.	   coli	   (Invitrogen	   18265017)	   were	   used	   for	   general	  
subcloning	   and	   DNA	   generation	   for	   protoplast	   work.	   ONE	   SHOT	   BL21	   (DE3)	   pLYSs	   E.	   coli	  
(Invitrogen	  C606010)	  were	  used	  for	  in	  vitro	  protein	  expression.	  TOP10	  One	  Shot	  competent	  E.	  
coli	   (Invitrogen	   C404003)	   were	   used	   in	   the	   Yeast-­‐2-­‐Hybrid	   analysis.	   GV3101	   Agrobacterium	  
tumefaciens	   (kindly	   provided	   by	   Kim	   Johnston)	   were	   used	   for	   stable	   transformation	   of	  
Arabidopsis.	  
2.2.5.2	  –	  Preparation	  of	  electro-­‐competent	  GV3101	  A.	  tumefaciens	  
A	  50ml	  LB	  culture	  of	  GV3101	  was	  grown	  overnight	  at	  28°C	  with	  the	  appropriate	  antibiotics	  (see	  
section	  2.2.5.5).	  The	  following	  day	  400ml	  of	  fresh	  LB	  was	  inoculated	  with	  4ml	  of	  the	  overnight	  
culture	  and	  grown	  at	  28°C	  until	  the	  OD600	  value	  was	  between	  0.4	  and	  0.7.	  At	  this	  point,	  the	  
entire	  400ml	  culture	  was	  stored	  on	  ice	  for	  15	  minutes	  before	  centrifuging	  at	  3000x	  g	  for	  10	  
minutes	  (at	  4°C).	  The	  supernatant	  was	  discarded	  and	  the	  pellet	  re-­‐suspended	  in	  10ml	  
ultrapure	  water,	  before	  being	  centrifuged	  for	  10	  minutes	  at	  3000x	  g	  (4°C).	  The	  supernatant	  
Figure	  2.1	  –	  Equation	  for	  DNA	  ligation	  reaction	  
Equation	  used	  to	  calculate	  the	  mass	  of	  vector	  and	  insert	  DNA	  for	  DNA	  ligation	  reactions.	  Equation	  
adapted	  from	  the	  Promega	  Subcloning	  Notebook	  	  (http://www.promega.co.uk).	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was	  discarded	  and	  the	  pellet	  re-­‐suspended	  once	  more	  in	  10ml	  ultrapure	  water.	  This	  
supernatant	  was	  then	  discarded	  and	  the	  pellet	  re-­‐suspended	  in	  10ml	  10%	  (v/v)	  glycerol	  before	  
being	  transferred	  to	  a	  50ml	  Falcon	  tube	  and	  centrifuged	  at	  3000x	  g	  for	  10	  minutes.	  The	  pellet	  
was	  re-­‐suspended	  in	  1ml	  of	  10%	  (v/v)	  glycerol,	  aliquoted	  into	  40μl	  volumes,	  frozen	  in	  liquid	  
nitrogen	  and	  stored	  at	  -­‐80°C.	  This	  method	  was	  adapted	  from	  the	  John	  Innes	  Centre	  Standard	  
Operating	  Procedure	  (CDB-­‐SC-­‐023)	  written	  by	  Nicola	  Stacey.	  
2.2.5.3	  –	  Chemical	  transformation	  of	  bacteria	  
This	   technique	  was	  used	   for	  DH5α	  competent	  E.	  coli	   (Invitrogen	  18265017),	  ONE	  SHOT	  BL21	  
(DE3)	  pLYSs	  E.	  coli	  (Invitrogen	  Ltd	  C606010)	  and	  TOP10	  One	  Shot	  competent	  E.	  coli	  (Invitrogen	  
C404003).	  	  
1-­‐10µg	  (in	  1-­‐5μl)	  of	  DNA	  was	  added	  to	  a	  50μl	  aliquot	  of	  bacteria	  in	  a	  1.5ml	  tube	  and	  incubated	  
on	  ice	  for	  30	  minutes.	  The	  tube	  was	  heat-­‐shocked	  for	  30	  seconds	  at	  42°C	  and	  returned	  to	  ice	  
for	  two	  minutes.	  250μl	  of	  S.O.C	  medium	  (Invitrogen	  15544-­‐034)	  was	  added	  to	  each	  tube	  and	  
then	  the	  tubes	  were	  incubated	  at	  37°C	  for	  one	  hour	  at	  220rpm.	  After	  this	  incubation	  step,	  50μl	  
of	   the	   transformation	   solution	  was	   pipetted	   onto	   an	   appropriate	   plate	   (see	   section	   2.2.5.5)	  
and	  incubated	  overnight	  at	  37°C.	  
2.2.5.4	  –	  Electro-­‐transformation	  of	  bacteria	  
This	  technique	  was	  used	  for	  the	  transformation	  of	  GV3101	  A.	  tumefaciens.	  	  
1-­‐10µg	   (in	   1-­‐5μl)	   of	   DNA	   was	   added	   to	   a	   40μl	   aliquot	   of	   electro-­‐competent	   bacteria	   in	   an	  
electroporation	   cuvette	   (Geneflow	   E6-­‐0060)	   on	   ice.	   An	   electric	   pulse	   was	   applied	   (field	  
strength:	   1.25kv/mm,	   capacitance:	   25uF,	   resistance:	   400Ω,	   pulse	   length:	   8-­‐12milliseconds),	  
immediately	   followed	   by	   the	   transfer	   of	   cells	   to	   1ml	   of	   LB	   in	   a	   1.5ml	   tube.	   The	   bacterial	  
solution	   was	   then	   incubated	   at	   28°C	   for	   one	   hour	   followed	   by	   plating	   10μl	   and	   100μl	   on	  
appropriate	  plates	  (see	  section	  2.2.5.5)	  and	  incubation	  at	  28°C	  for	  three	  days.	  	  
2.2.5.5	  –	  Making	  plates	  
	   	   	  
LB	   1%	  (w/v)	   Tryptone	  
	   0.5%	  (w/v)	   Yeast	  Extract	  
	   1%	  	  (w/v)	   NaCl	  
	   1%	  (w/v)	   Agar	  (for	  solid	  LB)	  
	   Adjusted	  to	  pH	  7.0	  with	  NaOH	   	  
Table	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100ml	  of	  LB	  agar	  (sufficient	  volume	  for	  three	  90mm	  petri	  dishes)	  was	  melted	  in	  a	  microwave	  
and	  left	  to	  cool	  at	  room	  temperature.	  When	  cooled,	  relevant	  antibiotics	  were	  added	  to	  their	  
respective	   final	   concentrations	   (kanamycin	   50µg.ml-­‐1,	   ampicillin	   100µg.ml-­‐1,	   gentamycin	  
10µg.ml-­‐1,	   spectinomycin	   50µg.ml-­‐1,	   carbenicillin	   100µg.ml-­‐1,	   rifampicin	   25µg.ml-­‐1)	   and	   plates	  
were	   poured.	  When	  making	   plates	   for	  A.	   tumefaciens,	   all	   antibiotics,	   with	   the	   exception	   of	  
rifampicin,	  were	  added	  at	  half	  the	  concentrations	  stated	  above.	  
2.2.6	  –	  Vectors	  




2.2.7	  –	  Primers	  
All	  primers	  used	  in	  this	  thesis	  were	  purchased	  from	  either	  from	  Sigma	  Genosys	  (Sigma-­‐Aldrich)	  
or	  Metabion	  International	  AG,	  Germany.	  
	  
	  
	   	   	   	  
Vector	  Name	  	   Vector	  Type	  	   Vector	  Layout	  	   Reference	  	  
pAM-­‐GW-­‐YFPc	   Binary	  Vector	   35S-­‐Gateway-­‐YFPc	   Lefebvre	  et	  al,	  2010	  
pAM-­‐GW-­‐YFPn	   Binary	  Vector	   35S-­‐Gateway-­‐YFPn	   Lefebvre	  et	  al,	  2010	  
pAM-­‐YFPn-­‐GW	   Binary	  Vector	   35S-­‐YFPn-­‐Gateway-­‐	   Lefebvre	  et	  al,	  2010	  
pAM-­‐YFPc-­‐GW	   Binary	  Vector	   35S-­‐YFPc-­‐Gateway-­‐	   Lefebvre	  et	  al,	  2010	  
pEarleyGate	  201	   Binary	  Vector	   35S-­‐HA	  tag-­‐Gateway-­‐	   Earley	  et	  al,	  2006	  
pw1211	   Binary	  Vector	   35S-­‐Gateway-­‐FLAG	  tag	   Phil	  Wigge,	  SLCU	  
pMDC32	   Binary	  Vector	   35S-­‐Gateway-­‐FLAG	  tag	   (Curtis	  and	  Grossniklaus,	  2003)	  
pAmiR	   Binary	  Vector	   35S-­‐amiRNA	   (Schwab	  et	  al.,	  2006)	  
pGEX4T2	   In	  vitro	  expression	   Ptac-­‐GST-­‐polylinker	   GE	  Life	  Science	  
pGEX4T1	   In	  vitro	  expression	   Ptac-­‐GST-­‐polylinker	   GE	  Life	  Science	  
pET24a	   In	  vitro	  expression	   T7-­‐polylinker-­‐HIS	   Novagen	  
peTnT	   In	  vitro	  expression	   T7-­‐FLAG-­‐HA-­‐polylinker-­‐HIS	   Adapted	  from	  Novagem	  
Table	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Primer	  Identity	   Primer	  sequence	  
Primers	  for	  pGEX4T2	  cloning	   	  	  
DA1	   Forward	   gcgggatccGGTTGGTTTAACAAGATCTT	  
	  	   Reverse	   cgccgctcgagTTAAACCGGGAATCTAC	  
DAR1	   Forward	   gcgggatccGGGTGGCTAACTAAAATCCTTA	  
	  	   Reverse	   ccgctcgagTTAAGGAAATGTACCGGTCAAG	  
GUS	   Forward	   cggGGATCCgtccgtcctgtagaaaccc	  
	  	   Reverse	   ggcCTCGAGttgtttgcctccctgctg	  
DA2	   Forward	   CGAggatccGTAATAAGTTGGGAAGGAAGAG	  
	  	   Reverse	   ccgCTCGAGttattgccaggtaacttcagtt	  
Primers	  for	  pETnT	  cloning	   	  	  
DA1	   Forward	   gcgggatccGGTTGGTTTAACAAGATCTT	  
	  	   Reverse	   cgccgctcgagAACCGGGAATCTACCGGTC	  
GUS	   Forward	   cggGGATCCgtccgtcctgtagaaaccc	  
	  	   Reverse	   ggcCTCGAGttgtttgcctccctgctg	  
Nterm	   Forward	   gcgggatccGGTTGGTTTAACAAGATCTT	  
	  	   Reverse	   ggcCTCGAGaggatgatatctctccctgtaac	  
Cterm	   Forward	   cggGGATCCaaatgtgatgtctgcagccacttt	  
	  	   Reverse	   ggcCTCGAGaaccgggaatctaccggtcatct	  
TCP15	   Forward	   gcggtcgacaATGGATCCGGATCCGGATCA	  
	  	   Reverse	   cgtctcgagGGAATGATGACTGGTGC	  
LRRfrag	   Forward	   gtgaattcGCAGGCACATTCGGTTAT	  
	  	   Reverse	   gtgctcgagCCGACCATCAGCTGAATCG	  
DA2	   Forward	   CGAggatccGTAATAAGTTGGGAAGGAAGAG	  
	  	   Reverse	   ccgCTCGAGTTGCCAGGTAACTTCAGTTG	  
EOD1	   Forward	   cgaggatccAATGGAGATAATAGACCAGTGGA	  
	  	   Reverse	   ccgctcgagATGAATGCTGGGCTCCCCA	  
BBR	   Forward	   TATAGAATTCATGCCCATGGAGAACGACA	  
	  	   Reverse	   TATACTCGAGGCTTTGTCCAGAGGTCGAAG	  
DA1pep	   Forward	  (mutagenic)	  
GGTTCGATTCTAGCTGCAGAGATGATGGCAGCGT
GGATGAGGCTC	  
	  	   Reverse	  (mutagenic)	  
GAGCCTCATCCACGCTGCCATCATCTCTGCAGCTA
GAATCGAACC	  
SIS3	   Forward	   TATAGGATCCATGGCGATGAGAGGTGTC	  
	  	   Reverse	   TATACTCGAGTCTCCGAGATGGAGATAGATCG	  
Primers	  for	  pDBleu	  cloning	   	  	  
DA1(truncated)	   Forward	   gaggtcgaCTATTACTTTTCAAATGGATTTC	  
	  	   Reverse	   aaagcggccgcTTAAACCGGGAATCTACCGG	  
Primers	  for	  pEXP-­‐AD502	  cloning	   	  	  
TCP15	   Forward	   gcggtcgacaATGGATCCGGATCCGGATCA	  
	  	   Reverse	   ggtgcggccgcCTAGGAATGATGACTGGTG	  
LRR	   Forward	   ttgtcgaccATGGAGGCTCCTACGCC	  
	  	   Reverse	   atgcggccgcTCACCGACCATCAGCTG	  
Table	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Primers	  for	  Sequencing	   	  	  
T7	   Forward	   AATACGACTCACTATAGG	  
	  	   Reverse	   GCTAGTTATTGCTCAGCG	  
pDBleu	   Forward	   CAAGCTATACCAAGCATACAATC	  
	  	   Reverse	   ACCTCTGGCGAAGAAGTCCAAAGC	  
pEXP-­‐AD502	   Forward	   Tataacgcgtttggaatcact	  
	  	   Reverse	   Taaatttctggcaaggtagac	  
pAMIR	   Forward	   ATATAAGGAAGTTCATTTCATTTGGAG	  
	  	   Reverse	   Gagcctcgacatgttgtcgc	  
p35S	   Forward	   Tcgcaagacccttcctctatataagga	  
M13	   Forward	   Gtaaaacgacggccag	  
	  	   Reverse	   Caggaaacagctatgac	  
Primers	  for	  pENTr	  cloning	   	  	  
DA1	   Forward	   caccATGGGTTGGTTTAACAAGATC	  
	  	   Reverse	  (STOP)	   TTAAACCGGGAATCTACCGGTC	  
	  	   Reverse	  (NO	  STOP)	   AACCGGGAATCTACCGGTCATC	  
DA2	   Forward	   caccATGGGTAATAAGTTGGGAAGGA	  
	  	   Reverse	  (STOP)	   ccgCTCGAGttattgccaggtaacttcagtt	  
	  	   Reverse	  (NO	  STOP)	   ccgCTCGAGTTGCCAGGTAACTTCAGTTG	  
EOD1	   Forward	   caccATGAATGGAGATAATAGA	  
	  	   Reverse	  (STOP)	   TCAATGAATGCTGGGCTCC	  
	  	   Reverse	  (NO	  STOP)	   ATGAATGCTGGGCTCCCCA	  
BBR	   Forward	   caccATGCCCATGGAGAACGAC	  
	  	   Reverse	  (NO	  STOP)	   GCTTTGTCCAGAGGTCGAAG	  
Primers	  for	  plant	  genotyping	   	  	  
da1ko1	   Salk_126092	  LP	   AAGCCAGCTAAATATGATTGG	  
	  	   Salk_126092	  RP	   AATCCGTTTGGAACTCGTTTG	  
tcp14	   N108688	  SMLP	   	  CGCTTCCACTTTTAGCCCTAATAACATA	  
	  	   N108688	  SMRP	   	  TGTTTTTGTGTGTGTCTAATCTTGCTGAT	  
	  
N108688	  3’dSpm32	   TACGAATAAGAGCGTCCATTTTAGAGTGA	  
tcp15	   SALK_011491	  LP	  	   	  AGAACCACGTAAGCCCATCTC	  
	  	   SALK_011491	  RP	   	  CACCACTACTCCAAAACGGTG	  
eod1-­‐2	   SALK_045169	  LP	   GAGCGATGCATCTCTAACCAC	  
	  	   SALK_045169	  RP	   AGTAGGAACAGAAAGCAGGGG	  
da2-­‐1	   SALK_150003	  LP	   AGATGATGAAGACGGTGTTGC	  
	  	   SALK_150003	  RP	   AGCTCGGCCTACTCAGTATCC	  
dar1-­‐1	   SALK_067100	  LP	   ATTTAGTCGAAGCCATGCATG	  
	  	   SALK_067100	  RP	   TTACAAGGAGCAGCATCATCC	  
tcp22	   Salk	  027490	  	  LP	   	  CGCATGAAGTACCAAGCTCTC	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2.3	  –	  Plant	  growth	  
2.3.1	  –	  Plant	  material	  
All	  Arabidopsis	  lines	  used	  in	  this	  work	  were	  accessions,	  RILs,	  mutants	  or	  T-­‐DNA	  insertion	  lines	  
of	   Arabidopsis	   thaliana	   (assistance	   with	   Arabidopsis	   work	   was	   kindly	   provided	   by	   Caroline	  
Smith	  and	  Fiona	  Corke	  from	  the	  Bevan	  Lab).	  
The	   lines	  used	   in	  Chapters	  3-­‐5	  are	   listed	   in	  Table	  2.8.	   T-­‐DNA	   insertion	   lines	  were	  genotyped	  
using	  the	  DNA	  extraction	  protocol	  in	  section	  2.2.3.4,	  the	  colony	  PCR	  protocol	  in	  section	  2.2.2.2	  
and	  the	  primers	  listed	  in	  section	  2.2.8.	  	  
The	   analysis	   described	   in	   Chapter	   6	   uses	   the	   Multiparent	   Advanced	   Generation	   Inter-­‐Cross	  
(MAGIC)	   population	   described	   in	   Kover	   et	   al	   (2009),	   and	   a	   Swedish	   subset	   of	   the	   1001	  
genomes	  project	  population	  (Weigel	  &	  Mott	  2009).	  The	  MAGIC	  lines	  were	  kindly	  provided	  by	  
Phil	   Wigge	   at	   the	   Sainsbury	   Laboratory	   Cambridge	   University,	   Cambridge.	   The	   Swedish	  
accessions	   were	   kindly	   provided	   by	   Caroline	   Dean	   at	   the	   John	   Innes	   Centre,	   Norwich.	   The	  
identities	  of	  the	  Swedish	  accessions	  used	  in	  the	  GWAs	  analysis	  are	  listed	  in	  Table.	  S2.	  	  
	   	  
Arabidopsis	  Line	  	   T-­‐DNA/Mutation	  
Col-­‐0	   	  N/A	  
da1ko1	   Salk_126092	  
tcp14	   N108688	  
tcp15	   SALK_011491	  	  
bak1-­‐4	   SALK_116202.39.60	  
eod1-­‐2	   SALK_045169	  
da2-­‐1	   SALK_150003	  
dar1-­‐1	   SALK_067100	  
tcp22	   SALK_027490	  	  
da1-­‐1	   Mutant	  (Li	  et	  al	  2009)	  
Table	  2.8	  –	  Arabidopsis	  lines	  used	  in	  this	  thesis	   	  
	  
2.3.2	  –	  Growth	  conditions	  
All	  mature	   Arabidopsis	   plants	   were	   grown	   in	   compost	   composing	   of	   eight	   parts	   peat-­‐based	  
compost	  (Levington	  F2	  soil,	  N150:P200:	  K200mg/L,	  pH=5.3-­‐5.7)	  and	  one	  part	  grit.	  	  
For	  the	  GWAs	  analysis,	  five	  seeds	  of	  each	  accession	  were	  sown	  into	  randomised	  strips	  of	  five	  
P40	  pots	   (five	   seeds	  per	  pot,	  25	   seeds	  per	  accession).	  Plants	  were	   stratified	  at	  4°C	   for	   three	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days	  and	  vernalised	  at	  for	  six	  weeks	  under	  30µM	  white	  light	  (seedlings	  were	  thinned	  after	  one	  
week	  of	  vernalisation	  to	  leave	  one	  seedling	  per	  plot).	  After	  vernalisation	  plants	  were	  moved	  to	  
growth	   chambers	  until	   flowering	   (16h	   light	   /	   8h	  dark	   cycle,	   20°C	  day,	   80%	  humidity,	   170µM	  
white	   light).	   During	   growth,	   pots	   were	   moved	   (randomly)	   to	   different	   positions	   within	   the	  
growth	  chamber.	  	  
For	   the	  MAGIC	   analysis,	   plants	  were	   stratified	   for	   three	   days	   and	   vernalised	   for	   4	  weeks	   in	  
short	  days	  under	  30µM	  white	  light.	  After	  vernalisation	  plants	  were	  moved	  to	  growth	  chambers	  
until	   flowering	   (16h	   light	   /	   8h	   dark	   cycle,	   21°C	   day/17°C	   night,	   80%	   humidity,	   170µM	  white	  
light).	  	  
For	  the	  phenotyping	  of	  plants	  in	  Chapters	  3-­‐5,	  seeds	  were	  sown	  in	  FP9	  pots,	  stratified	  for	  three	  
days	  at	  4°C	  and	  then	  moved	  directly	  to	  growth	  chambers	  (20°C,	  16	  hours	  light,	  8	  hours	  dark).	  
After	  one	  week	  of	  growth,	  seedlings	  were	  pricked	  out	  into	  randomly	  assigned	  positions	  in	  P24	  
trays	  and	  moved	  back	  into	  the	  same	  growth	  chamber.	  	  
For	  the	  Agrobacterium-­‐mediated	  transformation	  of	  plants	  (see	  section	  2.3.3),	  seeds	  were	  sown	  
in	  FP9	  pots,	  stratified	  for	  three	  days	  at	  4°C	  and	  then	  moved	  directly	  to	  glass-­‐house	  conditions	  
(16h	   light	   /	  8h	  dark	  cycle	   supplemented	  with	  120	  µmol	  m-­‐2	  s-­‐1	   fluorescent	   lighting,	  21-­‐23°C	  
day,	  16°C	  night).	  After	  one	  week,	  12	  seedlings	  were	  transplanted	  to	  individual	  pots	  in	  P24	  trays	  
and	  returned	  to	  the	  same	  glass-­‐house	  conditions	  until	   inflorescence	  bolts	  emerged.	  For	  cross	  
pollination	  of	  Arabidopsis,	  a	   similar	  procedure	  was	   followed,	  except	   that	   individual	   seedlings	  
were	  pricked	  out	  into	  individual	  F7	  pots.	  	  
2.3.3	  –	  Agrobacterium-­‐mediated	  transformation	  of	  Arabidopsis	  
10ml	  LB	  (with	  appropriate	  antibiotics	  (see	  section	  2.2.5.5))	  was	  inoculated	  with	  A.	  tumefaciens	  
and	  incubated	  at	  28°C	  for	  2	  days	  at	  200rpm.	  1ml	  of	  this	  10ml	  culture	  was	  used	  to	  inoculate	  a	  
new	  400ml	  culture,	  which	  was	  then	  incubated	  overnight	  at	  28°C	  and	  200rpm.	  	  
The	  following	  day	  the	  culture	  was	  centrifuged	  for	  10	  minutes	  at	  3000x	  g	  and	  the	  supernatant	  
discarded.	  The	  pellet	  was	   resuspended	   in	  400ml	   transformation	  buffer	   (0.5xMS	  salts,	   0.5g.l-­‐1	  
MES,	   5%	   sucrose,	   300μl.l-­‐1	   Silwet	   L-­‐77	   (Lehle	   Seeds,	   Texas,	  USA	  VIS-­‐01)	   and	  prepared	  plants	  
(see	  section2.3.2)	  were	  dipped	   into	  this	  solution	  for	  30	  seconds	  (with	  gentle	  agitation).	  After	  
dipping,	  plants	  were	   laid	  on	  their	  sides	  and	  covered	  with	  plastic	  to	  maintain	  humidity.	  Plants	  
were	   left	  overnight	  and	  then	  returned	  to	  an	  upright	  position	  and	  moved	   into	  the	  glasshouse	  
conditions	  described	  in	  section	  2.3.2.	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When	  ripe,	  seed	  was	  manually	  threshed.	  Threshed	  seed	  was	  sterilised	  by	  shaking	  100μl	  of	  seed	  
in	   a	   1.5ml	   tube	   containing	   1ml	   sterilisation	   solution	   (50%	   (v/v)	   ethanol	   and	   0.625%	   (w/v)	  
dichloroisocyanuric	  acid)	  for	  18	  minutes.	  Immediately	  afterwards,	  the	  sterilisation	  solution	  was	  
removed	  and	  seeds	  were	  washed	  with	  3x	  1ml	  100%	  ethanol.	  Seeds	  were	  left	  to	  dry	  on	  sterile	  
filter	  paper.	  Once	  sterile,	  seeds	  were	  sown	  on	  GM	  plates	  (0.43%	  (w/v)	  Murashige	  and	  Skoog,	  
1%	   (w/v)	   sucrose,	   0.01%	   (w/v)	   inositol,	   10ppm	   (w/v)	   thiamine,	   50ppm	   (w/v)	   pyridoxine,	  
50ppm	  (w/v)	  nicotinic	  acid,	  0.05%	  (w/v)	  MES,	  9%	  (w/v)	  agar,	  pH	  5.7)	  with	  the	  appropriate	  final	  
concentration	  of	  antibiotic	   (spectinomycin-­‐	  25μl.μl-­‐1)	  and	   incubated	  at	  20°C,	   in	  24	  hour	   light,	  
for	  10-­‐15	  days.	  Transformed	  seedlings	  were	  selected	  based	  on	  their	  antibiotic	  resistance.	  	  
2.3.4	  –	  Crossing	  plants	  
Maternal	  flowers	  (see	  section	  2.3.2	  for	  growth	  conditions)	  were	  selected	  before	  opening,	  and	  
the	  immature	  anthers	  were	  removed	  from	  all	  flowers	  of	  a	  single	  inflorescence,	  then	  a	  mature	  
paternal	  flower	  was	  introduced	  (using	  forceps)	  to	  the	  paternal	  flower	  and	  the	  paternal	  anther	  
was	   rubbed	   on	   the	   stigmatic	   surface	   of	   the	  maternal	   plant.	   The	   relevant	   inflorescence	   was	  
labelled	   seeds	   were	   harvested	   when	   ripe.	   Seedlings	   were	   grown	   in	   individual	   P40	   pots	   (in	  
glass-­‐house	   conditions	   documented	   in	   section	   2.3.2)	   and	   genotyped	   as	   described	   in	   section	  
2.3.1.	  
2.3.5	  –	  Phenotyping	  plants	  
2.3.5.1	  –	  Petal	  and	  seed	  area	  measurements	  
Individual	  petals	  were	  harvested	  from	  the	  first	  flowers	  to	  form	  on	  each	  plant.	  These	  were	  then	  
stuck	   to	   a	   custom	   black	   perspex	   background	   using	   transparent	   adhesive	   tape.	   Petals	   were	  
scanned	   using	   a	   desktop	   scanner	   (Hewlett	   Packard	   Scanjet	   4370)	   at	   a	   high	   resolution	  
(<3600dpi).	   Images	   were	   stored	   as	   black	   and	   white	   8-­‐bit	   images,	   and	   subjected	   to	   image	  
analysis	  using	  the	  ImageJ	  software	  (http://rsbweb.nih.gov/ij/)	  	  -­‐	  see	  Box	  2.3.5.1	  for	  details.	  	  
Seed	   area	   was	   measured	   using	   the	   same	   protocol,	   with	   the	   exception	   that	   seeds	   were	  
scattered	  in	  a	  petri	  dish	  and	  scanned	  against	  a	  white	  background.	  
2.3.5.2	  –	  Inflorescence	  stem	  height	  	  
Inflorescence	  stem	  height	  was	  measured	  a	  28	  days	  after	  bolting	  (rather	  than	  after	  sowing)	  to	  
ensure	  that	  all	  plants	  were	  at	  a	  developmentally	  equivalent	  stage.	  The	  length	  of	  the	  stem	  was	  





2.4	  –	  Brassinosteroid	  root	  growth	  assay	  
Seeds	  were	  sterilised	  using	  the	  protocol	  described	  in	  section	  2.3.3	  and	  then	  added	  to	  a	  1.5ml	  
tube	  with	  1ml	   sterile	  water.	  The	   tube	  was	  vortexed	   for	  10	   seconds,	   then	  wrapped	   in	   tin	   foil	  
and	  left	  at	  4°C	  for	  seven	  days	  to	  stratify.	  100mm	  square	  plates	  were	  made	  with	  modified	  ½	  MS	  
(0.22%	  (w/v)	  Murashige	  and	  Skoog,	  1%	  (w/v)	  sucrose,	  0.8%	  (w/v)	  phytoagar,	  pH5.7)	  including	  
epibrassinolide	  (Sigma-­‐Aldrich	  E1641)	  at	  the	  appropriate	  concentration.	  Seeds	  were	  placed	  on	  
to	  plates	   at	   a	   rate	  of	   ten	  per	   treatment	  per	   genotype	   (a	   total	   of	   30	   seeds	  per	  plate).	   Plates	  
were	  placed	  upright	  in	  a	  growth	  chamber	  (20°C,	  16	  hours	  light,	  8	  hours	  dark)	  for	  9	  days.	  Roots	  
were	  carefully	  unravelled,	  plates	  were	  scanned	  in	  a	  desktop	  scanner	  (Hewlett	  Packard	  Scanjet	  
4370),	   and	   root	   lengths	   calculated	   using	   ImageJ	   software	   (http://rsbweb.nih.gov/ij/).	   This	  
method	  was	  kindly	  provided	  by	  the	  Zipfel	  Group,	  The	  Sainsbury	  Lab,	  Norwich,	  UK.	  
2.5	  –	  In	  vitro	  protein	  biochemistry	  
2.5.1	  –	  Western	  Blots	  
20%,	   12%	   or	   4-­‐20%	   precast	   SDS-­‐polyacrylamide	   gels	   (RunBlue	   NXG02012,	   NXG01227,	  
NXG42027)	  were	   submerged	   in	  RunBlue	  SDS-­‐TRIS-­‐tricine	   run	  buffer	   (RunBlue	  NXB0500),	   in	  a	  
gel	  tank	  (Atto	  Japan	  	  AE6450)	  Samples	  were	  mixed	  with	  2x	  Laemmli	  sample	  buffer	  (Bio-­‐Rad	  Ltd	  
161-­‐0737)	  placed	   in	  a	  heat	  block	  for	  10	  minutes	  at	  96°C	  and	  then	  loaded	  into	  rinsed	  wells	   in	  
the	  gel	  in	  either	  10μl	  or	  20μl	  aliquots.	  The	  gels	  were	  run	  at	  160V	  for	  60	  minutes	  along	  with	  a	  
Box	  2.1	  -­‐	  Instructions	  for	  ImageJ	  analysis	  
Open	   image	   in	   ImageJ	  and	  set	  threshold	  (Ctrl+Shift+T)	  such	  that	  all	  petals	  are	  completely	  red	  and	  
most	  other	  structures	  are	  not.	  Select	  all	  petals	  with	  the	  “rectangular	  selection”	  tool	  and	  chose	  the	  
analyse	  option	  (Analyze	  >	  Analyze	  Particles).	  In	  the	  dialog	  box	  set	  a	  size	  threshold	  to	  exclude	  smaller	  
(non-­‐petal)	   structures	   and	   large	   structures	   such	   as	   aggregations	   of	   petals.	   Do	   this	   by	   choosing	   a	  
minimum	   value	   of	   half	   the	  mean	   petal	   size	   and	   a	  maximum	   value	   of	   twice	   the	  mean	   petal	   size	  
(check	  by	  eye	  to	  ensure	  accuracy).	  Additionally,	  ensure	  that	  “Display	  results”,	  “Exclude	  on	  edges”	  
and	  “Include	  holes”	  are	  enabled	  and	  click	  “OK”.	  	  
This	  protocol	  is	  adapted	  from	  the	  John	  Innes	  Centre	  standard	  operating	  procedure	  CDB-­‐SC-­‐022,	  
written	  by	  Nicola	  Stacey.	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3ul	  aliquot	  of	  PageRuler	  Plus	  Prestained	  Protein	   Ladder,	  10	   to	  250kDa	   (Fermentas	  26619).	   If	  
appropriate,	  gels	  were	  stained	  at	  this	  stage	  (see	  section	  2.5.1.1).	  
Transfers	  were	  carried	  out	  using	  the	  Bio-­‐Rad	  Mini	  Trans-­‐Blot®	  Cell	  kit	  (Bio-­‐Rad	  170-­‐3836).	  Gels	  
were	  removed	  from	  their	  glass	  casing	  and	   laid	  on	  top	  of	  a	  sponge	  (from	  Bio-­‐Rad	  Mini	  Trans-­‐
Blot®	  Cell	   kit),	   two	  pieces	  of	   chromatography	  paper	   (VWR	  WHAT3030-­‐917)	   and	  a	  methanol-­‐
washed	  PVDF	  membrane	   (Roche	  Diagnostics	  03010040001).	  Air	  bubbles	  were	   removed	   from	  
between	  the	  gel	  and	  membrane	  and	  then	  two	  further	  pieces	  of	  Whatman	  paper	  and	  a	  sponge	  
were	  applied	  to	  the	  gel.	  This	  was	  enclosed	  in	  a	  gel	  holder	  cassette	  (from	  Bio-­‐Rad	  Mini	  Trans-­‐
Blot®	  Cell	  kit),	  submerged	  in	  transfer	  buffer	  (25mM	  TRIS,	  192mM	  glycine,	  10%	  (v/v)	  methanol)	  
and	  run	  at	  90V	  for	  70	  minutes	  at	  4°C.	  
Following	  the	  transfer	  the	  membrane	  was	  washed	  for	  10	  minutes	  in	  50ml	  PBS	  (140mM	  NaCl,	  
2.7mM	   KCl,	   10mM	   Na2HPO4,	   1.8mM	   KH2PO4,	   pH	   7.3)	   at	   room	   temperature,	   before	   being	  
agitated	  in	  50ml	  blocking	  solution	  (5%	  (w/v)	  milk	  powder,	  0.1%	  (v/v)	  Tween-­‐20)	  for	  either	  one	  
hour	   at	   room	   temperature	   or	   overnight	   at	   4°C.	   Primary	   antibodies	   were	   diluted	   to	   their	  
appropriate	   concentration	   (see	   Table	   2.9)	   in	   blocking	   solution	   and	   incubated	   with	   the	  
membrane	  (10ml	  per	  membrane	  with	  gentle	  agitation)	   for	  one	  hour	  before	  five	  washes	  with	  
50ml	   PBST	   (140mM	   NaCl,	   2.7mM	   KCl,	   10mM	   Na2HPO4,	   1.8mM	   KH2PO4,	   0.1%	   (v/v)	   Tween-­‐
20,pH	   7.3)	   at	   room	   temperature.	   If	   secondary	   antibody	  was	   required,	   staining	   and	  washing	  
steps	  were	  repeated.	  
The	  washed	  membrane	  was	  held	  with	  forceps	  and	  carefully	  one	  corner	  was	  blotted	  onto	  blue-­‐
roll	   to	   remove	   excess	  moisture.	   It	   was	   then	   laid	   in	   a	   petri	   dish	   and	   treated	  with	   peroxidise	  
substrate	  (SuperSignal	  West	  FEMTO	  Max.	  Sensitivity	  substrate	  (Fisher	  Scientific	  PN34095))	  at	  a	  
rate	  of	  800μl	  substrate	  per	  membrane.	  Membranes	  were	  left	  in	  this	  substrate	  for	  five	  minutes,	  
dried	   as	   before	   and	   placed	   in	   an	   X-­‐ray	   cassette	   under	   a	   piece	   of	   X-­‐ray	   film	   (Fuji	   Film	   X-­‐RAY	  
18x24cm	  –	  (FujiFilm	  497772RXNO)).	  X-­‐ray	  films	  were	  developed	  using	  a	  Konica	  SRX-­‐101	  Table	  
Top	  X-­‐ray	  film	  developer	  (Konica	  106931659).	  	  
Subsequent	  to	  analysis,	   if	   required,	  membranes	  were	  washed	   in	  50ml	  PBST	  and	  stained	  with	  
10ml	  Ponceau	  S	   solution	   (Sigma-­‐Aldrich	  P7170)	   for	  30	  minutes,	   followed	  by	  a	   single	  wash	   in	  
50ml	  PBST	  and	  drying	  at	  room	  temperature.	  
2.5.1.1	  –	  Staining	  protein	  gels	  
Protein	  gels	  were	  stained	  by	  agitation	  with	  InstantBlue	  Coomassie	  stain	  (Expedeon	  ISB1L)	  for	  
30	  minutes	  at	  room	  temperature	  (20ml	  per	  gel).	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  Epitope	   Host	   Manufacturer	   Working	  	  
dilution	  
a-­‐FLAG®M2-­‐HRP	   Mouse	  monoclonal	   Sigma-­‐Aldrich	  A8592.	  Lot:	  060M6000	   1:1000	  
a-­‐HIS6	  HRP	   Mouse	  monoclonal	   Sigma-­‐Aldrich	  A7058,	  Lot:	  101M4765	   1:4000	  
a-­‐HA-­‐HRP	   Mouse	  monoclonal	   Sigma-­‐Aldrich	  H6533.	  Lot:	  030M4814	   1:1000	  
a-­‐Ubiquitin	   Mouse	  monoclonal	   BostonBiochem	  AB-­‐001.	  Lot:	  027A37010	   1:1000	  
a-­‐Ubiquitin	   Mouse	  monoclonal	   Sigma-­‐Aldrich	  U0508.	  Lot:	  110M1664	   1:1000	  
a-­‐GST-­‐HRP	   Mouse	  monoclonal	   Santa	  Cruz	  Biotechnology	  	  SC-­‐138.	  Lot:A2513	   1:1000	  
a-­‐GST	  rabbit	   Goat	  polyclonal	   GE	  Healthcare	  UK	  Ltd,	  Bucks	  	  27-­‐4577-­‐50	   1:1000	  
a-­‐Goat-­‐HRP	   Donkey	   Santa	  Cruz	  Biotechnology	  	  sc-­‐2020	   1:6000	  
a-­‐Mouse-­‐HRP	   Goat	   Santa	  Cruz	  Biotechnology	  	  sc-­‐2005.	  Lot:C2011	   1:6000	  
Table	  2.9	  	  –	  Antibodies	  used	  in	  this	  thesis	   	   	   	  
	  	  
2.5.2	  –	  Co-­‐Immunoprecipitation	  analysis	  
All	  bait	  proteins	  for	  these	  studies	  were	  GST-­‐tagged	  and	  glutathione	  sepharose	  beads	  (GE	  Life	  
Science	  17-­‐0756-­‐01)	  were	  used	  for	  their	  pull-­‐down.	  
A	  flask	  of	  10ml	  LB	  with	  appropriate	  antibiotics	  (see	  section	  2.2.5.5)	  was	  inoculated	  with	  a	  BL21	  
(see	   section	   2.2.5.1)	   glycerol	   stock	   of	   the	   appropriate	   expression	   construct	   and	   left	   to	   grow	  
overnight	   at	   37°C	   and	   220rpm.	   The	   following	   morning	   the	   10ml	   preculture	   was	   used	   to	  
inoculate	  an	  100ml	  LB	  flask	  (at	  a	  ratio	  of	  1:100),	  and	  this	  culture	  was	  incubated	  at	  37°C	  for	  two	  
hours	   at	   220rpm.	   The	   flask	   was	   removed	   from	   the	   incubator,	   IPTG	   (Melford	   MB1008)	   was	  
added	  to	  a	  final	  concentration	  of	  1mM	  before	  the	  culture	  was	  incubated	  at	  28°C	  (and	  220rpm)	  
for	  another	  three	  hours.	  Following	  this	  growth	  phase,	  the	  cultures	  were	  centrifuged	  at	  4500x	  g	  
for	  10	  minutes,	  the	  supernatants	  were	  discarded	  and	  the	  pellets	  resuspended	  at	  4°C	  in	  2.5ml	  
TGH	  Buffer	  (50mM	  HEPES	  (pH7.5),	  150mM	  NaCl,	  1%	  Triton-­‐X-­‐100,	  10%	  Glycerol,	  1mM	  DTT,	  1	  
cOmplete	  EDTA-­‐free	  protease	  inhibitor	  tablet	  (per	  50ml)	  (Roche	  11873580001)).	  The	  bacterial	  
suspension	  was	  then	  sonicated	  (on	  ice)	  for	  four	  bursts	  of	  ten	  seconds,	  separated	  by	  20-­‐second	  
intervals,	   before	   being	   centrifuged	   at	   12	   000x	   g	   for	   20minutes	   to	   pellet	   any	   cellular	   debris.	  
Cleared	  sonicates	  were	  then	  stored	  on	  ice	  while	  a	  50%	  slurry	  of	  washed	  glutathione	  sepharose	  
beads	   (GE	   Life	   Sciences	   17-­‐0756-­‐01)	   was	   prepared	   according	   to	   the	   manufacturer’s	  
instructions.	   	  20μl	  of	  the	  50%	  glutathione	  sepharose	  slurry	  was	  then	  combined	  with	  2.5ml	  of	  
protein	   extract	   from	   bait	   protein	   (GST-­‐tagged)	   expressing	   cells	   and	   2.5ml	   of	   protein	   extract	  
from	  prey	  protein	  (HA-­‐/FLAG-­‐/HIS-­‐tagged)	  expressing	  cells.	  This	  mixture	  was	  incubated	  for	  30	  
minutes	  at	  4°C	  on	  a	   rotating	  wheel	  and	   then	   the	  glutathione	   sepharose	  beads	  were	  washed	  
five	  times	  with	  an	  excess	   (500μl)	  of	  TGH	  buffer	   (following	  manufacturer’s	   instructions).	  After	  
73	  
washing,	   proteins	   were	   eluted	   with	   35μl	   GST-­‐elution	   buffer	   (50mM	   TRIS-­‐glycine	   (pH8.0),	  
10mM	   reduced	   glutathione)	   over	   30	  minutes	   at	   4°C	   before	   being	   analysed	   by	  western	   blot	  
analysis	  (see	  section	  2.5.1).	  
2.5.3	  –	  UIM	  binding	  assays	  
Proteins	  in	  this	  assay	  were	  GST-­‐tagged	  and	  glutathione	  sepharose	  beads	  (GE	  Life	  Sciences	  17-­‐
0756-­‐01)	  were	  used	  for	  their	  purification.	  
Bacteria	  was	  grown,	  induced	  and	  lysed	  as	  described	  in	  section	  2.5.2	  and	  the	  cleared	  sonicate	  
was	  subjected	  to	  Bradford	  analysis	  to	  calculate	  protein	  content	  (see	  section	  2.5.6).	  A	  volume	  of	  
sonicate	  containing	  4mg	  of	  protein	  was	  added	  to	  20μl	  50%	  glutathione	  sepharose	  (prepared	  as	  
in	  section	  2.5.2)	  and	  incubated	  on	  a	  rotating	  wheel	  at	  4°C	  for	  30	  minutes.	  The	  beads	  were	  then	  
washed	   with	   1ml	   of	   TGH	   buffer	   and	   then	   added	   to	   10µg	   ubiquitin	   (Boston	   Biochem,	   USA-­‐	  
U100)	  to	  a	  volume	  of	  100μl	  (Fisher	  et	  al.,	  2003).	  This	  was	  followed	  by	  rotation	  for	  two	  hours	  at	  
4°C.	  The	  beads	  were	  washed	  four	  times	  with	  1ml	  TGH	  buffer	  and	  then	  added	  directly	  to	  50μl	  
2x	   Laemmli	   sample	   buffer	   (Bio-­‐Rad	   Ltd	   161-­‐0737)	   followed	   by	   western	   blot	   analysis	   (see	  
section	  2.5.1).	  
2.5.4	  –	  Ubiquitination	  assays	  
Proteins	  used	  in	  this	  assay	  were	  either	  GST-­‐tagged,	  FLAG-­‐tagged,	  or	  HIS-­‐tagged.	  Purification	  of	  
these	  proteins	  used	  glutathione	  sepharose	  beads	  (GE	  Life	  Sciences	  17-­‐0756-­‐01),	  Anti-­‐FLAG	  M2	  
Magnetic	   Beads	   (Sigma-­‐Aldrich	   M8823),	   and	   Dynabeads	   His-­‐Tag	   Isolation	   &	   Pulldown	  
(Invitrogen	  Ltd	  101-­‐04D)	  respectively.	  	  
Bacteria	  were	  grown,	   induced	  and	   lysed	  as	  described	   in	  section	  2.5.2,	  apart	   from	  the	  pellets	  
being	  re-­‐suspended	  in	  5ml	  TGH	  buffer	  without	  DTT.	  Cleared	  sonicates	  were	  then	  incubated	  (by	  
rotation)	  with	   either	   100µl	   of	   50%	   glutathione	   sepharose	   slurry	   or	   100μl	   of	   the	   appropriate	  
magnetic	   bead	   (all	   of	   which	   were	   prepared	   according	   to	   the	   respective	   manufacturer’s	  
instructions)	   for	   30	   minutes	   at	   4°C.	   Beads	   were	   then	   washed	   twice	   with	   1ml	   TGH	   buffer	  
(without	  DTT)	  and	  twice	  with	  1ml	  modified	  TGH	  buffer	  (without	  cOmplete	  EDTA-­‐free	  protease	  
inhibitor	   tablet,	   DTT	   and	   Triton-­‐X-­‐100).	   Proteins	   were	   eluted	   from	   beads	   by	   incubating	   (by	  
rotation)	   for	   30	  minutes	   at	   4°C	  with	   100µl	   elution	   buffer	   (see	   Table	   2.10).	   Purified	   proteins	  
were	  assessed	  for	  protein	  content	  using	  Bradfords	  assay	  (see	  section	  2.5.6)	  and	  were	  aliquoted	  
and	  frozen	  at	  -­‐80°C.	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Glutathione	  Sepharose	  Beads	   	  
50mM	   TRIS-­‐glycine	  (pH8.0)	  
10mM	   Reduced	  glutathione	  
10%	  (v/v)	   Glycerol	  
Anti-­‐FLAG	  M2	  Magnetic	  Beads	   	  
50mM	   TRIS-­‐glycine	  (pH8.0)	  
100µg.ml-­‐1	   3xFLAG	  Peptide	  (Sigma-­‐Aldrich,	  F4799)	  
10%	  (v/v)	   Glycerol	  
Dynabeads	  His-­‐Tag	  Isolation	  &	  Pulldown	   	  
300mM	   Imidazole	  
50mM	   Na2HPO4	  
300mM	   NaCl	  
0.01%	  (v/v)	   Tween-­‐20	  
10%	  (v/v)	   Glycerol	  
Table	  2.10	  –	  Elution	  buffers	   	  
	  
Basic	  ubiquitination	  assays	  were	  made	  according	  to	  the	  scheme	  in	  Table	  2.11	  in	  a	  final	  volume	  
of	   30µl	   in	   reaction	   buffer	   (See	   Table	   2.12).	   Reactions	  were	   run	   for	   two	   hours	   at	   30°C,	   then	  
terminated	   by	   incubation	   for	   ten	   minutes	   at	   4°C	   before	   being	   subjected	   to	   western	   blot	  
analysis	  (see	  section	  2.5.1).	  
	   	   	  
Enzyme	   Amount	   Source	  
E1	   100ng	   Human	  UBE1	  (Boston	  Biochem	  	  E-­‐304,	  E-­‐305,	  E-­‐306)	  
E2	   500ng	   GST-­‐UBC10	  (plasmid	  kindly	  provided	  by	  Michal	  Lenhard)	  	  
OR	  Human	  UbcH5b/UBE2D2	  (Boston	  Biochem	  USA	  E2-­‐622)	  
E3	   200ng	   See	  Chapter	  5	  
Table	  2.11	  –	  Ubiquitination	  assay	  protocol	   	   	  
	  
	   	  
50mM	   TRIS-­‐HCl	  (pH7.4)	  
5mM	   MgCl2	  
2mM	   ATP	  
2mM	   DTT	  
Table	  2.12	  –	  Ubiquitination	  assay	  reaction	  buffer	   	  
	  
	  Other	  modifications	  of	  this	  basic	  ubiquitination	  assay	  were	  made.	  These	  are	  described	  in	  the	  
following	  sections.	  
2.5.4.1	  –	  DA1-­‐ubiquitination	  assays	  and	  E3	  cleavage	  assays	  
These	   assays	   share	   exactly	   the	   same	   experimental	   lay-­‐out	   and	   differ	   from	   the	   basic	  
ubiquitination	  assay	  (section	  2.5.4)	  by	  the	  addition	  of	  200ng	  DA1	  only.	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2.5.4.2	  –	  Two-­‐step	  EOD1	  cleavage	  assay	  
This	   assay	   involves	   the	   generation	   of	   ubiquitinated	   DA1	   from	   a	   DA1-­‐ubiquitination	   assay	  
(section	   2.5.4.1),	   the	   purification	   of	   this	   ubiquitinated	   DA1,	   and	   its	   addition	   to	   a	   second	  
reaction	  containing	  only	  E3	  ligase.	  This	  assay	  uses	  pETnT-­‐DA1.	  
A	   300μl	   first	   reaction	   is	   carried	   out	   as	   described	   in	   section	   2.5.4.1,	   except	   that	   the	   reaction	  
buffer	  does	  not	   contain	  DTT.	  After	   two	  hours	  at	  30°C	  and	  10	  minutes	  at	  4°C,	  20µl	  Anti-­‐FLAG	  
M2	  Magnetic	  Beads	   (Sigma-­‐Aldrich	  M8823)	  were	  added	  to	  the	  300µl	   reaction	  and	   incubated	  
(rotating)	   for	   one	  hour	   at	   4°C.	   The	   beads	  were	  washed	   twice	  with	   1ml	   TGH	  buffer	   (without	  
DTT)	  and	  twice	  with	  1ml	  modified	  TGH	  buffer	  (without	  cOmplete	  EDTA-­‐free	  protease	  inhibitor	  
tablet,	  DTT	  and	  Triton-­‐X-­‐100)	  before	  elution	  with	  20µl	  elution	  buffer	  (see	  Table	  2.10).	  
5µl	  of	  the	  purified	  DA1	  from	  the	  first	  reaction	  was	  added	  to	  a	  30μl	  second	  reaction	  containing	  
200ng	   E3	   ligase	   and	   reaction	   buffer	   (50mM	  TRIS-­‐HCL	   (pH7.4),	   5mM	  MgCl2,	   2mM	  ATP,	   2mM	  
DTT).	  This	  reaction	  was	  run	  for	  two	  hours	  at	  30°C,	  before	  being	  terminated	  by	  10	  minutes	  at	  
4°C	  and	  samples	  subjected	  to	  western	  blot	  analysis.	  
2.5.4.3	  –	  Assays	  using	  modified	  ubiquitin	  molecules	  
Two	  assays	  involved	  the	  addition	  of	  modified	  ubiquitin.	  These	  assays	  follow	  exactly	  the	  same	  
protocol	   of	   the	   basic	   ubiquitination	   assay	   (section	   2.5.4)	   and	   include	   either	   methylated	  
ubiquitin	   (Boston	   Biochem	   U-­‐502),	   K48R	   ubiquitin	   (Boston	   Biochem	   UM-­‐K48R)	   or	   K63R	  
ubiquitin	  (Boston	  Biochem	  UM-­‐K63R).	  
2.5.5	  –	  De-­‐ubiquitinase	  assay	  
200ng	  GST-­‐DA1	  or	  200ng	  empty	  vector	  was	  incubated	  with	  500ng	  of	  K63-­‐linked	  poly	  ubiquitin	  
(Recombinant	  Human	  His6-­‐PolyUb	  WT	  Chains	   (2-­‐7,K63-­‐linked)	   –	   Boston	  Biochem	  USA:	  UCH-­‐
330-­‐100)	  or	  K48-­‐	  linked	  poly-­‐ubiquitin	  (Recombinant	  Human	  His6-­‐PolyUb	  WT	  Chains	  (2-­‐7,K63-­‐
linked)	  –	  Boston	  Biochem:	  UCH-­‐230-­‐100)	  for	  2hr	  at	  30°C	  in	  a	  30µl	  reaction	  with	  reaction	  buffer	  
(50mM	  TRIS-­‐HCL	  pH7.4,	  5mM	  MgCL2,	  2mM	  ATP	  and	  2mM	  DTT).	  Reactions	  were	  stopped	  by	  
the	  addition	  of	  30µl	  2x	  Laemmli	  sample	  buffer	  (Bio-­‐Rad	  Ltd,	  161-­‐0737)	  and	  samples	  subjected	  
to	  western	  blot	  analysis.	  
2.5.6	  –	  Bradford	  Assay	  	  
A	  standard	  curve	  was	  created	  by	  diluting	  BSA	  (New	  England	  BioLabs	  B9001S)	  in	  aliquots	  of	  the	  
lysis	   buffer	   (TGH)	   used	   to	   extract	   proteins	   on	   the	   day	   of	   use.	   Dilutions	   for	   standard	   curves	  
were	  only	  used	  once	  and	  also	  made	  fresh	  every	  day.	  5µl	  of	  each	  dilution	  was	  added	  to	  a	  single	  
well	  of	  a	  96	  well	  plate	   (Fischer	  Scientific	  TKT-­‐180-­‐070U)	  with	  245µl	  of	  Bradford	  reagent	   (one	  
76	  
part	  Bio-­‐Rad	  Protein	  Assay	  Dye	  Reagent	  Concentrate	  (Bio-­‐Rad	  Ltd	  500-­‐0006),	  five	  parts	  ultra-­‐
pure	  water).	   All	   protein	   standards	  were	  made	   in	   triplicate.	   5µl	   aliquots	   of	   purified	   proteins	  
were	  added	  to	  single	  wells	  of	   the	  same	  96	  well	  plate	  along	  with	  245µl	  of	  the	  same	  Bradford	  
reagent	  (also	  in	  triplicate).	  All	  samples	  were	  analysed	  at	  595nm	  using	  a	  Tecan	  Safire	  microplate	  
reader	  (Tecan	  Instruments).	  
2.6	  –	  Arabidopsis	  protoplast	  work	  
Assistance	  with	  Arabidopsis	  protoplast	  work	  was	  kindly	  provided	  by	  Caroline	  Smith	  (Bevan	  
Lab).	  
2.6.1	  –	  Protoplast	  harvesting	  
Protoplasts	  were	  prepared	  from	  leaves	  of	  4-­‐5	  week	  old	  plants	  grown	  in	  16hrs	  light	  (20°C)	  and	  
8hrs	  dark	  (18°C).	  Leaves	  were	  stuck	  by	  their	  upper	  epidermis	  to	  Sellotape	  (Henkel	  Limited,	  UK)	  
while	  Magic	   tape	   (3M	  UK	  Plc)	  was	  pressed	  down	  onto	   the	   lower	   epidermis	   and	   then	  pulled	  
away	   and	  discarded.	   The	   remaining	   leaf	  material	  was	  placed	   in	   a	   petri	   dish	   containing	  10ml	  
enzyme	  solution	  (20mM	  MES(pH5.7),	  20mM	  KCl,	  0.4M	  mannitol,	  1.0%	  cellulose	  R10	  (Yakult),	  
0.25%	  macerozyme	  (Yakult),	  10mM	  CaCl2,	  0.1%	  (w/v)BSA)	  and	  shaken	  for	  120	  minutes	  at	  room	  
temperature	  at	  40rpm.	  The	  leaf	  fragments	  were	  discarded	  and	  the	  liberated	  protoplasts	  were	  
filtered	   through	   70µm	   mesh	   (Falcon	   352350)	   into	   a	   50ml	   tube	   and	   centrifuged	   for	   three	  
minutes	  at	  100x	  g.	   The	  protoplasts	  were	   then	  washed	   twice	  with	  10ml	   ice	   cold	  W5	  solution	  
(2mM	   MES	   (pH	   5.7),	   154mM	   NaCl,	   125mM	   CaCl2,	   5mM	   KCl).	   The	   protoplasts	   were	  
resuspended	  in	  5ml	  ice	  cold	  W5	  solution	  and	  kept	  on	  ice	  for	  30	  minutes	  before	  resuspending	  
them	   in	   a	   concentration	   of	   2-­‐5	   x	   105cells/ml	   with	   buffer	   MMg	   (4mM	  MES	   (pH	   5.7),	   0.4M	  
mannitol,15mM	  MgCl2).	  
2.6.2	  –	  Protoplast	  Transformation	  
20µg	  (20µl)	  of	  plasmid	  (see	  section	  2.2.3.1)	  was	  added	  to	  a	  1.5ml	  tube	  with	  100μl	  protoplasts	  
(protoplasts	   were	   aliquoted	   with	   a	   cut	   off	   1000µl	   pipette	   tip).	   120µl	   PEG/Ca	   solution	   (40%	  
(v/v)	  PEG	  4,000,	  0.2M	  mannitol,	  100mM	  CaCl2)	  was	  added	  to	  the	  protoplasts	  and	  mixed	  gently	  
by	  inverting	  the	  tube,	  before	  incubating	  for	  10	  minutes	  at	  room	  temperature.	  The	  protoplasts	  
were	   then	   diluted	   with	   600µl	   W5	   solution,	   mixed	   slowly	   (by	   inverting	   the	   tube)	   and	   then	  
diluted	  with	  a	  further	  600µl	  W5	  and	  mixed	  again.	  The	  tube	  was	  then	  centrifuged	  at	  100x	  g	  for	  
one	  minute	  and	  as	  much	  supernatant	  as	  possible	  was	  removed	  before	  re-­‐suspending	  pellets	  in	  
250µl	  W5	  and	  aliquoting	  into	  a	  24	  well	  plate	  .	  For	  the	  EOD1	  and	  DA2	  cleavage	  assays	  (section	  
5.3.4.2)	   50µM	   MG132	   (Sigma-­‐Aldrich	   C2211)	   was	   included	   in	   the	   final	   treatment	   of	   W5.	  
Protoplasts	  were	  left	  for	  16	  hours	  at	  20°C	  before	  analysis.	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This	  method	  was	  adapted	  from	  (Wu	  et	  al.,	  2009).	  
2.6.3	  –	  Spit-­‐YFP	  analysis	  in	  protoplasts	  
Protoplasts	  were	  aliquoted	  onto	  standard	  microscopy	  slides	  (Skan	  Ltd	  631-­‐0114)	  covered	  with	  
a	  cover	  slip,	  and	  sealed	  by	  nail	  polish.	  Protoplasts	  were	  analysed	  using	  a	  Leica	  SP5	  (II)	  confocal	  
microscope	  with	  an	  excitation	  wavelength	  of	  488nm	  and	  emission	  wavelengths	  505nm-­‐550nm.	  
Images	   were	   processed	   using	   the	   ImageJ	   software	   (http://rsbweb.nih.gov/ij/)	   and	   are	  
presented	  as	  individual	  and	  overlay	  images.	  
2.6.3	  –	  EOD1	  and	  DA2	  cleavage	  assays	  
Protoplasts	  were	   transferred	   to	   a	   1.5ml	   tube,	   the	   tubes	  were	   centrifuged	   at	   100x	   g	   for	   one	  
minute	   and	   the	   supernatant	  was	   discarded.	   50µl	   extraction	   buffer	  was	   added	   (100mM	  TRIS	  
HCl	  pH7.5,	  150mM	  NaCl,	  5mM	  EDTA,	  5%	  (v/v)	  glycerol,	  10mM	  DTT,	  1%	  (v/v)	  protease	  inhibitor	  
cocktail	  (Sigma-­‐Aldrich,	  P9599),	  0.5%	  (v/v)	  Triton-­‐X-­‐100,	  1%	  (v/v)	  Igepal,	  50µm	  MG132	  (Sigma-­‐
Aldrich,	  C2211))	  and	  the	  tubes	  were	  vortexed	  for	  30	  seconds	  before	  being	  centrifuged	  for	  20	  
minutes	  at	  12	  000x	  g	  and	  4°C.	  The	  supernatant	  was	  harvested	  and	  subjected	  to	  western	  blot	  
analysis	  as	  described	  in	  section	  2.5.1.	  
2.7	  –	  Yeast-­‐2-­‐Hybrid	  screen	  
2.7.1	  –	  Yeast	  strain	  and	  media	  
The	   yeast	   strain	   used	   was	   PJ69-­‐4α	   (James	   et	   al.,	   1996),	   bait	   genes	   were	   inserted	   into	   the	  
pDBleu	  vector	  and	   the	  prey	   library	   (kindly	  provided	  by	  Phil	  Wigge)	  was	  present	   in	   the	  pEXP-­‐
AD502	  vector	   (see	  section	  2.2.7),	  both	  of	  which	  are	  both	  part	  of	   the	  ProQuestTM	  Two-­‐Hybrid	  
System	  from	  Invitrogen.	  The	  screen	  was	  a	  co-­‐transformation	  screen.	  
	   	   	  
YPD	   1%	  (w/v)	  	   Peptone	  
	   1%	  (w/v)	  	   Yeast	  Extract	  
	   0.5%	  (w/v)	  	   NaCl	  
	   2%	  (w/v)	  	   Sucrose	  
	   (2%	  (w/v)	   Agar)	  
SC	   0.67%	  (w/v)	   Yeast	  Nitrogen	  Base	  without	  amino	  acids	  (Becton,	  Dickinson	  &	  Co	  291940)	  
	   2%	  (w/v)	   Sucrose	  
	   Appropriate	  %	   Amino	   acid	   DO	   supplement	   (Clontech	   8619-­‐1,	   8609-­‐1,8605-­‐1,	   8610-­‐1,	  
8680-­‐1,	  8604)	  
	   (2%	  (w/v)	   Agar)	  
Table	  2.13	  –	  Yeast	  Media	   	   	  
	  
78	  
2.7.2	  –Preliminary	  transformation	  
A	   lithium	   acetate	   transformation	   protocol	  was	   used	   to	   generated	   the	   bait	   expressing	   strain	  
(pDBLeu-­‐DA1),	   to	   test	   for	   auto-­‐activation	  of	   strains	   expressing	  non-­‐interacting	  bait	   and	  prey	  
proteins	   (pDBleu-­‐DA1,	   pEXP-­‐AD502-­‐Ø)	   on	   SC-­‐Leu-­‐Trp-­‐His,	   and	   to	   perform	   the	   drop-­‐tests	   used	   to	  
validate	  the	  interactions.	  No	  autoactivation	  of	  the	  HIS3	  reporter	  was	  detected.	  
2.7.2.1	  –	  Transformation	  protocol	  
DAY1	  
A	  50ml	  liquid	  culture	  was	  inoculated	  with	  a	  single	  colony	  of	  yeast	  and	  grown	  overnight	  at	  28°C	  
at	  220rpm.	  	  
DAY2	  
The	  overnight	  culture	  was	  diluted	  to	  OD600=0.4	  with	  fresh	  media	  and	  grown	  at	  30°C	  (220rpm)	  
until	  OD600=0.3-­‐1.0,	  then	  cells	  were	  harvested	  by	  centrifuging	  for	  5	  minutes	  at	  4000x	  g.	  	  
Cells	   were	   washed	   with	   50ml	   sterile	   water,	   centrifuged	   for	   5	   minutes	   at	   4000x	   g	   and	   the	  
remaining	  pellet	  was	  re-­‐suspended	  in	  solution	  A	  at	  a	  rate	  of	  100µl	  per	  transformation.	  
5µl	   carrier	   DNA	   was	   mixed	   with	   5µg	   transforming	   DNA	   (keeping	   total	   volume	  ≤	   20µl)	   and	  
added	  to	  the	  100µl	  yeast	  solution	  along	  with	  700µl	  of	  Solution	  B.	  	  
Samples	  were	  shaken	  for	  30	  minutes	  at	  28°C	  and	  then	  heat	  shocked	  for	  15	  minutes	  at	  42°C	  in	  a	  
waterbath.	   Cells	   were	   then	   centrifuged	   for	   five	   seconds,	   re-­‐suspended	   in	   200µl	   TE	   (10mM	  
TRIS-­‐Cl	  pH7.5,	  1mM	  EDTA)	  and	  spread	  onto	  appropriate	  plates	  (stored	  at	  28°C).	  
	   	   	  
Solution	  A	   100mM	   LiAc	  pH7.5	  
	   10mM	   TRIS-­‐HCl	  pH7.5	  
	   1mM	   EDTA	  
Solution	  B	   40%	  (w/v)	   PEG-­‐4000	  
	   10mM	   TRIS-­‐HCl	  pH7.5	  
	   1mM	   EDTA	  
	   100mM	   LiAc	  pH7.5	  
Carrier	  DNA	   10mg.ml-­‐1	   Salmon	  Sperm	  DNA	  (Fluka	  31149)	  




2.7.3	  –	  Library	  screen	  
	   	   	  
Solution	  C	   100mM	   LiAc	  pH7.5	  
	   10mM	   TRIS-­‐HCl	  pH7.5	  
	   1mM	   EDTA	  
	   1M	   Sorbitol	  
Solution	  D	   33%	  
(w/v)	  
PEG-­‐4000	  
	   100mM	   LiAc	  pH7.5	  
	   27.6µg	   Salmon	  Sperm	  DNA	  (Sigma-­‐Aldrich	  AM9680)	  
Table	  2.15	  –	  Materials	  for	  library	  transformation	   	   	  
	  
DAY1	  	  
Four	  3ml	  liquid	  cultures	  of	  SC-­‐Leu	  were	  inoculated	  with	  yeast	  expressing	  pDBleu-­‐DA1.	  Cultures	  
were	  grown	  overnight	  at	  28°C	  (at	  220rpm).	  
DAY2	  
All	   overnight	   cultures	   were	   combined	   and	   diluted	   with	   SC-­‐Leu	   to	   form	   100ml	   culture	   of	  
OD600=0.1.	  This	  culture	  was	  grown	  for	  seven	  hours	  (28°C	  and	  220rpm),	  before	  diluting	  to	  form	  
a	  200ml	  culture	  of	  OD600=0.1.	  This	  culture	  was	  grown	  overnight	  at	  28°C	  and	  220rpm.	  
DAY3	  
When	   the	   OD600	   reached1.3,	   the	   overnight	   culture	   was	   diluted	   to	   form	   a	   200ml	   culture	   of	  
OD600=0.4	  and	  then	  grown	  at	  28°C	  and	  220rpm	  until	  the	  OD600	  reached	  0.85.	  The	  200ml	  culture	  
was	  split	  into	  four	  50ml	  falcon	  tubes,	  which	  were	  centrifuged	  at	  1800x	  g	  for	  five	  minutes.	  The	  
pellets	  were	  washed	  twice	  with	  5ml	  solution	  C	  and	  then	  the	  contents	  of	  the	  four	  tubes	  were	  
combined	  in	  1ml	  Solution	  C	  and	  kept	  on	  ice	  for	  10	  minutes.	  
Cells	  were	  then	  centrifuged	  at	  1800x	  g	  for	  five	  minutes,	  the	  pellet	  was	  resuspended	  in	  720µl	  
Solution	  C	  and	  then	  split	  into	  two	  tubes	  containing	  360µl	  each.	  10µg	  of	  library	  DNA	  was	  added	  
to	   each	   tube	   and	  mixed	   by	   vortexing,	   followed	   by	   heating	   at	   28°C	   for	   30	  minutes	   and	   then	  
heatshocking	  for	  40	  minutes	  at	  42°C.	  
Cells	  were	  centrifuged	  at	  1800x	  g	  for	  five	  minutes	  and	  the	  pellet	  re-­‐suspended	  in	  1000µl	  water.	  
100µl	   aliquots	   were	   spread	   on	   140mm	   SC-­‐Leu-­‐Trp-­‐His	   plates	   and	   left	   out	   of	   sunlight	   at	   room	  
temperature.	  Additionally,	  the	  re-­‐suspended	  pellet	  was	  diluted	  one	  in	  four	  and	  one	  in	  ten,	  and	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spread	   on	   SC-­‐Leu-­‐Trp	   plates	   in	   order	   to	   calculate	   transformational	   efficiency.	   Transformational	  
efficiency	   was	   263,200	   transformational	   events	   per	   screen.	   Two	   screens	   were	   carried	   out,	  
resulting	  in	  526	  400	  transformational	  events	  in	  total.	  
2.7.3.1	  –	  Selecting	  colonies	  	  
Colonies	  that	  grew	  on	  SC-­‐Leu-­‐Trp-­‐His	  plates	  were	  used	  to	  inoculate	  3ml	  SC-­‐Leu-­‐Trp-­‐His	  liquid	  cultures,	  
which	  were	  then	  subjected	  to	  miniprep	  (section	  2.2.3.3),	  PCR	  (section	  2.2.2.3)	  and	  sequencing	  
(section	   2.2.2.4)	   analyses.	   Sequenced	   colonies	  were	   screened	   for	   those	  with	   genes	   in-­‐frame	  
with	  the	  GAL4	  activation	  domain	  present	  in	  pEXP-­‐AD502.	  Only	  these	  colonies	  were	  reported	  in	  
Chapter	  4.	  
2.7.3.2	  -­‐	  Drop	  testing	  
Candidate	  genes	  selected	  for	  further	  study	  were	  subject	  to	  drop	  testing.	  The	  respective	  pEXP-­‐
AD502	   prey	   constructs	   (isolated	   from	   colonies)	   were	   transformed	   into	   TOP10	   One	   Shot	  
competent	  cells	  (Invitrogen	  C404003)	  and	  subjected	  to	  a	  further	  round	  of	  sequencing	  analysis	  
(section	   2.2.2.4).	   Complete	   coding	   sequences,	   generated	   from	   cDNA	   (section	   2.2.2.1)	   were	  
cloned	   into	   empty	  pEXP-­‐AD502	   vector	   (section	   2.2)	   and	   re-­‐transformed	   into	   yeast	   using	   the	  
protocol	  described	  in	  section	  2.7.2.1.	  Transformed	  yeast	  were	  diluted	  and	  grown	  on	  SC-­‐Leu-­‐Trp,	  
SC-­‐Leu-­‐Trp-­‐His,	  and	  SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  plates	  and	  incubated	  at	  both	  room	  temperature	  and	  28°C	  (data	  
presented	  in	  Chapter	  4	  is	  from	  growth	  at	  28°C).	  Drop	  tests	  were	  repeated	  a	  total	  of	  four	  times.	  
2.8	  –	  MAGIC	  analysis	  
The	  lines	  used	  in	  this	  study	  are	  described	  in	  section	  2.3.1	  and	  the	  growth	  conditions	  used	  are	  
described	  in	  section	  2.3.2.	  Organs	  were	  phenotyped	  following	  the	  protocols	  documented	  in	  
section	  2.3.5.	  	  
The	  MAGIC	  analysis	  was	  kindly	  performed	  in	  collaboration	  with	  Mathew	  Box	  at	  the	  Sainsbury	  
Laboratory	  Cambridge	  University,	  Cambridge.	  QTLs	  were	  identified	  using	  HAPPY:	  ‘a	  software	  
package	  for	  multipoint	  QTL	  mapping	  in	  genetically	  heterogeneous	  animals’	  (Mott,	  2000,	  Mott	  
et	  al.,	  2000).	  The	  genotype	  information	  used	  in	  the	  HAPPY	  analysis	  was	  from	  1250	  SNPs,	  
spaced	  roughly	  100Kb	  apart	  (Kover	  et	  al.,	  2009,	  Mott	  et	  al.,	  2011).	  Genotype	  interrogation	  of	  
parental	  lines	  used	  publicly	  available	  sequence	  data	  (Gan	  et	  al.,	  2011)	  and	  the	  Rätsch	  lab	  
GBrowse	  platform	  (http://gbrowse.cbio.mskcc.org/gb/gbrowse/thaliana-­‐19magic/).	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2.9	  –	  GWAS	  analysis	  
The	  accessions	  used	  in	  this	  study	  are	  listed	  in	  Table	  S2	  and	  the	  growth	  conditions	  used	  are	  
described	  in	  section	  2.3.2.	  Organs	  were	  phenotyped	  following	  the	  protocols	  documented	  in	  
section	  2.3.5.	  	  
The	  genome	  wide	  association	  (GWA)	  analysis	  was	  performed	  in	  collaboration	  with	  Mathew	  
Box	  at	  the	  Sainsbury	  Laboratory	  Cambridge	  University,	  and	  Justin	  Borevitz	  and	  Riyan	  Cheng	  at	  
the	  Australian	  National	  University,	  Canberra,	  Australia.	  The	  analysis	  was	  carried	  out	  using	  the	  
QTLRel	  package	  (Cheng	  et	  al.,	  2011)	  and	  call_method_75_	  TAIR9	  SNP	  data	  (Horton	  et	  al.,	  2012).	  
Alleles	  with	  a	  frequency	  of	  less	  than	  0.05	  were	  excluded	  from	  the	  analysis.	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Chapter	  3	  -­‐	  A	  Structural	  Analysis	  of	  the	  DA1	  Protein	  
	  
3.1	  Introduction	  
The	  aim	  of	  the	  research	  conducted	  in	  this	  Chapter	  was	  to	  achieve	  a	  greater	  understanding	  of	  
DA1	  function,	  beyond	  the	  preliminary	  observations	  of	  growth	  and	  developmental	  effects	  seen	  
in	  genetic	  studies	  (Li	  et	  al.,	  2008).	  The	  initial	  research	  demonstrated	  clearly	  that	  DA1	   is	  a	  key	  
regulator	  of	  organ	  growth	  (Li	  et	  al.,	  2008),	  however	  it	  did	  not	  identify	  the	  mechanism	  through	  
which	   DA1	   controls	   this	   growth.	   	   The	   work	   described	   in	   this	   Chapter	   uses	   the	   conserved	  
protein	  domains	   found	   in	  DA1	   to	  uncover	   the	  biochemical	   functions	  of	  DA1,	   and	   thereby	   to	  
gain	  a	  deeper	  understanding	  of	  the	  mechanisms	  controlling	  growth	  in	  Arabidopsis.	  Moreover,	  
due	  to	  the	  extensive	  similarity	  in	  protein	  structure	  shared	  between	  DA1	  and	  other	  DA1	  family	  
members,	  progress	  made	   in	   this	  Chapter	   is	   likely	   to	  be	   relevant	   to	   the	  study	  of	  other	   family	  
members	   (Fig.	   3.1).	   This	   work	   may	   therefore	   be	   of	   significant	   interest	   to	   research	   areas	  
including	  cold	  tolerance,	  pathogen	  response	  and	  the	  regulation	  of	  root	  meristem	  size	  (Yang	  et	  
al.,	  2010,	  Bi	  et	  al.,	  2011,	  Peng	  et	  al.,	  2013).	  
As	   illustrated	   in	  Fig.	  3.1	  DA1	   is	  predicted	  to	  contain	  4	   identifiable	  protein	  domains:	   two	  UIM	  
domains,	  one	  LIM	  domain	  and	  a	  C-­‐terminal	  metallopeptidase	  domain	  embedded	  in	  the	  highly	  
conserved	  C	  terminal	  region.	  	  
3.1.1	  -­‐	  The	  Ubiquitin-­‐Interacting	  Motif	  (UIM)	  
The	   UIM	   is	   a	   specific	   type	   of	   ubiquitin	   binding	   domain	   (UBD)	   made	   up	   of	   a	   short	   motif	  
containing	  the	  highly	  conserved	  sequence:	  Φ-­‐x-­‐x-­‐Ala-­‐x-­‐x-­‐x-­‐Ser-­‐x-­‐x-­‐Ac	  at	  its	  core	  (where	  Φ	  is	  a	  
large	   hydrophobic	   residue,	   and	   ‘Ac’	   acidic	   residue)	   (Hofmann	   and	   Falquet,	   2001).	   The	   UIM	  
moiety	   is	   thought	   to	   form	  an	  short	  alpha-­‐helix,	  which	   is	  able	   to	   insert	   into	  protein	   folds	  and	  
bind	   ubiquitin	   (Hofmann	   and	   Falquet,	   2001).	   Interestingly	   the	   ubiquitin	   binding	   capacity	   of	  
UIMs	   is	  not	   limited	  to	  one	  molecule	  per	  domain,	  with	   recent	  work	   illustrating	   that	  UIMs	  are	  
able	   to	  bind	   two	  ubiquitin	  molecules;	  one	  on	  either	   face	  of	   the	  helix	   (Harper	  and	  Schulman,	  
2006).	  Although	  a	  diverse	  variety	  of	  proteins	  contain	  UIMs,	   it	   is	  particularly	  pertinent	   to	   this	  
work	  that	  UIMs	  have	  been	  shown	  to	  be	  present	  in	  many	  proteins	  involved	  in	  the	  proteasomal	  





















A	   further	   feature	   of	   UIM	   containing	   proteins	   (but	   not	   exclusive	   to	   UIMs)	   is	   their	   ability	   to	  
promote	   cis-­‐mono-­‐ubiquitination	   at	   a	   location	   distinct	   from	   that	   of	   the	  UIM	   (Oldham	  et	   al.,	  
2002).	   This	   process	   is	   termed	   coupled	   mono-­‐ubiquitination	   and	   has	   been	   observed	   for	   the	  
mammalian	  UBD-­‐containing	   proteins,	   STS1,	   STS2,	   EPS15	   and	  HRS	   (Hoeller	   et	   al.,	   2006).	   This	  
process	  involves	  the	  mono-­‐ubiquitination	  of	  UBD	  containing	  proteins,	  which	  results	  in	  a	  UBD-­‐
cis-­‐ubiquitin	   interaction,	  and	  generates	  a	  change	   in	  protein	  confirmation	  (Woelk	  et	  al.,	  2006,	  
Haglund	  and	  Stenmark,	  2006,	  Hoeller	  et	  al.,	  2006).	  UIMs	  have	  been	  shown	  to	  be	  sufficient	  for	  
Figure	  3.1	  –	  The	  DA1	  protein	  family	  	  
All	   DA1	   family	   members	   possess	   a	   C-­‐terminal	   zinc	   metallopeptidase	   domain	   and	   central	   or	   C-­‐
terminal	  LIM	  domain.	  Four	  members	  contain	  UIM	  domains	  and	  two	  specialised	  members	  contain	  
unique	  domains;	  DAR4	  a	  NB-­‐ARC	  and	  LRR	  domain,	  and	  DAR5	  an	  RPW8	  domain	  -­‐	  all	  three	  of	  which	  
are	  characterised	  pathogen	  response	  domains	  (Bi	  et	  al.,	  2001,	  Xiao	  et	  al.,	  2001).	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coupled	   mono-­‐ubiquitination,	   with	   GST-­‐UIM	   chimeric	   proteins	   capable	   of	   causing	   mono-­‐
ubiquitination	  of	   the	  GST	   (Oldham	  et	  al.,	  2002).	  The	  exact	  mechanism	   is	  unclear,	  although	   it	  
has	   been	   shown	   for	   the	   human	   protein	   EPS15	   that	   a	   UIM	   interaction	   with	   an	   E3	   ligase-­‐
conjugated	  ubiquitin	  is	  necessary	  to	  recruit	  the	  E3	  ligase	  to	  EPS15	  (Woelk	  et	  al.,	  2006).	  As	  for	  
the	   role	   of	   coupled	  mono-­‐ubiquitination,	   it	   is	   possible	   that	   the	   UIMs	   preferentially	   interact	  
with	   ubiquitin	   in	   cis,	   and	   therefore	   their	   mono-­‐ubiquitination	   serves	   to	   modify	   the	  
confirmation	  of	  the	  protein	  they	  are	  in	  and	  alter	  its	  biochemical	  activity.	  	  
In	  addition	  to	  these	  cis-­‐mediated	  mechanisms,	  UIMs	  have	  been	  showed	  to	  play	  a	  role	   in	   the	  
trans-­‐regulation	   of	   target	   proteins,	   such	   as	   the	   ubiquitin	   dependent	   recognition	   and	  
internalisation	   of	   plasma	   membrane	   signal	   receptors	   (Hofmann	   and	   Falquet,	   2001).	   In	   this	  
system	  it	   is	  postulated	  that	  UIM	  proteins	  act	  as	  adaptors	  and	  cargo	  receptors,	  and	  direct	  the	  
specific	   movement	   of	   ubiquitinated	   proteins	   through	   the	   endosomal	   pathway	   to	   specific	  
destinations.	  It	  is	  thought	  that	  the	  covalently	  attached	  ubiquitin	  on	  the	  target	  protein	  acts	  as	  a	  
bait	  that	  draws	  the	  UIM-­‐containing	  adaptor	  protein	  into	  specific	  intimate	  contact.	  	  
Of	   particular	   interest	   to	   this	   work	   is	   the	   abundance	   of	   UIM	   domains	   in	   de-­‐ubiquitinating	  
enzymes	   (DUBs).	  These	  enzymes	  specifically	   remove	  ubiquitin	   from	  proteins	  and	   reverse	   the	  
biological	  consequences	  of	  ubiquitination.	  The	  ubiquitin	  specific	  protease	  (USP),	  Josephin,	  and	  
ovarian	   tumour	  protease	   (OTU)	   families	   (Komander	  et	  al.,	  2009),	   show	  similarities	   in	  protein	  
structure	   to	  DA1	  as	   they	  all	   contain	  UIM	  and	  peptidase	  domains.	   For	  many	  UIM-­‐	   containing	  
DUBs	  the	  UIMs	  are	  necessary	  for	  de-­‐ubiquitinating	  activity	  (Mao	  et	  al.,	  2005,	  Meulmeester	  et	  
al.,	  2008),	  and	  in	  some	  cases	  UIMs	  determine	  the	  specificity	  of	  the	  DUB.	  For	  example,	  the	  UIM	  
present	  in	  mammalian	  DUB,	  ATXN3	  confers	  specificity	  towards	  K63	  linked	  poly-­‐ubiquitin	  chains	  
(Winborn	  et	  al.,	  2008).	  In	  addition,	  there	  is	  evidence	  that	  different	  UIM	  domains	  have	  different	  
affinities	  for	  different	  ubiquitin	  chain	  lengths	  (Woelk	  et	  al.,	  2006).	  
3.1.2	  -­‐	  The	  LIM	  domain	  
The	  LIM	  	  (Lin11,	  Isi1	  and	  Mec-­‐3)	  domain	  (Prosite:	  PS00478)	  is	  a	  highly	  conserved	  tandem	  zinc	  
finger	  domain	   that	  acts	  as	  a	  platform	  for	  highly	  specific	  protein-­‐protein	   interactions	   in	  many	  
organisms	  (Schmeichel	  and	  Beckerle,	  1994,	  Kadrmas	  and	  Beckerle,	  2004,	  Agulnick	  et	  al.,	  1996).	  
Characterised	  by	  the	  sequence	  C-­‐x2-­‐C-­‐x16-­‐23-­‐H-­‐x2-­‐C-­‐x2-­‐C-­‐x2-­‐C-­‐x16-­‐21-­‐C-­‐x2-­‐(C/H/D),	  two	  quartets	  of	  
cysteine	   and	   histidine	   residues	   co-­‐ordinate	   the	   zinc	   ions	   at	   the	   core	   of	   the	   two	   zinc	   fingers	  
(Kadrmas	  and	  Beckerle,	  2004)	  (Fig.	  3.2).	  	  
LIM	   proteins	   are	   involved	   in	   a	   wide	   variety	   of	   cellular	   roles,	   from	   actin	   binding	   to	  
transcriptional	  regulation	  (Maul	  et	  al.,	  2003,	  Shirasaki	  and	  Pfaff,	  2002,	  Moes	  et	  al.,	  2012).	  This	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diversity	  in	  function	  makes	  it	  difficult	  to	  infer	  any	  specific	  functions	  of	  DA1	  from	  the	  presence	  
of	  a	  LIM	  domain	  alone.	  For	  example	  the	  LIM	  domains	  present	  in	  LIM-­‐Homeodomain	  (LIM-­‐HD)	  
protein	  are	  involved	  in	  mediating	  the	  trans-­‐interaction	  with	  its	  binding	  partner	  LBD1	  (Agulnick	  
et	  al.,	  1996),	  whereas	  the	  LIM	  domain	  in	  LIM	  kinase-­‐1	  is	  thought	  to	  cis-­‐regulate	  kinase	  activity	  
by	  auto-­‐inhibition	  of	  the	  kinase	  domain	  (Nagata	  et	  al.,	  1999).	  Because	  it	  is	  difficult	  to	  infer	  the	  
biological	  function	  of	  members	  of	  the	  DA1	  family	  from	  the	  presence	  of	  a	  LIM	  domain	  alone,	  a	  
detailed	  functional	  investigation	  is	  required.	  	  	  
Although	  the	  core	  LIM	  motif	  –	  the	  zinc	  coordinating	  sequence	  –	   is	  highly	  conserved	  amongst	  
protein	   species,	   the	   flanking	   protein	   sequence	   is	   thought	   to	   be	   that	   which	   determines	   the	  
specificity	  of	  the	  LIM	  interaction,	  and	  mutations	  in	  these	  regions	  are	  sufficient	  to	  abolish	  LIM	  
function.	   For	   example,	   mutations	   in	   residues	   in,	   and	   immediately	   adjacent	   to,	   the	   zinc-­‐
coordinating	  region	  of	  the	  LMX1B	  LIM	  domain	  in	  Humans,	  are	  sufficient	  to	  generate	  the	  loss-­‐
of-­‐function	   phenotype	   responsible	   for	   Nail-­‐Patella	   Syndrome	   (NPS)	   (Clough	   et	   al.,	   1999,	  





Figure	  3.2	  –	  The	  LIM	  domain	  	  
Eight	   highly	   conserved	   histidine	   and	   cysteine	   residues	   (purple	   circles)	   coordinate	   two	   zinc	   ions	  
that	   form	   the	   core	   of	   the	   zinc	   fingers.	   Variation	   in	   the	   length	   and	   composition	   of	   the	   finger	  
domains	   and	   the	   peripheral	   protein	   sequence	   determines	   the	   specificity	   of	   the	   LIM	   domain.	  
(Figure	  from	  Kadrmas	  and	  Beckerle,	  (2004))	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3.1.3.	  –	  The	  C-­‐terminal	  peptidase	  
The	  C-­‐terminal	  region	  of	  DA1	  is	  the	  most	  distinctive	  yet	  most	  enigmatic	  domain	  in	  the	  protein.	  
The	  published	  da1-­‐1	  mutation,	  with	  a	  single	  amino	  acid	  transition	   in	   the	  highly	  conserved	  C-­‐
terminal	  region,	  is	  sufficient	  to	  generate	  a	  dominant	  negative-­‐interfering	  growth	  phenotype	  (Li	  
et	   al.,	   2008).	   This	   indicates	   that	   conserved	   regions	   of	   the	   C-­‐terminal	   domain	   are	   probably	  
essential	  for	  DA1	  function.	  	  	  
The	   dominant	   negative	   nature	   of	   da1-­‐1,	   and	   the	   functional	   redundancy	   between	   DA1	   and	  
DAR1	   (Li	   et	   al.,	   2008)	   suggest	   that	   the	  da1-­‐1	   phenotype	  may	  be	   a	   consequence	  of	   the	  non-­‐
functional	  da1-­‐1	  protein	  forming	  a	  complex	  with	  a	  	  binding	  partner	  –	  for	  example	  DA1	  or	  DAR1	  
–	  	  and	  forming	  a	  non-­‐functional	  complex	  (Fig.	  3.4a,b).	  This	  explanation	  would	  be	  similar	  to	  the	  
proposed	  mechanism	  for	  the	  dominant	  negative	  effects	  of	  the	  ERECTA	  ΔKinase	  mutant,	  where	  
the	   formation	   of	   a	   non-­‐functional	   receptor	   heterodimer	   is	   thought	   to	   cause	   the	   observed	  
developmental	  phenotypes	  (Shpak	  et	  al.,	  2003).	  Therefore,	  one	  prediction	  to	  be	  tested	  is	  that	  
DA1	  homo-­‐	  and	  hetero-­‐oligomerises	  with	  DA1	  and	  DAR1.	  	  
An	   alternative	   explanation	   for	   the	   observed	   dominant	   negative	   phenotype	   of	   the	   da1-­‐1	  
mutant	  is	  that	  the	  non-­‐functional	  da1-­‐1	  protein	  binds	  to	  its	  target	  protein	  and	  competes	  with	  
both	   DA1	   and	   DAR1	   for	   their	   common	   target	   protein	   (Fig.	   3.4c,d).	   This	   form	   of	   substrate	  
competition	  is	  similar	  to	  that	  observed	  for	  the	  mammalian	  peptidase	  SPP	  (Schrul	  et	  al.,	  2010).	  
The	  C-­‐terminal	  domain	  (Pfam:PF12315)	  is	  highly	  conserved	  amongst	  DA1	  family	  members	  	  and	  
defines	  the	  DA1	  family	  (Fig.	  3.1).	  It	  has	  strong	  homology	  over	  a	  short	  region	  with	  members	  of	  
the	  higher-­‐order	  peptidase	  MA	  clan	  (Pfam:CL0126),	  containing	  proteins	  from	  a	  wide	  diversity	  
organisms	   including	   archaea,	   bacteria,	  metazoans,	   fungi	   and	  plants	   (Pfam).	  Members	  of	   this	  
clan	  are	  defined	  by	  a	  neutral	  zinc	  metallopeptidase	  domain	  (PROSITE:PS00142),	  characterised	  
by	  an	  H-­‐E-­‐x-­‐x-­‐H	  motif	  (henceforth	  termed	  HExxH),	  where	  the	  two	  histidine	  residues	  coordinate	  
a	  zinc	  atom	  to	  form	  the	  active	  site	  of	  the	  peptidase	  (Matthews	  et	  al.,	  1972,	  Devault	  et	  al.,	  1988,	  
Jongeneel	  et	  al.,	  1989).	  The	  peptidase	  MA	  clan	  contains	  diverse	  proteins	  with	  a	  wide	  variety	  of	  
functions.	  For	  example,	  members	  of	  the	  WLM	  family	  (PF08325)	  have	  been	  shown	  to	  have	  de-­‐
ubiquitination	   and	   de-­‐sumoylation	   activities	   (Iyer	   et	   al.,	   2004,	   Su	   and	   Hochstrasser,	   2010,	  
Mullen	  et	  al.,	  2010).	  Other	  clan	  members	  include	  virus	  expressed	  enhancin	  peptidases,	  whose	  
function	  is	  to	  facilitate	  infections	  (Wang	  and	  Granados,	  1997,	  Lepore	  et	  al.,	  1996);	  reprolysin-­‐
family	   snake	   venom	   endopeptidases	   (Fox	   and	   Serrano,	   2005);	   and	   astacin,	   a	   crustacean	  
digestive	  enzyme	  (Bond	  and	  Beynon,	  1995).	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The	  presence	  of	  two	  UIM	  domains	  and	  a	  zinc	  metallopeptidase	  active	  site	  suggests	  that	  DA1	  
and	   related	   family	   members	   may	   have	   a	   peptidase	   function	   and	   be	   involved	   in	   an	   as	   yet	  
unknown	   aspect	   of	   the	   ubiquitin	   system.	   Therefore	   the	   functional	   characterisation	   of	   the	  
activities	   of	   these	   domains,	   together	  with	   the	   LIM	   domain,	  will	   provide	   new	   information	   to	  



























3.2	  –	  DA1	  interacts	  with	  DA1	  and	  DAR1	  in	  vitro,	  in	  a	  LIM-­‐independent	  manner	  
3.2.1	  –	  Overexpressing	  DA1R358K-­‐HA	  partially	  phenocopies	  da1-­‐1	  
The	  observed	  genetic	  redundancy	  between	  DA1	  and	  DAR1,	  and	  the	  dominant	  negative	  nature	  
of	  the	  da1-­‐1	  mutation	  (Li	  et	  al.,	  2008),	  suggests	  that	  the	  da1-­‐1	  protein	  may	  interfere	  with	  the	  
function	  of	  wild-­‐type	  DAR1,	   leading	  to	   its	   large	  organ	  phenotype	  (Li	  et	  al.,	  2008)(Fig.	  3.4).	  To	  
explore	  whether	   the	  da1-­‐1	  protein	  also	  had	  a	  negative	   interfering	  activity	   towards	  wild-­‐type	  
DA1,	  DA1R358K	   (incorporating	  the	  da1-­‐1	  R358K	  transition)	  was	  overexpressed	   in	  Col-­‐0	  plants,	   in	  
which	   there	   are	   wild-­‐type	   levels	   of	   DA1.	   To	   achieve	   this,	   DA1R358K-­‐HA	   was	   cloned	   into	   the	  
pMDC32	   vector	   (Curtis	   and	   Grossniklaus,	   2003),	   where	   it	   was	   under	   the	   control	   of	   35S	  
promoter,	   and	   transformed	   into	   Col-­‐0.	   Data	   presented	   in	   Fig.	   3.3,	   shows	   that	   expression	   of	  
Figure	  3.3	  –	  The	  DA1R358K	  mutation	  is	  negatively	  interfering	  towards	  DA1	  and	  DAR1	  
Over-­‐expression	  of	  DA1R358K-­‐HA	  in	  Col-­‐0	  partially	  phenocopies	  the	  da1-­‐1	  large	  organ	  phenotype.	  
(*)	  Petals	  of	  both	  da1-­‐1	  and	  35S:DA1R358K-­‐HA	  plants	  are	  significantly	  larger	  than	  Col-­‐0	  (Student’s	  
T-­‐test,	   p<0.05;	   n=25).	   Similar	   results	   were	   observed	   by	   Li	   et	   al	   (2008).	   The	   35S::DA1R358K-­‐HA	  
construct	  was	  kindly	  provided	  by	  Yunhai	  Li	  and	  the	  relative	  expression	  level	  of	  DA1R358K	  in	  these	  
lines	  is	  eight	  times	  wild-­‐type	  levels	  (Li	  et	  al.,	  2008).	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p35S::DA1R358K-­‐HA	   in	   a	   Col-­‐0	   background	   generates	   a	   large	   organ	   phenotype	   that	   partially	  
phenocopies	   the	  da1-­‐1	  mutation.	   	  This	   large	  petal	  phenotype,	  although	  not	  as	  severe	  as	   the	  
da1-­‐1	  phenotype,	  was	  present	   in	  a	  wild-­‐type	  DA1	  and	  DAR1	  background	  suggesting	   that	   the	  
DA1R358K	  protein	  has	  a	  negative	  interfering	  effect	  towards	  both	  DA1	  and	  DAR1.	  The	  increased	  
level	   of	   expression	   of	   DA1R358K-­‐HA	   in	   this	   line	   relative	   to	   wild-­‐type	   DA1	   (eightfold;	   Li	   et	   al	  
(2008))	  suggests	  that	  da1-­‐1	  might	  not	  have	  a	  true	  dosage	  dependent	  effect.	  However,	  the	  high	  
level	   of	   instability	   of	   DA1	   protein	   expression	   in	   Arabidopsis	   tissues	   that	   leads	   to	   it	   being	  
undetectable	  in	  stable	  transgenics	  (Yunhai	  Li,	  personal	  communication),	  may	  mean	  that	  higher	  



















Figure	  3.4	  –	  Models	  for	  explaining	  the	  da1-­‐1	  dominant	  negative	  phenotype	  
(A,B)	  The	  non-­‐functional	  complex	  model:	  in	  wild-­‐type	  cells,	  a	  DA1-­‐DAR1	  oligomer	  functions	  as	  an	  
active	  complex	  (A),	  however,	  the	  da1-­‐1-­‐DAR1	  complex	  is	  inactive	  (B),	  which	  results	  in	  a	  reduction	  
in	   overall	   DA1	   (and	   DAR1)	   activity.	   (C,D)	   The	   substrate	   competition	   model:	   DA1	   binds	   to	   and	  
processes	   a	   substrate	   molecule	   (large	   grey	   triangle)	   into	   its	   product	   (small	   grey	   triangles)	   (C).	  
However,	   da1-­‐1	   is	   only	   able	   to	  bind	   the	   substrate	  molecule	   and	  not	   able	   to	  process	   it	   (D).	   The	  
inactive	   da1-­‐1	   protein	   competes	   with	   wild-­‐type	   DA1	   (and	   DAR1)	   for	   substrate	   binding,	   and	  
therefore	  reduces	  DA1	  activity.	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There	  are	  at	  least	  two	  possible	  explanations	  of	  the	  observed	  dominant	  negative	  phenotype	  of	  
da1-­‐1	  plants	  (Fig.	  3.4).	  One	  is	  that	  DA1	  and	  DAR1	  interact	  physically	  as	  well	  as	  genetically,	  and	  




3.2.2	  –	  FLAG-­‐DA1	  physically	  interacts	  with	  GST-­‐DAR1	  and	  GST-­‐DA1	  in	  vitro	  
There	  are	  several	  methods	   that	  can	  be	  used	   to	   investigate	  putative	  protein	   interactions;	   the	  
strengths	  and	  weaknesses	  of	   these	  methods	  are	  discussed	   in	  Box	  3.1.	   In	   this	  experiment	  the	  
primary	   goal	  was	   to	   establish	  whether	   or	   not	   DA1	   and	  DAR1	  were	   able	   to	   directly	   interact.	  
Based	   on	   the	   observation	   that	   DA1	  was	   undetectable	   in	   stable	   transgenic	   Arabidopsis	   lines	  
(Yunhai	  Li,	  personal	  communication),	  an	  in	  vitro	  approach	  was	  chosen.	  	  
In	   this	   in	   vitro	   system,	   recombinant	   GST-­‐tagged	   bait	   proteins	   were	   incubated	   with	  
recombinant	   FLAG-­‐tagged	   prey	   proteins	   before	   precipitation	   of	   GST-­‐tagged	   bait	   proteins	   on	  
glutathione	   sepharose	   beads.	   The	   purified	   proteins	  were	   then	   eluted	   and	   subjected	   to	   SDS-­‐
PAGE	  and	  immunoblot	  analysis.	  The	  ability	  of	  β-­‐glucuronidase	  (GUS)	  to	  form	  a	  homo-­‐tetramer	  
was	   utilised	   to	   design	   a	   positive	   control	   of	   GST-­‐GUS	   vs	   FLAG-­‐GUS.	   Two	   sets	   of	   negative	  
controls	  were	  also	  used;	  these	  were	  GST-­‐GUS	  vs	  FLAG-­‐prey,	  and	  GST-­‐bait	  vs	  FLAG-­‐GUS.	  	  
Box	  3.1	  –	  Methods	  of	  assaying	  for	  protein-­‐protein	  interactions	  
	  
In	  vitro	  co-­‐Immunoprecipitation	  (co-­‐IP)	  
This	   tests	   for	   direct	   physical	   interactions	   between	   proteins	   in	   the	   absence	   of	   species-­‐specific	  
proteins.	   The	   artificial	   nature	   of	   this	   system	   ensures	   that	   co-­‐purifications	   are	   due	   to	   direct	  
interaction	  between	  bait	  and	  prey	  and	  not	  intermediate	  adaptor	  proteins	  or	  higher	  order	  protein	  
complexes.	  
	  
In	  planta	  co-­‐Immunoprecipitation	  (co-­‐IP)	  
The	  endogenous	  conditions	  in	  this	  system	  give	  added	  confidence	  to	  the	  validity	  of	  any	  observed	  in	  
vitro	   interaction.	   However	   this	   endogenous	   background	   allows	   for	   the	   formation	   of	   naturally	  
occurring	  higher-­‐order	  protein	  complexes	  and	   therefore	  does	  not	  allow	  one	   to	   infer	  direct	  bait-­‐
prey	  physical	  interactions.	  
	  
In	  planta	  bimolecular	  fluorescence	  complementation	  (BiFC)	  
Unlike	   in	   planta	   co-­‐IP	   experiments,	   due	   to	   the	   requirements	   for	   protein-­‐protein	   proximity	   for	  
positive	  BiFC	   results,	   this	   system	  gives	  more	   confidence	   that	  an	  observed	   interaction	   is	   a	  direct	  
bait-­‐prey	   interaction.	   It	   is	   however,	   still	   possible	   for	   positive	   results	   to	   be	   due	   to	   candidate	  
proteins	   being	   in	   extremely	   close	   proximity	   through	   higher-­‐order	   protein	   complexes	   and	   not	  
through	  a	  direct	  physical	  interaction.	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From	  Fig.	  3.5	   it	   can	  be	   seen	  clearly	   that	  GST-­‐DA1	  directly	   interacts	  with	  both	  FLAG-­‐DA1	  and	  
FLAG-­‐DAR1.	   These	   data	   show	   that	   DA1	   is	   able	   to	   both	   homo-­‐	   and	   hetero-­‐oligomerise,	  
indicating	   that	   the	   ‘non-­‐functional	   complex’	   hypothesis	   for	   explaining	   the	   DA1	   dominant	  
negative	  phenotype	  (Fig.	  3.4a,b)	  is	  feasible.	  	  However,	  it	  is	  not	  clear	  from	  this	  data	  whether	  the	  
complexes	  formed	  are	  dimeric	  or	  oligomeric,	  so	  henceforth	  products	  of	  the	  DA1-­‐DA1	  and	  DA1-­‐























Figure	  3.5	  –	  FLAG-­‐DA1	  interacts	  with	  GST-­‐	  DA1,	  GST-­‐DAR1	  and	  GST-­‐da1-­‐1	  in	  vitro	  
E.	  coli	  expressed	  GST-­‐tagged	  bait	  proteins	  were	  incubated	  with	  E.	  coli	  expressed	  FLAG-­‐tagged	  prey	  
proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   GST	   and	  
FLAG.	  FLAG-­‐DA1	  co-­‐purified	  with	  GST-­‐DA1	  (lane	  4),	  GST-­‐DAR1	  (lane	  6)	  and	  GST-­‐da1-­‐1	  (lane	  8)	  but	  
not	  with	   the	  negative	   control	  GST-­‐GUS	   (lane	  2).	   The	  GST-­‐da1-­‐1	  –	  FLAG-­‐DA1	   interaction	   (lane	  8)	  
was	   significantly	   weaker	   than	   all	   other	   positive	   interactions,	   but	   stronger	   than	   the	   negative	  




3.2.3	  –	  The	  LIM	  domain	  is	  not	  necessary	  for	  the	  DA1-­‐DA1	  interaction	  
Due	   to	   its	   widely	   documented	   role	   in	   protein-­‐protein	   interactions	   (reviewed	   in	   Kadrmas	   &	  
Beckerle	   (2004)),	   the	   LIM	   domain	   was	   a	   promising	   candidate	   region	   for	   mediating	   DA1	  
oligomerisation.	  To	  investigate	  this	  hypothesis,	  DA1	  proteins	  with	  mutated	  LIM	  domains	  were	  
assayed	  in	  vitro	  for	  their	  ability	  to	  homo-­‐oligomerise	  with	  wild-­‐type	  DA1.	  	  
This	  work	  used	  the	  DA1lim8	  mutant	  (originally	  designed	  by	  Yunhai	  Li),	  which	  incorporates	  four	  
Cys-­‐Gly	  transitions	  into	  four	  of	  the	  eight	  zinc-­‐coordinating	  positions	  of	  the	  LIM	  domain	  (C172,	  
C175,	   C199	   and	   C202).	   	   This	   mutation	   was	   predicted	   to	   abrogate	   LIM	   function	   based	   on	  
evidence	  that	  individual	  amino	  acid	  changes	  at	  these	  positions	  are	  sufficient	  to	  interfere	  with	  
and	  abolish	  LIM	  function	   (Taira	  et	  al.,	  1994,	  Agulnick	  et	  al.,	  1996).	  Taira	  et	  al	   (1994)	  showed	  
that,	  by	  making	  a	  single	  Cys-­‐Gly	  transition	  at	  the	  fourth	  zinc-­‐coordinating	  position	  of	  both	  LIM	  
domains	   in	   the	   XLIM-­‐1	   protein,	   the	   negative	   regulatory	   capacity	   of	   the	   LIM	   domains	   were	  
abolished.	  They	  also	  showed	  that	  this	  effect	  is	  equivalent	  to	  deleting	  both	  entire	  LIM	  domains.	  
This	  observation	  is	  supported	  by	  Agulnick	  et	  al	  (1996),	  who	  showed	  that	  a	  Cys-­‐Gly	  transition	  in	  
the	  equivalent	  position	  of	  both	  LIM	  domains	  in	  the	  LHX1	  protein,	  almost	  completely	  abolishes	  
its	  ability	  to	  interact	  with	  its	  binding	  partner	  LBD1.	  	  
The	   experimental	   format	   for	   this	   work	   was	   similar	   to	   that	   used	   to	   investigate	   DA1-­‐DAR1	  
oligomerisation	  in	  section	  3.2.2.	  	  However,	  when	  designing	  this	  experiment	  it	  was	  important	  to	  
consider	  the	  hypothesised	  role	  the	  LIM	  might	  play	  in	  the	  interaction;	  whether	  the	  LIM	  domain	  
interacted	  with	  the	  LIM	  domain	  of	  its	  partner,	  or	  a	  different	  protein	  region.	  To	  ensure	  that	  the	  
assay	  was	  robust	  to	  the	  possibility	  of	  the	  LIM	  domain	  binding	  a	  non-­‐LIM	  region	  of	  its	  partner,	  
lim8	  mutations	  were	  included	  in	  both	  bait	  and	  prey	  constructs.	  
The	  data	  presented	  in	  Fig.	  3.6	  show	  that	  mutating	  the	  LIM	  domain	  in	  either	  one	  or	  both	  of	  the	  
interacting	  partners	  did	  not	  abolish	  their	  interaction.	  This	  suggests	  that	  the	  LIM	  domain	  is	  not	  
involved	   in	   mediating	   the	   DA1-­‐DA1	   oligomerisation	   event.	   This	   also	   indicates	   that	   the	   LIM	  
domain	  may	  have	  other	  roles;	  perhaps	  mediating	  interactions	  with	  other	  proteins	  or	  mediating	  











































3.2.4	  –	  DA1	  interacts	  with	  da1-­‐1	  in	  vitro	  
To	  investigate	  whether	  the	  R358K	  mutation	  affects	  the	  ability	  of	  DA1	  to	  form	  a	  putative	  homo-­‐
oligomer,	   an	   interaction	   between	   DA1	   and	   da1-­‐1	   was	   tested.	   Using	   the	   in	   vitro	   co-­‐
immunoprecipitation	  analysis	  described	   in	  section	  3.2.2,	  GST-­‐DA1	  bait	  protein	  was	   incubated	  
with	  FLAG-­‐da1-­‐1	  prey	  protein	  before	  immunoprecipitation	  and	  western	  blot	  analysis.	  
These	  data	  demonstrate	  that	  GST-­‐DA1	  physically	  interacts	  with	  FLAG-­‐da1-­‐1	  (Fig.	  3.5).	  The	  band	  
in	   lane	   eight	   demonstrates	   that,	   compared	   to	   the	   negative	   controls	   (lanes	   two	   and	   seven)	  
there	  is	  a	  clear	  GST-­‐DA1	  –	  FLAG-­‐da1-­‐1	  interaction	  in	  vitro.	  However,	  it	  is	  notable	  that	  the	  DA1-­‐
da1-­‐1	  band	  (lane	  eight)	   in	  this	  blot	   is	  considerably	  weaker	  than	  that	  of	  the	  DA1-­‐DA1	  positive	  
control.	   The	   relative	   weakness	   of	   the	   DA1-­‐da1-­‐1	   interaction	   was	   surprising	   considering	   the	  
genetics	  and	  biochemistry	  studies	  suggested	  that	  the	  ‘non-­‐functional	  complex’	  model	  (Fig.	  3.4)	  
might	   explain	   the	   da1-­‐1	   phenotype.	   Nevertheless,	   it	   is	   still	   conceivable	   that	   the	   reduced	  
affinity	  of	  da1-­‐1	  for	  DA1	  (and	  DAR1)	  shown	  in	  Fig.	  3.5	  is	  sufficient	  to	  enable	  the	  incorporation	  
of	  the	  da1-­‐1	  protein	  in	  the	  majority	  of	  DA1	  oligomers	  in	  da1-­‐1	  mutant	  tissues.	  
This	  data	   is	  nonetheless	   consistent	  with	   the	  genetic	  data	  presented	   in	   Fig.	  3.3,	  which	   shows	  
that	  overexpression	  of	   the	  DA1R358K	   protein	   in	   a	  Col-­‐0	  background	  only	  partially	   rescued	   the	  
da1-­‐1	  phenotype.	   If	   the	  DA1R358K	  mutant	  protein	  had	  a	  weaker	  binding	  affinity	   than	   its	  wild-­‐
Figure	  3.6	  –	  The	  DA1	  LIM	  domain	  is	  not	  necessary	  for	  DA1	  homo-­‐oligomerisation	  
E.	  coli	  expressed	  GST-­‐tagged	  bait	  proteins	  were	  incubated	  with	  E.	  coli	  expressed	  FLAG-­‐tagged	  prey	  
proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   GST	   and	  
FLAG.	  FLAG-­‐DA1	  and	  FLAG-­‐da1lim8	  co-­‐purified	  with	  GST-­‐DA1	  and	  GST-­‐da1lim8	  (lanes	  5,6,8,9)	  but	  
not	  with	  the	  negative	  control	  GST-­‐GUS	  (lanes	  2,3);	  revealing	  that	  mutating	  the	  LIM	  domain	  in	  DA1	  




type	  counterpart,	  then	  added	  wild-­‐type	  DA1	  in	  the	  Col-­‐0	  background	  might	  reduce	  the	  relative	  
abundance	  of	  the	  DA1R358K	  protein	  in	  the	  predicted	  DA1-­‐DAR1	  oligomers.	  
	  
A 
                                                             
                                          |---------------- LIM DOMAIN ----- 
Zn Coordinating:                           C  C                 H  C  C  C 
DA1             ---NGDIYYPR------PITFQMDFRICAGCNMEIGHGRFLNCLNSLWHPECFRCYGCSQ 204  
DAR1            ---PGNILQPY------PFLIPSSHRICVGCQAEIGHGRFLSCMGGVWHPECFCCNACDK 222  
DAR2            ---FIPPYEP-------SYQYRRRQRICGGCNSDIGSGNYLGCMGTFFHPECFRCHSCGY 194 
DAR3            ---SKDVVEE---------DVNPPPS--IDGKSEIGDGTSVN-------PRCLCCFHCHR 104  
DAR4            ---SKDHVEE---------EVNPPLSKCKDCKSAIEDGISINAYGSVWHPQCFCCLRCRE 1272  
DAR5            EVECRDEIEENEKLP----EVNPPLSMCGGCNSAVKHEESVNILGVLWHPGCFCCRSCDK 379  
DAR6            ---SKDEVEGDGMLL----ELNPPPSLCGGCNFAVEHGGSVNILGVLWHPGCFCCRACHK 318  
DAR7            ---FKDPVEEDGNLPRVDLNVNHPHSICDGCKSAIEYGRSVHALGVNWHPECFCCRYCDK 233  




                ----------------------|       |……………………… LIM-LIKE DOMAIN ……… 
Zn Coordinating:                  H  C         C  C                        C 
DA1             PISEYEFSTSG---NYPFHKACYRERY-HPKCDVCSHFIPTNHAGLIEYRAHPFWVQKYC 260  
DAR1            PIIDYEFSMSG---NRPYHKLCYKEQH-HPKCDVCHNFIPTNPAGLIEYRAHPFWMQKYC 278  
DAR2            AITEHEFSLSG---TKPYHKLCFKELT-HPKCEVCHHFIPTNDAGLIEYRCHPFWNQKYC 250 
DAR3            PFVMHEILKK-----GKFHIDCYKEYYRNRNCYVCQQKIPVNAEGIRKFSEHPFWKEKYC 159  
DAR4            PIAMNEISDLR----GMYHKPCYKELR-HPNCYVCEKKIPRTAEGL-KYHEHPFWMETYC 1326  
DAR5            PIAIHELENHVSNSRGKFHKSCYER-----YCYVCKEKK------MKTYNIHPFWEERYC 428  
DAR6            PIAIHDIENHVSNSRGKFHKSCYER-----YCYVCKEKK------MKTYNNHPFWEERYC 367  
DAR7            PIAMHEFS----NTKGRCHITCYERSH--PNCHVCKKKFP-----GRKYKEHPFWKEKYC 282  




                             + 
                …………………………………………………………………………………………………| 
Zn Coordinating:  H       C  C                   C  C  
DA1             PSHEHDATPRCCSCERMEPRNTRYVELNDGRKLCLECLDSAVMDTMQCQPLYLQIQNFYE 320  
DAR1            PSHERDGTPRCCSCERMEPKDTKYLILDDGRKLCLECLDSAIMDTHECQPLYLEIREFYE 338  
DAR2            PSHEYDKTARCCSCERLESWDVRYYTLEDGRSLCLECMETAITDTGECQPLYHAIRDYYE 310 
DAR3            PIHDEDGTAKCCSCERLEPRGTNYVMLGDFRWLCIECMGSAVMDTNEVQPLHFEIREFFE 219  
DAR4            PSHDGDGTPKCCSCERLEHCGTQYVMLADFRWLCRECMDSAIMDSDECQPLHFEIREFFE 1386  
DAR5            PVHEADGTPKCCSCERLEPRGTKYGKLSDGRWLCLECG-KSAMDSDECQPLYFDMRDFFE 487  
DAR6            PVHEADGTPKCCSCERLEPRESNYVMLADGRWLCLECMNSAVMDSDECQPLHFDMRDFFE 427  
DAR7            PFHEVDGTPKCCSCERLEPWGTKYVMLADNRWLCVKCMECAVMDTYECQPLHFEIREFFG 342  





                     |---------------- LIM DOMAIN ------------------------|      |…………………………………… 
Zn coordinating aa:   C  C                 H  C  C  C                 H  C        C  C 
Q DA1:      166 QMDFRICAGCNMEIGHGRFLNCLNSLWHPECFRCYGCSQPISEYEFSTSGNYPFHKACYRERYHPKCDVCSHFIPTNHAG  245  
Q Consensus 166 ~~~~~~C~~C~~~I~~g~~v~a~gk~wHpeCF~C~~C~~~L~~~~F~~~dg~~YC~~Cy~~~~~pkC~~C~~~I~~~~~g  245 
                ....+.|++|+++|..+.++.++|+.||++||+|..|+.+|.+..|. .++++||..||.++++++|.+|+++|.+++ .    
T Consensus  57 ~~~~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~l~~~~~~-~~~~~~C~~c~~~~~~~~C~~C~~~i~~~~-~  134  
T (Lhx3)     57 TPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFS-RGESVYCKDDFFKRFGTKCAACQLGIPPTQ-V  134 
 
 
                   ………………… LIM-LIKE DOMAIN …………………………………………………………………………| 
Zn coordinating aa:              *  * *  *  C  C                   C  C 
Q DA1:         246 LIEYRAHPFWVQKYCPSHEHDATPRCCSCERMEPRNTRYVELNDGRKLCLECLDSA  301  
Q Consensus    246 ~I~~~~hpfw~qkyC~~h~H~~CF~C~~C~r~l~~g~~f~~l~dGr~yC~~C~~~~  301 
                   .+.+.          +.+||..||+|..|+++|..++.|+...||++||..||+++    
T Consensus    135 ~~~~~----------~~~~H~~CF~C~~C~~~l~~~~~~~~~~dg~~~C~~Cy~~~  180 






3.2.5	  –	  DA1	  family	  proteins	  contain	  a	  LIM-­‐like	  domain	  
Because	  in	  vitro	  experiments	  demonstrated	  that	  the	  LIM	  domain	  was	  not	  necessary	  for	  a	  DA1-­‐
DA1	   interaction	   (section	   3.2.3),	   more	   effort	   was	   placed	   on	   in	   silico	   analysis	   of	   the	   DA1	  
structure	   in	   order	   to	   identify	   other	   domains	   with	   a	   potential	   role	   in	   protein-­‐protein	  
interactions.	  	  
Typical	  web-­‐based	  domain	  prediction	  software	  (R.D.	  Finn	  et	  al.,	  2012,	  Schultz	  J	  et	  al.,	  1998,	  De	  
Castro	   E	   et	   al.,	   2006),	   search	   target	   protein	   sequences	   for	   known	   domains	  with	   a	   relatively	  
high	   stringency.	   For	   this	   reason,	   such	   programmes	   may	   fail	   to	   identify	   novel,	   divergent	  
domains	  that	  differ	  from	  the	  canonical	  motif	  by	  a	  small	  number	  of	  conserved	  residues.	  In	  the	  
case	  of	  DA1,	  these	  tools	  predict	  the	  presence	  of	  four	  domains	  shown	  in	  Fig.	  3.1;	   in	  particular	  
they	  predict	  only	  one	  LIM	  domain	   (170aa-­‐230aa)	   (Fig.	  3.7a).	  To	  relax	   the	  stringency	  of	   these	  
software	   searches,	   a	   simple	   two-­‐step	   analysis	   was	   carried	   out.	   First,	   an	   initial	   homology	  
detection	   screen	   (Biegert	   A	   et	   al.,	   2006)	   was	   carried	   out	   to	   identify	   proteins	   with	   similar	  
domains	  and	  structures.	  This	  was	  then	  followed	  by	  a	  domain	  prediction	  screen	  (R.D.	  Finn	  et	  al.,	  
Figure	  3.7	  –	  DA1	  contains	  a	  cryptic	  LIM-­‐like	  domain	  
(A)	  ClustalW	  alignment	  of	  the	  DA1	  family	  members’	  LIM	  and	  LIM-­‐like	  domains.	  LIM	  domain	  zinc-­‐
coordinating	   residues	   and	   LIM-­‐like	   domain	   putative	   zinc-­‐coordinating	   residues	   are	   indicated	   by	  
‘H/C’;	  ‘+’	  denotes	  the	  cysteine	  residue	  mutated	  to	  tyrosine	  in	  the	  chs3-­‐2D	  protein	  (Bi	  et	  al.,	  2011,	  
Larkin	  MA	  et	  al.,	  2007,	  Goujon	  et	  al.,	  2010,	  Larkin	  et	  al.,	  2007).	  For	  explanation	  of	  colour	  codes	  
used	   see	   supplementary	   information	   (Table	   S3).	   (B)	   HMM-­‐HMM	   alignment	   of	   DA1	   and	  mouse	  
LHX3	  based	  on	  structural	  predictions	  and	  protein	  homology,	  generated	  by	  HHpred	   (Biegert	  A	  et	  
al.,	   2006,	  Remmert	  et	   al.,	   2011,	   Söding,	  2005,	   Söding	  et	  al.,	   2005).	  Conserved	   zinc-­‐coordinating	  
residues	   are	   indicated	   by	   ‘H/C’	   and	   uncertain	   residues	   are	   marked	   with	   a	   ‘*’.	   The	   alignment	  




2012,	   Schultz	   J	   et	   al.,	   1998,	   De	   Castro	   E	   et	   al.,	   2006),	   which	   used	   these	   proteins	   as	   query	  
sequences.	   This	   strategy	   revealed	   that	   a	   large	   region	   of	   DA1	   (167aa-­‐303aa)	   had	   significant	  
structural	   similarities	  with	  a	  number	  of	  other	  proteins.	   In	  particular,	   the	   region	  230aa-­‐297aa	  
shared	  significant	  structural	  homology	  with	  the	  LIM	  domains	  of	  other	  proteins	  (including	  the	  
mouse	   LIM/homeobox	  protein	   LHX3	   (Zhadanov	  et	   al.,	   1995)),	   as	   illustrated	   in	   Fig.	   3.7b.	   This	  
new	  putative	  domain	  was	  termed	  the	  LIM-­‐like	  domain.	  
The	  purported	  second	  pair	  of	  zinc	  coordinating	  amino	  acids	  in	  the	  LIM-­‐like	  domain	  of	  DA1	  was	  
not	   detected	  by	   classical	   domain	  prediction	   software	   (R.D.	   Finn	   et	   al.,	   2012,	   Schultz	   J	   et	   al.,	  
1998,	  De	  Castro	  E	  et	  al.,	  2006)	  because	  of	  significant	  sequence	  divergence	  from	  the	  canonical	  
LIM	  pattern.	  By	  considering	  a	  CxxH	  pairing	  at	  position	  261aa-­‐264aa,	   it	  was	  apparent	   that	  an	  
insertion	   in	   the	   first	   zinc	   finger	   domain	   and	   the	   inter-­‐finger	   region	   causes	   the	   sequence	   to	  
deviate	  significantly	  from	  the	  LIM	  consensus	  pattern.	  This	  results	  in	  a	  finger	  length	  of	  24aa	  and	  
an	   inter-­‐finger	   region	   of	   7aa	   (rather	   that	   16-­‐23aa	   and	   2aa	   respectively).	   Currently	   it	   is	   not	  
known	   if	   these	   changes	   result	   in	   a	   functional	   domain	  or	  whether	   they	   abolish	   LIM	   function.	  
Observations	   from	  a	   recent	   publication	   on	   another	  member	   of	   the	  DA1	   family,	   CHS3/DAR4,	  
suggest	  that	  this	  LIM-­‐like	  domain	  is	  both	  functional	  and	  essential	  for	  DAR4	  function	  (Bi	  et	  al.,	  
2011).	   	  They	  showed	  that	  a	   single	  Cys-­‐Tyr	   transition	  at	  position	  1340aa	   in	   the	  chs3-­‐2D	  allele	  
has	  a	  dominant	  gain-­‐of-­‐function	  phenotype,	  with	  plants	  showing	  severe	  stunting,	  curled	  leaves,	  
constitutive	   expression	   of	   PATHOGENESIS-­‐RELATED	   (PR)	   genes	   and	   accumulation	   of	   salicylic	  
acid.	   Fig.	   3.7a	   shows	   that	   this	   cysteine	   residue	   is	   predicted	   to	   form	   the	   second	   zinc-­‐
coordinating	   residue	   of	   the	   second	   zinc-­‐finger	   in	   the	   LIM-­‐like	   domain.	   The	   fact	   that	   this	  
mutation	   causes	   such	   a	   significant	   phenotype	   suggests	   that	   this	   LIM-­‐like	   domain	   is	   indeed	  
functional.	   It	   is	  therefore	  possible	  that	  the	  LIM-­‐like	  domain	  in	  DA1	  plays	  an	  important	  role	  in	  
DA1	   function,	   and	   that	   mutations	   in	   this	   domain	   in	   DA1	   may	   also	   generate	   a	   dominant	  
negative	  phenotype.	  This	  opens	  up	  additional	  approaches	  to	  the	  structure-­‐functional	  analysis	  
of	  DA1.	  	  
3.3	  –	  Only	  one	  DA1	  UIM	  domain	  binds	  mono-­‐ubiquitin	  
Four	   members	   of	   the	   DA1	   family	   contain	   predicted	   UIM	   domains	   (Fig3.1),	   but	   it	   is	   unclear	  
whether	  these	  are	  functional	  UIM	  domains	  or	  relics.	  For	  example	  in	  DAR1	  (Fig.	  3.8)	  inspection	  
of	  UIM2	  shows	  that	  it	  lacks	  the	  highly	  conserved	  serine	  residue	  in	  the	  C-­‐terminal	  section	  of	  the	  
domain.	  This	  divergence	  in	  sequence	  presents	  the	  possibility	  that	  the	  UIM	  is	  non-­‐functional.	  In	  
order	   to	   determine	  whether	   the	   UIMs	   are	   indeed	   functional	   and	   to	   determine	   their	   role	   in	  
96	  
organ	  size	  control,	  a	  semi-­‐quantitative	   in	  vitro	  ubiquitin-­‐binding	  assay	  was	  conducted	  to	   test	  







                          *     *           
DA1 UIM1          QENEDIDRAI AL.SLLEENQ E    
DA1 UIM2          DEDEQLARAL QE.SMVVGNS P    
DAR1 UIM1         FDKEEIECAI AL.SLSEQEH V    
DAR1 UIM2         DEDEEYMRAQ LE.AAEEEER R   
DAR1 UIM3         EEDELLAKAL QE.SMNVGSP P    
Q9LM05/295-314    DDTALLQQAI AM.SMAQAAQ A  
Q9HA18/233-252    GDDLRLQMAI EE.SKRETGG K  
Q9V8R1/685-701    QEQEMIEQAL KL.SLQEH-- -  
ENSG0000013275    EDDDLLQFAI QQ.SLLEAGT E  
CE17317|B0205-    TEEQQLEWAL RL.SMQENAP A  
YMI8_YEAST/517    ENDIQLRIAL LE.SQEAQAR N  
Q9MA77/5-24       QEDEDLKLAL KM.SMQYNPP E  
O74423/258-277    DSEAELQKAI QL.SKEEDEA R  
VP27_YEAST/258    DEEELIRKAI EL.SLKESRN S  
Q9MA26/374-393    EEEEELQRAL AA.SLEDNNM K  
Q9V8R1/510-529    DEDDMLQYAI EQ.SLVETSG A  
Q05785/175-194    SYQDDLEKAL EE.SRITAQE D  
Q9P2G1/976-995    EDDPNILLAI QL.SLQESGL A  
Q17796/291-310    KEEEDLALAI AI.SQSEAEA K  
O23197/65-84      FDKEEIECAI AL.SLSEQEH V  
AAK61871/105-1    EEEELLRKAI AE.SLNSCRP S  
Q9D0W4/197-216    SEDEALQRAL EL.SLAEAKP Q  
AAH11090/250-2    SEDEDLQLAM AY.SLSEMEA A  
Q9D0W4/221-240    QEEDDLALAQ AL.SASEAEY Q  
O15286/347-366    SEEDMLQAAV TM.SLETVRN D  





Figure	  3.8	  –	  SMART	  alignment	  of	  DA1	  and	  DAR1	  UIM	  domains	  
Highly	  conserved	  Alanine	  and	  Serine	  residues	  marked	  with	  *	  were	  converted	  to	  Glycines	  
in	  order	   to	   generate	  UIM	  mutants.	   Considerable	   variation	   can	  be	   seen	   in	   the	  DA1	  and	  




This	  investigation	  used	  a	  similar	  approach	  similar	  to	  that	  used	  by	  Oldham	  et	  al	  (2002)	  in	  their	  
study	  of	  the	  UIMs	  in	  Epsin.	  An	  N-­‐terminal	  GST	  tag	  was	  fused	  to	  a	  52aa	  DA1	  fragment	  spanning	  
both	  UIM	  domains.	  Each	  UIM	  domain	  was	  mutated	  separately	  and	  in	  combination,	  to	  generate	  
a	   total	   of	   four	   constructs	   (Fig.	   3.9).	   The	   mutations	   introduced	   in	   order	   to	   abrogate	   UIM	  
function	  were	  Ala-­‐Gly	  and	  Ser-­‐Ala	  transitions	  at	  the	  highly	  conserved	  residues	  indicated	  in	  Fig.	  
3.8.	  GST-­‐UIMwt	  contained	  both	  wild-­‐type	  UIM	  domains;	  GST-­‐uim1	  contained	  a	  mutated	  UIM1	  
and	  a	  wild-­‐type	  UIM2;	  GST-­‐uim2	  contained	  a	  wild-­‐type	  UIM1	  and	  a	  mutated	  UIM2;	  and	  GST-­‐
uim12	  had	  both	  UIMs	  mutated.	  These	  constructs	  were	  kindly	  provided	  by	  Yunhai	  Li	  from	  the	  
Bevan	  lab.	  
Figure	   3.10	   shows	   that	   GST-­‐UIMwt	   and	   GST-­‐uim1	   were	   both	   able	   to	   bind	   mono-­‐ubiquitin,	  
whereas	  GST-­‐uim2	  and	  GST-­‐uim12	  were	  not.	  The	  lack	  of	  ubiquitin	  binding	  by	  GST-­‐uim2	  (where	  














Figure	  3.9	  –	  E.	  coli	  UIM	  expression	  constructs	  
A	   52aa	   fragment	   of	   DA1	   spanning	   both	  UIM	  domains	  was	   subcloned	   into	   the	   pGEX4T2	  
expression	   vector.	   Mutated	   constructs	   were	   made	   by	   introducing	   serine-­‐alanine	   and	  
alanine-­‐glycine	   transitions	   at	   the	   residues	   marked	   S	   and	   A	   respectively.	   In	   total	   four	  
constructs	  were	  made:	  one	  wild-­‐type	  (GST-­‐UIMwt),	  one	  with	  UIM1	  mutated	  (GST-­‐uim1),	  
one	   with	   UIM2	   mutated	   (GST-­‐uim2),	   and	   one	   with	   both	   UIMs	   mutated	   (GST-­‐uim12).	  




The	  UIMs	   in	  the	  human	  de-­‐ubiquitinating	  enzyme	  ATXN3	  preferentially	  target	  the	  enzyme	  to	  
K63-­‐	   (rather	   than	   K48-­‐)	   linked	   ubiquitin	   chains,	   which	   suggests	   that	   the	   UIMs	   have	   a	  
preference	   to	   binding	   a	   particular	   ubiquitin	   chain	   architecture	   (Winborn	   et	   al.,	   2008).	  
Furthermore,	  the	  UIM	  domain	  of	  the	  human	  26S	  proteasome	  subunit,	  S5a,	  has	  a	  significantly	  
reduced	  affinity	  towards	  mono-­‐ubiquitin	  compared	  to	  the	  UIMs	  of	  EPS15	  and	  HRS	  (Woelk	  et	  
al.,	   2006).	   This	   difference	   may	   be	   because	   the	   26S	   proteasome	   is	   involved	   in	   binding	   and	  
degrading	  poly-­‐ubiquitinated	   substrate	  proteins	   (Voges	  et	   al.,	   1999,	   Young	  et	   al.,	   1998),	   and	  
EPS15	   and	  HRS	   are	  well	   characterised	   targets	   of	   coupled	  mono-­‐ubiquitination	   (Woelk	   et	   al.,	  
2006,	  Hoeller	  et	  al.,	  2006).	   It	   is	   therefore	  possible	  that	  S5a	  UIMs	  have	  a	  preference	  for	  poly-­‐
ubiquitin,	  and	  EPS15	  and	  HRS	  have	  a	  preference	  to	  mono-­‐ubiquitin.	  
Based	   on	   these	   observations,	   the	   inability	   of	   DA1	   UIM1	   to	   bind	   mono-­‐ubiquitin	   does	   not	  
confirm	   that	   the	   UIM	   is	   non-­‐functional.	   Instead,	   it	   may	   be	   that	   DA1	   UIM1	   is	   specialised	   to	  
binding	   poly-­‐ubiquitin	   chains	   or	   perhaps	   chains	   attached	   to	   specific	   substrate	   proteins.	   The	  
observation	  that	  DA1	  is	  ubiquitinated	  (section	  5.3.3),	  raises	  the	  possibility	  that	  UIM2	  may	  bind	  
cis-­‐ubiquitin	   in	   a	   coupled	   mono-­‐ubiquitination	   mechanism	   that	   regulates	   DA1	   activity,	   in	   a	  

















Figure	  3.10	  –	  DA1	  UIM2	  binds	  mono-­‐ubiquitin	  in	  vitro	  
	  Recombinant	   GST-­‐tagged	   UIM	   fragments	   were	   incubated	   with	   mono-­‐ubiquitin	   before	  
purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblot	   analysis.	  Mono-­‐ubiquitin	  
co-­‐purified	   with	   GST-­‐UIMwt	   and	   GST-­‐uim1	   only,	   revealing	   that	   UIM2	   is	   the	   only	   UIM	  




3.4	  –	  DA1	  metallopeptidase	  is	  not	  active	  towards	  K48	  or	  K63	  poly-­‐ubiquitin	  
The	  DA1	  C-­‐terminal	  peptidase	  domain	  belongs	  to	  the	  MA	  clan	  of	  peptidases	  that	  includes	  the	  
WLM	  family	  of	  proteins,	  which	  have	  been	  shown	  to	  be	  involved	  in	  de-­‐sumoylation	  and	  de-­‐
ubiquitination	  (Iyer	  et	  al.,	  2004,	  Su	  and	  Hochstrasser,	  2010,	  Mullen	  et	  al.,	  2010).	  Because	  both	  
DA1	  and	  WLM	  DUBs	  contain	  UIMs	  and	  a	  peptidase	  domain,	  it	  was	  hypothesised	  that	  DA1	  was	  
a	  de-­‐ubiquitinating	  enzyme.	  To	  test	  this	  hypothesis	  the	  ability	  of	  DA1	  to	  hydrolyse	  poly-­‐
ubiquitin	  was	  assayed	  in	  an	  in	  vitro	  system.	  	  Recombinant	  GST-­‐DA1	  was	  incubated	  with	  poly-­‐
ubiquitin	  chains	  (a	  mixture	  of	  2-­‐7mers)	  for	  two	  hours	  at	  30°C,	  before	  aliquots	  were	  run	  on	  SDS-­‐
PAGE	  and	  subjected	  to	  western	  blot	  analysis.	  Because	  K48	  and	  K63	  linked	  ubiquitin	  chains	  are	  
the	  most	  abundant	  forms	  of	  poly-­‐ubiquitin	  in	  nature	  (Peng	  et	  al.,	  2003,	  Saracco	  et	  al.,	  2009),	  
only	  poly-­‐ubiquitin	  chains	  joined	  by	  these	  linkages	  were	  tested	  in	  this	  assay.	  Empty	  GST	  vector	  
(GST-­‐Φ)	  was	  used	  as	  a	  negative	  control	  in	  this	  assay.	  
The	   western	   blots	   in	   Fig.	   3.11	   showed	   that	   DA1	   had	   no	   de-­‐ubiquitinating	   activity	   towards	  
either	  K63	  and	  K48	  linked	  ubiquitin	   in	  these	  experimental	  conditions.	  Although	  it	  remained	  a	  
possibility	   that	   DA1	   possessed	   a	   de-­‐ubiquitinating	   activity	   towards	   other	   poly-­‐ubiquitin	  
structures,	  the	  identification	  of	  other	  substrates	  for	  the	  DA1	  peptidase	  in	  Chapter	  5	  led	  to	  the	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Figure	  3.11	  –	  DA1	  is	  not	  able	  to	  cleave	  K48-­‐	  and	  K63-­‐	  linked	  poly-­‐ubiquitin	  in	  vitro	  
Poly-­‐ubiquitin	  chains	  of	  various	  lengths	  (2-­‐7mers)	  were	  incubated	  with	  either	  GST-­‐DA1	  or	  
GST,	  before	  SDS-­‐PAGE	  and	  immunoblot	  analysis.	  The	  addition	  of	  GST-­‐DA1	  did	  not	  result	  
in	   an	   accumulation	   mono-­‐ubiquitin	   or	   lower-­‐molecular	   weight	   ubiquitin	   chains,	  






3.5	  -­‐	  Discussion	  
The	  biochemical	   analyses	   reported	   in	   this	   chapter	  have	   improved	  our	  understanding	  of	  DA1	  
protein	   function,	   provided	   plausible	   explanations	   for	   its	   genetic	   interactions,	   and	   helped	   to	  
focus	  research	  on	  promising	  leads.	  	  
Based	   on	   predictions	   from	   da1-­‐1	   genetic	   interactions,	   it	   was	   shown	   that	   DA1	   and	   DAR1	  
physically	  interact	  in	  vitro.	  This	  suggests	  that	  the	  active	  forms	  of	  these	  proteins	  may	  be	  hetero-­‐	  
and	  homo-­‐oligomeric	   complexes.	  The	  genetic	  analysis	   carried	  out	  by	  Li	  et	  al	   (2008)	   revealed	  
that	   DA1	   and	   DAR1	   redundantly	   influence	   the	   duration	   of	   cell	   proliferation	   in	   developing	  
organs.	   The	   analysis	   also	   showed	   that	   the	   da1-­‐1	   protein	   had	   a	   negative	   influence	   on	   the	  
activity	  of	  DAR1	   (Li	  et	  al.,	  2008).	  Together	   these	  observations	   suggested	   that	  DA1	  and	  DAR1	  
might	  be	  active	  in	  a	  multimeric	  complex,	  which	  is	  rendered	  non-­‐functional	  with	  the	  inclusion	  
of	   the	   da1-­‐1	   protein.	   The	   evidence	   in	   section	   3.2.2	   that	   DA1	   and	   DAR1	   interact	   in	   vitro	  
supports	  the	  prediction	  that	  DA1	  and	  DAR1	  operate	  in	  a	  multimeric	  complex.	  In	  addition,	  the	  
in	  vitro	  observation	  that	  da1-­‐1	  binds	  both	  DA1	  and	  DAR1	  supports	  the	  prediction	  that	  da1-­‐1	  is	  
able	  to	  interact	  physically	  with	  wild-­‐type	  DA1	  and	  DAR1	  in	  this	  multimeric	  complex.	  	  	  
By	  integrating	  this	  genetic	  and	  biochemical	  evidence	  it	   is	  possible	  to	  postulate	  that	  members	  
of	  the	  DA1	  family	  may	  act	  together,	  as	  interchangeable	  subunits.	  For	  example,	  DA1	  and	  DAR1	  
may	   form	   a	   complex	   whose	   functions	   are	   different	   from	   those	   of	   the	   respective	   homo-­‐
oligomeric	   complexes.	   This	   idea	   is	   supported	   by	   the	   significant	   sequence	   similarity	   between	  
family	  members,	  and	  emerging	  evidence	  of	  different	  roles	  for	  the	  different	  family	  members	  (Bi	  
et	  al.,	  2011,	  Yang	  et	  al.,	  2010,	  Peng	  et	  al.,	  2013).	   	  This	  ability	  of	  different	   family	  members	  to	  
form	   into	   different	   complexes	   could	   serve	   to	   integrate	   different	   stimuli	   into	   a	   single	  
coordinated	  biological	  response.	  	  
The	   human	  muscle	   differentiation	   cofactors	   CRP1	   and	   CRP2	   are	   an	   example	   of	   LIM	   domain	  
containing	  proteins	   that	   form	  modular	  complexes	   (Chang	  et	  al.,	  2003).	  These	  proteins	  utilise	  
their	  dual	  LIM	  domains	   to	  bind	  different	   interacting	  partners;	  SRF	  at	   the	  N-­‐terminal	  LIM	  and	  
GATA4/6	  at	  the	  C-­‐terminal	  LIM	  (Chang	  et	  al.,	  2003).	  The	  identification	  of	  the	  LIM-­‐like	  domain	  
in	  DA1,	  and	  evidence	  of	  its	  significance	  in	  DAR4	  (Yang	  et	  al.,	  2010),	  suggests	  that	  the	  dual	  LIM	  
and	  LIM-­‐like	  domains	  in	  DA1	  may	  act	  as	  a	  scaffold	  for	  modular	  complex	  formation,	  akin	  to	  that	  
seen	   for	  CRP1	  and	  CRP2	   (Chang	  et	  al.,	  2003).	   In	   support	  of	   this,	   the	   in	  vitro	  da1lim8	  binding	  
studies	  show	  that	  the	  LIM	  domain	  is	  not	  required	  for	  the	  DA1-­‐DA1	  interaction,	  which	  suggests	  
that	  it	  has	  a	  role	  in	  the	  binding	  of	  other	  DA1	  family	  members	  or	  putative	  substrates.	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As	  the	  LIM	  domain	   is	  not	  required	  for	  DA1-­‐DA1	   interactions,	   it	   is	  possible	  that	   it	  may	  have	  a	  
role	   in	   either	   intramolecular	   interactions	   (perhaps	   associated	   with	   coupled	   mono-­‐
ubiquitination	   and	   controlling	   peptidase	   activity)	   or	   in	   mediating	   interactions	   of	   DA1	   with	  
other	   as	   yet	   unknown	   proteins.	   The	   well	   characterised	   role	   of	   LIM	   domains	   in	   mediating	  
protein-­‐protein	   interactions	   (Schmeichel	   and	   Beckerle,	   1994,	   Kadrmas	   and	   Beckerle,	   2004,	  
Agulnick	   et	   al.,	   1996)	   and	   the	   evidence	   that	   the	  DA1-­‐DA1	   interaction	   is	   independent	   of	   LIM	  
function,	   suggests	   that	   the	   DA1	   LIM	   domain	   could	   be	   utilised	   to	   identify	   de	   novo	   DA1	  
interacting	  partners.	  Such	  interactors	  could	  be	  upstream	  regulators	  of	  DA1,	  other	  components	  
of	   DA1	   complexes,	   or	   the	   downstream	   targets	   of	   DA1	   complex	   activity.	   To	   explore	   these	  
possibilities,	  a	  truncated	  version	  of	  DA1	  containing	  the	  LIM	  and	  C-­‐terminal	  domain	  was	  used	  in	  
Chapter	  4	  to	  identify	  binding	  partners	  in	  a	  yeast-­‐2-­‐hybrid	  screen.	  
Finally,	  evidence	  that	  DA1	  has	  no	  de-­‐ubiquitinating	  activity	  in	  vitro	  suggested	  that	  the	  putative	  
DA1	  peptidase	  may	  have	  other	  substrates.	  This	  observation,	  together	  with	  the	  identification	  of	  
UIM2	  as	  a	  functional	  ubiquitin-­‐binding	  motif,	  has	  helped	  to	  focus	  functional	  analysis	  of	  DA1	  on	  
the	   observed	   genetic	   interactions	  with	   the	   E3	   ubiquitin	   ligases,	   EOD1/BB	   and	  DA2	   (Li	   et	   al.,	  
2008,	  Disch	  et	  al.,	  2006,	  Xia,	  2013).	  This	  is	  explored	  further	  in	  Chapter	  5.	  	  The	  revelation	  that	  
DA1	   is	   probably	   not	   a	   de-­‐ubiquitinating	   enzyme	   suggests	   that	   it	  may	   have	   alternative	   roles	  
within	  the	  ubiquitin	  system.	  For	  example	  DA1	  may	  act	  as	  an	  E3	  ligase	  adaptor	  protein	  that	  may	  
recruit	   its	   cognate	   E3	   ligase	   to	   a	   target.	   This	   is	   seen	   with	   the	   mammalian	   UIM-­‐containing	  
protein	   RAP80,	   which	   recruits	   BRCA1	   to	   double-­‐strand	   breaks	   (Sobhian	   et	   al.,	   2007).	   An	  
alternative	   possibility	   is	   that	   the	   DA1	   UIMs	   recruit	   a	   cognate	   E3	   ligase	   by	   binding	   to	   its	  
ubiquitinated	   from	   and	   consequently	   initiate	   a	   coupled	   mono-­‐ubiquitination	   reaction	   that	  
subsequently	  alters	  DA1	  activity	   (Woelk	  et	  al.,	  2006,	  Komander	  et	  al.,	  2009).	  The	   role	  of	   the	  
putative	  DA1	  peptidase	  activity	  in	  these	  mechanisms	  is	  not	  yet	  known,	  but	  it	  could	  involve	  the	  
modification	   of	   E3	   behaviour,	   as	   is	   the	   case	   for	   the	   human	   E3	   ligases,	   RNF13	   and	   Parkin	  









Current	   understanding	   of	   DA1	   function	   has	   been	   obtained	   from	   knowledge	   of	   DA1	   protein	  
structure,	  DA1	  biochemistry	  (Chapter	  3),	  genetic	  analysis	  of	  the	  da1-­‐1	  mutant	  (Li	  et	  al.,	  2008),	  
and	  two	  observed	  genetic	  interactions	  with	  EOD1/BB	  (Li	  et	  al.,	  2008)	  and	  MED25/PFT1	  (Xu	  and	  
Li,	  2011).	  Biochemical	  work	  has	  yielded	  significant	  insights	  into	  the	  relationship	  between	  DA1	  
and	  DAR1,	  as	  well	  as	  the	  role	  of	  DA1	  in	  the	  ubiquitin	  system	  (Chapter	  3).	  The	  observed	  genetic	  
interaction	  between	  DA1	  and	  the	  E3	  ligase	  EOD1	  (Li	  et	  al.,	  2008)	  suggested	  DA1	  might	  have	  a	  
role	   in	   the	   regulation	   of	   EOD1	   (Chapter	   5),	  which	   emphasises	   the	   potential	   significance	   and	  
promise	   of	   identifying	   DA1	   interacting	   proteins	   for	   advancing	   the	   understanding	   of	   the	  
regulation	  of	  growth	  control.	  This	  is	  the	  subject	  of	  research	  described	  in	  this	  Chapter.	  
4.1.1	  –	  Identifying	  physical	  interactors	  of	  DA1	  
To	  complement	  and	  extend	  the	  observations	  of	  a	  genetic	  interaction	  between	  DA1	  and	  EOD1,	  
work	   in	   this	   Chapter	   focussed	   on	   identifying	   physical	   interactions	   between	   DA1	   and	   other	  
proteins.	  The	  reasons	  for	  screening	  for	  physical	  interactors	  rather	  than	  genetic	  interactors	  are	  
as	  follows:	  first,	  growth	  and	  developmental	  phenotypes	  are	  often	  highly	  pleiotropic,	  and	  there	  
is	  considerable	  risk	  that	  enhancer	  and	  suppressor	  screens	  may	  identify	  non-­‐related	  genes.	  For	  
example,	  the	  da1-­‐1	  enhancer	  EOD3	  was	  recently	  shown	  to	  be	  independent	  of	  DA1	  (Fang	  et	  al.,	  
2012).	   Second,	   a	   genetic	   interaction	   does	   not	   indicate	   biochemical	   or	   developmental	  
proximity;	  it	  can	  establish	  that	  the	  two	  genes	  in	  question	  may	  be	  in	  the	  same	  pathway,	  but	  not	  
that	   they	   function	   at	   the	   same	   step	   within	   that	   pathway.	   Therefore,	   depending	   on	   the	  
complexity	   of	   a	   pathway,	   a	   genetic	   interaction	   can	   be	   relatively	   uninformative,	   such	   as	   the	  
observed	  interaction	  between	  MED25/PFT1	  and	  DA1	  (Xu	  and	  Li,	  2011).	  	  
In	   contrast,	   the	   identification	   of	   physical	   interactions	   between	   proteins	   provides	   the	  
foundations	  for	  a	  variety	  of	  informative	  biochemical	  and	  genetic	  experiments	  that	  can	  define,	  
in	  molecular	  detail,	   the	  cellular	  functions	  of	  the	   interaction	  and	  the	  partner	  proteins.	  A	  good	  
example	   of	   this	   power	   is	   the	   discovery,	   through	   a	   Y2H	   screen	   (see	   section	   4.1.2),	   that	   the	  
Arabidopsis	  F-­‐box	  protein	  AtFBS1	  interacts	  with	  14-­‐3-­‐3	  proteins	  (Sepúlveda-­‐García	  and	  Rocha-­‐
105	  
Sosa,	   2012).	   This	   observation	   has	   led	   to	   new	   hypotheses	   for	   the	   dimerization	   and	   auto-­‐
ubiquitination	  of	  AtFBS1,	  which	  will	  undoubtedly	  be	  tested	  in	  the	  near	  future.	  
A	  further	  reason	  for	  screening	  for	  physical	  interactions	  is	  an	  interest	  in	  the	  significance	  of	  the	  
DA1	   peptidase.	   The	   presence	   of	   this	   domain	   in	   DA1	   suggests	   a	   role	   in	   the	   irreversible	  
modification	  of	   target	  proteins;	   a	  process	   known	   to	  play	  a	   critical	   role	   in	   regulating	   the	  uni-­‐
directionality	   of	   the	   cell-­‐cycle	   and	   cell	   proliferation	   in	   human	   cancer	   cells	   (Elledge,	   1996,	  
Mason	  and	   Joyce,	  2011).	  The	   irreversible	  nature	  of	   this	  modification	   indicates	   that	  potential	  
substrates	  of	  DA1	  identified	  through	  interaction	  screens	  may	  be	  novel	  candidate	  regulators	  of	  
the	  progression	  of	  cell	  proliferation.	  Therefore	  such	  screens	  for	  DA1-­‐interacting	  proteins	  form	  
a	  necessary	  part	  of	  our	  work	  towards	  understanding	  the	  control	  of	  organ	  and	  seed	  growth.	  	  
4.1.2	  –	  Yeast-­‐2-­‐Hybrid	  –	  An	  overview	  
Two	  key	  methods	  are	  suitable	  for	  identifying	  the	  physical	  interactors	  of	  DA1:	  a	  Yeast-­‐2-­‐Hybrid	  
screen	  (henceforth	  Y2H)	  and	  an	   in	  planta	  co-­‐immunoprecipitation	  screen.	  The	   latter	   involves	  
the	   immunopurification	   of	   epitope-­‐tagged	   bait	   protein	   from	   transgenic	   plant	   tissue	   and	   the	  
subsequent	  proteomic	  identification	  of	  binding	  partners.	  This	  method	  relies	  on	  the	  stability	  of	  
the	  bait	  protein	  in	  planta,	  however	  as	  the	  DA1	  protein	  is	  unstable	  in	  planta	  (Yunhai	  Li,	  personal	  
communication)	   this	   technique	   was	   unsuitable.	   For	   this	   reason	   a	   Y2H	   based	   experimental	  
strategy	  was	  used.	  	  
The	   Y2H	   screen,	   originally	   developed	   in	   the	   1980s	   (Fields	   and	   Song,	   1989),	   is	   a	   yeast-­‐based	  
method	   for	   identifying	   physically	   interacting	   proteins.	   As	   illustrated	   in	   Fig.	   4.1,	   the	  
transcriptional	  activation	  of	  a	  specific	  set	  of	  reporter	  genes	  is	  dependent	  upon	  the	  interaction	  
of	   both	   a	   bait	   and	   a	   prey	   protein.	   Using	   the	   Invitrogen	   Pro-­‐QuestTM	   system,	   the	   coding	  
sequence	  of	  the	  bait	  protein	  (DA1)	  was	  fused	  in-­‐frame	  to	  the	  DNA-­‐binding	  domain	  of	  the	  GAL4	  
transcription	   factor	   (GAL4-­‐DB),	   and	   a	   library	   of	   coding	   sequences	   of	   potential	   prey	   proteins	  
was	  fused	  to	  the	  activation	  domain	  of	  GAL4	  (GAL4-­‐AD).	  The	  prey	   library	  was	  generated	  from	  
cDNA	  from	  Arabidopsis	  inflorescences	  and	  kindly	  provided	  by	  Phil	  Wigge	  and	  Vinod	  Kumar	  at	  
the	  John	  Innes	  Centre,	  Norwich.	  The	  physical	   interaction	  of	  DA1	  and	   its	  prey	  brings	  GAL4-­‐DB	  
and	   GAL4-­‐AD	   into	   close	   proximity	   such	   that	   a	   functional	   GAL4	   transcription	   factor	   is	  
reconstituted,	  leading	  to	  activation	  of	  the	  reporter	  genes.	  In	  order	  to	  reduce	  the	  occurrence	  of	  
false-­‐positives	   in	   the	   screen,	   two	   independent	   reporter	   genes	  were	  used	   in	   this	   screen.	   The	  
yeast	  strain	  used	  in	  this	  assay	  (PJ69-­‐4α),	  had	  its	  HIS3	  and	  ADE2	  genes	  under	  the	  control	  of	  the	  
GAL4	  transcription	  factor	  (see	  fig.	  4.2)	  (James	  et	  al.,	  1996).	  These	  genes	  enable	  autotrophy	  for	  
histidine	   and	   adenine	   respectively,	   and	   therefore	   a	   bait	   and	   prey	   interaction	   is	   required	   for	  
106	  
yeast	   to	   grow	   on	  media	   deficient	   for	   histidine	   and	   adenine.	   In	   the	   screen	   described	   in	   this	  
Chapter,	   growth	   on	   a	   histidine	   deficient	   medium	   was	   initially	   used	   to	   identify	   positive	  
interactors.	  This	  was	  then	  followed	  by	  a	  further	  validating	  screen	  on	  medium	  deficient	  for	  both	  




































Figure	  4.1	  –	  The	  yeast-­‐2-­‐hybrid	  screen	  
The	  bait	  gene	  is	  fused	  to	  the	  GAL4	  DNA	  binding	  domain	  (GAL4-­‐DB)	  and	  the	  prey	  gene	  to	  the	  GAL4	  
activation	   domain	   (GAL4-­‐AD).	   Both	   GAL4	   domains	   are	   required	   for	   the	   activation	   of	   the	   GAL4	  
reported	  gene.	  When	  bait	  and	  prey	  proteins	  interact,	  bait-­‐GAL4-­‐DB	  recruits	  the	  prey-­‐GAL4-­‐AD	  to	  
the	  promoter	  of	  the	  reported	  gene	  and	  transcription	  is	  initiated.	  In	  yeast	  where	  there	  is	  no	  bait-­‐




4.2	  –	  DA1	  Yeast-­‐2-­‐Hybrid	  identifies	  31	  candidate	  interactors	  
4.2.1	  –	  Experimental	  strategy	  
The	  experiments	  were	  carried	  out	  in	  three	  steps:	  
1. A	  first-­‐round	  screen	  was	  used	  to	  identify	  a	  pool	  of	  positive	  interactors.	  This	  was	  done	  by	  
initially	  selecting	  all	  colonies	  that	  were	  able	  to	  grow	  on	  SC-­‐Leu-­‐Trp-­‐His	  medium	  (see	  Box	  
4.1).	  This	  pool	  of	  117	  primary	  transformants	  was	  then	  assessed	  –	  based	  on	  known	  
biochemical	  and	  developmental	  roles	  –	  for	  promising	  candidates.	  	  
2. Candidate	  interactors	  were	  taken	  forward	  for	  a	  second-­‐round	  of	  Y2H	  to	  confirm	  the	  initial	  
interaction.	  This	  was	  done	  through	  a	  re-­‐transformation	  of	  the	  yeast	  with	  both	  bait	  and	  
prey,	  followed	  by	  selection	  on	  SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  medium	  (see	  Box	  4.1).	  This	  added	  
confidence	  to	  the	  original	  interaction	  through	  the	  use	  of	  -­‐Ade	  selection,	  which	  has	  a	  
background	  level	  two	  orders	  of	  magnitude	  lower	  than	  -­‐His	  selection	  (James	  et	  al.,	  1996).	  
Negative	  controls	  consisting	  of	  empty	  vectors	  (GAL4-­‐DB	  and	  GAL4-­‐AD)	  were	  used	  to	  assay	  
for	  specific	  interactions.	  
3. Following	  this	  second	  round,	  remaining	  candidate	  interactors	  were	  cloned	  into	  bacterial	  
expression	  vectors	  and	  tested	  for	  interaction	  with	  DA1	  in	  vitro.	  Only	  at	  his	  stage	  were	  
candidates	  taken	  forward	  for	  genetic	  analyses.	  
	  
	  
Box	  4.1	  –	  Yeast-­‐2-­‐hybrid	  selection	  genes	  
The	  PJ69-­‐4a	  yeast	  strain	  used	  in	  this	  screen	  is	  deficient	  for	  LEU2	  and	  TRP1,	  and	  has	  the	  HIS3	  and	  
ADE2	  genes	  under	  the	  control	  of	  GAL4.	  The	  bait	  vector,	  pDBleu	  contains	  the	  LEU2	  gene	  and	  the	  
prey	  vector,	  pEXP-­‐AD502	  contains	  the	  TRP1	  gene.	  Interaction	  of	  bait	  and	  prey	  constructs	  results	  in	  
an	  active	  GAL4	  protein	  and	  therefore	  the	  transcription	  of	  HIS3	  and	  ADE2	  
LEU2	   Confers	  ability	  to	  grow	  on	  SC-­‐Leu	  media	  
Selects	  for	  presence	  of	  bait	  construct	  (pDBleu)	  
TRP1	   Confers	  ability	  to	  grow	  on	  SC-­‐Trp	  media	  
Selects	  for	  the	  prey	  construct	  (pEXP-­‐AD-­‐502)	  
GAL1-­‐HIS3	   Confers	  ability	  to	  grow	  on	  SC-­‐His	  media	  
Selecting	  for	  a	  bait:prey	  interaction	  
GAL2-­‐ADE2	   Confers	  ability	  to	  grow	  on	  SC-­‐Ade	  media	  
Selecting	  for	  a	  bait:prey	  interaction	  








4.2.2	  –	  Truncated	  DA1	  was	  used	  to	  reduce	  false	  positives	  
As	  demonstrated	   in	   section	  3.3,	  DA1	  UIM2	   interacts	  non-­‐covalently	  with	  ubiquitin,	  and	  both	  
UIMs	  may	  have	  the	  potential	  to	  bind	  poly-­‐ubiquitin.	   In	  order	  to	  reduce	  false	  positives	  arising	  
from	  non-­‐specific	  binding	  between	  DA1	  UIMs	  and	  endogenous	  yeast	  ubiquitin	  (free	  ubiquitin	  
and	  ubiquitinated	  proteins),	  a	   truncated	  DA1	  bait	  protein	  was	  used	   in	   the	  Y-­‐2-­‐H	  screen.	  The	  
construct	  had	  the	  N-­‐terminal	  162aa	  removed,	  leaving	  both	  the	  LIM	  domain	  and	  the	  C-­‐terminal	  
peptidase	  domain.	  The	  removal	  of	  such	  a	  large	  protein	  fragment	  had	  the	  potential	  to	  increase	  
the	   number	   of	   false	   negatives.	   However	   biochemical	   data	   suggesting	   the	   LIM	   and	   LIM-­‐like	  
domains	  may	  be	   involved	   in	  binding	  non-­‐DA1	   family	  members	   (section	  3.2)	   gave	   confidence	  
that	  this	  construct	  could	  identify	  candidate	  binding	  partners.	  	  	  
4.2.3	  –	  DA1	  interacts	  with	  31	  candidate	  genes	  	  
Adjusted	  to	  remove	  multiple	  colonies	  of	  the	  same	  clone,	  Fig.	  4.1	  displays	   identities	  of	  the	  in-­‐
frame	  prey	  proteins	  that	  were	  fused	  to	  GAL4-­‐AD	  in	  colonies	  that	  grew	  robustly	  on	  SC-­‐Leu-­‐Trp-­‐
His	   medium.	   The	   table	   lists	   many	   genes	   that	   initially	   appear	   to	   be	   involved	   in	   growth	   and	  
development.	   UNFERTILISED	   EMBRYO	   SAC	   16	   (UNE16),	   and	   MATERNAL	   EFFECT	   EMBRYO	  
ARREST	   14	   (MEE14)	   both	   have	   published	   seed	   development	   phenotypes	   (Pagnussat	   et	   al.,	  
2005),	   and	   were	   considered	   to	   be	   potential	   candidates	   for	   further	   study.	   ARABIDOPSIS	  
THALIANA	  UBIQUITIN	  ACTIVATING	  ENZYME	  (ATUBA1)	   is	  also	  an	   interesting	  candidate,	  as	   it	   is	  
one	  of	  only	   two	  E1	  activating	  enzymes	   in	  Arabidopsis	   and	  has	   a	  published	  pathogen-­‐related	  
growth-­‐response	   phenotype	   (Goritschnig	   et	   al.,	   2007).	   This	   is	   particularly	   interesting	   as	   it	  
shows	  biochemical	  and	  developmental	  overlap	  with	  DA1	  –	  through	  the	  ubiquitin	  system,	  and	  
growth	  and	  development	  respectively.	  	  
The	  LOB	  DOMAIN-­‐CONTAINING	  PROTEIN	  41	  (LBD41)	  was	  also	  of	  interest.	  This	  gene	  is	  related	  
to	   the	   LOB-­‐domain	   containing	  protein,	  ASYMMETRIC	   LEAVES	  2	   (AS2),	   the	   knockout	  of	  which	  
causes	   leaf	   lobing,	   short	  petioles	  and	   the	   formation	  of	   leaflet-­‐like	   structures	   (Semiarti	   et	   al.,	  
2001).	  AS2	   is	  involved	  in	  the	  repression	  of	  KNOX	  gene	  expression	  in	  the	  lateral	  regions	  of	  the	  
SAM	   (Guo	   et	   al.,	   2008,	   Hay	   et	   al.,	   2006),	   and	   influences	   leaf	   development	   and	   the	  
establishment	  of	  adaxial-­‐abaxial	  polarity	  (Semiarti	  et	  al.,	  2001,	  Xu	  et	  al.,	  2003,	  Lin	  et	  al.,	  2003).	  
Over-­‐expression	  of	  the	  LBD41	  homolog	   in	  Celosia	  cristata	  has	  been	  shown	  induce	   leaf	   lobing	  
and	  ectopic	  leaf	  blade	  formation	  on	  the	  petiole	  (Meng	  et	  al.,	  2010).	  	  
It	   is	   also	  noteworthy	   that	  15	  out	  of	   the	  31	   interacting	  proteins	  have	  a	  predicted	   chloroplast	  
localisation.	  These	  included	  genes	  involved	  in	  photosynthesis	  ,	  such	  as	  PSAE-­‐1	  (Varotto	  et	  al.,	  
109	  
2000),	  FERREDOXIN	  2	  (Hanke	  et	  al.,	  2004)	  and	  two	  RUBISCO	  subunits	  (Spreitzer	  and	  Salvucci,	  
2002)	   as	   well	   as	   non-­‐photosynthetic	   genes	   such	   as	   the	   transcription	   factor	   TCP15	   (Uberti-­‐
Manassero	  et	  al.,	  2012,	  Li	  et	  al.,	  2012,	  Kieffer	  et	  al.,	  2011)	  and	  the	  DNA	  binding	  storekeeper	  
protein-­‐related	  gene	  AT4G00270.	  
Despite	  the	  potential	  interest	  of	  many	  of	  these	  genes,	  the	  candidates	  selected	  for	  further	  
characterisation	  were	  TCP15	  and	  the	  Leucine	  Rich	  Repeat	  Receptor-­‐Like	  Kinase	  (LRR-­‐RLK)	  
TMK4.	  The	  decision	  to	  pursue	  TCP15	  was	  largely	  based	  on	  observations	  from	  whole-­‐proteome	  
screens	  of	  protein	  interactions	  relevant	  to	  plant	  pathology,	  which	  appeared	  to	  suggest	  an	  
interaction	  between	  DARs	  and	  the	  TCPs	  (Mukhtar	  et	  al.,	  2011).	  Furthermore,	  TCPs	  have	  a	  well-­‐
described	  role	  in	  organ	  growth	  and	  development	  (Kieffer	  et	  al.,	  2011,	  Koyama	  et	  al.,	  2010,	  Li	  et	  
al.,	  2012,	  Steiner	  et	  al.,	  2012,	  Uberti-­‐Manassero	  et	  al.,	  2012).	  	  
The	  decision	  to	  pursue	  TMK4	  was	  based	  on	  observations	  that	  TMK4	  is	  a	  promoter	  of	  organ	  
growth,	  through	  both	  cell	  proliferation	  and	  cell	  expansion,	  and	  has	  a	  reduced	  sensitivity	  to	  
auxin.	  Moreover,	  preliminary	  data	  showing	  a	  genetic	  interaction	  between	  da1-­‐1	  and	  the	  LRR-­‐
RLK	  FLAGELLIN	  SENSITIVE2	  (FLS2)	  (Cyril	  Zipfel,	  personal	  communication),	  and	  data	  from	  animal	  
systems	  implicating	  UIM	  containing	  proteins	  in	  the	  processing	  of	  LRR-­‐RLKs	  (Marmor	  and	  
Yarden,	  2004)	  suggested	  that	  TMK4	  and	  DA1	  may	  interact	  to	  influence	  organ	  growth	  and	  
development.	  
Additional	  reasons	  for	  pursuing	  TCP15	  and	  TMK4	  will	  be	  described	  in	  further	  detail	  in	  section	  
4.3	  and	  section	  4.4	  respectively.
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Clone	   	  Locus	   Gene	  
name	  
Gene	  description	   Predicted	  Location	  
1	   AT2G22230	   	   Beta-­‐Hydroxyacyl-­‐ACP	  Dehydratase,	  Putative	   CW,	  CH	  
2	   AT4G00270	   	   DNA-­‐Binding	  Storekeeper	  Protein-­‐Related	   CH	  
3	   AT1G30460	   ATCPSF30	   Cleavage	  And	  Polyadenylation	  Specificity	  Factor	  
Subunit	  
NU	  
4	   AT5G35100	   	   Peptidyl-­‐Prolyl	  Cis-­‐Trans	  Isomerase	   CH	  
5	   AT5G60390	   	   Elongation	  factor	  Tu	  family	  protein	   PM,	  VC,	  MT,	  NU,	  CY	  	  
6	   AT4G36260	   SHR2	   SHI	  Related	  Sequence	  2	   NU	  
7	   AT4G13640	   UNE16	   Unfertilized	  Embryo	  Sac	  16	   NU	  
8	   AT1G69690	   TCP15	   TCP	  Family	  Transcription	  Factor	   CH	  
9	   AT2G15890	   MEE14	   Maternal	  Effect	  Embryo	  Arrest	  14	  	   CH	  
10	   AT2G28790	   	   Osmotin-­‐Like	  Protein,	  Putative	   CW	  
11	   AT4G28750	   PSAE-­‐1	   PSA	  E1	  Knockout,	  	   CH	  
12	   AT2G30110	   ATUBA1	   Ubiquitin-­‐Activating	  Enzyme	  1	   CY,	  NU,	  PM,	  PD	  	  
13	   AT1G67090	   RBCS1a	   Ribulose	  Bisphosphate	  Carboxylase	  Small	  Chain	  1a	  	   CH	  
14	   AT3G23750	   TMK4	   LRR-­‐RLK	  Family	  Protein	  	   PM	  
15	   AT3G04120	   GAPC1	   Glyceraldehyde-­‐3-­‐Phosphate	  Dehydrogenase	  C	  
Subunit	  
CY,	  MT,	  CH,	  
NU,PM,AP	  
16	   AT5G38410	   RBCS3B	   Ribulose	  Bisphosphate	  Carboxylase	  Small	  Chain	  3B	  	   CH	  
17	   AT1G74030	   ENO1	   Enolase	  1	   CH	  
18	   AT5G65950	   	   Unknown	  Protein	   Unknown	  
19	   AT2G23350	   PAB4	   Poly(A)	  Binding	  Protein	  4	   CY	  
20	   AT3G15360	   ATHM4	   Arabidopsis	  Thioredoxin	  M-­‐Type	  4	   CW,CH	  
21	   AT1G54630	   ACP3	   Acyl	  Carrier	  Protein	  3	   CH	  
22	   AT1G36390	   	   Co-­‐Chaperone	  Grpe	  Family	  Protein	   CH	  
23	   AT1G60950	   ATFD2	   Ferredoxin	  2	   CH	  
24	   AT5G60670	   	   60S	  Ribosomal	  Protein	  L12	  	   RB	  
25	   AT5G08160	   ATPK3	   Arabidopsis	  Thaliana	  Serine/Threonine	  Protein	  
Kinase	  3	  
Unknown	  
26	   AT5G49460	   ACLB-­‐2	   ATP	  Citrate	  Lyase	  Subunit	  B	  2	   CY,	  PM	  
27	   AT2G18030	   	   Peptide	  Methionine	  Sulfoxide	  Reductase	  Family	  
Protein	  
EM	  
28	   AT4G32880	   HTHB8	   Homeobox	  Gene	  8	   NU	  
29	   AT3G02550	   LBD41	   Lob	  Domain-­‐Containing	  Protein	  41	   NU	  
30	   AT5G24490	   	   30S	  Ribosomal	  Protein,	  Putative	   RB,CH	  




4.3	  –	  DA1	  interacts	  with	  TCP15	  
4.3.1	  –	  TCPs	  –	  An	  overview	  
4.3.1.1	  –	  TCP	  biochemistry	  
TCPs	   are	   a	   family	   of	   transcription	   factors	   named	   after	   their	   first	   characterised	   members;	  
TEOSINTE	  BRANCHED	  1	   (TB1),	  CYCLOIDEA	   (CYC),	   and	  PROLIFERATING	  CELL	   FACTORS	  1	   and	  2	  
(PCF1	   and	  PCF2)	   (Cubas	   et	   al.,	   1999).	   They	   are	   characterised	   by	   the	   presence	  of	   an	   atypical	  
basic-­‐Helix-­‐Loop-­‐Helix	  structure	  that	  is	  capable	  of	  DNA	  binding	  and	  protein-­‐protein	  interaction	  
(Kosugi	   and	  Ohashi,	   1997).	   The	   TCP	   family	   (of	  which	   there	   are	   24	  members	   in	   Arabidopsis)	  
forms	   two	   distinct	   groups	   with	   distinctive	   effects	   on	   growth:	   Class	   I	   TCPs,	   which	   are	   most	  
similar	  to	  PCF1	  and	  PCF2;	  and	  Class	  II	  TCPs,	  which	  are	  more	  similar	  to	  CYC	  and	  TB1;	  Figure	  4.2	  
shows	  the	  relationships	  between	  TCP	  family	  members	  defined	  by	  protein	  sequence	  similarities	  
across	   the	   TCP	   domain.	   TCPs	   have	   been	   shown	   to	   bind	   DNA	   as	   well	   as	   homo-­‐and	   hetero-­‐
dimerise	  (Viola	  et	  al.,	  2011,	  Kosugi	  and	  Ohashi,	  2002,	  Masuda	  et	  al.,	  2008,	  Kosugi	  and	  Ohashi,	  
1997).	   Both	   classes	   of	   TCPs	   are	   thought	   to	   bind	   DNA	   through	   the	   basic	   region	   of	   their	   TCP	  
domain	   (Kosugi	   and	   Ohashi,	   1997),	   and	   consensus	   sequences	   for	   both	   classes	   have	   been	  
described	   as	   GGNCCCAG	   and	  GTGGNCCC	   	   for	   class	   I	   and	   II	   respectively	   (Kosugi	   and	  Ohashi,	  
2002).	   The	   biochemistry	   of	   TCP	   protein-­‐protein	   interactions,	   however,	   is	   less	   clear;	   the	  
presence	  of	  an	  ΦxxLL	  sequence	  (where	  Φ	  is	  an	  hydrophobic	  amino	  acid)	  in	  the	  second	  helix	  of	  
the	  TCP	  domain	   is	  thought	  to	  be	  a	  good	  candidate	  region	  based	  on	   its	  similarity	  to	  the	  LxxLL	  
motif	   shown	   to	  mediate	   the	   binding	   of	   transcriptional	   co-­‐activators	   to	   nuclear	   receptors	   in	  
animals	   (Martín-­‐Trillo	   and	   Cubas,	   2010,	   Heery	   et	   al.,	   1997).	   However,	   the	   high	   level	   of	  
sequence	   conservation	   within	   the	   TCP	   domain	   and	   the	   large	   degree	   of	   diversity	   amongst	  
binding	   partners,	   suggests	   that	   –	   as	   with	   the	   LIM	   domain	   –	   binding	   specificity	   might	   be	  
determined	  by	  the	  sequences	  immediately	  adjacent	  to	  the	  TCP	  domain.	  	  
4.3.1.2	  –	  TCPs	  influence	  organ	  growth	  and	  development	  
As	  a	  family,	  the	  TCPs	  are	  well	  characterised	  as	  regulators	  of	  growth	  and	  development.	  Family	  
members	   have	   been	   classified	   as	   class	   I,	   which	   are	   thought	   to	   promote	   growth	   and	  
Table	  4.1	  -­‐	  List	  of	  DA1-­‐interacting	  proteins	  identified	  from	  the	  first	  round	  of	  the	  yeast-­‐2-­‐hybrid	  
screen.	  
(CY=cytosol;	   CW=cell	   wall;	   NU=nucleus;	   CH=chloroplast;	   PM=plasma	   membrane;	  









development,	  and	  class	  II	  TCPs,	  which	  have	  been	  shown	  to	  repress	  growth	  and	  development.	  	  
Severe	  developmental	  defects	   in	  overexpression	  lines	  and	  a	  high-­‐level	  of	  genetic	  redundancy	  
amongst	  class	  I	  TCPs,	  such	  as	  TCP15	  and	  TCP20,	  means	  that	  developmental	  phenotypes	  have	  
been	  extremely	  hard	  to	  interpret	  (Hervé	  et	  al.,	  2009,	  Kieffer	  et	  al.,	  2011).	  For	  this	  reason,	  the	  
notion	   that	   class	   I	   TCPs	   promote	   growth	   and	   development	   needs	   to	   be	   taken	   with	   caution	  
(Martín-­‐Trillo	   and	  Cubas,	   2010).	  Conversely,	   class	   II	   TCPs	  have	  well	   documented	  growth	  and	  
developmental	   phenotypes.	   For	   example	   hyper-­‐activation	   of	   TCP4,	   by	   fusing	   it	   to	   the	   C-­‐
terminal	  activation	  domain	  of	  VP16	  (Sadowski	  et	  al.,	  1988),	  results	  in	  a	  significant	  reduction	  in	  
leaf	  size,	  which	   is	  thought	  to	  be	  a	  consequence	  of	  a	  reduction	  of	  the	  duration	  of	  the	  growth	  
period	  (Sarvepalli	  and	  Nath,	  2011).	  Moreover,	  enhanced	  expression	  of	  miR319a	  –	  a	  microRNA	  
known	  to	  down-­‐regulate	  TCP2,	  TCP3,	  TCP4,	  TCP10,	  and	  TCP24	  –	  results	  in	  a	  distinctive	  curled-­‐
leaf	  phenotype	  (Palatnik	  et	  al.,	  2003),	  and	  the	  miR319a129	  loss-­‐of-­‐function	  mutant	  shows	  floral	  
development	  defects	  such	  as	  significantly	  reduced	  sepal	  length	  (Nag	  et	  al.,	  2009).	  In	  addition,	  
Antirrhinum	  cin	  mutants	  show	  increased	  leaf	  area	  and	  curvature	  (Nath	  et	  al.,	  2003).	  	  
The	   mechanism	   through	   which	   mutations	   in	   class	   II	   TCPs	   cause	   these	   phenotypes	   is	   still	  
unclear,	   however	   some	   evidence	   points	   to	   the	   direct	   regulation	   of	   cell-­‐cycle	   genes.	   For	  
example,	  TCP24	  binds	  to	  the	  promoter	  regions	  of	  the	  pre-­‐replication	  complex	  (pre-­‐RC)	  control	  
factors	  CDT1a	  and	  CDT1b,	  and	  there	  is	  good	  evidence	  to	  suggest	  that	  this	  interaction	  reduces	  
expression	   of	   the	   genes	   (Masuda	   et	   al.,	   2008).	   The	   pre-­‐RC	   genes	   are	   required	   for	   S	   phase	  
licensing,	  and	   therefore	   their	   repression	   is	   likely	   to	   result	   in	   slower	  S	  phase	  progression	  and	  
reduced	  cell	  proliferation.	  Similarly,	  there	  is	  evidence	  that	  suggests	  the	  class	  I	  TCPs	  TCP20	  and	  
TCP15	   activate	   the	   expression	   of	   the	   cell	   cycle	   effectors.	   These	   include:	   CYCA1;1,	   CYCB1;1,	  
CYCB1;2,	  CDC20,	  and	  CDKB2;1	  (Li	  et	  al.,	  2005a,	  Kieffer	  et	  al.,	  2011).	  
TCPs	   have	   also	   been	   shown	   to	   influence	   SAM	   development,	  with	   gain	   of	   function	   (miR319-­‐
resistant)	  TCP3-­‐expressing	  plants	  unable	   to	  develop	  a	   functional	  SAM	   (Koyama	  et	  al.,	  2010a,	  
Koyama	  et	  al.,	  2007).	  It	  has	  been	  shown	  that	  TCP3	  supresses	  the	  expression	  of	  the	  CUC	  (CUP	  
SHAPED	   COTELYDON)	   genes	   (Koyama	   et	   al.,	   2010a,	   Koyama	   et	   al.,	   2007),	   which	   have	   been	  
shown	   to	   promote	   SAM	   formation	   (Hibara	   et	   al.,	   2006,	   Aida	   et	   al.,	   1997).	   In	   particular,	   this	  
suppression	  of	  CUC	  genes	   is	   thought	   to	  be	  a	  consequence	  of	   the	   induced	  expression	  of	  AS1,	  
miR164,	   IAA3/SHY2	   (INDOLE-­‐3-­‐ACETIC	   ACID3/SHORT	  HYPOCOTYL2)	   and	   SAUR	   (SMALL	  AUXIN	  








4.3.1.3	  –	  TCP15	  influences	  organ	  growth	  and	  development	  
Recently,	   several	   publications	   have	   described	   the	   developmental	   significance	   of	   TCP14	   and	  
TCP15	   (Kieffer	   et	   al.,	   2011,	   Li	   et	   al.,	   2012,	   Uberti-­‐Manassero	   et	   al.,	   2012).	   However,	   as	  
evidence	  of	  the	  complexity	  of	  TCP	  genetics,	  there	  is	  considerable	  conflict	  within	  the	  data	  and	  it	  
is	  difficult	  to	  draw	  many	  firm	  conclusions.	  Nonetheless,	  it	  is	  clear	  that	  both	  TCP14	  and	  TCP15	  
are	   expressed	   in	   young	   developing	   organs,	   in	   a	   pattern	   consistent	  with	   that	   of	   proliferating	  
tissue	   (Kieffer	  et	  al.,	  2011,	  Uberti-­‐Manassero	  et	  al.,	  2012).	   Indeed	  the	   leaf	  GUS	  staining	  data	  
from	  Uberti-­‐Manassero	  et	  al	  (2012)	  is	  reminiscent	  of	  that	  seen	  for	  DA1	  (Li	  et	  al.,	  2008).	  
* 
** 
Figure	  4.2	  –	  The	  TCP	  family	  of	  transcription	  factors	  
(A)	  An	  alignment	  of	  the	  TCP	  domain	  of	  the	  TCP	  family	  of	  transcription	  factors	  and	  (B)	  a	  neighbour-­‐
joining	  phylogram	  with	  midpoint	  rooting	  based	  on	  sequence	  analysis	  of	  the	  TCP	  domain.	  Adapted	  








Another	   point	   of	   agreement	   between	   Kieffer	   et	   al	   (2011),	   Li	   et	   al	   (2012),	   and	   Uberti-­‐
Manassero	  et	   al	   (2012)	   is	   that	   the	   redundancy	  amongst	   the	  most	   closely	   related	  TCPs	   limits	  
the	  insight	  that	  can	  be	  gained	  from	  the	  use	  of	  single	  gene	  knock-­‐out	  mutations.	  Using	  a	  double	  
knock-­‐out	   approach,	   Kieffer	   et	   al	   (2011)	   report	   that	   the	   tcp14/tcp15	   double	   mutant	   has	  
reduced	  internode	  length	  (resulting	  in	  a	  reduced	  inflorescence	  height),	  reduced	  pedicel	  length	  
and	   a	   quantitative	   effect	   on	   leaf	   blade	   expansion.	   The	   reduction	   in	   internode	   and	   pedicel	  
length	   appears	   to	   agree	  with	   the	   perceived	   role	   of	  TCP14	   and	  TCP15	   as	   class	   I	   TCPs,	   in	   the	  
promotion	  of	  growth	  and	  development.	  Another	  strategy	  used	  by	  Kieffer	  et	  al	  (2011),	  Li	  et	  al	  
(2012),	  and	  Uberti-­‐Manassero	  et	  al	  (2012),	  in	  order	  to	  overcome	  the	  problem	  of	  redundancy,	  
was	  the	  fusion	  of	  EAR	  (SRDX)	  domains	  to	  the	  C-­‐termini	  of	  the	  proteins,	  which	  turned	  them	  into	  
dominant	   transcriptional	   repressors	   (Hiratsu	   et	   al.,	   2003).	   However,	   taking	   into	   account	   the	  
evidence	  that	  TCP	  proteins	  form	  hetero-­‐dimers	  with	  family	  and	  non-­‐family	  members	  (Viola	  et	  
al.,	  2011,	  Kosugi	  and	  Ohashi,	  2002,	  Masuda	  et	  al.,	  2008),	  the	  observed	  phenotypes	  are	  likely	  to	  
be	  significantly	  more	  complex	  than	  those	  resulting	  from	  single	  gene	  tcp	  knockouts.	  	  In	  addition	  
to	   leaf	   curling	  and	   leaf	   shape	  phenotypes,	  pTCP15:TCP15SDRX	   expressing	  plants	  had	   smaller	  
rosette	   leaves	   early	   on	   in	   development,	   which	   were	   made	   up	   of	   smaller	   cells	   (Uberti-­‐
Manassero	   et	   al.,	   2012,	   Li	   et	   al.,	   2012).	   These	   data	   further	   support	   the	   notion	   that	   TCP15	  
promotes	  organ	  growth,	  and	  more	  specifically,	  also	  predict	  that	  it	  does	  so	  through	  increasing	  
the	   initial	   rate	   of	   cell	   expansion.	   This	   is	   supported	   by	   the	   observation	   that	   in	  
pTCP15:TCP15SDRX	  plants,	  cotyledon	  cell	  size	  is	  reduced	  (Li	  et	  al.,	  2012).	  
Surprisingly,	  and	  contradicting	  the	  pTCP15:TCP15SDRX	  data	  showing	  reduced	  growth	  (Uberti-­‐
Manassero	  et	  al.,	  2012,	  Li	  et	  al.,	  2012),	  evidence	  from	  DEX-­‐inducible	  over-­‐expression	  of	  wild-­‐
type	  TCP15	   reveals	   a	   reduction	   in	   epidermal	   cell	   size	   and	   a	   reduction	   of	   high	   ploidy	   cells	   in	  
rosette	  leaves	  (Li	  et	  al.,	  2012).	  This,	  along	  with	  evidence	  that	  pTCP15:TCP15SDRX	  plants	  have	  
increased	  trichome	  branching	  (Li	  et	  al.,	  2012),	  suggested	  that	  TCP15	  may	  also	  act	  to	  negatively	  
regulate	  cell	  size	  and	  endoreduplication.	  	  
4.3.1.4	  –	  TCP14	  and	  TCP15	  are	  implicated	  in	  pathogen	  response	  pathways	  
Recently,	  two	  sets	  of	  evidence	  have	  linked	  TCP15	  and	  its	  closest	  relative,	  TCP14,	  to	  pathogen	  
response	  pathways.	  Firstly,	  a	  partial	  correlation	  analysis	  of	  microarray	  data,	  carried	  out	  by	  Dan	  
Maclean	   in	  The	  Sainsbury	  Laboratory,	   identified	  DA1	  as	  a	  hub	   in	  a	  network	  of	   interactions	   in	  
response	   to	   flg22	   (the	  pathogen-­‐associated	  molecular	   pattern	   (PAMP)	   for	   flagellin)	   (Fig.	   S2).	  
This	  network	  predicted	  a	  directional	  relationship	  from	  DA1	  to	  TCP15,	  suggesting	  that	  DA1	  was	  
upstream	  of	  TCP15.	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Secondly,	   a	   recent	   large	   scale	   Y2H	   screen	   investigating	   the	   interactome	   network	   of	   plant-­‐
pathogen	  effectors,	  identified	  TCP14	  as	  a	  hub	  in	  response	  to	  both	  Pseudomonas	  syringae	  and	  
Hyaloperonospora	  arabidopsidis	   infection	  (Mukhtar	  et	  al.,	  2011).	   Interestingly,	  this	  study	  also	  
identified	   a	   physical	   interaction	   between	   TCP14	   and	   DAR1.	   This	   link	   between	   the	   TCPs	   and	  
pathogen	  response	  is	  not	  surprising	  when	  one	  considers	  that	  treatment	  of	  seedlings	  with	  the	  
bacterial	  peptides	  flg22	  (flagellin),	  and	  elf18	  (EF-­‐Tu),	  results	  in	  an	  inhibition	  of	  growth	  (Gómez




















Figure	  4.3	  –	  In	  yeast	  drop-­‐test:	  DA1	  interacts	  with	  TCP15	  in	  yeast	  
Yeast	   co-­‐expressing	   pDBLeu-­‐DA1	   and	   pEXP-­‐AD-­‐502-­‐TCP15	   were	   able	   to	   grow	   on	   SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  
medium,	   demonstrating	   a	   physical	   interaction.	   All	   negative	   controls,	   including	   DA1	  with	   empty	  
vector,	   and	   TCP15	   with	   empty	   vector	   were	   unable	   to	   grow	   on	   SC-­‐Leu-­‐Trp-­‐His-­‐Ade	   medium.	   All	  
treatments	   were	   able	   to	   grow	   on	   SC-­‐Leu-­‐Trp	   medium,	   demonstrating	   that	   both	   bait	   and	   prey	  







4.3.2	  –	  DA1	  physically	  interacts	  with	  TCP15	  
Sequencing	   of	   the	   interacting	   Y2H	   clone	   revealed	   that	   the	   full-­‐length	   TCP15	   sequence	   was	  
fused	  to	  the	  GAL4-­‐AD	  fragment.	  To	  re-­‐test	  the	  interaction	  in	  yeast,	  full	  length	  TCP15-­‐GAL4-­‐AD	  
was	   re-­‐transformed	   into	   yeast	   and	   screened	   for	   an	   interaction	   with	   DA1.	   TCPs	   have	   been	  
shown	  to	  auto-­‐activate	  in	  Y2H	  screens	  (Kosugi	  and	  Ohashi,	  2002)	  and	  therefore	  ensure	  TCP15	  
auto-­‐activation	  was	   not	   generating	   a	   false	   positive,	   a	   negative	   control	   of	   the	   TCP15	   and	   an	  
empty	  bait	  vector	  was	  used.	  The	  drop	  test	  shown	  in	  Fig.	  4.3	  demonstrates	  a	  strong	  interaction	  
between	  DA1	  and	  TCP15,	  and	  no	  interaction	  between	  any	  of	  the	  three	  negative	  controls.	  
Following	  this	  observation,	  TCP15	  was	  cloned	  into	  the	  pETnT	  bacterial	  expression	  vector	  for	  in	  
vitro	   analysis.	   Following	   the	   procedure	   described	   in	   section	   3.2.2;	   recombinant	   GST-­‐tagged	  
bait	   proteins	   were	   incubated	   with	   recombinant	   FLAG-­‐tagged	   prey	   proteins	   before	  
precipitation	   of	   GST-­‐tagged	   bait	   proteins	   on	   glutathione	   sepharose	   beads.	   The	   purified	  
proteins	  were	  then	  eluted	  and	  subjected	  to	  SDS-­‐PAGE	  and	  immunoblot	  analysis.	  The	  ability	  of	  
β-­‐glucuronidase	   (GUS)	   to	   form	   a	   homo-­‐tetramer	  was	   utilised	   to	   design	   a	   positive	   control	   of	  
GST-­‐GUS	  vs	  FLAG-­‐GUS.	  Two	  sets	  of	  negative	  controls	  were	  also	  used;	  these	  were	  GST-­‐GUS	  vs	  
FLAG-­‐TCP15,	  and	  GST-­‐DA1	  vs	  FLAG-­‐GUS.	  	  
Fig.	  4.6	  shows	  that,	  in	  vitro,	  DA1	  physically	  interacts	  with	  TCP15.	  This	  observation,	  combined	  
with	  the	  Y2H	  data	  suggested	  that	  the	  DA1-­‐TCP15	  relationship	  is	  a	  bona	  fide	  physical	  
interaction.	  
4.3.3	  –	  DA1-­‐TCP15	  genetic	  interactions	  
Due	   to	   the	   large	  degree	  of	   redundancy	  among	  TCP	   family	  members,	   and	   in	   agreement	  with	  
recent	  publications	  (Kieffer	  et	  al.,	  2011,	  Li	  et	  al.,	  2012,	  Uberti-­‐Manassero	  et	  al.,	  2012),	  very	  few	  
developmental	   phenotypes	  were	   visible	  with	   the	   single	   tcp15	   knockout	  mutant.	   In	   order	   to	  
overcome	   this,	   double	   knockout	   lines	   were	   generated	   with	   the	   most	   closely	   related	   family	  
member	  of	  TCP15;	  TCP14	   (Martín-­‐Trillo	  and	  Cubas,	  2010,	  Aggarwal	  et	  al.,	  2010).	  Using	  these	  
lines,	  and	  a	  triple	  knockout	  line	  incorporating	  the	  da1-­‐1	  mutation,	  plants	  were	  phenotyped	  for	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4.3.3.1	  –	  DA1	  interacts	  with	  TCP14	  and	  TCP15	  to	  control	  stem	  height	  
Fig.	   4.5c	   shows	   that	   da1-­‐1	   plants	   have	   significantly	   longer	   inflorescence	   stems	   than	   Col-­‐0	  
(Student’s	  T-­‐test,	  p=0.034),	  revealing	  that	  da1-­‐1	   is	  a	  negative	  regulator	  of	   inflorescence	  stem	  
growth.	  It	  also	  shows	  that,	  in	  agreement	  with	  Kieffer	  et	  al	  (2011),	  tcp14/tcp15	  plants	  exhibit	  a	  
significantly	  shorter	  inflorescence	  stem	  than	  Col-­‐0	  (Student’s	  T-­‐test,	  p<0.001).	  This	  reveals	  that,	  
as	   is	  predicted	  for	  class	   I	  TCPs	   (Martín-­‐Trillo	  and	  Cubas,	  2010),	  TCP14	  and	  TCP15	  are	  positive	  
regulators	   of	   growth	   and	   development,	   promoting	   the	   elongation	   of	   inflorescence	   stems.	  
Interestingly,	  the	  da1-­‐1	  related	  increase	  in	  stem	  height	  is	  abolished	  in	  the	  tcp14/tcp15/da1-­‐1	  
triple	  mutant,	   which	   has	   a	   phenotype	   equivalent	   to	   the	   tcp14/tcp15	   double	   knockout.	   This	  
suggests	  that	  in	  the	  regulation	  of	  inflorescence	  stem	  height,	  DA1,	  TCP14	  and	  TCP15	  are	  in	  the	  
same	  pathway,	  and	  that	  the	  TCPs	  may	  function	  downstream	  of	  DA1.	  
Figure	  4.4	  -­‐	  DA1	  interacts	  with	  TCP15	  in	  vitro	  
E.	  coli	  expressed	  GST-­‐tagged	  bait	  proteins	  were	  incubated	  with	  E.	  coli	  expressed	  FLAG-­‐tagged	  prey	  
proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   GST	   and	  












































































































4.3.3.2	  –	  DA1	  and	  TCP15	  genetically	  interact	  to	  control	  petal	  area	  
Analysis	   of	   petal	   area	   (Fig.	   4.5a)	   showed	   that	   tcp14/tcp15	   plants	   had	   significantly	   smaller	  
petals	   that	   Col-­‐0	   (Student’s	   T-­‐test,	   p<0.001).	   This	   is	   consistent	  with	   the	  a	   priori	   expectation	  
that	   class	   I	   TCPs	   are	   promoters	   of	   petal	   growth	   and	   development	   (Martín-­‐Trillo	   and	   Cubas,	  
2010).	  Consistent	  with	  the	  original	  research	  (Li	  et	  al.,	  2008),	  da1-­‐1	  plants	  had	  enlarged	  petals	  
(Students	   T-­‐test,	   p<0.001),	   however	   tcp14/tcp15/da1-­‐1	   plants	   also	   had	   this	   phenotype	  
(Student’s	  T-­‐test,	  p<0.001).	  In	  fact	  there	  was	  no	  significant	  difference	  between	  petal	  size	  in	  the	  
da1-­‐1	   and	   tcp14/tcp15/da1-­‐1	   lines,	   indicating	   that	   the	   negative	   effect	   of	   the	   tcp14/tcp15	  
genotype	  had	  been	  completely	  abolished	  by	  the	  da1-­‐1	  allele.	  This	  suggested	  that	  TCP15	  may	  
function	  upstream	  of	  DA1,	  which	  is	   inconsistent	  with	  the	  interpretation	  that	  TCP15	  functions	  
downstream	  of	  DA1	  with	  respect	  to	  inflorescence	  height.	  
Figure	  4.5	  –	  TCP15	  genetic	  interactions	  
(A-­‐E)	   Phenotypes	   of	   Col-­‐0,	   da1-­‐1,	   tcp14,	   tcp15,	   tcp14/tcp15	   and	   da1-­‐1/tcp14/tcp15	   plants.	   (A)	  
Petal	  area	  (n=10),	  (B)	  seed	  area	  (n=600),	  (C)	  inflorescence	  stem	  height	  (n=6).	  Values	  are	  presented	  








Nonetheless,	  it	  is	  still	  possible	  that	  the	  data	  is	  consistent	  with	  TCP15	  functioning	  downstream	  
of	  DA1	  in	  determining	  petal	  area.	  The	  petal	  area	  increase	  in	  da1-­‐1	  lines	  is	  significantly	  greater	  
that	   the	   decrease	   observed	   in	   tcp14/tcp15	   lines	   (Fig.	   4.5a),	   suggesting	   the	   effect	   of	   DA1	   is	  
stronger	  than	  that	  of	  TCP14/15.	  As	  DA1	  may	  have	  multiple	  effects	  on	  growth	  through	  several	  
peptidase	   substrates	   (see	   Chapter	   5),	   TCP14/TCP15	   could	   be	   just	   be	   one	   of	   its	   targets.	   The	  
relatively	   small	   phenotypic	   effect	   of	   the	   tcp14/tcp15	   mutation	   compared	   to	   the	   da1-­‐1	  
phenotype	  is	  consistent	  with	  this	  interpretation.	  	  
4.3.3.3	  –	  DA1	  and	  TCP15	  do	  not	  genetically	  interact	  to	  regulate	  seed	  area	  
As	   displayed	   in	   Fig.	   4.5b,	   seed	   area	   for	   all	   genotypes	   (da1-­‐1,	   tcp14,	   tcp15,	   tcp14/tcp15,	  
tcp14/tcp15/da1-­‐1)	  was	   significantly	   different	   from	   that	   of	   Col-­‐0	   (Student’s	   T-­‐test,	   p<0.001).	  
Consistent	  with	  published	  data	  (Li	  et	  al.,	  2008),	  da1-­‐1	  plants	  had	  larger	  seeds,	  and	  consistent	  
with	  section	  4.3.3.2	  and	  the	  notion	  that	  class	  I	  TCPs	  are	  promoters	  of	  growth	  and	  development,	  
tcp14/tcp15	   plants	   had	   smaller	   seeds	   than	   Col-­‐0.	   In	   agreement	   with	   petal	   data	   (section	  
4.3.3.2),	   tcp14/tcp15/da1-­‐1	   seed	   resembled	   da1-­‐1	   seed,	   with	   the	   effect	   of	   the	   tcp14/tcp15	  
genotype	   being	   completely	   abolished.	   However,	   interestingly	   the	   tcp14	   and	   tcp15	   single	  
knockouts	   had	   significantly	   enlarged	   seeds	   relative	   to	   Col-­‐0,	   influencing	   seed	   size	   in	   the	  
opposite	  direction	  to	  the	  double	  knock-­‐out.	  	  
This	  contradictory	  effect	  of	  the	  single	  and	  double	  tcp	  mutants	  may	  be	  due	  to	  the	  ability	  of	  the	  
TCPs	  to	  hetero-­‐dimerise	  (Viola	  et	  al.,	  2011,	  Kosugi	  and	  Ohashi,	  2002,	  Masuda	  et	  al.,	  2008).	  This	  
suggests	  that	  other	  binding	  partners	  may	  be	  involved	  with	  TCP14	  and	  TCP15	  in	  the	  regulation	  
of	   seed	   development.	   Furthermore	   the	   prospect	   that	   the	   TCPs	   are	   differentialy	   regulated	  
through	   their	   phosphorylatable	   residues	   (Martín-­‐Trillo	   and	   Cubas,	   2010)	   allows	   for	   the	  
possibility	   that	   hetero-­‐complex	   members	   are	   differentialy	   regulated.	   A	   speculative	   model	  
exists	   to	  explain	   the	  observed	  phenotypes	   in	  which;	  TCP14,	  TCP15	  and	  possible	  other	  as	  yet	  
unknown	  factors	  oligomerise	  to	  promote	  seed	  growth,	  and	  where	  the	  TCPs	  are	  also	  targets	  for	  
repressive	  phosphorylation.	  This	   leads	   to	  a	  possible	  model	   in	  which,	  when	  TCP14	  and	  TCP15	  
are	   present	   in	   complexes,	   seed	   growth	   is	   promoted,	   but	   under	   tight	   control.	   In	   single	   tcp	  
knockout	   lines,	   less	   repressive	   phosphorylation	   is	   present	   and	   growth	   is	   accelerated,	   and	   in	  
tcp14/tcp15	   double	   knockout	   lines,	   insufficient	   transcription	   factors	   are	   present	   to	   promote	  
growth,	  and	  growth	  is	  repressed.	  	  
4.3.3.4	  -­‐	  Summary	  
With	  the	  exception	  of	  the	  tcp14	  and	  tcp15	  seed	  phenotype,	  these	  data	  collectively	  support	  a	  
role	  for	  TCP14	  and	  TCP15	  in	  the	  promotion	  of	  growth	  and	  development.	  However,	  in	  line	  with	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recent	  work	  (Kieffer	  et	  al.,	  2011),	  these	  TCPs	  also	  appear	  to	  have	  contradictory	  tissue-­‐specific	  
effects.	  They	  exhibited	  no	  genetic	  interaction	  to	  regulate	  seed	  area,	  and	  the	  observed	  genetic	  
interaction	   for	   petal	   size	   may	   be	   misleading,	   and	   possibly	   due	   to	   an	   epistatic	   interaction	  
between	   da1-­‐1	   and	   tcp14/tcp15.	   Despite	   this,	   a	   genetic	   interaction	   was	   observed	   between	  
DA1	   and	  TCP14/15	   in	   the	   regulation	  of	   inflorescence	  height.	  Previous	  work	   investigating	   the	  
relationship	   between	   TCP14	   and	   TCP15,	   and	   SPINDLY	   (Steiner	   et	   al.,	   2012)	   highlights	   the	  
difficulty	   in	   observing	   genetic	   interactions	   with	   TCP	   family	   members.	   Genetic	   redundancy	  
amongst	  family	  members	  and	  lethality	  of	  gene	  over-­‐expression	  resulted	  in	  Steiner	  et	  al	  (2012)	  
using	   tissue-­‐specific	   overexpression	   of	   TCP14,	   in	   order	   to	   identify	   an	   interaction.	   This	  
publication	   supports	   section	  4.3.3.2	   in	   arguing	   that	  due	   to	   the	   complexities	  of	  TCP	   genetics,	  
and	  the	  fact	  that	  DA1	  has	  other	  bona	  fide	  target	  proteins	  (Chapter	  5),	  further	  biochemical	  and	  
functional	  evidence	  will	  be	  required	  to	  establish	  the	  biological	  significance	  of	  the	  interactions	  
between	  DA1	  and	  TCP15.	  	  
4.4	  –	  DA1	  interacts	  with	  the	  C-­‐terminal	  domain	  of	  the	  LRR-­‐RLK,	  TMK4	  
4.4.1	  –	  Leucine-­‐rich	  repeat	  receptor-­‐like	  kinases	  (LRR-­‐RLKs)	  –	  an	  overview	  
Leucine-­‐rich	  repeat	  receptor-­‐like	  kinases	  (LRR-­‐RLKs)	  are	  the	  largest	  sub-­‐family	  of	  the	  receptor-­‐
like	  kinase	  (RLK)	  family	  in	  Arabidopsis	  (Diévart	  and	  Clark,	  2003).	  Of	  the	  610	  predicted	  RLKs,	  216	  
are	  LRR-­‐RLKs	  (Diévart	  and	  Clark,	  2003).	  RLKs	  are	  defined	  as	  membrane	  spanning	  proteins	  with	  
C-­‐terminal	   Ser/Thr	   kinases,	   and	   “versatile”	   N-­‐terminal	   extra-­‐cellular	   domains	   (Shiu	   and	  
Bleecker,	  2003)	  and	  the	  LRR-­‐RLKs	  are	  characterised	  by	  the	  presence	  of	  LRR	  motifs	  present	   in	  
their	  N-­‐terminal	  domains	  (Diévart	  and	  Clark,	  2003).	  	  
4.4.1.1	  –	  LRR-­‐RLKs	  are	  involved	  in	  plant	  development	  and	  pathogen	  response	  
The	   LRR-­‐RLK	   family	   includes	   key	   regulators	   of	   growth	   and	   development	   such	   as	   CLAVATA1	  
(CLV1),	   BRASSINOSTEROID-­‐INSENSITIVE1	   (BRI1),	   ERECTA	   (ER)	   and	  TMK1-­‐4	   (Clark	   et	   al.,	   1997,	  
Clouse	   et	   al.,	   1996,	   Torii	   et	   al.,	   1996,	   Dai	   et	   al.,	   2013).	   CLV1,	   a	   regulator	   of	   shoot	   apical	  
meristem	  (SAM)	  size	  (Clark	  et	  al.,	  1997,	  Schoof	  et	  al.,	  2000),	  has	  recently	  been	  linked	  to	  DA1.	  
Work	   carried	   out	   by	   Yunhai	   Li	   at	   the	   Chinese	   Academy	   of	   Sciences	   in	   Beijing	   (personal	  
communication)	   has	   shown	   that	   the	   expression	   domain	   of	  WUSCHEL	   is	   greatly	   increased	   in	  
da1-­‐1	  mutants,	  akin	  to	  the	  effect	  in	  clv	  mutants	  (Schoof	  et	  al.,	  2000).	  
Also	   of	   relevance	   to	   this	  work	   is	   BRI1,	   a	   receptor	   in	   the	   brassinosteroid	   signalling	   pathway,	  
whose	  mutants	  show	  severe	  developmental	  defects	   including	  dwarfed	  stature	  and	  thickened	  
leaves	   (Clouse	  et	  al.,	  1996).	   	  BRI1	   is	  activated	  by	   the	  binding	  of	  brassinosteroids	   to	   its	  extra-­‐
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cellular	  domain	  (Kinoshita	  et	  al.,	  2005),	  which	  in	  turn	  causes	  the	  release	  of	  the	  inhibitory	  BRI1	  
KINASE	  INHIBITOR	  1	  (BKI1)	  from	  the	  cytoplasmic	  domain	  (Wang	  and	  Chory,	  2006).	  This	  results	  
in	  the	  recruitment	  of	  the	  LRR-­‐RLK,	  BRI1-­‐ASSOCIATED	  RECEPTOR	  KINASE1	  (BAK1),	  which	  binds	  
to	  BRI1	  to	  form	  the	  active	  signal	  complex	  (Li	  et	  al.,	  2002a,	  Nam	  and	  Li,	  2002).	  Importantly	  BAK1	  
also	  complexes	  with	  FLS2,	  the	  pattern	  recognition	  receptor	  (PRR)	  for	  flagellin	  in	  Arabidopsis,	  to	  
initiate	   the	  defence	   response	   (Chinchilla	   et	   al.,	   2006,	   Chinchilla	   et	   al.,	   2007a,	  Gómez-­‐Gómez	  
and	  Boller,	  2000).	  BAK1	  also	  appears	  to	  have	  a	  role	  in	  brassinosteroid-­‐independent	  cell	  death	  
(Kemmerling	  et	  al.,	  2007),	  however,	  its	  association	  with	  both	  BRI1	  and	  FLS2	  is	  of	  most	  interest	  
to	  this	  work.	  	  
4.4.1.2	  –	  da1-­‐1	  partially	  phenocopies	  bak1-­‐4	  in	  brassinosteroid	  response	  assays	  
As	   described	   in	   section	   4.3.1.4,	   a	   recent	   partial	   correlation	   analysis	   (Fig.	   S2)	   (Maclean,	  
unpublished)	   identified	   DA1	   as	   a	   hub	   in	   a	   transcriptome	   network	   in	   response	   to	   flg22	  
treatment;	  suggesting	  a	  role	  for	  DA1	  in	  the	  flg22	  PAMP	  response.	  Based	  on	  the	  role	  of	  BAK1	  in	  
both	   flg22	  PAMP	  responses	  and	  brassinosteroid	  signalling,	  a	  potential	   link	  between	  DA1	  and	  



































Figure	  4.6	  –	  da1-­‐1	  seedlings	  have	  reduced	  sensitivity	  to	  epibrassinolide	  
Root	   lengths	   of	   9-­‐day	   old	   seedlings	   of	   Col-­‐0,	  da1ko1/dar1-­‐1	  and	  bak1-­‐4	   in	   response	   to	   varying	  
concentrations	   of	   epibrassinolide	   (n=20).	   Values	   are	   presented	   as	  means	   ±	   SE,	   relative	   to	   root	  
length	  in	  the	  absence	  of	  epibrassinolide.	  Red	  circles	  denote	  values	  that	  are	  significantly	  different	  







In	   order	   to	   do	   this,	   a	   seedling	   root	   growth	   experiment,	   assaying	   for	   sensitivity	   to	  
epibrassinolide,	   was	   carried	   out.	   Increasing	   concentrations	   of	   epibrassinolide	   cause	   a	  
reduction	   in	   root	   length	   in	   seedlings,	   however	   seedlings	   that	   are	   insensitive	   to	  
brassinosteroids	   show	   a	   smaller	   reduction	   in	   root	   growth.	   bak1-­‐4	   seedlings	   are	   partially	  
insensitive	  to	  brassinosteroids,	  and	  over	  intermediate	  concentrations	  of	  epibrassinolide,	  their	  
root	   length	   is	   significantly	   longer	   that	   Col-­‐0	   (Kemmerling	   et	   al.,	   2007).	   Fig.	   4.6	   shows	   that,	  
although	  not	  as	  severe	  as	  the	  bak1-­‐4	  phenotype,	  da1-­‐1	  seedlings	  have	  a	  reduced	  sensitivity	  to	  
epibrassinolide	   relative	   to	   Col-­‐0	   in	   epibrassinolide	   concentrations	   between	   1nM	   to	   100nM	  
(Student’s	  T-­‐test,	  p<0.02).	  These	  data	  suggest	  that	  da1-­‐1	  affects	  sensitivity	  to	  brassinosteroids,	  
and	   therefore	   DA1	   may	   be	   involved	   in	   fine-­‐tuning	   the	   transduction	   of	   brassinosteroid	  
signalling.	   Furthermore,	   based	   on	   a	   potential	   role	   for	   DA1	   in	   FLS2	   response	   signalling,	   this	  
‘fine-­‐tuning’	  may	  indicate	  a	  relationship	  between	  DA1	  and	  BAK1.	  
One	   potential	   role	   of	   DA1	   in	   LRR-­‐RLK	   mediated	   signalling	   may	   involve	   the	   processing	   of	  
ubiquitinated	   LRR-­‐RLKs.	   Many	   plasma	   membrane	   signal	   receptors	   are	   internalised	   by	  
endocytosis	   subsequent	   to	   activation	   by	   the	   signal	   ligand	   (Marmor	   and	   Yarden,	   2004).	   This	  
internalization	   can	   either	   lead	   to	   attenuation	   of	   signal	   transduction	   or	   the	   facilitation	   of	   a	  
further	  signalling	  step	  once	  internalised.	  In	  both	  processes,	  following	  endocytosis	  a	  decision	  is	  
made	   to	   direct	   the	   internalised	   signal	   receptor	   to	   the	   multivesicular	   body	   (MVB)	   for	  
degradation,	   or	   to	   recycle	   the	   receptor	   back	   to	   the	  membrane	   (Marmor	   and	  Yarden,	   2004).	  
Many	   mammalian	   membrane	   receptor	   tyrosine	   kinases	   (RTKs)	   such	   as	   human	   epidermal	  
growth	  factor	  receptor	  (EGFR)	  require	  ubiquitination	  for	  internalisation	  (Haglund	  et	  al.,	  2003),	  
and	   others	   require	   ubiquitination	   of	   endocytotic	   machinery	   (Dunn	   and	   Hicke,	   2001).	   The	  
abundance	  of	  UIMs	  in	  proteins	  involved	  in	  the	  processing	  of	  RTKs	  in	  animal	  systems	  has	  led	  to	  
the	   postulation	   of	   an	   ‘UIM-­‐cycle’,	   where	   UIM-­‐containing	   adaptor	   proteins	   recognise	   and	  
mediate	  the	  internalisation	  of	  activated	  RTKs	  (Marmor	  and	  Yarden,	  2004).	  The	  presence	  of	  an	  
active	   UIM	   domain	   in	   DA1	   indicates	   that	   DA1	   may	   be	   involved	   in	   the	   ubiquitin	   mediated	  
processing	   of	   LRR-­‐RLKs,	   particularly	   in	   light	   of	   evidence	   that	   FLS2	   is	   ubiquitinated	   (Lu	   et	   al.,	  
2011).	  
4.4.1.3	  –	  TMK4	  (TRANSMEMBRANE	  KINASE	  4)	  	  
BLAST	  analysis	  of	   the	  TMK4	  protein	  sequence	  reveals	   that	   it	   is	  a	  member	  of	  sub-­‐family	   IX	  of	  








      1 MEAPTPLLLLVLLTTITFFTTSVADDQTAMLALAKSFNPPPSDWSSTTDFCKWSGVRCTG 60  
 
     
     61 GRVTTISLADKSLTGFIAPEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNF 120  
 
    
    121 VGVETGAFAGLTSLQILSLSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDS 180  
 
    
    181 LASLQNLRLSYNNITGVLPPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKN 240   
 
   
    241 HFFGPIPDLSKSENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV 300   
 
   
    301 KVTIDHNVFCTTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAG 360   
 
   
    361 KNVVTLNLGKHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNN 420  
 
                                                             TMD>> 
    421 LRGEIPKFPATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVI 480  
 
           
    481 VAVLVFLAILGFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGAN 540   
 
                                                KINASE DOMAIN>> 
    541 NFNALNSPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDG 600   
 
   
    601 TKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGN 660  
 
    
    661 LGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMR 720  
 
                               |------------------------------------ 
    721 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGR 780  
 
        --------Yeast-2-Hybrid Fragment (185aa)--------------------- 
    781 KALDDSLPDERSHLVTWFRRILINKENIPKALDQTLEADEETMESIYRVAELAGHCTARE 840  
 
        ------------------------------------------------------------ 
    841 PQQRPDMGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQRWQNEGTSSSTMFHG 900   
 
        ----------------------------| 
    901 DFSYSQTQSSIPPKASGFPNTFDSADGR* 929     
	  
	  
Figure	  4.7	  –	  Protein	  sequence	  of	  AT3G23750	  
The	  protein	  sequence	  of	  AT3G23750	  (TMK4)	  with	  the	  transmembrane	  domain	  (TMD)	  marked	   in	  
blue,	  the	  kinase	  domain	  marked	  in	  red,	  and	  the	  fragment	  identified	  in	  the	  DA1	  Y2H	  marked	  with	  a	  








TMK4	  has	  recently	  been	  identified	  as	  a	  positive	  regulator	  of	  growth	  and	  development	  through	  
the	  study	  of	  combinational	  knockouts	  mutations	  with	  its	  most	  closely	  related	  proteins	  (Dai	  et	  
al.,	  2013).	  tmk1/tmk4	  double	  mutants	  display	  reduced	  root	  and	  aerial	  organ	  size,	  and	  a	  dwarf-­‐
like	   phenotype.	   All	   of	   these	   phenotypes	   are	  more	   severe	   in	   the	   tmk1/tmk3/tmk4	   triple	   and	  
tmk1/tmk2/tmk3/tmk4	  quadruple	  mutants	  (Dai	  et	  al.,	  2013).	  The	  reduced	  root	  length	  in	  these	  
mutants	   is	  primarily	  a	  consequence	  of	  reduced	  cell	  expansion,	  however	  the	  reduction	   in	   leaf	  
area	  is	  primarily	  a	  consequence	  of	  reduced	  cell	  proliferation	  (Dai	  et	  al.,	  2013).	  Dai	  et	  al	  (2013)	  
also	  demonstrated	   that	   tmk1/tmk4	  mutants	  had	   reduced	  sensitivity	   to	  auxin	   (reminiscent	  of	  
da1-­‐1	   and	   bak1-­‐4	   to	   brassinosteroids),	   and	   that	   the	   tmk1/tmk3/tmk4	   triple	   mutant	   is	  
insensitive	  to	  auxin.	  
Recent	   data	   also	   revealed	   that	   TMK4	   may	   be	   involved	   in	   the	   flg22	   PAMP	   response.	   flg22	  
treatment	  of	  Arabidopsis	   cell	   cultures	   resulted	   in	   the	  enrichment	  of	  TMK4	   in	   lipid	   rafts	  with	  
FLS2	  (Keinath	  et	  al.,	  2011).	  	  
4.4.2	  –	  DA1	  physically	  interacts	  with	  the	  C-­‐terminal	  fragment	  of	  TMK4	  
Sequencing	  of	   the	  Y2H	  colony	  14	  (Table	  4.1)	   revealed	  that	  the	  185aa	  C-­‐terminal	   fragment	  of	  
TMK4	  (Fig.4.7)	  was	  fused	  in-­‐frame	  to	  the	  GAL4-­‐AD.	  The	  fragment	  extends	  from	  the	  extreme	  C-­‐
terminus	   of	   TMK4	   into	   the	   kinase	   domain	   (Fig.	   4.7).	   Subsequent	   to	   identification	   of	   the	  
interacting	   colony	   containing	   a	   region	   of	   TMK4,	   the	   gene	   fragment	   was	   cloned	   and	   re-­‐
transformed	  into	  yeast	  and	  a	  second-­‐round	  screen	  was	  run.	  Fig.	  4.11	  shows	  the	  positive	  drop	  
test	   results,	   demonstrating	   that	   only	   yeast	   containing	   both	   pDBleu-­‐DA1	   and	   pEXPAD-­‐502-­‐
TMK4frag	  could	  grow	  on	  SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  selective	  media.	  	  
Following	  confirmation	  of	  the	  interaction	  in	  yeast,	  the	  TMK4	  C-­‐terminal	  fragment	  was	  cloned	  
into	  the	  pETnT	  bacterial	  expression	  vector	  and	  expressed	  in	  E.	  coli	  as	  an	  N-­‐terminal	  HA	  epitope	  
fusion	  protein	  for	  in	  vitro	  coIP	  analysis.	  	  
Following	   the	   procedure	   described	   in	   section	   3.2.2;	   recombinant	   GST-­‐tagged	   bait	   proteins	  
were	  incubated	  with	  recombinant	  HA-­‐tagged	  prey	  proteins	  before	  precipitation	  of	  GST-­‐tagged	  
bait	   proteins	   on	   glutathione	   sepharose	   beads.	   The	   purified	   proteins	   were	   then	   eluted	   and	  
subjected	  to	  SDS-­‐PAGE	  and	  immunoblot	  analysis.	  The	  ability	  of	  DA1	  to	  form	  a	  homo-­‐oligomer	  
was	  utilised	  to	  design	  a	  positive	  control	  of	  GST-­‐DA1	  vs	  FLAG-­‐DA1.	  Two	  sets	  of	  negative	  controls	  
were	  also	  used;	  these	  were	  GST-­‐	  Ø	  vs	  FLAG-­‐TCP15,	  and	  GST-­‐DA1	  vs	  HA-­‐	  Ø.	  Fig.	  4.9	  shows	  that	  
GST-­‐DA1	   is	  able	   to	  pull	  down	  HA-­‐DA1	   (positive	  control)	  and	   the	  HA-­‐tagged	  TMK4	  C-­‐terminal	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Figure	  4.8	  –	  In	  yeast	  drop-­‐test:	  DA1	  interacts	  with	  the	  C-­‐terminus	  of	  TMK4	  	  
Yeast	   co-­‐expressing	   pDBLeu-­‐DA1	   and	   pEXP-­‐AD-­‐502-­‐TMK4frag	   (C-­‐terminal	   fragment	   of	   TMK4)	  
were	  able	  to	  grow	  on	  SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  medium,	  demonstrating	  a	  physical	   interaction.	  The	  negative	  
control,	  DA1	  with	  empty	  vector,	  was	  unable	  to	  grow	  on	  SC-­‐Leu-­‐Trp-­‐His-­‐Ade	  	  medium.	  Both	  treatments	  
were	  able	   to	  grow	  on	  SC-­‐Leu-­‐Trp	  medium,	  demonstrating	   that	  both	  bait	   and	  prey	   constructs	  were	  







Figure	  4.9	  –	  DA1	  interacts	  with	  TMK4	  in	  vitro	  
E.	  coli	  expressed	  GST-­‐tagged	  bait	  proteins	  were	  incubated	  with	  E.	  coli	  expressed	  HA-­‐tagged	  prey	  
proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   HA.	   HA-­‐







4.4.3	  –	  Cloning	  of	  full-­‐length	  TMK4	  	  
Repeating	  the	  Y2H	  and	  in	  vitro	  interaction	  studies	  (section	  4.4.2)	  with	  a	  full-­‐length	  TMK4	  
protein	  would	  confirm	  that	  the	  observed	  interaction	  is	  not	  an	  artefact	  of	  the	  truncated	  protein.	  	  
PCR	  amplification	  of	  the	  2.8	  Kb	  coding	  sequence	  of	  TMK4	  from	  cDNA	  was	  straightforward.	  
However	  upon	  subcloning	  the	  construct	  into	  E.	  coli,	  no	  intact	  full-­‐length	  clones	  were	  recovered.	  
This	  may	  be	  because	  the	  cells	  were	  unable	  to	  tolerate	  the	  kinase	  domain	  of	  TMK4,	  perhaps	  
reflected	  in	  the	  fact	  that	  any	  full-­‐length	  genes	  that	  were	  successfully	  cloned	  were	  extensively	  
mutated	  in	  the	  C-­‐terminal	  kinase	  domain.	  Despite	  employing	  strategies	  involving	  two-­‐step	  
cloning	  of	  the	  gene	  and	  the	  growth	  of	  E.	  coli	  at	  28°C,	  no	  full-­‐length	  non-­‐mutated	  construct	  
could	  be	  stably	  maintained	  in	  E.	  coli.	  	  
An	  alternative	  strategy	  to	  validate	  the	  observed	  in	  yeast	  and	  in	  vitro	  interactions	  was	  to	  carry	  
out	   an	   in	   planta	   co-­‐IP	   (see	   Box	   3.1)	   with	   full-­‐length	   protein.	   In	   order	   to	   achieve	   this,	   and	  
thereby	  avoid	   the	  problems	  with	   the	  accumulation	  of	  E.	  coli	  derived	  mutations	   in	   the	  kinase	  
domain,	   the	   genomic	   DNA	   was	   used	   and	   the	   gene	   was	   cloned	   with	   its	   intron	   intact.	  
Unfortunately	  TMK4	  only	  has	  one	  intron,	  located	  downstream	  of	  the	  kinase	  active	  site.	  Despite	  
the	  absence	  of	  a	  bacterial	  promoter	  and	  the	  growth	  of	  bacteria	  at	  28°C,	  the	  kinase	  domain	  still	  
accumulated	  mutations.	   This	  meant	   that	   despite	   occasionally	   successfully	   sub-­‐cloning	   a	   full-­‐
length	   intact	   gene	   into	   an	   entry	   vector	   (pDONR),	   the	   additional	   cloning	   steps	   into	   the	  
destination	  vector	  led	  to	  mutations	  in	  the	  kinase	  domain.	  For	  this	  reason,	  and	  due	  to	  progress	  
made	   in	  other	  areas,	  validation	  of	   the	  observed	   interaction	  with	  DA1	  (section	  4.4.2)	  was	  not	  
carried	  out	  with	  full-­‐length	  protein.	  
4.4.4	  –	  amiRNA	  TMK4	  knockdown	  lines	  reveal	  developmental	  defects	  
For	  genetic	  analysis	  of	  TMK4,	  T-­‐DNA	  insertion	  lines	  were	  acquired	  to	  assay	  for	  developmental	  
phenotypes	  and	  a	  putative	  genetic	  interaction	  with	  DA1.	  Unfortunately,	  at	  the	  time	  this	  work	  
was	  carried	  out	  no	  TMK	  insertion	  lines	  were	  publicly	  available.	  As	  a	  consequence	  an	  amiRNA	  
knockdown	  approach	  was	  taken.	  
An	   amiRNA	   construct	   was	   acquired	   from	   the	   Arabidopsis	   thaliana	   amiRNA	   library	   at	   Open	  
Biosystems	  (Thermo	  Scientific).	  The	  library	  was	  developed	  by	  Dr.	  Greg	  Hannon	  at	  Cold	  Spring	  
Harbour	   laboratories	   and	   the	   amiRNA	  design	   is	   based	  on	  work	  by	  Detlef	  Weigel	   at	   the	  Max	  
Planck	   Institute	   for	   Developmental	   Biology	   (Open_Biosystems).	   Based	   on	   this,	   the	   construct	  
was	  designed	  to	  be	  targeted	  specifically	  to	  TMK4	  and	  none	  of	  its	  closest	  relatives	  (Schwab	  et	  
al.,	  2006).The	  amiRNA	  construct	  is	  expressed	  in	  a	  mi319a	  backbone,	  under	  the	  control	  of	  a	  35S	  
promoter,	  in	  the	  pAmiR	  binary	  vector	  (see	  supplementary	  information	  Fig.	  S1).	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Wild-­‐type	  Col-­‐0	  plants	  were	   transformed	  with	   this	   construct	   and	   transformants	  assessed	   for	  
their	   phenotypes.	   Fig.	   4.13	   shows	   the	   phenotypes	   of	   four	   T1	   amiRNA	   transformants.	  
Preliminary	  observations	  showed	  that	  these	  T1	  plants	  exhibited	  severe	  developmental	  defects,	  
ranging	   from	   dwarfed	   overall	   stature	   and	   serrated	   leaves,	   to	   later	   flowering	   with	   rounder	  
leaves.	   It	   is	  possible	  that	   the	  differences	   in	  severity	  of	  phenotype	  are	  due	  to	  variation	   in	  the	  
level	   of	   amiRNA	   expression.	   The	   different	   phenotypes	   depicted	   in	   Fig.	   4.13	   shows	   that	   the	  
amiRNA	   construct	   strongly	   influences	   plant	   development.	   These	   data	   show	   that	   amiRNA	  
knockdown	   of	   TMK4	   largely	   phenocopies	   the	   tmk1/tmk4,	   tmk1/tmk3/tmk4	   and	  
tmk1/tmk2/tmk3/tmk4	   mutants	   (Dai	   et	   al.,	   2013).	   It	   is	   interesting	   that	   the	   variation	   in	  
developmental	  defects	  is	  not	  simply	  a	  linear	  escalation	  of	  a	  particular	  phenotype	  (for	  example	  
leaf	  curling),	  but	  rather	  a	  wide	  variety	  of	  different	  phenotypes	  of	  varying	  severity.	  This	  implies	  
that	  TMK4	  may	  have	  a	  general,	  higher-­‐order	  role	  in	  regulating	  growth	  and	  development,	  and	  
as	  its	  expression	  is	  reduced,	  its	  effect	  becomes	  more	  severe	  and	  pleiotropic.	  
Due	  to	  progress	  being	  made	   in	  other	  areas	  of	  my	  research,	   further	   investigation	  of	   this	  area	  
was	   not	   continued.	   	   The	   Y2H	   and	   in	   vitro	   data	   provide	   strong	   evidence	   of	   an	   interaction	  
between	  DA1	  and	  TMK4,	  and	  amiRNA	  knockdown	  and	  mutant	   (Dai	  et	   al.,	   2013)	  phenotypes	  
show	  that	  TMK4	   is	  a	  promoter	  of	  growth	  and	  development.	  Taken	  together	  with	  predictions	  
that	   DA1	   is	   involved	   in	   the	   flg22	   response	   (Fig.	   S2),	   and	   that	   da1-­‐1	   seedlings	   are	   partially	  
insensitive	   to	   epibrassinolide	   (Fig.	   4.6),	   it	   is	   possible	   that	   DA1	   may	   be	   involved	   in	   the	  
processing	   of	   LRR-­‐RLKs.	   Moreover,	   based	   on	   work	   in	   animal	   systems	   highlighting	   the	  
importance	  of	  UIM-­‐containing	  proteins	  in	  the	  processing	  of	  RTKs	  (Marmor	  and	  Yarden,	  2004),	  
and	   in	   vitro	   evidence	   that	   DA1	   binds	   to	   the	   cytoplasmic	   domain	   of	   TMK4	   (Fig.	   4.9),	   it	   is	  
reasonable	  to	  suggest	  a	  model	  whereby	  DA1	  is	   involved	  in	  the	  ubiquitin-­‐mediated	  regulation	  
and	  processing	  of	  LRR-­‐RLKs.	  The	  UIM-­‐cycle	  postulated	  by	  Marmor	  and	  Yarden	  (2004)	   implies	  
that	   DA1	   may	   play	   a	   role	   as	   an	   ubiquitin-­‐targeted	   adaptor	   protein,	   however	   recent	   data	  
showing	  that	  FLS2	   is	  ubiquitinated	  by	   the	  E3	   ligases	  PUB12	  and	  PUB13	   in	  a	  BAK1-­‐dependent	  
manner	   (Lu	   et	   al.,	   2011)	   suggests	   another	   possibility.	   In	   light	   of	   data	   from	   Chapter	   5	   that	  
demonstrates	  DA1	  is	  able	  to	  proteolytically	  process	  two	  E3	   ligases	   in	  vitro	  and	   in	  planta,	   it	   is	  
possible	  that	  DA1	  regulates	  the	  activity	  of	  E3	   ligases	  recruited	  to	  process	  LRR-­‐RLKs.	  Although	  
PUB12	   and	   PUB13	   are	   not	   necessary	   for	   flg22	   perception,	   they	   effect	   the	   sensitivity	   of	  
perception	   (Marino	   et	   al.,	   2012,	   Lu	   et	   al.,	   2011).	   This	   is	   similar	   to	   the	   effect	   of	   da1-­‐1	   on	  
epibrassinolide	   perception,	   and	   presents	   an	   interesting	   and	   intriguing	   possibility	   that	   DA1	  




4.5	  -­‐	  Discussion	  
The	  Y2H	  screen	  described	  in	  this	  Chapter	  identified	  several	  interacting	  proteins	  that	  implicate	  
DA1	  in	  growth	  and	  development	  and	  possibly	  pathogen	  responses	  (Table	  4.1).	  Two	  interacting	  
proteins,	   TCP15	  and	  TMK4,	  were	   selected	   for	   further	   study	  based	  on	   their	  potential	   links	   to	  
growth	   and	   development	   and	   the	   flagellin	   PAMP	   response.	   For	   TCP15;	   a	   clear	   role	   in	   the	  
regulation	   of	   cell	   proliferation	   and	   growth	   (Kieffer	   et	   al.,	   2011,	   Li	   et	   al.,	   2012,	   Uberti-­‐
Manassero	  et	  al.,	  2012,	  Steiner	  et	  al.,	  2012)	  has	  recently	  been	  combined	  with	  data	  from	  TCP14	  
(Mukhtar	  et	  al.,	  2011)	  and	  transcriptomic	  analysis	  (Maclean,	  unpublished)	  that	  suggests	  a	  role	  
in	   the	  response	  to	  the	  bacterial	  elicitor	   flagellin.	  TMK4	  has	  been	  demonstrated	  to	  negatively	  
regulate	  cell	  expansion	  (in	  roots)	  and	  cell	  proliferation	  (in	   leaves)	  (Dai	  et	  al.,	  2013)	  and	  has	  a	  
possible	  connection	  to	  FLS2	  and	  the	  flagellin	  PAMP	  response	  (Keinath	  et	  al.,	  2011).	  Combined	  
with	  evidence	  that	  da1-­‐1	  partially	  phenocopies	  bak1-­‐4	  in	  response	  to	  epibrassinolide	  (section	  
Figure	  4.10	  –	  Preliminary	  evidence	  of	  developmental	  phenotypes	  of	  TMK4	  amiRNA	  knockdown	  
lines	  
Four	  T1	  Col-­‐0	   lines	  expressing	  an	  AT3G23750	   (TMK4)	  amiRNA	  knockdown	  construct.	   The	  plants	  
exhibit	  a	  variety	  of	  developmental	  phenotypes	  including;	  dwarfed	  stature,	  and	  narrow	  and	  crinkly	  










4.4.1.2),	  it	  may	  be	  that	  the	  LRR-­‐RLK	  link	  provided	  by	  TMK4	  can	  be	  extended	  to	  both	  FLS2	  and	  
BRI1.	  Future	  experiments,	  based	  on	  improved	  knowledge	  of	  DA1	  function,	  will	  include	  detailed	  
analyses	   of	   phenotypes	   and	   genetic	   interactions	   of	   the	   amiRNA	   lines	   and	   analysis	   of	   TMK4	  
protein	  levels,	  modifications	  and	  localization	  during	  organ	  growth.	  
Control	   of	   the	   cell	   cycle	   is	   fundamentally	   important	   for	   plant	   growth	   as	   it	   establishes	   the	  
numbers	  and	  sizes	  of	  cells	  that	  comprise	  a	  growing	  organ.	  The	  interaction	  between	  TCP15	  and	  
DA1,	  and	  evidence	  that	  TCP15	  directly	  regulates	  the	  expression	  of	  key	  cell-­‐cycle	  genes	  (Kieffer	  
et	  al.,	  2011,	  Li	  et	  al.,	  2012),	  provides	  a	  promising	  link	  between	  DA1	  function	  and	  the	  cell-­‐cycle.	  
The	   da1-­‐1	   large	   organ	   phenotype	   is	   due	   to	   developing	   organs	   being	   mitotically	   active	   for	  
longer	  (Li	  et	  al.,	  2008).	  The	  interaction	  of	  DA1	  with	  a	  transcription	  factor	  that	  has	  been	  shown	  
to	   repress	   cell	   proliferation	   in	   leaf	   and	   floral	   tissues	   (Kieffer	   et	   al.,	   2011)	   reveals	   a	   possible	  
mechanism	   for	   this	  phenotype.	  However,	   the	  often-­‐contradictory	  phenotypes	   revealed	   from	  
genetic	  studies	  of	  TCP15	  (Fig.	  4.5)	  (Kieffer	  et	  al.,	  2011,	  Li	  et	  al.,	  2012,	  Uberti-­‐Manassero	  et	  al.,	  
2012),	   have	  made	   it	   difficult	   to	   establish	   direct	   genetic	   evidence	   of	   a	   role	   of	   DA1	   in	   TCP15	  
function.	   Speculatively,	   assuming	   that	   TCP15,	   as	   a	   canonical	   class	   I	   TCP,	   is	   a	   promoter	   of	  
growth,	   and	   that	   the	  dependence	  of	   its	   function	  on	  DA1	   indicated	  by	   the	  partial	   correlation	  
analysis	   is	   correct,	   then	   a	   model	   can	   be	   proposed	   in	   which	   DA1	   negatively	   regulates	   the	  
growth	   promoting	   activity	   of	   TCP15.	   This	   model	   is	   supported	   by	   data	   showing	   a	   genetic	  
interaction	   to	   regulate	   inflorescence	   stem	   height	   (section	   4.3.3.1),	   but	   contradicted	   by	   data	  
from	   other	   sources	   that	   report	   a	   growth	   repressing	   activity	   of	   TCP15	   (Kieffer	   et	   al.,	   2011).	  
Despite	  the	  uncertainty	  surrounding	  the	  details	  of	  the	  interaction,	  the	  observation	  that	  DAR1	  
has	  also	  been	  shown	  to	  interact	  with	  TCP14	  (Mukhtar	  et	  al.,	  2011)	  supports	  the	  observed	  DA1-­‐
TCP15	  interaction,	  generating	  important	  insight	  that	  may	  allow	  us	  to	  explain	  certain	  aspects	  of	  
the	  da1-­‐1	  phenotype.	  
The	  observation	  that	  DA1	  physically	   interacts	  with	  the	  cytoplasmic	  domain	  of	  TMK4,	  an	  LRR-­‐
RLK,	   provides	   sufficient	   insight	   to	   be	   able	   to	   propose	   a	   tentative	   role	   for	   DA1	   in	   LRR-­‐RLK-­‐
mediated	   regulation	   of	   growth	   and	   development.	   The	   ‘UIM-­‐cycle’	   model	   for	   the	   ubiquitin	  
dependent	  processing	  of	  RTKs	   in	  animal	   systems	   (Marmor	  and	  Yarden,	  2004)	  predicts	  a	   role	  
for	   DA1	   as	   an	   adaptor	   protein	   in	   the	   internalisation	   or	   recycling	   of	   LRR-­‐RLKs.	   However,	  
evidence	   that	   the	  DA1	  peptidase	   is	   active	   towards	   two	  E3	   ligases	   (Chapter	   5),	   and	  evidence	  
that	   FLS2	   is	   ubiquitinated	  by	   PUB12	   and	  PUB13	   (Lu	   et	   al.,	   2011),	   suggests	   that	  DA1	  may	  be	  
involved	   in	   the	   proteolytic	   regulation	   of	   E3	   ligases	   involved	   in	   RLK-­‐mediated	   signal	  
transduction.	   Indeed,	   the	   way	   that	   PUB12	   and	   PUB13	   affect	   the	   sensitivity	   of	   the	   flg22	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response	  (Marino	  et	  al.,	  2012,	  Lu	  et	  al.,	  2011)	  is	  reminiscent	  of	  how	  DA1	  affects	  sensitivity	  of	  
brassinosteroid	  perception	  (section	  4.4.1.2).	  It	  is	  possible	  that	  ubiquitination	  of	  some	  LRR-­‐RLKs	  
is	   required	   for	   their	   activity	   and	   that	   DA1	   acts	   to	   recruit	   and	   regulate	   E3	   ligases	   at	   the	  
cytoplasmic	  domain	  of	   the	   respective	  RLK.	  Due	   to	   the	   fact	   that	  BAK1	   is	   involved	   in	  both	   the	  
flg22	  and	  brassinosteroid	   responses,	   it	   is	   tempting	   to	   speculate	   that	  DA1	  also	   interacts	  with	  
the	  C-­‐terminal	  domain	  of	  BAK1.	  
Although	   it	   is	   possible	   that	   DA1	   regulates	   TCP15	   and	   TMK4	   independently	   and	   at	   distinct	  
cellular	  locations,	  it	  is	  also	  possible	  that	  DA1	  interacts	  with	  both	  proteins	  in	  the	  same	  location.	  
Evidence	   from	   animal	   systems	   reveals	   that	   the	   sterol	   regulatory	   element	   binding	   proteins	  
(SREBPs),	  ER-­‐membrane	  bound	  transcription	  factors,	  are	   ‘activated’	  by	  a	  proteolytic	  cleavage	  
event	   that	   liberates	   the	   DNA-­‐binding	   domain	   from	   the	   membrane,	   before	   transition	   the	  
nucleus	   (Brown	   and	   Goldstein,	   1997,	   Eberle	   et	   al.,	   2004).	   This	   example	   suggests	   a	   possible	  
mechanism	  of	  DA1	  action,	   involving	   ligand	  binding	  of	   LRR-­‐RLKs	   resulting	   in	   the	  RLK-­‐proximal	  
ubiquitin-­‐mediated	   regulation	   of	   TCP15	   activity.	   This	   model,	   although	   very	   speculative,	   is	  
supported	  by	  strong	  evidence	  that	  TCP14	  is	  a	  network	  hub	  in	  response	  to	  pathogen	  response	  
(Mukhtar	  et	  al.,	  2011),	  and	  that	  TCP15	  interacts	  physically	  with	  the	  E3	  ligase	  PUB14	  (Dreze	  et	  
al.,	  2011).	  Detailed	  genetic	  analysis	  would	  help	  to	  dissect	  these	  interactions,	  but	  they	  may	  be	  
very	  complex	  due	  to	  substantial	  genetic	  redundancy	  of	  TCP	  genes.	  
The	   suggestion	   that	   DA1	   may	   play	   a	   role	   in	   growth	   and	   development	   and	   the	   pathogen	  
response	   is	   supported	   by	   the	   identification	   of	   the	   E1-­‐activating	   enzyme	  ATUBA1	   in	   the	   Y2H	  
screen.	  A	  15bp	  deletion	  in	  the	  C-­‐terminal	  region	  of	  ATUBA1	  (named	  mos5	  (modifier	  of	  snc1	  5))	  
was	   able	   to	   rescue	   the	   dwarf	   phenotype	   of	   the	   npr1-­‐1	   snc1	   double	   mutant,	   which	   has	  
constitutively	   activated	   defence	   responses	   (Goritschnig	   et	   al.,	   2007).	   mos5	   has	   enhanced	  
disease	  susceptibility,	  which	  suggests	  that	  ATUBA1	  is	  involved	  in	  activating	  pathogen	  response	  
pathways	  (Goritschnig	  et	  al.,	  2007).	  The	  ability	  of	  mos5	  to	  rescue	  the	  dwarf	  phenotype	  of	  the	  
npr1-­‐1	   snc1	   double	   mutant	   suggests	   that	   ATUBA1	   negatively	   regulates	   a	   growth	   control	  
pathway	  (Goritschnig	  et	  al.,	  2007);	  something	  that	   is	  well	  characterised	  in	  defence	  responses	  
(Gómez‐Gómez	  et	  al.,	  1999,	  Gómez-­‐Gómez	  and	  Boller,	  2000,	  Zipfel	  et	  al.,	  2006).	  
The	  regulation	  of	  a	  specific	  set	  of	  pathways	  by	  an	  E1-­‐activating	  enzyme	  is	  surprising,	  seeing	  as	  
specificity	   in	   the	   ubiquitination	   cascade	   is	   considered	   to	   be	   determined	   by	   E3	   enzymes	  
(Hershko	   and	   Ciechanover,	   1998).	   Based	   on	   observations	   in	   Chapter	   5,	   that	   reveal	   DA1	  
interacts	  with	  two	  E3	  ligases,	  it	  is	  difficult	  to	  see	  how	  DA1	  may	  also	  interact	  with	  an	  E1	  enzyme.	  
One	   explanation	   would	   be	   if	   the	   E1,	   E2	   and	   E3	   enzymes	   form	   a	   temporary	   complex	   that	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shuttles	   ubiquitin	   through	   the	   ubiquitin	   cascade	   to	   the	   substrate.	   Regardless	   of	   the	  
explanation,	  the	  identification	  of	  ATUBA1	  as	  an	  interactor	  of	  DA1	  unifies	  the	  ubiquitin	  system,	  
the	   pathogen	   response,	   and	   growth	   and	   development	   pathways;	   all	   pathways	   that	  DA1	   has	  
been	  links	  to.	  
Other	   candidate	   DA1-­‐interacting	   proteins	   from	   the	   Y2H	   screen	   include	   the	   Class	   III	  
homeodomain-­‐leucine	  zipper	  (HD-­‐Zip	  III)	  protein	  ATHB8	  (HOMEOBOX	  GENE	  8),	  which	  is	  part	  of	  
a	  small	  gene	  family	  shown	  to	  be	  involved	  in	   leaf	  development,	  meristem	  regulation,	  vascular	  
development	   and	   auxin	   transport	   (reviewed	   in	   (Prigge	   et	   al.,	   2005)).	  ATHB8	   expression	   has	  
been	  shown	  to	  promote	  cell	  differentiation	  during	  vascular	  development	  (Baima	  et	  al.,	  2001)	  
and	   to	   be	   highly	   correlated	   with	   cell	   division	   in	   the	   developing	   vascular	   system	   (Kang	   and	  
Dengler,	   2002).	   Consistent	  with	   its	   role	   in	   vascular	  development,	   there	   is	   also	  evidence	   that	  
ATHB8	  expression	  is	  positively	  regulated	  by	  auxin	  (Baima	  et	  al.,	  1995,	  Mattsson	  et	  al.,	  2003).	  In	  
addition,	   there	   is	   evidence	   that	   ATHB8	   antagonises	   the	   effect	   of	   REVOLUTA	   (REV),	   and	  
promotes	   meristem	   and	   floral	   organ	   development	   (Prigge	   et	   al.,	   2005).	   The	   fact	   that	   this	  
growth	  promoting	  transcription	  factor	  is	  auxin-­‐responsive	  (Baima	  et	  al.,	  1995,	  Mattsson	  et	  al.,	  
2003),	   presents	   the	   possibility	   that	   it	   may	   operate	   in	   a	   similar	   pathway	   to	   TMK4,	   which	   is	  
involved	   in	   auxin	   sensing	   (Dai	   et	   al.,	   2013).	   It	   is	   therefore	   conceivable	   that	   any	   interaction	  
between	  DA1	  and	  ATHB8,	  may	  be	  related	  to	  the	  DA1-­‐TMK4	  interaction.	  
Also	  identified	  in	  the	  first	  round	  of	  the	  Y2H	  screen	  was	  LOB	  DOMAIN-­‐CONTROLING	  PROTEIN	  41	  
(LBD41),	   related	   to	   the	   LOB-­‐domain	   containing	  protein,	  ASYMMETRIC	   LEAVES	  2	   (AS2),	  which	  
affects	  leaf	  lobing,	  petiole	  length	  and	  the	  ectopic	  formation	  of	  leaflet-­‐like	  structures	  (Semiarti	  
et	   al.,	   2001).	   The	  LBD41	   homolog	   in	  Celosia	   cristata	   has	  also	  been	   shown	   induce	   leaf	   lobing	  
and	  ectopic	   leaf	  blade	  formation	  on	  the	  petiole	   (Meng	  et	  al.,	  2010).	  This	   is	  possibly	  due	  to	  a	  
similar	   repression	  of	  KNOX	   gene	  activity	   as	   that	   seen	  with	  AS2	   (Guo	  et	   al.,	   2008,	  Hay	  et	   al.,	  
2006).	  	  
	  
4.5.1	  –	  DA1,	  TCP15	  and	  the	  chloroplast:	  a	  role	  in	  retrograde	  signalling?	  
Finally,	  the	  abundance	  of	  chloroplast	  localised	  proteins	  in	  the	  Y2H	  screen	  (Table	  4.1)	  suggests	  
that	  DA1	  may	   function	   in	   the	   chloroplast.	   Recent	  work	  by	  Andriankaja	   et	   al	   (2012)	   revealed	  
that	   the	   cell	   proliferation	   arrest	   front	   appears	   to	   be	   induced	   by	   chloroplast	   retrograde	  
signalling.	  It	  was	  shown	  that	  genes	  involved	  in	  the	  synthesis	  of	  chlorophylls	  and	  hemes,	  whose	  
action	  is	  thought	  to	  promote	  retrograde	  signalling	  (Voigt	  et	  al.,	  2010),	  were	  up-­‐regulated	  prior	  
to	  the	  onset	  of	  cell	  expansion	  (Andriankaja	  et	  al.,	  2012).	   It	  was	  also	  shown	  that	  the	  group	  of	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genes	   that	   was	   differentially	   expressed	   during	   the	   transition	   from	   cell	   proliferation	   to	  
expansion	  was	  enriched	   in	   for	  genes	  also	  shown	  to	  be	  differentially	  regulated	   in	  response	  to	  
Norflurazon	  (NF),	  a	  chemical	  inhibitor	  of	  chloroplast	  differentiation	  (Andriankaja	  et	  al.,	  2012).	  
Moreover,	  the	  transition	  from	  cell	  proliferation	  to	  cell	  expansion	  in	  the	  leaf	  tip	  was	   inhibited	  
when	   NF	   was	   applied	   (Andriankaja	   et	   al.,	   2012),	   further	   supporting	   a	   role	   of	   chloroplast	  
retrograde	  signalling	  in	  the	  promotion	  of	  cell	  expansion	  in	  the	  developing	  leaf.	  
	  Although	   the	   precise	   details	   of	   chloroplast	   retrograde	   signal	   transduction	   remain	   unclear	  
(Nott	   et	   al.,	   2006,	   Leister,	   2012,	   Caldana	   et	   al.,	   2012),	   reactive	   oxygen	   species	   (ROS),	  
tetrapyrrole	   biosynthesis	   and	  plastid	   gene	  expression	   are	   all	   thought	   to	  play	   a	   role	   in	   signal	  
initiation	   (Galvez‐Valdivieso	   and	  Mullineaux,	   2010,	   Voigt	   et	   al.,	   2010).	   As	   the	   onset	   of	   the	  
cell-­‐proliferation	  arrest	  front	  is	  delayed	  in	  da1-­‐1	  organs,	  it	  is	  possible	  that	  DA1	  acts	  to	  promote	  
the	   onset	   of	   arrest	   and	   thereby	   accelerate	   the	   transition	   from	   proliferation	   to	   expansion	  
across	   the	   developing	   organ.	   It	   is	   possible	   that	   DA1	   might	   promote	   this	   transition	   by	  
promoting	  chloroplast	  retrograde	  signalling.	  This	  hypothesis	   is	  supported	  by	  preliminary	  data	  
from	   the	   Y2H	   screen,	  which	   shows	   that	  DA1	   interacts	  with	   15	   chloroplast	   localised	   proteins	  
including,	   FERREDOXIN	   2	   and	   PSAE-­‐1	   (Fig.	   4.3),	   both	   of	   which	   are	   involved	   in	   linear	  
photophosphorylation	   (Allen,	   2003,	   Nott	   et	   al.,	   2006).	   Interference	   with	   linear	  
photophosphorylation	   can	   induce	   the	   rapid	   accumulation	   of	   singlet	   oxygen	   (1O2),	   which	   is	  
thought	  to	  be	   involved	   in	   initiating	  retrograde	  signalling	   (Galvez‐Valdivieso	  and	  Mullineaux,	  
2010).	  This	  suggests	  that	  any	  DA1-­‐mediated	  inhibition	  of	  either	  FERREDOXIN	  or	  PSAE-­‐1	  might	  
promote	  retrograde	  signalling	  and	  therefore	  promote	  the	  onset	  of	  the	  cell	  proliferation	  arrest	  
front.	  Additionally,	  because	  TCP15	  is	  predicted	  to	  be	  localised	  to	  the	  chloroplast	  (Wagner	  and	  
Pfannschmidt,	  2006),	  it	  is	  possible	  that	  DA1-­‐TCP15	  interactions	  might	  promote	  the	  expression	  
of	  chloroplast	  genes,	  and	  thereby	  activate	  retrograde	  signalling	  (Voigt	  et	  al.,	  2010).	  	  
Consistent	  with	  the	  possibility	  that	  DA1	  promotes	  retrograde	  signalling	  through	  elevated	  ROS	  
levels,	   is	   evidence	   from	  microarray	  analyses	   that	   shows	  enhanced	  expression	  of	  FSD1	   (IRON	  
SUPEROXIDE	   DISMUTASE	   1)	   in	   da1-­‐1	   plants	   (Yunhai	   Li,	   personal	   communication).	   FSD1	   is	  
involved	  in	  protecting	  chloroplasts	  from	  oxidative	  stress	  (Myouga	  et	  al.,	  2008)	  and	  is	  involved	  
in	  de-­‐toxifying	  1O2	  by	  converting	  it	  to	  H2O2;	  the	  first	  of	  a	  two-­‐step	  pathway	  resulting	  in	  H2O.	  It	  
may	   be,	   therefore,	   that	   DA1	   negatively	   regulates	   FSD1;	   thereby	   promoting	   1O2-­‐induced	  
retrograde	  signalling	  and	  positively	  regulating	  the	  arrest	  front.	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Chapter	  5	  -­‐	  DA1	  is	  an	  ubiquitin-­‐activated	  peptidase	  
	  
5.1	  –	  Introduction	  
This	   chapter	   identifies	   functions	   of	   the	   DA1	   metallopeptidase	   domain	   and	   its	   role	   in	   the	  
processing	  and	  regulation	  of	  E3	  ligases.	  Through	  a	  combination	  of	  genetics	  and	  biochemistry,	  
these	  experiments	  identify	  the	  E3	  ligases	  EOD1	  and	  DA2	  as	  targets	  of	  DA1	  peptidase	  activity,	  
and	  reveal	  a	  novel	  mechanism	  for	  the	  ubiquitin-­‐dependent	  peptidase-­‐mediated	  regulation	  of	  
E3	  ligases.	  
5.1.1	  –	  E3	  Ligases:	  a	  diverse	  group	  of	  proteins	  unified	  by	  functional	  similarity	  	  
The	   final	   step	   in	   the	   ubiquitin	   cascade	   (see	   section	   1.7)	   is	   the	   targeted	   transfer	   of	   E2-­‐
conjugated	  ubiquitin	  molecules	  to	  substrate	  proteins.	  E3	  ubiquitin	   ligases	  are	  responsible	   for	  
determining	   the	   specificity	   of	   this	   E2-­‐mediated	   ubiquitin	   transfer;	   a	   centrally	   important	  
function	   consistent	   with	   the	   identification	   of	   1415	   E3	   ubiquitin	   ligases	   in	   Arabidopsis	  
(Mazzucotelli	  et	  al.,	  2006).	  In	  the	  most	  general	  terms,	  an	  E3	  ubiquitin	  ligase	  is	  an	  enzyme	  that	  
facilitates,	  directly	  or	  indirectly,	  the	  transfer	  of	  E2-­‐conjugated	  ubiquitin	  molecules	  to	  a	  specific	  
substrate.	   However	   despite	   this	   functional	   conservation,	   E3	   ligases	   are	   an	   exceptionally	  
diverse	  group	  of	  enzymes.	  According	  to	  their	  protein	  structures,	  there	  are	  two	  general	  groups	  
of	  E3	  ligase:	  monomeric	  E3s,	  where	  E2-­‐binding	  domains	  and	  substrate	  binding	  domains	  are	  on	  
the	   same	  polypeptide;	   and	  multimeric	   E3s,	  which	   consist	   of	   an	   E2-­‐interacting	  module	   and	  a	  
target-­‐specifying	   module	   joined	   by	   a	   CUL	   (CULLIN)	   or	   CUL-­‐like	   protein	   (Mazzucotelli	   et	   al.,	  
2006)	  (Fig.	  5.1).	  	  
E3	   ligases	   can	  also	  be	   categorized	  according	   to	   their	  E2-­‐binding	  domains.	  These	  are	  either	  a	  
HECT	  (Homology	  to	  E6-­‐AP	  C-­‐Terminus)	  domain	  or	  a	  RING	  (Really	  Interesting	  New	  Gene)/U-­‐box	  
domain.	  All	  HECT	  E3s,	  including	  UPL3	  (UBIQUITIN	  PROTEIN	  LIGASE	  3)	  -­‐	  a	  regulator	  of	  trichome	  
development	  in	  Arabidopsis	  (Downes	  et	  al.,	  2003),	  are	  monomeric	  E3s;	  whereas	  RING	  E3s	  exist	  
as	  both	  monomeric	  E3s	  and	  as	  subunits	  in	  multimeric	  modular	  E3	  complexes	  (Mazzucotelli	  et	  
al.,	  2006).	  Some	  RING	  E3s,	  such	  as	  BB/EOD1	  (Disch	  et	  al.,	  2006)	  and	  the	  negative	  regulator	  of	  
ABA	  signalling	  KEG	  (KEEP	  ON	  GOING)	  (Stone	  et	  al.,	  2006),	  as	  well	  as	  the	  closely	  related	  PLANT	  
U-­‐BOX	  (PUB)	  E3s,	   including	  PUB12	  and	  PUB13	  (Lu	  et	  al.,	  2011),	  are	  single	  polypeptide	  E3s.	   In	  
contrast	   the	   RING	   protein	   atRBX1	   (RING	   BOX	   PROTEIN1),	   the	   knockdown	   of	   which	   causes	  
severe	   developmental	   phenotypes	   such	   as	   poorly	   developed	   leaves	   and	   loss	   of	   apical	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dominance	   (Lechner	   et	   al.,	   2002),	   is	   part	   of	   a	   multimeric	   E3	   ligase.	   RBX1	   is	   the	   E2-­‐binding	  
subunit	   of	   SCF	   (SKP1-­‐CULLIN-­‐F-­‐BOX),	   CUL3-­‐BTB/POZ	   (CULLIN-­‐3	   –	   BRIC-­‐A-­‐BRAC,	   TRAMTRACK	  
and	   BROAD	   COMPLEX/POX	   VIRUS	   and	   ZINC	   FINGER),	   and	   CUL4-­‐DDB1	   (UV-­‐DAMAGED	   DNA-­‐
BINDING	  PROTEIN1)	  E3	   ligases;	  henceforth	  termed	  the	  cullin-­‐ring	   ligases	   (CRLs)	   (Mazzucotelli	  
et	   al.,	   2006).	   All	   E3	   ligases,	   except	   HECT	   E3s,	   coordinate	   the	   ligation	   of	   the	   E2-­‐conjugated	  
ubiquitin	   to	   the	   substrate,	   without	   themselves	   covalently	   binding	   the	   ubiquitin.	   HECT	   E3	  
ligases,	  however,	  form	  a	  thioester	  intermediate	  with	  the	  ubiquitin	  molecule	  before	  transfer	  of	  
the	  ubiquitin	  moiety,	  by	  ligation,	  to	  the	  substrate	  (Hershko	  and	  Ciechanover,	  1998).	  
The	  modular	   nature	   of	  multimeric	   E3	   ligases	   and	   the	   diversity	   of	   their	   subunits	   generates	   a	  
large	  number	  of	  substrate	  specificities.	  Indeed,	  the	  most	  abundant	  E3	  subgroup	  in	  Arabidopsis,	  
with	  724	  members,	  is	  that	  of	  the	  F-­‐BOX	  proteins	  (Mazzucotelli	  et	  al.,	  2006).	  F-­‐BOX	  proteins	  are	  
the	   substrate	   binding	   modules	   of	   the	   SCF-­‐type	   E3	   ligases,	   which	   determine	   the	   target	  
specificity	   of	   the	   multimeric	   E3s.	   They	   have	   been	   identified	   to	   play	   a	   role	   in	   many	  
developmental	   processes	   in	   Arabidopsis.	   For	   example,	   the	   F-­‐BOX	   protein	   UNUSUAL	   FLORAL	  
ORGANS	   (UFO)	   is	   a	   regulator	   of	   floral	   development	   and	   meristem	   identity	   (Levin	   and	  
Meyerowitz,	  1995);	  and	  SLEEPY1	  (SLY1)	  is	  a	  positive	  regulator	  of	  gibberellin	  signalling	  (Dill	  et	  al.,	  
2004,	  McGinnis	  et	  al.,	  2003).	  
5.1.2	  –	  Regulation	  of	  E3	  ligase	  activity	  
Ubiquitination	  of	  a	  target	  protein	  often	  leads	  to	  its	  irreversible	  destruction	  by	  targeting	  to	  the	  
proteasome	   (Glickman	   and	   Ciechanover,	   2002,	   Hochstrasser,	   1996).	   In	   the	   cell	   cycle	   for	  
example,	  ubiquitin-­‐mediated	  protein	  destruction	  ensures	  unidirectional	  cell-­‐cycle	  progression.	  
Examples	  of	  this	  include	  the	  APC	  (anaphase	  promoting	  complex)	  mediated	  ubiquitination	  of	  A-­‐	  
and	  B-­‐type	  cyclins	  and	  the	  SCF-­‐mediated	  ubiquitination	  of	  D-­‐type	  cyclins	  (Dewitte	  and	  Murray,	  
2003).	  To	  enable	   these	  cellular	  decisions	   to	  be	  executed	  quickly	  and	  completely,	  pools	  of	  E3	  
ligase	  enzymes	  are	  often	  pre-­‐existing	  and	  tightly	   regulated	   (Peters,	  2006).	  For	   this	   reason	  E3	  
ligases	  are	  subject	  to	  a	  large	  amount	  of	  regulatory	  post-­‐translational	  modification.	  
The	   activity	   and	   specificity	   of	   multimeric	   E3	   ligases	   is	   dependent	   on	   the	   presence	   of	   all	  
required	  subunits,	  and	  mechanisms	  that	   interfere	  with,	  or	  enhance	  subunit	  assembly	  can	  act	  
as	  regulators	  of	  E3	  ligase	  activity.	  In	  humans,	  the	  inhibitory	  CAND1	  (CULLIN-­‐ASSOCIATED	  AND	  
NEDDYLATION-­‐DISSASSOCIATED)	  protein	  competes	  with	  the	  substrate	  recognition	  module	  (e.g.	  
DDB1)	   for	   the	   binding	   of	   the	   E2-­‐binding	   module	   (CUL1/RBX),	   thus	   preventing	   complex	  
formation	  and	  repressing	  E3	   function	   (Zheng	  et	  al.,	  2002).	  Conversely,	   there	   is	  also	  evidence	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that	   the	   dimerisation	   of	   CRL	   subunits	   can	   result	   in	   an	   increased	   concentration	   of	   E2	   and	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Figure	  5.1	  –	  Three	  different	  classes	  of	  E3	  ligases	  
(A-­‐C)	   A	   simplified	   classification	   of	   E3	   ligases	   into	   three	   key	   classes.	   (A)	   HECT	   E3	   ligases	   are	  
monomeric	  and	  form	  a	  thioester	  intermediate	  with	  the	  ubiquitin	  molecule	  (black	  ellipse)	  prior	  to	  
ligation.	   (B)	   The	   RING/U-­‐BOX	   family	   of	   E3	   ligases	   can	   also	   be	   monomeric,	   but	   do	   not	   form	   a	  
thioester	   intermediate	   with	   ubiquitin	   during	   the	   ligation	   reaction.	   (C)	   CRL	   E3	   ligases	   are	  
multimeric	   protein	   complexes,	   with	   specific	   E2-­‐binding	   and	   substrate-­‐binding	  modules.	   CRL	   E3	  




In	   addition	   to	   regulating	   subunit	   availability,	   post-­‐translational	   manipulation	   of	   protein	  
structure	   can	   also	   affect	   CRL	   activity.	   The	   ligation	   of	   the	   small	   ubiquitin	   related	   peptides	  
NEDD8	  (in	  mammals)	  and	  RUB	  (in	  plants)	  to	  the	  CUL	  backbone	  of	  CRLs	  has	  been	  shown	  to	  be	  
sufficient	  to	  modify	  CUL	  tertiary	  structure	  and	  thereby	  alter	  its	  binding	  affinity	  to	  RBX1	  (Duda	  
et	   al.,	   2008,	   Biedermann	   and	   Hellmann,	   2011).	   This	   results	   in	   a	   more	   flexible	   E2-­‐binding	  
module,	   reducing	   the	   distance	   from	   E2	   to	   substrate,	   and	   enhancing	   E3	   activity	   through	   the	  
facilitation	  of	  multiple	  catalytic	  geometries	  (Duda	  et	  al.,	  2008,	  Merlet	  et	  al.,	  2009).	  	  
Similarly	   to	   CRLs,	   monomeric	   E3s	   are	   also	   regulated	   by	   a	   combination	   of	   post-­‐translational	  
modification	  and	  the	  availability	  of	  cognate	  substrate-­‐binding	  adaptor	  proteins.	  For	  example,	  
and	   perhaps	   comparable	   to	   the	   neddylation	   of	   CRLs,	   poly-­‐ubiquitination	   of	  monomeric	   E3s,	  
such	   as	   the	   auto-­‐ubiquitination	   of	   the	   human	   BRCA1/BARD1	   complex,	   has	   been	   shown	   to	  
stimulate	  E3	  activity	  (Mallery	  et	  al.,	  2002).	  In	  contrast,	  poly-­‐ubiquitination	  of	  the	  human	  RING	  
E3,	  MDM2	  is	  a	  repressive	  signal,	  and	  the	  activity	  of	  this	  enzyme	  is	  regulated	  by	  the	  antagonism	  
of	  its	  auto-­‐ubiquitination	  by	  the	  de-­‐ubiquitinating	  activity	  of	  its	  cognate	  DUB;	  USP2a	  (Fang	  et	  
al.,	  2000,	  Stevenson	  et	  al.,	  2007).	   It	  has	  also	  been	  shown	  that	  post-­‐translational	  modification	  
of	  the	  Human	  E3	  ligase,	  PARKIN	  is	  sufficient	  to	  de-­‐repress	  the	  enzyme	  and	  alter	  its	  specificity.	  
PARKIN	   exists	   in	   an	   auto-­‐inhibitory	   state	   that	   can	   be	   released	   in	   vitro	   by	   the	   addition	   of	  N-­‐
terminal	   epitope	   tags	   (Burchell	   et	   al.,	   2012),	   and	   can	   be	   converted	   from	   a	   mono-­‐ubiquitin	  
ligase	   to	   a	   poly-­‐ubiquitin	   ligase	   by	   an	   N-­‐terminal	   truncation	   in	   vitro	   (Chew	   et	   al.,	   2012).	  
Together	  these	  data	  suggest	  that	  E3	  ligases	  can	  contain	  auto-­‐inhibitory	  domains,	  which	  may	  be	  
removed	  through	  cleavage	  of,	  or	  steric	  interference	  with	  the	  inhibitory	  region.	  	  
In	   addition	   to	   the	   steric	   activation	   of	   E3	   ligases,	   there	   is	   also	   evidence	   that	   proteolytic	  
processing	  of	  E3s	  can	  cause	  their	  activation	  by	  re-­‐localisation.	  The	  membrane	  localised	  Human	  
PA-­‐TM-­‐RING	  E3	  ligase,	  RNF13,	  is	  cleaved	  at	  its	  trans-­‐membrane	  domain,	  which	  releases	  the	  C-­‐
terminal	   RING-­‐containing	   domain	   to	   the	   cytoplasm	   (Bocock	   et	   al.,	   2010).	   This	   re-­‐localisation	  
may	  be	  required	  to	  bring	  it	   into	  contact	  with	  its	  substrate,	  and	  therefore	  may	  be	  essential	  to	  
activate	  the	  enzyme.	  
For	  monomeric	   E3s,	   the	   availability	   of	   adaptor	   proteins	   also	   provides	   an	   additional	   level	   of	  
regulatory	   control.	   An	   extreme	   example	   of	   this	   is	   the	   human	   HECT	   E3	   ligase,	   SMURF2,	   a	  
regulator	  of	  TGF-­‐β	  endocytosis.	   Its	  cognate	  adaptor,	  SMAD7,	  acts	  as	  an	  additional	  E2	  binding	  
site,	  increasing	  the	  affinity	  for	  the	  E2	  and	  thereby	  enhancing	  its	  ligase	  activity	  (Ogunjimi	  et	  al.,	  
2005).	   Also,	   and	   comparable	   to	   the	   dependence	   on	   the	   availability	   of	   substrate-­‐binding	  
modules	   in	  modular	   E3s,	   the	   yeast	   E3	   ligase	   RSP5	   requires	   an	   adaptor	   protein	   complex	   for	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target	  specificity	  (Léon	  and	  Haguenauer-­‐Tsapis,	  2009).	  In	  this	  example	  three	  proteins	  –	  BSD2,	  
TRE1	  and	  TRE2	  –	  interact	  to	  target	  RSP5	  to	  its	  substrate;	  SMF1	  (Stimpson	  et	  al.,	  2006,	  Hettema	  
et	  al.,	  2004).	  Finally,	  highlighting	  the	  diverse	  regulatory	  roles	  carried	  out	  by	  adaptors,	  SMAD7’s	  
interaction	  with	  SMURF2	  also	  causes	   the	   re-­‐localisation	  of	   the	  E3	   ligase	   from	  the	  nucleus	   to	  
the	   cytoplasm	   and	   plasma	   membrane	   (Kavsak	   et	   al.,	   2000),	   and	   disrupts	   its	   native	  
autoinhibitory	  conformation	  (Wiesner	  et	  al.,	  2007).	  	  
5.1.3	  –	  Ubiquitin	  chains:	  	  a	  diversity	  of	  signalling	  modifications	  
Ubiquitin	  modifications	  occur	  in	  a	  variety	  of	  forms	  ranging	  from	  mono-­‐ubiquitination	  to	  long-­‐
chain	  poly-­‐ubiquitination	   (Pickart	  and	  Fushman,	  2004,	   Ikeda	  and	  Dikic,	  2008,	  Kerscher	  et	  al.,	  
2006).	   Mono-­‐ubiquitination	   is	   chiefly	   used	   as	   a	   reversible	   post-­‐translational	   modification	  
similar	  to	  that	  of	  phosphorylation,	  and	  its	  role	  in	  coupled	  mono-­‐ubiquitination	  is	  discussed	  in	  
more	  detail	  in	  section	  3.1.1.	  This	  section	  will	  focus	  on	  the	  diversity	  in	  structure	  and	  function	  of	  
poly-­‐ubiquitin	  chains.	  
Poly-­‐ubiquitin	  chains	  are	  formed	  through	  the	  creation	  of	  an	  isopeptide	  linkage	  between	  the	  C-­‐
terminal	  glycine	  of	  ubiquitin	  (Gly76)	  and	  a	  lysine	  residue	  on	  the	  preceding	  ubiquitin	  molecule	  
(Pickart	  and	  Fushman,	  2004).	  There	  are	  seven	  lysines	  in	  ubiquitin	  -­‐	  K6,	  K11,	  K27,	  K29,	  K33,	  K48	  
and	   K63	   –	   allowing	   for	   seven	   possible	   ubiquitin	   chain	   ‘architectures’.	   Five	   out	   of	   the	   seven	  
architectures	  have	  been	  detected	  in	  Arabidopsis	  in	  the	  following	  order	  of	  abundance:	  K48	  >>	  
K63	  >	  K11	  >>	  K33	  >	  K29	  (Saracco	  et	  al.,	  2009).	  In	  yeast,	  all	  seven	  linkages	  have	  been	  detected	  
in	  the	  order	  of	  abundance:	  K48	  >	  K63	  &	  K11	  >>	  K33,	  K27,	  K6	  &	  (K29);	  with	  K29	  linkages	  only	  
being	  detected	  on	  proteins	  also	  ubiquitinated	  at	  K33	  (Peng	  et	  al.,	  2003).	  The	  identification	  of	  
all	   seven	   linkages	   in	  vivo	   suggests	   that	   all	   architectures	  are	  genuine	   signalling	  modifications.	  
Linear	  poly-­‐ubiquitin	  chains	  –	  where	  a	  peptide	   linkage	   forms	  between	   the	  α-­‐amino	  group	  of	  
Met1	  of	  one	  ubiquitin	  and	  the	  α-­‐carboxyl	  group	  of	  the	  C-­‐terminal	  Gly76	  of	  another	  (Rieser	  et	  
al.,	  2013)	  –	  have	  also	  been	  identified	  in	  animal	  systems.	  These	  chains	  are	  formed	  through	  the	  
linear	  ubiquitin	  chain	  assembly	  complex	  (LUBAC)	  (Kirisako	  et	  al.,	  2006),	  and	  are	  thought	  to	  be	  
non-­‐degradative	   signals	   involved	   in	   the	   regulation	   of	   proteins	   such	   as	   TUMOUR	   NECROSIS	  
FACTOR	  RECEPTOR1	  (TNFR1)	  (Rieser	  et	  al.,	  2013).	  	  
K48-­‐linked	  poly-­‐ubiquitin	  chains	  are	  generally	  accepted	  to	  be	  necessary	  for	  targeting	  proteins	  
to	  the	  proteasome-­‐mediated	  degradation	  pathway	  (Hershko	  and	  Ciechanover,	  1998,	  Jacobson	  
et	   al.,	   2009,	   Thrower	   et	   al.,	   2000),	   whereas	   other	   linkages	   are	   assumed	   to	   have	   non-­‐
degradative	  signalling	   functions.	  K63	   linked	  ubiquitin	  has	  been	  shown	  to	  be	  non-­‐degradative	  
and	   necessary	   to	   regulate	   human	   pattern	   recognition	   receptor	   signalling	   (Kawai	   and	   Akira,	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2010),	   as	   well	   as	   the	   activation	   of	   the	   CHK1	   checkpoint	   kinase	   (Cheng	   et	   al.,	   2013b).	   The	  
biological	   function	   of	   the	   other	   ubiquitin	   linkages	   is	   less	  well	   understood,	   although	   there	   is	  
evidence	   that	   K29-­‐	   and	   K33-­‐linked	   ubiquitin	   are	   negative	   regulators	   of	   the	   human	   kinases	  
NUAK1	   and	  MARK1	   (Al-­‐Hakim	  et	   al.,	   2010).	   Interestingly,	   K29-­‐linked	  ubiquitin	   has	   also	   been	  
shown	   to	   play	   a	   significant	   role,	   alongside	   K48-­‐linked	   ubiquitin	   chains,	   in	   signalling	   the	  
proteasome-­‐mediated	  destruction	  of	  DELLA	  proteins	  (Wang	  et	  al.,	  2009).	  	  
5.1.4	  –	  EOD1/BB	  and	  DA2	  are	  RING	  E3	  ligases	  
EOD1/BB	   and	   DA2	   are	   both	   RING-­‐finger	   proteins	   that	   negatively	   influence	   the	   duration	   of	  
proliferative	   growth	   in	   Arabidopsis	   (Disch	   et	   al.,	   2006,	   Xia,	   2013).	   Original	   research	  
demonstrated	   that	   EOD1	   is	   an	   active	   E3	   ligase	   in	   vitro	   and	   that	   it	   interacts	   with	   the	   E2	  
conjugating	  enzyme	  UBC10	  (Disch	  et	  al.,	  2006).	  	  
eod1	  null	  mutants	  have	  enlarged	  petals	  and	  sepals,	  and	  thicker	  stems	  than	  the	  wild-­‐type;	  leaf	  
size	  is	  not	  increased	  in	  these	  null	  mutants,	  but	  is	  decreased	  in	  overexpression	  lines,	  indicating	  
that	  it	  acts	  as	  a	  negative	  regulator	  of	  growth	  (Disch	  et	  al.,	  2006).	  In	  the	  eod1	   loss	  of	  function	  
mutant,	  the	  enlarged	  organs	  consist	  of	  an	  increased	  number	  of	  wild-­‐type	  sized	  cells,	  which	  is	  a	  
consequence	   of	   a	   prolonged	   duration	   of	   cell	   proliferation	   (Disch	   et	   al.,	   2006).	   eod1	   null	  
mutants	   also	  have	  enlarged	  gynoecia,	  which	  occasionally	   form	  multiple	   carpels	   (Disch	  et	   al.,	  
2006);	  they	  also	  have	  enlarged	  floral	  meristems,	  which	  sometimes	  results	  in	  the	  initiation	  of	  an	  
additional	  petal	   (Yunhai	  Li,	  personal	  communication).	  These	  phenotypes	  are	  strikingly	  similar	  
to	   those	   seen	   for	   da1-­‐1.	   Moreover,	   in	   addition	   to	   sharing	   petal	   size,	   sepal	   size	   and	   stem	  
thickness	   phenotypes,	   both	   mutants	   negatively	   influence	   organ	   growth	   through	   the	   same	  
developmental	  mechanism-­‐	  a	  reduction	  in	  the	  duration	  of	  cell	  proliferation.	  	  
da2-­‐1	   leaves	  and	  petals	  are	  also	  enlarged	  relative	  to	  the	  wild-­‐type,	  with	  the	  enlarged	  organs	  
consisting	  of	  an	  increased	  number	  of	  normally-­‐sized	  cells	  (Xia,	  2013).	  da2-­‐1	  seeds	  are	  heavier	  
that	  wild-­‐type	  seeds,	  and	  have	  a	  size	  distribution	  that	  is	  different	  to	  the	  wild-­‐type	  (more	  larger	  
seeds	  and	  fewer	  smaller	  seeds)	  (Xia,	  2013).	  Interestingly,	  the	  increase	  in	  seed	  size	  is	  maternally	  
controlled	  and	   is	  a	  consequence	  of	  an	   increased	  duration	  of	  proliferation	   in	  the	   integuments	  
(Xia,	   2013).	   This	   is	   analogous	   to	   the	   large-­‐seed	   phenotype	   of	   da1-­‐1	   plants,	   which	   is	   also	  
maternally	  inherited.	  Collectively	  these	  data	  demonstrate	  that	  DA1,	  DA2	  and	  EOD1	  negatively	  
influence	   the	  duration	  of	   cell	  proliferation	  during	  organ	  growth.	  This	   is	   consistent	  with	   their	  
high	  expression	  levels	  in	  proliferating	  tissues	  (Xia,	  2013,	  Li	  et	  al.,	  2008,	  Disch	  et	  al.,	  2006).	  
eod1-­‐2	  and	  da2-­‐1	  do	  not	  genetically	   interact	  with	  each	  other	  to	  control	  organ	  and	  seed	  size,	  
but	   they	   both	   have	   been	   shown	   to	   interact	   synergistically	   with	   da1-­‐1	   to	   influence	   organ	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growth	   (Li	   et	   al.,	   2008,	   Xia,	   2013).	   Taken	   together,	   the	   biochemical,	   cell-­‐biological	   and	  
developmental	   similarities	   shared	   between	   DA1,	   and	   EOD1	   and	   DA2	   suggest	   that	   DA1	  may	  
influence	   the	   activities	   of	   both	   E3	   ligases	   to	   regulate	   organ	   growth.	   Due	   to	   the	   initial	  
characterisation	  being	   carried	   out	  with	   the	  da1-­‐1	  allele	   only,	   it	   is	   not	   possible	   to	   determine	  
whether	  the	  observed	  genetic	  interactions	  are	  with	  DA1	  specifically,	  or	  whether	  they	  are	  with	  
the	  multimeric	  complex	  of	  DA1	  family	  members	  with	  which	  the	  da1-­‐1	  mutation	  is	  predicted	  to	  
interfere.	  In	  order	  to	  elucidate	  this,	  it	  was	  important	  to	  initially	  determine	  genetic	  interactions	  
between	  da2-­‐1	  and	  eod1-­‐2	  ,	  and	  the	  da1ko1	  single	  loss	  of	  function	  mutant.	  
	  
5.2	  –	  DA1	  interacts	  with	  EOD1	  and	  DA2	  
DA1,	  DA2	  and	  EOD1	  are	  all	  negative	  regulators	  of	  growth	  as	  shown	  by	  the	  increased	  organ	  size	  
of	   loss	   of	   function	   mutations	   (Li	   et	   al.,	   2008,	   Xia,	   2013,	   Disch	   et	   al.,	   2006).	   DA1	   interacts	  
synergistically	  with	  both	  EOD1	  and	  DA2	  to	  further	  negatively	  influence	  growth	  (Li	  et	  al.,	  2008,	  
Xia,	  2013),	  suggesting	  that	  they	  may	  work	  in	  a	  common	  mechanism	  in	  which	  one	  may	  enhance	  
the	  function	  of	  the	  other.	  The	  ability	  of	  DA1	  to	  bind	  ubiquitin	  (section	  3.3),	  and	  the	  fact	  that	  
EOD1	  and	  DA2	  encode	  E3	  ligases,	  suggests	  that	  these	  synergic	  genetic	  interactions	  may	  result	  
from	  the	  respective	  proteins	  functioning	  together	  in	  a	  complex.	  	  
5.2.1	  –	  DA1	  genetically	  interacts	  with	  EOD1	  and	  DA2	  to	  influence	  seed	  and	  petal	  size	  
The	  original	  work	  that	  identified	  a	  genetic	  interaction	  between	  DA1	  and	  the	  DA1-­‐interacting	  E3	  
ligases,	   EOD1	   and	   DA2	   (termed	   DIEs)	   was	   performed	   with	   the	   dominant	   negative	   da1-­‐1	  
mutant	  (Xia,	  2013,	  Li	  et	  al.,	  2008).	  Work	  in	  section	  3.2.2	  identified	  that	  the	  dominant	  negative-­‐
interfering	  effect	  of	  this	  allele	  is	  likely	  to	  be	  due	  to	  the	  physical	  interaction	  of	  DA1	  and	  DAR1	  in	  
an	  active	  complex.	  As	  such,	  it	  is	  possible	  that	  the	  DIEs	  interact	  with	  either	  DA1,	  DAR1	  or	  both.	  	  
In	   order	   to	   investigate	   whether	   the	   genetic	   interaction	   is	   with	   DA1	   specifically,	   a	   genetic	  
analysis	  of	  eod1-­‐2	  and	  da2-­‐1	  with	  da1ko1	  (rather	  than	  with	  da1-­‐1)	  was	  carried	  out.	  
5.2.1.1	  –	  da1ko1	  seeds	  and	  petals	  are	  significantly	  larger	  that	  Col-­‐0	  
Seed	  and	  petal	  areas	  were	  measured	  using	  a	  high-­‐resolution	  scanner	  and	  subsequent	  ImageJ	  
analysis	  (see	  section	  2.3.5.1	  for	  details).	  
For	   each	   genotype,	   20	   petals	  were	   collected	   and	   placed	   –	   intact	   –	   on	   transparent	   adhesive	  
tape	  and	  attached	  to	  a	  clean	  polished	  black	  background.	  Petal	  area	  was	  recorded	  using	  a	  high-­‐
resolution	   scanner	   following	   a	   protocol	   adapted	   from	   (Herridge	   et	   al.,	   2011).	   Images	   were	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scanned,	   and	   areas	   were	   calculated	   using	   the	   ImageJ	   image	   analysis	   software	  
(http://rsbweb.nih.gov/ij/links.html).	  
Seed	  areas	  were	  calculated	  using	  a	  similar	  method.	  However,	  due	  to	  their	  smaller	  size	  (relative	  
to	   the	   fixed	   resolution	  of	   the	   scanner)	   the	  number	  of	   seeds	   in	   the	   sample	  was	   increased	   to	  
n>100,	   and	   instead	   of	   adhering	   to	   tape,	   the	   seeds	   were	   scattered	   in	   a	   petri	   dish	   prior	   to	  
scanning.	  
This	  method	  permitted	  extremely	  accurate	  measurements	  and	  was	  much	  more	  precise	   than	  
previous	   seed-­‐size	   analysis	   methods,	   which	   assessed	   differences	   in	   seed	   size	   through	   the	  
distribution	   of	   seed	   size	   (Li	   et	   al.,	   2008,	   Xia,	   2013).	   Instead	  of	   looking	   at	   the	  percentages	   of	  
seeds	   in	   three	   or	   four	   different	   size	   categories,	   this	   method	   directly	   measured	   the	   area	   of	  
individual	  seeds.	  It	  was	  also	  automated	  and	  therefore	  allowed	  the	  high	  throughput	  analysis	  of	  
large	  datasets.	  
For	   these	   reasons,	   this	   analysis	   has	   revealed	   hitherto	   undetected	   phenotypes	   for	   da1ko1	  
single	  knockout	  seeds	  and	  petals.	  Fig.	  5.2	  shows	  that	  da1ko1	  seeds	  (Student’s	  T-­‐test,	  p=0.043)	  
and	   petals	   (Student’s	   T-­‐test,	   p=0.019)	   are	   significantly	   larger	   than	   Col-­‐0.	   This	   result	  
demonstrates	   that	   DA1	   is	   not	   100%	   redundant	   with	   DAR1,	   and	   suggests	   that	   some	   DA1	  
function	  is	  independent	  of	  DAR1.	  Taken	  with	  evidence	  from	  section	  3.2.2	  confirming	  that	  DA1	  
can	  homo-­‐	  and	  hetero-­‐oligomerise,	  these	  data	  suggest	  that	  in	  some	  aspects	  of	  seed	  and	  petal	  
size	  regulation,	  DA1	  might	  function	  as	  a	  homo-­‐oligomer.	  
5.2.1.2	  –	  DA1	  genetically	  interacts	  with	  EOD1	  and	  DA2	  to	  influence	  seed	  and	  petal	  size	  
In	  agreement	  with	  observations	  from	  Dish	  et	  al	  (2006)	  and	  Xia	  et	  al	  (in	  press),	  Fig.	  5.2b	  shows	  
that	  eod1-­‐2	  and	  da2-­‐1	  petals	  are	  significantly	  larger	  than	  Col-­‐0	  (Student’s	  T-­‐test,	  P<0.005).	  The	  
data	  also	  show	  that	  da1ko1/eod1-­‐2	  and	  dako1/da2-­‐1	  petals	  are	  significantly	  larger	  than	  petals	  
of	  eod1-­‐2	  and	  da2-­‐1	  plants	  (Student’s	  T-­‐test,	  P<0.001).	  Importantly,	  the	  increase	  in	  petal	  area	  
(relative	  to	  Col-­‐0)	  in	  da1ko1/eod1-­‐2	  and	  dako1/da2-­‐1	  plants	  is	  significantly	  larger	  than	  that	  of	  
their	  constituent	  single	  mutations	  (Student’s	  T-­‐test,	  p<0.002)	  (Fig.	  5.2e).	  This	  shows	  that	  there	  
is	  a	  synergistic	  interaction	  between	  da1ko1	  and	  eod1-­‐2,	  and	  between	  da1ko1	  and	  da2-­‐1.	  This	  
data	  builds	  on	  earlier	  observations	  that	  the	  DIEs	  synergistically	   interact	  with	  the	  da1-­‐1	  allele,	  
and	  demonstrates	  that	  they	  interact	  with	  DA1	  directly	  to	  set	  petal	  size.	  
eod1-­‐2	  was	  crossed	  with	  dar1	  and	  da1ko1/dar1	  plants	   in	  order	  to	   investigate	  whether	  EOD1	  
also	  genetically	  interacts	  with	  DAR1.	  The	  data	  displayed	  in	  Fig.	  5.2c	  confirm	  that	  in	  addition	  to	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interacting	  with	  da1ko1,	  eod1-­‐2	  interacts	  with	  the	  da1ko1/dar1	  genotype.	  However,	  the	  data	  
also	  reveal	  that	  there	  is	  no	  synergistic	   interaction	  between	  dar1	  and	  eod1-­‐2.	  This	  shows	  that	  
EOD1	   interacts	  specifically	  with	  DA1	  to	  set	  petal	  size,	  and	  that	  the	  observed	   interaction	  with	  
da1-­‐1	  (Li	  et	  al.,	  2008)	  and	  da1ko1/dar1	  is	  dependent	  on	  the	  presence	  of	  a	  da1	  null	  allele.	  
Analysis	  of	   seed	   size	  phenotypes	   (Fig.	  5.2)	   reveals	   that	  EOD1	   and	  DA2	   differentially	   regulate	  
the	  setting	  of	  seed	  and	  petal	  size.	  Unlike	  for	  petals,	  eod1-­‐2	  and	  da2-­‐1	  have	  no	  effect	  on	  seed	  
area.	   	   Interestingly,	   despite	   this	   lack	   of	   phenotype,	   the	   da1ko1/eod1-­‐2	   and	   da1ko1/da2-­‐1	  
double	   mutants	   both	   have	   significantly	   larger	   seeds	   than	   the	   da1ko1	   single	   knockouts.	  
Although	  not	  by	  definition	  a	  synergistic	  interaction,	  these	  data	  do	  appear	  to	  show	  that	  eod1-­‐2	  
and	  da2-­‐1	  enhance	  the	  da1ko1	  seed	  area	  phenotype.	  	  
One	  reason	  for	  the	  different	  influence	  of	  eod1-­‐2	  and	  da2-­‐1	  on	  seed	  and	  petal	  growth	  may	  be	  
the	   dramatically	   different	   development	   of	   these	   organs.	   In	   particular,	   compared	   to	   petals,	  
seeds	  contain	  multiple	  tissue	  types	  and	  are	  developmentally	  influenced	  by	  two	  genotypes	  (see	  
Box.	  1.1).	  This	  developmental	  difference	   is	  supported	  by	  observations	   in	  Fig.	  5e,	  which	  show	  
crosses	   of	   eod1-­‐2	   with	   dar1	   and	   da1ko1/dar1	   plants.	   These	   lines	   showed	   weak	   genetic	  
interactions	   between	   da1ko1	   and	   eod1-­‐2,	   and	   dar1	   and	   eod1-­‐2,	   and	   a	   much	   stronger	  
interaction	  between	  eod1-­‐2	  and	  the	  da1ko1/dar1	  double-­‐knockout	  genotype.	  This	  contrasted	  
with	   the	   petal	   data,	   which	   showed	   that	   almost	   all	   of	   the	   increase	   in	   petal	   area	   in	   the	  
da1ko1/dar1/eod1-­‐2	   triple	   mutant	   was	   due	   to	   the	   da1ko1/eod1-­‐2	   genotype.	   These	  
observations	   suggest	   that	   while	   EOD1	   interacts	   specifically	   with	   DA1	   to	   set	   petal	   size,	   it	  
interacts	  with	  both	  DA1	  and	  DAR1	  to	  set	  seed	  size.	  Based	  on	  observations	  that	  DA1	  and	  DAR1	  
can	   homo-­‐	   and	   hetero-­‐oligomerise	   in	   vitro	   (section	   3.2.2),	   it	   is	   possible	   that	   EOD1	   interacts	  
with	   a	   DA1	   homo-­‐complex	   to	   influence	   petal	   growth,	   and	   a	   DA1-­‐DAR1	   hetero-­‐complex	   to	  
influence	  seed	  growth.	  
These	  data	  show	  that	  DA1	   interacts	  synergistically	  with	  both	  EOD1	  and	  DA2	   in	  the	  setting	  of	  
petal	   size.	   The	   absence	   of	   epistasis	   indicates	   that	   although	   in	   the	   same	   overall	   petal-­‐size	  
regulating	  pathway,	  the	  genes	  are	  not	  in	  a	  linear	  relationship,	  but	  rather	  they	  act	  together	  on	  a	  
common	   target	   or	   in	   a	   common	  pathway.	   Importantly,	   the	   observed	   synergism	   also	   reveals	  
that	   the	   interacting	  partners	   influence	  each	  other	   in	  a	  positive	  manner,	   suggesting	   that	  DA1	  
might	  enhance	  EOD1	  and	  DA2	  function,	  and	  vice	  versa	  (see	  Fig.	  5.11).	  
There	  are	   two	  ways	  of	  explaining	   this	   synergistic,	  enhancing	  phenotype.	  Firstly,	   it	   is	  possible	  
that	  DA1	  and	  the	  DIEs	   function	   in	   ‘parallel’	  pathways	  acting	  on	  a	  common	  target	  and	  do	  not	  
143	  
themselves	   physically	   interact.	   In	   this	  model,	   the	   observed	   genetic	   interaction	  would	   result	  
from	  the	  downstream	  convergence	  of	  the	  two	  pathways,	  and	  the	  enhancing	  effect	  would	  be	  a	  
consequence	   of	   the	   interaction	   of	   downstream	  proteins.	   An	   alternative	  model	   involves	  DA1	  
and	   the	   DIEs	   operating	   at	   the	   same	   step	   in	   a	   pathway	   through	   a	   physical	   interaction	   that	  
enhances	   their	   collective	   function.	   These	  models	   were	   tested	   by	   determining	   if	   there	  were	  






























































































































































































































Figure	  5.2	  –	  Genetic	  interactions	  between	  DA1,	  EOD1	  and	  DA2	  	  
(A-­‐B)	  da1ko1	   interacts	  with	  eod1-­‐2	  and	  da2-­‐1	   to	  regulate	  final	  seed	  (A)	  and	  petal	   (B)	  area.	  (A-­‐E)	  
Data	   are	   presented	   as	   means	   ±	   SE	   and	   significant	   values	   are	   according	   to	   Student’s	   T-­‐test	  
(p<0.05).	  (A)	  da1ko1	  seeds	  are	  significantly	  larger	  than	  Col-­‐0	  (marked	  with	  ‘*’),	  and,	  while	  eod1-­‐2	  
and	   da2-­‐1	   single	   mutants	   are	   not	   significantly	   different	   from	   da1ko1,	   da1ko1/eod1-­‐2	   and	  
da1ko1/da2-­‐1	  seeds	  are	  significantly	  larger	  than	  da1ko1	  (marked	  with	  ‘**’).	  (B)	  da1ko1	  and	  da2-­‐1	  
petals	  are	  significantly	  larger	  than	  Col-­‐0	  (marked	  with	  ‘*’),	  but	  not	  significantly	  different	  from	  one	  
another.	   eod1-­‐2	   petals	   are	   significantly	   larger	   than	   da1ko1	   petals	   (marked	   with	   ‘**’)	   and	  
da1ko1/eod1-­‐2	   petals	   are	   significantly	   larger	   than	   those	  of	   the	  eod1-­‐2	   single	   knockout	   (marked	  
with	   ‘***’).	  da1ko1/da2-­‐1	  petals	  are	   significantly	   larger	   that	  da1ko1	  petals.	   (C)	  eod1-­‐2	   interacts	  
with	   da1ko1	   specifically,	   in	   the	   regulation	   of	   petal	   size.	   da1ko1/eod1-­‐2	   petals	   are	   significantly	  
larger	   that	  eod1-­‐2,	  whereas	  dar1-­‐1/eod1-­‐2	   petals	   are	   smaller	   that	   eod1-­‐2.	  While	  da1ko1/dar1-­‐
1/eod1-­‐2	  petals	  are	  significantly	  larger	  than	  da1ko1/eod1-­‐2	  petals,	  their	  overall	  size	  is	  similar.	  (D)	  
da1ko1,	   dar1-­‐1	   and	   da1ko1/dar-­‐1	   all	   interact	   with	   eod1-­‐2	   to	   regulate	   seed	   area,	   however	  
da1ko1/dar1-­‐1/eod1-­‐2	   seeds	   are	   considerably	   larger	   than	   da1ko1/eod1-­‐2	   and	   dar1-­‐1/eod1-­‐2	  
seeds.	  (E)	  The	  increase	  in	  petal	  area	  (relative	  to	  Col-­‐0)	  in	  the	  double	  mutants	  da1ko1/eod1-­‐2	  and	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Figure	  5.3	  –	  DA1	  interacts	  with	  EOD1	  and	  DA2	  in	  vitro	  
(A)	  E.	   coli	   expressed	  GST-­‐tagged	  bait	  proteins	  were	   incubated	  with	  E.	   coli	   expressed	  HIS-­‐tagged	  
prey	   proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   GST	  
and	   HIS.	   HIS-­‐EOD1	   co-­‐purified	   with	   GST-­‐DA1	   (lane	   3)	   but	   not	   GST-­‐GUS	   (lane	   1).	   (B)	   E.	   coli	  
expressed	   GST-­‐tagged	   bait	   proteins	   were	   incubated	   with	   E.	   coli	   expressed	   FLAG-­‐tagged	   prey	  
proteins	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	   immunoblotting	   for	   GST	   and	  








5.2.2	  –	  DA1	  physically	  interacts	  with	  EOD1	  and	  DA2	  
The	  synergistic	  interactions	  between	  DA1	  and	  both	  DIEs	  suggested	  that	  DA1	  and	  each	  E3	  ligase	  
function	   together	   to	   influence	   seed	   and	   petal	   growth.	   Because	   DA1	   has	   a	   functioning	   UIM	  
domain	  (section	  3.3),	  and	  both	  DA2	  and	  EOD1	  are	  E3	   ligases,	  a	  potential	  physical	   interaction	  
based	  on	  this	  tentative	  biochemical	  association,	  was	  tested.	  	  
5.2.2.1	  –	  DA1	  interacts	  with	  EOD1	  and	  DA2	  in	  vitro	  
To	  test	  a	  possible	  physical	   interaction,	  an	   in	  vitro	  co-­‐immunoprecipitation	  (co-­‐IP)	  was	  carried	  
out	  using	  E.	  coli	  expressed	  recombinant	  proteins.	  To	  assess	  a	  DA1	  -­‐	  EOD1	  interaction,	  GST-­‐DA1	  
was	   incubated	   with	   HIS-­‐EOD1,	   before	   purification	   on	   glutathione	   sepharose	   beads	   and	  
immunoblotting.	  As	  negative	   controls,	  GST-­‐GUS	  was	   incubated	  with	  HIS-­‐EOD1,	   and	  GST-­‐DA1	  
with	  HIS-­‐GUS.	  Fig.	  5.3a	  shows	  that	  while	  there	  was	  no	   interaction	  between	  DA1	  and	  GUS,	  or	  
GUS	  and	  EOD1,	  GST-­‐DA1	  was	  able	  to	  pull	  down	  HIS-­‐EOD1.	  
To	   assess	   a	   possible	   DA1	   -­‐	   DA2	   interaction,	   GST-­‐DA2	   was	   incubated	   with	   FLAG-­‐DA1.	   As	  
negative	   controls,	   GST-­‐GUS	  was	   incubated	  with	   FLAG-­‐DA1,	   and	   GST-­‐DA2	  with	   FLAG-­‐GUS.	   In	  
addition,	  the	  homo-­‐oligomerisation	  of	  DA1	  and	  GUS	  was	  used	  to	  design	  two	  positive	  controls:	  
GST-­‐DA1	   interacting	   with	   FLAG-­‐DA1,	   and	   GST-­‐GUS	   interacting	   with	   FLAG-­‐GUS.	   Fig.	   5.3b	  
showed	  that,	  together	  with	  the	  GUS	  -­‐	  GUS	  and	  DA1	  -­‐	  DA1	  positive	  controls,	  the	  only	  positive	  
interaction	  shown	  by	  pull-­‐down	  was	  between	  GST-­‐DA2	  and	  FLAG-­‐DA1.	  	  
These	  data	  demonstrated	  that	  DA1	  interacts	  with	  both	  EOD1	  and	  DA2	  in	  vitro.	  	  
5.2.2.2	  –	  DA1	  interacts	  with	  EOD1	  and	  DA2	  in	  vivo	  
The	   in	  vitro	  data	  demonstrated	  a	  direct	  physical	   interaction	  between	  DA1	  and	  both	  DIEs	  (see	  
Box	  3.1).	  To	  increase	  the	  biological	  significance	  of	  these	  observations,	  an	  in	  vivo	  assessment	  of	  
the	   interaction	   was	   carried	   out.	   Due	   to	   the	   rapid	   turnover	   of	   DA1	   and	   EOD1	   in	   stable	  
transgenic	   lines	   (Lena	  Stransfeld	  and	  Michael	   Lenhard,	  personal	   communication),	  a	   transient	  
expression	   method	   using	   protoplasts	   and	   split-­‐YFP	   bi-­‐molecular	   fluorescence	  
complementation	  was	  devised	   (see	  Box	  3.1).	   In	   this	   experimental	   system,	  N-­‐terminal	   and	  C-­‐
terminal	  fragments	  of	  YFP	  (YFPn	  and	  YFPc	  respectively)	  were	  fused	  to	  bait	  and	  prey	  proteins,	  
which	  were	  co-­‐transfected	  into	  protoplasts.	  When	  bait	  and	  prey	  proteins	  exist	  in	  close	  contact	  
within	   the	   cell,	   the	   two	   fragments	   of	   YFP	   are	   able	   to	   re-­‐form	   the	   functional	   protein	   and	  
fluoresce.	  YFPn	  was	  fused	  to	  the	  N-­‐terminus	  of	  DA1	  and	  YFPc	  to	  the	  N-­‐terminus	  of	  EOD1	  and	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DA2.	  YFPc	  was	  also	  fused	  to	  the	  N-­‐terminus	  of	  ACLA2	  (ATP-­‐CITRATE	  LYASE2),	  which	  was	  used	  















Fig.	  5.4	  showed	  that	  although	  there	  is	  a	  weak	  background	  interaction	  between	  DA1	  and	  ACLA2,	  
there	  is	  considerably	  stronger	  YFP	  fluorescence	  from	  the	  DA1-­‐EOD1	  and	  DA1-­‐DA2	  treatments.	  
This	  demonstrates	  that	  in	  an	  in	  vivo	  system,	  DA1	  is	  in	  sufficiently	  close	  contact	  with	  EOD1	  and	  
DA2	  for	  the	  YFP	  fragments	  to	  create	  a	  functional	  protein.	  Although	  this	  did	  not	  prove	  that	  DA1	  
and	  the	  DIEs	  could	  form	  direct	  contacts,	  in	  vitro	  evidence	  in	  section	  5.2.2.1	  suggested	  that	  this	  
was	  highly	  likely.	  
Additional	   support	   for	   these	   interactions	   comes	   from	   recent	   transient	   co-­‐IP	   studies	   in	  
Nicotiana	  benthamiana	  by	  Yunhai	  Li	  at	  the	  Chinese	  Academy	  of	  Sciences.	  These	  data	  show	  an	  
interaction	   between	   DA1	   and	   DA2	   (Xia,	   2013),	   and	   between	   DA1	   and	   EOD1	   (personal	  
Figure	  5.4	  –	  DA1	  interacts	  with	  EOD1	  and	  DA2	  in	  vivo	  
A	   protoplast	   split-­‐YFP	   bi-­‐molecular	   fluorescence	   complementation	   assay	   demonstrating	   DA1	  
interacts	  with	   EOD1	   and	   DA2	   in	   vivo.	   Protoplasts	  were	   co-­‐transformed	  with	   bait	   (YFPn-­‐tagged)	  
and	  prey	  (YFPc-­‐tagged)	  constructs.	  Strong	  YFP	  fluorescence	  can	  be	  seen	  in	  YFPn-­‐DA1:YFPc-­‐EOD1	  
and	  YFPn-­‐DA1:YFPc-­‐DA2	  treatments,	  whereas	  only	  a	  weak	  background	  fluorescence	  was	  observed	  
for	  the	  negative	  control	  (YFPn-­‐DA1:YFPc-­‐ACLA2).	  Percentage	  values	  correspond	  to	  the	  percentage	  




communication).	  Taken	  together	  with	  the	  protoplast	  split-­‐YFP	  studies	  and	  the	  in	  vitro	  physical	  
interaction	  data,	  there	  is	  strong	  evidence	  that	  DA1	  and	  DA2,	  and	  DA1	  and	  EOD1	  are	  bona	  fide	  
physically	  interacting	  partners.	  
This	   physical	   interaction	   between	   DA1	   and	   the	   DIEs	   reveals	   that	   the	   synergistic	   genetic	  
interaction	   seen	   in	   section	   5.2.1.2	  may	   be	   a	   consequence	   of	   the	   direct	   physical	   interaction	  
between	  DA1	  and	   the	  E3s.	  This	   suggests	   that	   the	  enhancing	  phenotype	  measured	   in	   section	  
5.2.1.2	   might	   be	   due	   to	   DA1	   directly	   enhancing	   EOD1	   and	   DA2	   function	   and/or	   vice	   versa.	  
Evidence	  that	  DA1	  UIM2	  binds	  mono-­‐ubiquitin	  (section	  3.3)	  and	  evidence	  that	  EOD1	  and	  DA2	  
are	  both	  E3	   ligases	   (Disch	  et	  al.,	  2006,	  Song	  et	  al.,	  2007)	   further	  suggest	   that	   this	  enhancing	  
effect	  may	  involve	  ubiquitin-­‐mediated	  mechanisms.	  In	  humans,	  the	  UIM-­‐containing	  endocytic	  
adaptor	   protein	   EPS15	   is	   regulated	   by	   coupled	  mono-­‐ubiquitination	   (van	   Delft	   et	   al.,	   1997,	  
Woelk	   et	   al.,	   2006)	   and	   therefore	   it	   is	   possible	   that	   DA1	   may	   be	   regulated	   by	   a	   similar	  
ubiquitination	   event	   involving	   its	   cognate	   E3	   ligases;	   EOD1	   and	   DA2.	   Moreover,	   as	   DA1	  
contains	   a	   peptidase	   domain,	   it	   is	   possible	   that	   it	   is	   the	   putative	   peptidase	   activity	   that	   is	  
regulated	   by	   EOD1	   and	   DA2.	   Furthermore,	   and	   perhaps	   revealing	   a	   mutually	   enhancing	  
interaction,	  it	  may	  be	  that	  DA1	  enhances	  EOD1	  and	  DA2	  in	  a	  peptidase-­‐dependent	  manner.	  To	  
test	   these	   hypotheses,	   DA1	   peptidase	   activity	   and	   its	   potential	   regulation	   by	   ubiquitination	  
were	  tested.	  
5.3	  –DA1	  cleaves	  EOD1	  and	  DA2	  in	  a	  ubiquitin	  dependent	  manner	  
In	  vitro	  experimental	  evidence	  has	  shown	  that	  EOD1	  is	  an	  active	  E3	  ligase	  (Disch	  et	  al.,	  2006),	  
and	   that	   DA1	   non-­‐covalently	   interacts	   with	   ubiquitin	   via	   its	   UIMs	   (section	   3.3).	   These	  
established	  links	  to	  the	  ubiquitin	  system	  provide	  a	  starting	  point	  for	  exploring	  and	  defining	  the	  
mechanisms	  by	  which	  DA1	  and	  EOD1,	  and	  DA1	  and	  DA2	  mutually	  enhance	  their	  activities	  as	  
growth	   repressors.	   The	   DA2	   rice	   ortholog,	   GW2	   (GRAIN	   WEIGHT2),	   has	   been	   shown	   to	   be	  
active	  as	  an	  E3	  ligase	  in	  vitro	  (Song	  et	  al.,	  2007),	  but	  there	  was	  no	  evidence	  for	  the	  E3	  activity	  
of	  Arabidopsis	  DA2.	  In	  order	  to	  infer	  a	  mechanistic	  link	  between	  DA1	  and	  DA2	  it	  was	  important	  
to	  first	  assay	  the	  activity	  of	  DA2	  in	  vitro.	  
5.3.1	  –	  DA2	  is	  an	  active	  E3	  ligase	  in	  vitro	  
Ubiquitination	  assays	  were	  carried	  out	   in	  a	  minimal	   in	  vitro	  system	  using	  only	  E1,	  E2,	  E3	  and	  
ubiquitin	  (see	  section	  2.5.4),	  in	  which	  -­‐	  as	  is	  typical	  for	  these	  assays	  -­‐	  the	  ability	  of	  an	  E3	  ligase	  
to	  auto-­‐ubiquitinate	  was	  considered	  to	  be	  evidence	  of	  its	  activity	  (Disch	  et	  al.,	  2006,	  Song	  et	  al.,	  
2007,	   Zhang	   et	   al.,	   2005).	   Commercial	   E1	   activating	   enzyme	   (Human	   UBE1)	   and	   ubiquitin	  
(Human	   recombinant)	   were	   used	   in	   these	   assays.	   Based	   on	   its	   interaction	   and	   activity	   with	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EOD1	  (Disch	  et	  al.,	  2006),	  bacterially	  expressed	  Arabidopsis	  UBC10	  (construct	  kindly	  provided	  
by	  Michael	   Lenhard)	   was	   used	   as	   the	   E2-­‐conjugating	   enzyme	   in	   these	   reactions.	   The	   three	  
enzymatic	  components	  of	  the	  ubiquitin	  system	  were	  incubated	  with	  ubiquitin	  and	  ATP	  before	  
an	  aliquot	  of	  the	  reaction	  was	  subjected	  to	  SDS-­‐PAGE	  and	  immunoblot	  analysis.	  
Fig.	  5.5	  shows	  that	  in	  the	  presence	  of	  E1,	  E2	  and	  ubiquitin,	  high	  molecular	  weight	  (80-­‐140kDa)	  
DA2	   species	   are	   generated	   in	   a	   canonical	   ‘ubiquitin	   smear’.	   These	   high	   molecular	   weight	  
species	  are	  poly-­‐ubiquitinated	  DA2,	  confirming	  that	  DA2	  is	  able	  to	  auto-­‐poly-­‐ubiquitinate.	  The	  
data	   in	   this	   figure	  are	  consistent	  with	   those	   from	  GW2	   (Song	  et	  al.,	   2007),	   and	  confirm	   that	  




5.3.2	  –	  DA1	  cleaves	  EOD1	  in	  a	  ubiquitin-­‐dependent	  manner	  	  
To	   determine	   whether	   DA1	   cleaved	   EOD1,	   an	   ubiquitination	   assay	   was	   performed	   (as	  
described	   in	   section	   5.3.1)	   with	   the	   addition	   of	   purified	   bacterially-­‐expressed	   FLAG-­‐DA1.	   As	  
with	   the	   ubiquitination	   assay	   in	   section	   5.3.1,	   after	   the	   reaction	  was	   terminated,	   an	   aliquot	  
was	   run	   on	   SDS-­‐PAGE	   and	   subjected	   to	   immunoblot	   analysis.	   Consistent	   with	   earlier	  
Figure	  5.5	  –	  Arabidopsis	  DA2	  is	  an	  active	  E3	  ligase	  in	  vitro	  
An	   in	   vitro	   ubiquitination	   assay	   Arabidopsis	   with	   DA2	   as	   the	   E3	   ligase.	   In	   the	   presence	   of	   E1	  
(human	  UBE1),	  E2	  (GST-­‐UBC10)	  and	  ubiquitin,	  DA2-­‐HIS	  catalyses	  the	  formation	  of	  high	  molecular	  




observations	   (Disch	   et	   al.,	   2006)	   in	   the	   presence	   of	   E1,	   E2	   and	   ubiquitin,	   HIS-­‐EOD1	   auto-­‐
ubiquitinated	  (Fig.	  5.6a	  ,	  lane	  1).	  This	  Figure	  also	  shows	  that	  in	  the	  absence	  of	  ubiquitin	  (lanes	  
2	  and	  4)	  HIS-­‐EOD1	  remained	  stable	  (it	  was	  not	  degraded),	  even	  in	  the	  presence	  of	  DA1	  (lane	  4).	  
However,	  in	  the	  presence	  of	  ubiquitin	  and	  DA1	  (lane	  3)	  HIS-­‐EOD1	  was	  no	  longer	  observed	  on	  
the	   blot.	   Surprisingly,	   intermediate	  molecular-­‐weight	   products,	   indicating	   degradation,	  were	  
not	  visible	  in	  western	  blot	  experiments	  that	  used	  anti-­‐HIS	  antibodies	  (to	  detect	  HIS-­‐EOD1).	  As	  
the	  EOD1	  construct	  used	   in	  this	  assay	  had	  an	  N-­‐terminal	  HIS	  tag,	   the	  disappearance	  of	  a	  HIS	  
signal	   from	  the	  blot	   indicated	   that	  either	   the	  entire	  protein	  was	  being	   rapidly	  proteolytically	  
digested,	  or	  that	  there	  was	  a	  single	  N-­‐terminal	  cleavage	  event	  adjacent	  to	  the	  HIS	  tag	  (creating	  
a	   small	  peptide	   that	   ran	  off	   the	  gel).	   In	  order	   to	   investigate	   this	  possibility,	   a	  new	  EOD1-­‐HIS	  
construct	  was	  generated	  with	  a	  HIS	  tag	  at	  the	  C-­‐terminus.	  
With	  both	  DA1	  and	  ubiquitin	  present	  in	  this	  assay	  (Fig.	  5.6b	  lane	  3),	  a	  lower	  molecular	  weight	  
EOD1	   species	   was	   visible,	   which	   had	   lost	   approximately	   10kDa	   from	   its	   N-­‐terminus.	   This	  
showed	  that	  a	  10kDa	  fragment	  was	  cleaved	  from	  the	  N-­‐terminus	  of	  EOD1	  by	  the	  action	  of	  DA1	  
and	  ubiquitin.	  The	  EOD1	  vector	  used	  in	  this	  assay	  (pETnT	  (Fig.	  S1))	  had	  an	  N-­‐terminal	  HA-­‐FLAG-­‐	  
tag	  as	  well	  as	  a	  C-­‐terminal	  HIS-­‐tag.	   Interestingly,	  anti-­‐FLAG	  blots	  did	  not	  detect	  the	  expected	  
10kDa	   fragment	   (data	   not	   shown).	   This	   may	   have	   been	   due	   to	   either	   the	   instability	   of	   the	  
cleaved	  fragment,	  or	  the	  possibility	  of	  it	  adopting	  a	  new	  conformation	  that	  interfered	  with	  the	  
presentation	  of	  the	  N-­‐terminal	  epitope	  tag.	  	  
The	   relatively	   poor	   size	   resolution	   of	   SDS-­‐PAGE	   electrophoresis	   of	   proteins,	   and	   the	  
observation	  that	  EOD1	  electrophoresed	  at	  a	  larger	  molecular	  weight	  than	  predicted	  (which	  is	  
not	  unusual	  (Bocock	  et	  al.,	  2010)),	  meant	  that	  the	  location	  of	  the	  DA1-­‐mediated	  cleavage	  site	  
could	   not	   be	   precisely	   estimated	   using	   the	   resolution	   of	   SDS-­‐PAGE.	   In	   order	   to	   identify	   the	  
precise	  location	  of	  the	  cleavage	  site,	  a	  proteomics	  approach	  was	  taken.	  At	  the	  time	  of	  writing,	  
Edman	   sequencing	   of	   purified	   DA1-­‐cleaved	   EOD1	   has	   identified	   a	   putative	   cleavage	   site	   at	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Figure	  5.6	  –	  DA1	  cleaves	  EOD1	  in	  an	  ubiquitin-­‐dependent	  manner	  
In	  vitro	  ubiquitination	  assays	  with	  DA1	  and	  either	  HIS-­‐EOD1	  (A)	  or	  EOD1-­‐HIS	  (B).	  All	  assays	  include	  
E1	  (GST-­‐UBE1	  (human)),	  E2	  (GST-­‐UBC10)	  and	  ubiquitin.	  (A)	  High	  molecular-­‐weight	  species	  of	  HIS-­‐
EOD1	  (lane	  1)	  reveal	  that	  HIS-­‐EOD1	  is	  poly-­‐ubiquitinated	  in	  ubiquitin	  treatments.	  HIS-­‐EOD1	  is	  
stable	  when	  GST-­‐DA1	  is	  added	  in	  the	  absence	  of	  ubiquitin	  (lane	  4),	  however	  when	  ubiquitin	  and	  
GST-­‐DA1	  are	  both	  included	  in	  the	  reaction	  (lane	  3)	  HIS-­‐EOD1	  is	  no	  longer	  visible	  on	  the	  blot.	  (B)	  
High	  molecular-­‐weight	  species	  of	  EOD1-­‐HIS	  are	  not	  visible	  upon	  ubiquitin	  treatment	  (lane	  1),	  
indicating	  that	  HIS-­‐EOD1	  is	  unable	  to	  auto-­‐ubiquitinate.	  When	  ubiquitin	  and	  GST-­‐DA1	  are	  included	  
in	  the	  reaction	  a	  lower	  molecular-­‐weight	  species	  of	  EOD1-­‐HIS	  appears	  on	  the	  blot;	  this	  truncated	  




As	  discussed	  in	  section	  5.2,	  the	  synergistic	  (enhancing)	  genetic	  interactions	  between	  DA1	  and	  
EOD1	  predicted	  that	  DA1	  may	  enhance	  the	  function	  of	  EOD1.	  It	  is	  therefore	  possible	  that	  the	  
DA1-­‐	   and	   Ubiquitin-­‐mediated	   cleavage	   of	   EOD1	   may	   increase	   the	   activity	   of	   EOD1	   as	   a	  
negative	   regulator	   of	   growth.	   Current	   work	   is	   defining	   the	   specific	   cleavage	   site	   and	   the	  
activities	  of	  cleaved	  EOD1.	  Interestingly,	  there	  are	  some	  highly	  relevant	  examples	  of	  how	  the	  
activities	  of	  E3	  ligases	  are	  controlled	  by	  protein	  cleavage.	  In	  the	  human	  RING	  E3	  ligase	  PARKIN,	  
there	  is	  an	  auto-­‐repressive	  N-­‐terminal	  region	  that	  can	  be	  removed	  through	  cleavage	  (Burchell	  
et	  al.,	  2012,	  Chew	  et	  al.,	  2012).	  An	  alternative	  model	  involves	  proteolytic	  cleavage	  revealing	  or	  
removing	  a	  signal	  peptide,	  resulting	  in	  the	  spatial	  re-­‐localisation	  of	  the	  protein	  in	  a	  mechanism	  
similar	   to	   that	   seen	   in	   the	   human	   PA-­‐TM-­‐RING	   E3	   ligase	   RNF13	   (Bocock	   et	   al.,	   2010)	   (see	  
section	  5.1.2	  for	  a	  detailed	  review	  of	  these	  examples).	  	  
Although	  HIS-­‐EOD1	  is	  an	  active	  E3	  ligase,	  characterised	  by	  its	  ability	  to	  auto-­‐ubiquitinate	  (Fig.	  
5.6a),	  FLAG-­‐EOD1-­‐HIS	  does	  not	  auto-­‐ubiquitinate	  (Fig.	  5.6b).	  While	  surprising,	  this	  observation	  
is	  similar	  to	  that	  of	  Burchell	  et	  al	   (2012)	   in	  their	  study	  of	  the	  E3	   ligase	  PARKIN.	  They	  showed	  
that	   large	   N-­‐terminal	   tags	   (FLAG,	   HA	   etc…)	   were	   sufficient	   to	   de-­‐repress	   PARKIN	   auto-­‐
ubiquitination,	   whereas	   the	   smaller	   HIS	   tag	   was	   unable	   to	   do	   so.	   In	   the	   case	   of	   EOD1,	   it	  
appears	   that	   either	   the	   converse	   is	   true	   (small	   N-­‐terminal	   HIS	   tags	   permit	   E3	   auto-­‐
ubiquitination	   and	   large	  N-­‐terminal	   FLAG-­‐tags	   inhibit	   E3	   auto-­‐ubiquitination	   activity),	   or	   the	  
addition	   of	   a	   C-­‐terminal	   HIS	   tag	   is	   sufficient	   to	   inhibit	   E3	   auto-­‐ubiquitination.	   To	   clarify	   this	  
issue,	  two	  new	  constructs	  (FLAG-­‐EOD1	  and	  EOD1-­‐HIS)	  could	  be	  tested	  for	  auto-­‐ubiquitination.	  
However,	   in	  the	  absence	  of	  this	  data,	  the	  observations	  from	  Fig.	  5.6	  are	  sufficient	  to	  provide	  
evidence	   that	   epitope-­‐tags	   can	   alter	   EOD1	   activity;	   perhaps	   through	   interfering	   with	   auto-­‐
regulatory	  protein	  conformations.	  This	  would	   suggest	   that	  EOD1,	   in	  a	   similar	  way	   to	  PARKIN	  
(Burchell	  et	  al.,	   2012),	  may	  have	  an	   inhibitory	  protein	   conformation	   that	   is	   relieved	  by	  DA1-­‐
mediated	   cleavage.	   The	   experiments	   reported	   here	   strongly	   support	   a	   role	   for	   peptidase-­‐
mediated	  cleavage	  of	  EOD1	  by	  DA1	  as	  a	  mechanism	  for	  controlling	  its	  activity.	  A	  key	  question	  
is	   whether	   DA1-­‐mediated	   cleavage	   increases	   its	   activity	   towards	   other	   substrates,	   and/or	  
changes	  substrate	  specificity.	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Having	  established	  a	  promising	  mechanism	  by	  which	  DA1	  and	  ubiquitin	  may	  modulate	  EOD1	  
activity,	  the	  genetic	  analysis	  in	  section	  5.2.1	  predicts	  an	  enhancing	  interaction	  in	  which	  the	  E3	  
ligases	  EOD1	  and	  DA2	  may	  also	  activate	  or	  enhance	  DA1	  function.	  The	  observation	  that	  DA1	  
cleaved	   EOD1	   in	   an	   ubiquitin-­‐dependent	   manner	   suggested	   that	   DA1	   may	   be	   activated	   by	  
EOD1-­‐mediated	  ubiquitination.	  Therefore,	  the	  activity	  of	  the	  EOD1	  and	  DA2	  E3	  ligases	  towards	  
DA1	  was	  tested	  in	  vitro.	  	  
5.3.3	  –	  EOD1	  and	  DA2	  (but	  not	  BBR)	  ubiquitinate	  DA1	  in	  vitro	  
To	   test	   the	   hypothesis	   that	   the	   interactions	   of	   EOD1	   and	   DA2	   with	   DA1	   may	   lead	   to	   DA1	  
ubiquitination,	  ubiquitination	  assays	  incorporating	  E1,	  E2,	  the	  E3	  ligases	  HIS-­‐EOD1	  or	  DA2-­‐HIS,	  
and	   FLAG-­‐DA1	  were	   performed.	   Aliquots	   of	   the	   reactions	   were	   subjected	   to	   SDS-­‐PAGE	   and	  
immunoblot	   analysis	   to	   detect	   DA1	   modifications.	   To	   test	   the	   specificity	   of	   DA1-­‐E3	   ligase	  
reactions,	   the	   E3	   ligase	   BBR	   (BIG	   BROTHER	   RELATED,	   AT3G19910)	   was	   used	   as	   a	   negative	  
control.	  BBR	  is	  the	  most	  similar	  E3	  ligase	  to	  EOD1	  based	  on	  protein	  sequence	  (Fig.	  S4b),	  and	  is	  
an	  active	  E3	  ligase	  in	  vitro	  (Fig.	  S4a).	  	  
Fig.	  5.7	  shows	  that	  in	  the	  presence	  of	  EOD1	  and	  DA2	  (lanes	  5	  and	  6),	  DA1	  is	  ubiquitinated.	  It	  
also	  clearly	  shows	  that	  BBR	  (lane	  7)	  does	  not	  cause	  DA1	  ubiquitination.	  This	  demonstrates	  that	  
DA1	  is	  ubiquitinated	  by	  EOD1	  and	  DA2	  specifically,	  and	  that	  DA1	  is	  not	  a	  non-­‐specific	  target	  for	  
E3	  ligases.	  Interestingly,	  the	  ubiquitination	  patterns	  catalysed	  by	  EOD1	  and	  DA2	  are	  noticeably	  
dissimilar.	   EOD1	   catalyses	   the	   addition	  of	   approximately	   3	   to	   6	  ubiquitin	  molecules	  on	  DA1,	  
whereas	  DA2	   catalyses	   the	   addition	   of	   only	   1	   to	   3	   ubiquitin	  molecules	   on	  DA1.	   It	   is	   unclear	  
whether	   these	   modifications	   are	   functionally	   distinct.	   The	   ubiquitin	   modifications	   could	   be	  
short	  chains	   linked	  to	  a	  single	   lysine	  residue,	  or	  could	  be	  single	  ubiquitin	  molecules	   linked	  to	  
several	   different	   DA1	   lysine	   residues.	   The	   latter	   modifications	   are	   typical	   of	   ubiquitination	  
events	  that	  regulate	  protein	  activities	  (Woelk	  et	  al.,	  2006,	  Hoeller	  et	  al.,	  2006)).	  	  
Combined	  with	   the	   ubiquitin	   dependence	   of	   DA1	   function	   seen	   in	   section	   5.3.2,	   these	   data	  
suggest	  that	  DA1	  cleavage	  of	  EOD1	  could	  be	  activated	  by	  ubiquitination.	  To	  test	  this	  prediction	  
it	  was	  important	  to	  confirm	  that	  as	  well	  as	  being	  necessary	  for	  activation,	  DA1	  ubiquitination	  
was	   sufficient	   to	   stimulate	   the	   activity	   of	   the	   peptidase.	   To	   do	   this,	   ubiquitinated	   DA1	  was	  








- - - + + + +
- - + - - - +
- + - - - + - 
+ - - - + - - 








GST-DA1    
GST-DA1    
α-HIS 
DA2-HIS    
HIS -EOD1 














Figure	  5.7	  –	  EOD1	  and	  DA2	  ubiquitinate	  DA1	  in	  vitro	  
Ubiquitination	  reactions	  were	  run	  with	  E1	  (UBE),	  E2	  (UbcH5b),	  ubiquitin,	  GST-­‐DA1	  and	  either	  HIS-­‐
EOD1,	  DA2-­‐HIS	  or	  BBR-­‐HIS.	  Following	  EOD1	  and	  DA2	  treatments,	  high	  molecular-­‐weight	  species	  of	  
GST-­‐DA1	  are	  visible	  on	  the	  blot,	  revealing	  that	  GST-­‐DA1	  is	  ubiquitinated.	  Treatment	  with	  BRR	  does	  
not	  result	  in	  ubiquitination	  of	  GST-­‐DA1.	  This	  indicates	  that	  DA1	  is	  not	  a	  general	  target	  of	  E3	  ligase	  
activity.	  A	  lower	  molecular	  weight	  band	  that	  co-­‐purifies	  from	  E.	  coli	  with	  DA2-­‐HIS	  can	  be	  seen	  in	  
lanes	  2	  and	  6.	  This	  is	  thought	  to	  be	  due	  to	  an	  ectopic	  translational	  event	  from	  an	  intragenic	  ATG	  





5.3.4	  –	  Ubiquitinated	  DA1	  is	  sufficient	  to	  specifically	  cleave	  EOD1	  and	  DA2	  
5.3.4.1	  –	  Ubiquitinated	  DA1	  is	  sufficient	  to	  specifically	  cleave	  EOD1	  and	  DA2	  in	  vitro	  
To	   test	   the	   activity	   of	   ubiquitinated	   DA1	   (DA1-­‐ub)	   in	   cleaving	   EOD1	   or	   DA2,	   DA1-­‐ub	   was	  
purified	  and	  added	  to	  a	  reaction	  containing	  only	  EOD1	  or	  DA2	  E3	  ligase.	  	  In	  order	  to	  synthesise	  
DA1-­‐ub,	  an	  ubiquitination	  reaction	  containing	  E1,	  E2,	  HIS-­‐EOD1	  and	  FLAG-­‐DA1	  was	  carried	  out,	  
followed	  by	  immunopurification	  of	  DA1	  using	  α-­‐FLAG	  beads.	  This	  method	  also	  co-­‐purifies	  non-­‐
ubiquitinated	  DA1	  (see	  Fig.	  5.7),	  but	  due	  to	  the	  high	  activity	  of	  DA1-­‐ub,	  this	  did	  not	  alter	  the	  
interpretation	  of	  data.	  The	  experimental	  set-­‐up	  was	  designed	  to	  compare	  the	  activities	  of	  DA1-­‐
ub	   and	   non-­‐ubiquitinated	   DA1.	   In	   addition,	   it	   tested	   a	   possible	   role	   for	   the	   DA1	   peptidase	  
domain	   in	   the	   cleavage	   of	   EOD1	   and	   DA2.	   This	   was	   done	   by	   mutating	   the	   conserved	   zinc-­‐
coordinating	   histidines	   (to	   alanines)	   in	   the	   peptidase	   active	   site	   (see	   section	   3.1.3).	   These	  
changes	   resulted	   in	   the	   conversion	  of	   the	   conserved	  HEMMH	  domain	   to	  AEMMA,	  and	  were	  
predicted	  to	  abrogate	  peptidase	  function	  (McGwire	  and	  Chang,	  1996,	  Zhang	  et	  al.,	  2001).	  The	  
resulting	  mutant	  version	  of	  FLAG-­‐DA1	  was	  termed	  DA1pep	  and	  was	  ubiquitinated	  and	  purified	  
as	  described	  above.	  Finally,	  to	  test	  the	  specificity	  of	  DA1	  function	  on	  EOD1	  and	  DA2,	  a	  negative	  
control	  of	  BBR	  was	  included	  in	  the	  assay.	  
Fig.	  5.8	  shows	  that	  purified	  FLAG-­‐DA1-­‐ub	  was	  sufficient	  to	  cleave	  EOD1	  and	  DA2	  (lanes	  1	  and	  
2),	  whereas,	  neither	  DA1	  nor	  DA1pep-­‐ub	  was	  able	  to	  do	  so	  (lanes	  4,5,7	  and	  8).	  DA2	  was	  cleaved	  
resulting	   in	  an	  approximately	  17kDa	  DA2-­‐HIS	  product.	  The	   lack	  of	  activity	  of	  DA1-­‐ub	  towards	  
BBR	  (lane	  3)	  suggested	  that	  DA1-­‐ub	  is	  specifically	  active	  towards	  the	  EOD1	  and	  DA2	  RING	  E3	  
ligases.	  	  
In	  Fig.	  5.7	  and	  Fig.	  5.8	  ,	  E.coli	  expressed	  DA2	  has	  a	  lower	  molecular-­‐weight	  band	  (35kDa)	  that	  
co-­‐purifies	  with	  DA2	  (Fig.	  5.8	  lanes	  2,5	  and	  8).	  This	  band	  cross-­‐reacts	  with	  α-­‐HIS	  and	  is	  likely	  to	  
be	  an	  ectopic	  translational	  event	  from	  an	  intragenic	  ATG.	  In	  order	  to	  remove	  this	  band	  and	  to	  
further	  confirm	  the	  validity	  of	  DA1ub-­‐mediated	  cleavage	  activities,	   this	  assay	  was	  also	  carried	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Figure	  5.8	  –	  Ubiquitinated	  DA1	  is	  sufficient	  to	  cleave	  EOD1	  and	  DA2	  in	  vitro	  
Purified	   FLAG-­‐DA1,	   FLAG-­‐DA1-­‐ub	   (ubiquitinated	   DA1)	   and	   FLAG-­‐DA1pep-­‐ub	   (ubiquitinated	   DA1	  
peptidase	   mutant)	   was	   added	   to	   a	   reaction	   containing	   EOD1,	   DA2,	   or	   BBR.	   Only	   DA1-­‐ub	   was	  
sufficient	  to	  cleave	  EOD1	  (lane	  1)	  and	  DA2	  (lane	  2),	  and	  no	  treatments	  resulted	  in	  the	  cleavage	  of	  
BBR.	   A	   lower	  molecular	  weight	   band	   that	   co-­‐purifies	   from	   E.	   coli	   with	   DA2-­‐HIS	   can	   be	   seen	   in	  
lanes	  2,5	  and	  8.	  This	  is	  thought	  to	  be	  due	  to	  an	  ectopic	  translational	  event	  from	  an	  intragenic	  ATG	  
(see	  section	  5.3.4.1	  for	  further	  discussion).	  More	  complete	  cleavage	  of	  EOD1	  and	  DA2	  by	  DA1-­‐Ub	  




5.3.4.2	  –	  DA1	  specifically	  cleaves	  EOD1	  and	  DA2	  in	  Arabidopsis	  protoplasts	  
Due	   to	   the	   instability	   of	   EOD1	   in	   stable	   transgenic	   systems	   (Lena	   Stransfeld,	   personal	  
communication),	  transient	  expression	  systems	  were	  used	  for	  the	   in	  vivo	  investigation.	  Guided	  
by	   the	   success	   of	   expressing	   EOD1-­‐YFP	   and	   DA2-­‐YFP	   fusions	   in	   Arabidopsis	   mesophyll	  
protoplasts	   for	   BiFC	   analysis	   (section	   5.2.2.2),	   a	   protoplast	   system	  was	   used	   to	   assess	   DA1-­‐
dependent	  cleavage	  of	  EOD1	  and	  DA2	  in	  vivo.	  
To	   ensure	   that	   any	   observed	   cleavage	   of	   EOD1	   and	   DA2	   was	   dependent	   on	   added	   DA1	  
proteins,	  da1ko1/dar1	  protoplasts	   that	   lacked	  DA1	  and	  DAR1	  protein	  were	  used	   in	   the	  PEG-­‐
mediated	   co-­‐transfection	   experiments.	   	   Protoplasts	   were	   transfected	   with	   HA-­‐DA1	   or	   HA-­‐
DA1pep,	  and	  with	  C-­‐terminal	  FLAG-­‐tagged	  E3	  ligases	  EOD1,	  DA2	  or	  BBR.	  BBR	  was	  included	  as	  a	  
negative	  control	  to	  test	  the	  specificity	  of	  DA1	  towards	  EOD1	  and	  DA2.	  Fig.	  5.10	  shows	  that	  in	  
HA-­‐DA1	   transfected	  protoplasts,	   lower-­‐molecular	  weight	   cleavage	  products	  of	  EOD1	   (lane	  1)	  
and	   DA2	   (lane	   3)	   are	   produced	   (as	   in	   in	   vitro	   experiments	   (Figure	   5.8)).	   In	   contrast,	   these	  
cleavage	  products	  were	  not	  seen	   in	  DA1pep	  treatments	  (lanes	  2	  and	  4).	  Fig.	  5.10	  also	  showed	  
that	  BBR	  was	  not	  cleaved	  by	  DA1	  (lane	  5),	  confirming	  that	  DA1	  has	  specificity	  towards	  EOD1	  
and	  DA2.	  
In	  this	  experiment,	  all	  the	  E3	  ligases	  were	  tagged	  with	  a	  C-­‐terminal	  FLAG	  tag.	  Analysis	  of	  Fig.	  
5.10	   reveals	   that,	   in	   contrast	   to	   the	   N-­‐terminal	   cleavage	   of	   EOD1,	   DA2	   was	   cleaved	  
approximately	   20kDa	   from	   its	   C-­‐terminus.	   The	   FLAG	   epitope	   tag	   is	   approximately	   3kDa	  
suggesting	  that	  DA2	  was	  cleaved	  approximately	  17kDa	  from	  its	  C-­‐terminus.	  However,	  as	  DA2	  
has	  an	  N-­‐terminal	  RING	  domain	  and	  EOD1	  has	  a	  C-­‐terminal	  RING	  domain,	  both	  cleavage	  events	  
create	  proteins	  that	  contain	  an	  intact	  RING	  domain.	  	  
Taken	  together,	  the	  in	  vitro	  and	  in	  vivo	  data	  confirmed	  that	  DA1	  is	  a	  functional	  peptidase	  that	  
is	  activated	  by	  ubiquitination	  mediated	  by	  the	  E3	  ligases,	  EOD1	  and	  DA2.	  Interestingly,	  the	  E3	  
ligases	  required	  for	  the	  activation	  of	  DA1	  were	  those	  that	  are	  the	  targets	  of	  the	  peptidase.	  This	  
mutual	   dependence	   suggests	   a	   model	   in	   which	   EOD1	   and	   DA2	   activate	   the	   DA1	   peptidase	  
through	   ubiquitination.	   This	   peptidase	   then	   cleaves	   the	   E3	   ligases	   to	   create	   new	   truncated	  
proteins	   (Fig.	  5.12).	  The	  observed	  synergistic	  genetic	   interactions	   (section	  5.2.1)	  suggest	   that	  
these	   truncated	   E3	   ligases	   have	   new	   or	   increased	   activities	   with	   respect	   to	   inhibiting	   cell	  
proliferation	  during	  organ	   formation	   (Disch	  et	  al.,	  2006,	  Xia,	  2013,	  Song	  et	  al.,	  2007).	  Such	  a	  
novel	   feed-­‐forward	   mechanism,	   whereby	   E3	   ligases	   stimulate	   their	   activation	   through	  





































Figure	  5.9	  –DA1	  cleaves	  EOD1	  and	  DA2	  in	  vivo	  
Western	  blot	   from	  da1ko1/dar1-­‐1	   protoplasts	   co-­‐transfected	  with	  either	  EOD1-­‐FLAG,	  DA2-­‐FLAG	  
or	   BBR-­‐FLAG,	   and	   one	   of	   either	  HA-­‐DA1pep	   or	  HA-­‐DA1.	   In	  HA-­‐DA1	   treatments	   EOD1-­‐FLAG	   and	  
DA2-­‐FLAG	   are	   cleaved	   to	   reveal	   their	   truncated	   species	   (lanes	   1	   and	   3,	   respectively).	   Longer	  
exposure	  was	  required	  to	  visualise	   truncated	  DA2-­‐FLAG.	  HA-­‐DA1	  treatments	  were	  not	  sufficient	  
to	  cleave	  BBR-­‐FLAG,	  suggesting	  specificity	  towards	  EOD1	  and	  DA2.	  	  HA-­‐DA1pep	  treatments	  were	  
not	  sufficient	   to	  cleave	  EOD1-­‐FLAG	  and	  DA2-­‐FLAG,	  revealing	  that	   the	  DA1	  peptidase	   is	  essential	  




may	  have	  a	  more	  widespread	  role	   than	   just	  controlling	  E3	   ligase	  activity	   in	   the	   regulation	  of	  
cell	   proliferation	   in	   Arabidopsis.	   Given	   that	   the	   activity	   of	   the	   Human	   E3	   ligase	   PARKIN	   is	  
influenced	  by	  an	  N-­‐terminal	  cleavage	  event	  (Chew	  et	  al.,	  2012),	   it	   is	  also	  possible	  that	  such	  a	  
mechanism	  may	  also	  be	  relevant	  for	  the	  control	  of	  E3	  ligase	  activity	  in	  other	  organisms.	  	  
A	   peptidase-­‐mediated	   activation	   of	   an	   E3	   ligases	   would	   probably	   be	   an	   irreversible	  
modification,	   leading	   to	   increased	  and/or	  different	  activities	  of	   the	  E3.	   It	   is	  possible	   that	   the	  
observed	   auto-­‐ubiquitination	   of	   the	   E3	   ligases	   (Fig.	   5.5	   &	   5.6)	   may	   also	   be	   an	   additional	  
mechanism	   for	   regulating	   E3	   ligase	   activities.	   For	   example,	   this	   could	   be	   K48	   linked	   poly-­‐
ubiquitination	  leading	  to	  proteasome-­‐	  mediated	  degradation.	  The	  short	  half-­‐lives	  of	  EOD1	  and	  
DA2	   in	   plant	   cells	   suggests	   a	   rapid	   turnover	   consistent	   with	   ubiquitin-­‐directed	   proteasome-­‐
mediated	  degradation.	   In	  order	   to	   investigate	   this,	   an	   in	   vitro	   study	  of	   EOD1	  and	  DA2	  auto-­‐
ubiquitination	  was	  undertaken.	  
5.4	  –	  EOD1	  and	  DA2	  are	  ubiquitinated	  differently	  
Understanding	  poly-­‐ubiquitin	  chain	  architecture	  can	  reveal	  whether	  the	  chain	  is	  likely	  to	  be	  a	  
signal	   for	   proteasome-­‐mediated	   destruction	   or	   to	   provide	   another	   function.	   The	   two	   most	  
common	  poly-­‐ubiquitin	  chain	  linkage	  types	  are	  K48	  and	  K63	  (Saracco	  et	  al.,	  2009);	  	  K48	  –linked	  
ubiquitin	  chains	  have	  a	  well-­‐established	   role	   in	   targeting	  proteins	   for	  proteasome-­‐	  mediated	  
destruction	   (Hershko	   and	   Ciechanover,	   1998,	   Jacobson	   et	   al.,	   2009,	   Thrower	   et	   al.,	   2000).	  
Conversely,	  there	  is	  no	  consensus	  as	  to	  the	  role	  of	  K63-­‐linked	  ubiquitin	  chains,	  however	  there	  
is	   evidence	   that	   they	   are	   involved	   in	   enzyme	   activation	   (Cheng	   et	   al.,	   2013b)	   and	   receptor	  
signalling	   (Kawai	   and	  Akira,	   2010).To	   identify	   the	   types	  of	  ubiquitin	   linkages	   created	  by	  DA2	  
and	  EOD1	  auto-­‐ubiquitination,	  ubiquitination	  assays	  (see	  section	  5.3.1)	  were	  performed	  using	  
recombinant	  ubiquitin	  molecules	  with	  these	  K48	  or	  K63	  residues	  mutated	  to	  arginine.	  	  
Fig.	   5.10a	   shows	   that	   in	   ubiquitination	   assays	   using	   wild-­‐type	   and	   K63R	   ubiquitin	   (UbK63),	  
auto-­‐ubiquitination	  of	  EOD1	  resulted	  in	  a	  typical	  ‘ubiquitin	  smear’	  (lanes	  8	  and	  10).	  In	  contrast,	  
the	   use	   of	   K48R	   ubiquitin	   (UbK48)	   created	   only	   three	   EOD1-­‐ubiquitin	   bands	   (lane	   9).	   These	  
likely	   represent	  either	  a	  single	   triple-­‐ubiquitin	  chain	  or	   three	  mono-­‐ubiquitination	  events.	  To	  
distinguish	   between	   these	   possibilities,	   ubiquitination	   assays	   were	   performed	   using	  
methylated	  ubiquitin	  (Ub-­‐Me),	  which	  has	  all	  lysine	  residues	  methylated	  and	  as	  a	  consequence	  
is	  unable	  to	   form	  ubiquitin	  polymers.	  Fig.	  11b	  shows	  that	  when	  Ub-­‐Me	   is	  used	  (lane	  6),	  only	  
mono-­‐ubiquitinated	  EOD1	  is	  generated;	  revealing	  that	  EOD1	  is	  ubiquitinated	  at	  one	  site	  only.	  
This	  indicated	  that	  the	  three	  ubiquitinated	  species	  of	  EOD1	  in	  the	  UbK48	  treatment	  in	  Fig.	  11a	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Figure	  5.10	  –EOD1	  and	  DA2	  auto-­‐ubiquitination	  patterns	  
Ubiquitination	  reactions	  were	  run	  with	  E1	  (UBE	  (human)),	  E2	  (GST-­‐UBC10),	  and	  either	  HIS-­‐EOD1	  
or	  DA2-­‐HIS.	  The	  reactions	  included	  either	  wild-­‐type	  ubiquitin	  (Ub),	  ubiquitin	  mutated	  at	  lysine	  48	  
(UbK48),	   ubiquitin	   mutated	   at	   lysine	   63	   (UbK63)	   or	   methylated	   ubiquitin	   (Ub-­‐Me).	   (A)	   When	  
UbK48	  is	  used	  in	  the	  reaction,	  EOD1	  is	  unable	  to	  auto-­‐ligate	  more	  than	  three	  ubiquitin	  molecules	  
(lane	   9),	   suggesting	   that	   the	   majority	   of	   EOD1	   auto-­‐poly-­‐ubiquitin	   is	   linked	   through	   lysine	   48.	  
When	  UbK63	  is	  used	  in	  the	  reaction,	  the	  intensity	  of	  DA2-­‐HIS	  auto-­‐ubiquitination	  is	  reduced	  (lane	  
7),	  suggesting	  that	  DA2	  may	  be	  capable	  of	  forming	  K63-­‐linked	  auto-­‐poly-­‐ubiquitin.	  (B)	  When	  Ub-­‐
Me	  is	  used	  in	  a	  reaction	  with	  HIS-­‐EOD1,	  EOD1	  is	  only	  able	  to	  auto-­‐mono-­‐ubiquitinate,	  suggesting	  





These	   data	   showed	   that	   EOD1	   auto-­‐ubiquitination	   involves	   the	   formation	   of	   a	   K48-­‐linked	  
ubiquitin	   chain	   that	  may	   target	   EOD1	   for	   proteasome-­‐mediated	   destruction	   (Thrower	   et	   al.,	  
2000).	  The	  analyses	  also	  showed	  that	  although	  the	  majority	  of	  the	  poly-­‐ubiquitin	  chain	  is	  K48	  
linked,	  a	  short	  tri-­‐ubiquitin	  chain	  is	  able	  to	  be	  formed	  through	  an	  alternative	  linkage.	  Currently	  
the	   significance	  of	   this	   observation	   is	   not	   known,	   however,	   the	   auto-­‐ubiquitination	  of	   EOD1	  
with	  K48-­‐linked	  poly-­‐ubiquitin	  suggests	  a	  mechanism	  in	  which	  it	  promotes	  its	  own	  instability.	  It	  
is	   intriguing	   to	   speculate	   that	  DA1-­‐mediated	   cleavage	  of	   EOD1	  may	   influence	   its	   stability	   by	  
altering	   its	  auto-­‐ubiquitination.	  This	   could	  be	   tested	  by	   investigating	   the	  nature	  of	   the	  auto-­‐
poly-­‐ubiquitin	  ligated	  by	  the	  cleaved	  version	  of	  EOD1.	  
In	  contrast	  to	  the	  data	  for	  EOD1	  ubiquitination	  described	  above,	  UbK48	  had	  no	  effect	  on	  DA2	  
auto-­‐ubiquitination	   (Fig.	   5.10	   lane	   6).	   This	   showed	   that	   unlike	   EOD1,	   DA2	   does	   not	   auto-­‐
catalyse	   K48-­‐linked	   poly-­‐ubiquitin	   chains.	   The	   assay	   also	   showed	   that	   UbK63	   reduced	   the	  
degree	  of	  auto-­‐ubiquitination	   (lane	  7),	   suggesting	   that	  DA2	  poly-­‐ubiquitin	  chains	  can	  be	  part	  
K63-­‐linked	  and	  part	  an	  alternative	  linkage.	  These	  observations	  imply	  that	  the	  suggested	  model	  
for	   EOD1	   ‘stabilisation’	   through	   interference	   with	   K48	   chain	   formation,	   is	   not	   applicable	   to	  
DA2.	   It	  also	  suggests	  that,	   if	  DA1	  is	  assumed	  to	  regulate	  both	  E3	   ligases	   in	  the	  same	  fashion,	  
the	   model	   for	   activation	   of	   EOD1	   through	   stabilisation	   (with	   regards	   to	   proteasome	  
degradation)	  is	  also	  unlikely	  to	  be	  valid.	  	  
The	  observation	  that	  EOD1	  promotes	   its	  own	  instability	  through	  auto-­‐ubiquitination	  suggests	  
that	  its	  abundance	  and	  functions	  are	  tightly	  regulated.	  This	  indicates	  that	  it	  may	  be	  involved	  in	  
regulating	  rapid,	  or	  time-­‐bound	  cellular	  processes,	  and	  that	  its	  activity	  may	  be	  damaging	  if	  it	  is	  
not	  tightly	  controlled.	  This	   is	  consistent	  with	  the	  model	  of	  DA1-­‐mediated	  protein	  cleavage	  of	  
EOD1,	  which	   is	  a	  one-­‐way	  switch	  that	  drives	  the	  coordinated	  formation	  of	  EOD1	  and	  DA2	  E3	  
ligases	   that	   may	   have	   altered	   behaviours.	   Identifying	   putative	   targets	   of	   EOD1-­‐	   and	   DA2-­‐	  
mediated	  ubiquitination,	  in	  addition	  to	  DA1,	  is	  therefore	  a	  high	  priority.	  	  
5.6	  –	  Discussion	  
Research	   in	   this	   chapter	   has	   defined	   a	   novel	   mutually	   enhancing	   regulatory	   relationship	  
between	   two	   RING	   E3	   ligases	   that	   control	   growth	   through	   independent	   pathways,	   and	   a	  
cognate	   specific	   peptidase	   that	   is	   predicted	   to	   alter	   their	   activity	   in	   a	   coordinated	   and	   uni-­‐
directional	  manner.	  This	   is	  predicted	  to	  enhance	  and/or	  alter	   the	  activity	  of	   the	  E3s	   towards	  
unknown	   substrates	   that	   mediate	   cell	   proliferation	   and	   set	   final	   organ	   size.	   Fig.	   5.12	   is	   a	  
schematic	  representation	  of	  this	  regulatory	  system,	  where	  EOD1/DA2	  activation	  of	  DA1	  results	  
in	  their	  peptidase-­‐mediated	  cleavage	  and	  the	  possible	  modification	  of	  their	  activity.	  The	  ‘feed-­‐
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forward’	   aspect	   of	   this	   model	   implies	   that	   upon	   initiation	   (i.e.	   activation	   of	   DA1	   peptidase	  
activity)	  the	  process	   is	   irreversible.	   	  This	  suggests	  that	  DA1	  functions	  as	  a	   ‘molecular	  ratchet’	  
that	  ensures	  rapid	  and	  unidirectional	  decision-­‐making	  in	  a	  similar	  way	  to	  checkpoint	  decision-­‐
















Figure	   5.11	   –	   Together,	   DA1	   and	   EOD1	   and	   DA2	   collectively	   enhance	   their	   effect	   as	   growth	  
repressors	  	  
Model	  illustrating	  the	  enhancing	  relationship	  between	  DA1	  and	  the	  E3	  ligases,	  EOD1	  and	  DA2.	  All	  
three	  proteins	  are	  negative	  regulators	  of	  the	  duration	  of	  cell	  proliferation	  in	  the	  developing	  organ.	  
Genetic	  analysis	  predicts	  that	  when	  DA1	  and	  EOD1	  (or	  DA2)	  are	  both	  present,	  their	  collective	  role	  




5.6.1	  –	  DA1	  peptidase	  activity	  is	  activated	  by	  ubiquitination	  
Genetic	  analysis	   in	   section	  5.2.1	  predicted	   that	  EOD1	  and	  DA2	  act	   to	  enhance	  DA1	   function.	  
This	  was	  confirmed	  by	  observations	  that	  ubiquitination	  of	  DA1	  by	  EOD1	  is	  sufficient	  to	  activate	  
the	  DA1	  peptidase	  (section	  5.3).	  The	  mechanism	  of	  activation	  is	  unclear,	  however	  the	  presence	  
of	   an	  active	  UIM	  domain	   in	  DA1	   (section	  3.3)	   suggests	   that	   it	  may	  be	   through	  a	  mechanism	  
similar	  to	  that	  of	  coupled	  mono-­‐ubiquitination,	  such	  as	  in	  EPS15.	  The	  ubiquitination	  of	  EPS15	  is	  
dependent	  on	   the	   interaction	  of	   the	  EPS15-­‐UIM	  with	  a	  ubiquitinated	  E3	   ligase	   (Woelk	  et	  al.,	  
2006).	  This	  suggests	  that	  ubiquitination	  of	  DA1	  may	  involve	  the	  UIM	  targeting	  DA1	  to	  the	  auto-­‐
ubiquitinated	  EOD1/DA2.	  	  
The	   observation	   that	   non-­‐ubiquitinated	   DA1	   does	   not	   exhibit	   peptidase	   activity	   -­‐	   at	   least	  
towards	  EOD1	  and	  DA2	  -­‐	  suggested	  that	  the	  non-­‐ubiquitinated	  form	  of	  DA1	  exists	  in	  an	  auto-­‐
repressive	  state.	  Studies	  of	  coupled	  mono-­‐ubiquitination	  have	  led	  to	  the	  suggestion	  that	  UIM	  
binding	  to	  ubiquitin	  in	  cis	  can	  lead	  to	  major	  conformational	  changes	  (Hicke	  et	  al.,	  2005),	  which	  
could	   in	   turn	   alter	   the	   activity	   of	   the	   protein.	   It	   is	   therefore	   possible	   to	   speculate	   that	  UIM	  
interactions	  with	   cis-­‐ubiquitin	  would	   be	   sufficient	   to	   activate	   the	   peptidase.	   Both	   EOD1	   and	  
DA2	   undergo	   long	   chain	   auto-­‐poly-­‐ubiquitination	   (Fig.	   5.3.1-­‐2),	   but	   they	   also	   coordinate	   the	  
ligation	   of	   short	   ubiquitin	   chains	   onto	   DA1.	   It	   is	   possible	   that	   this	   is	   due	   to	   geometric	  
constraints	   of	   the	   EOD1/DA2-­‐UBC10	   complex,	   but	   it	   is	   also	   feasible	   that	   the	   DA1	   UIM	  
competes	   with	   the	   E3-­‐E2	   complex	   for	   binding	   of	   ubiquitin	   molecules	   on	   DA1,	   thereby	  
preventing	   chain	   elongation.	   Recent	   work	   in	   yeast	   has	   shown	   that	   the	   ubiquitin-­‐binding	  
domain	   of	   VPS23	   competes	   with	   the	   RSP5	   E3	   ligase	   for	   the	   binding	   of	   the	   mono-­‐ubiquitin	  
present	  on	  the	  arrestin-­‐related	  protein	  RIM8	  (Herrador	  et	  al.,	  2013).	  The	  trans-­‐interaction	  of	  
UBD	  and	  ubiquitin	   in	   this	   example	   is	   thought	   to	   be	   sufficient	   to	   repress	   poly-­‐ubiquitination,	  
and	  presents	  the	  possibility	  that	  the	  short	  chains	  present	  on	  DA1	  are	  a	  consequence	  of	  a	  cis-­‐
interaction	  of	  UIM	  and	  ubiquitin.	  
Another	  potential	  cis-­‐regulatory	  mechanism	  involves	  the	  DA1	  LIM	  domain,	  which	  is	  present	  in	  
all	  members	  of	  the	  DA1	  family,	  and	  in	  the	  same	  position	  relative	  to	  the	  conserved	  peptidase	  
domain.	  The	  LIM	  domain	  of	  LIM	  kinase-­‐1	  is	  proposed	  to	  have	  a	  cis-­‐inhibitory	  activity	  towards	  


















Figure	  5.12	  –	  DA1	  may	  exist	  in	  a	  reciprocally	  enhancing	  feed-­‐forward	  loop	  with	  EOD1	  and	  DA2.	  	  
A	  model	  explaining	  the	  observed	  genetic,	  physical	  and	  biochemical	  interactions	  between	  DA1,	  and	  
EOD1	   and	   DA2.	   First,	   EOD1	   and	   DA2	   activate	   DA1	   through	   an	   ubiquitination	   step.	   This	   is	   then	  
followed	   by	   the	   peptidase-­‐mediated	   cleavage	   of	   EOD1	   and	  DA2	   by	   ubiquitinated	  DA1,	   and	   the	  




DA1	  LIM	  (or	  LIM-­‐like)	  domain	  has	  an	  analogous	   role	  with	   respect	   to	   its	  peptidase	  domain.	   It	  
may	  be	   that	   this	   inhibitory	   LIM-­‐peptidase	   interaction	   is	  modulated	  by	  UIM	   interactions	  with	  
ubiquitin	   in	  cis.	   This	   is	   supported	  by	  evidence	   from	   section	  3.2.3	   that	   revealed	   that	   the	   LIM	  
domain	   is	   not	   involved	   in	   DA1-­‐DA1	   oligomerisation,	   and	   is	   therefore	   a	   good	   candidate	   for	  
interacting	  with	  the	  peptidase.	  
To	  test	  the	  sufficiency	  of	  DA1ub	  to	  cleave	  EOD1	  and	  DA2	  (section	  5.3.4),	  DA1-­‐ub	  was	  incubated	  
with	   EOD1	   and	   DA2.	   DA1-­‐ub	   was	   generated	   in	   an	   ubiquitination	   reaction	   using	   EOD1	   only.	  
Therefore,	  despite	  the	  fact	  that	  EOD1	  and	  DA2	  have	  both	  been	  identified	  as	  bona	  fide	  targets	  
of	  the	  DA1	  peptidase,	   it	  remains	  unclear	  whether	  DA2	  can	  activate	  DA1	  peptidase	  activity	  by	  
ubiquitination	  as	  well.	   The	   fact	   that	  DA2	  can	  ubiquitinate	  DA1	  and	   that	  BBR	  cannot	   (section	  
5.3.3),	  and	  that	  ubiquitination	  activates	  DA1,	  suggests	  that	  DA2	  is	  indeed	  able	  to	  activate	  DA1.	  	  
5.6.2	  –	  EOD1	  and	  DA2	  are	  modified	  by	  peptide	  cleavage	  
Based	  on	  the	  genetic	  analysis	  in	  section	  5.2,	  it	  was	  predicted	  that	  DA1	  might	  also	  enhance	  the	  
activities	   of	   EOD1	  and	  DA2	   (Fig.	   5.12).	   Research	  described	   in	   Section	  5.3	  demonstrated	   that	  
DA1	   specifically	   cleaves	   EOD1	   and	   DA2,	   and	   therefore	   it	   is	   predicted	   that	   this	   cleavage	  
enhances	  the	  activities	  of	  these	  two	  DIEs.	  The	  mechanism	  by	  which	  DA1-­‐ub-­‐mediated	  cleavage	  
enhances	   E3	   activity	   is	   currently	   not	   known.	   But	   some	   interesting	   examples	   of	   E3	   ligase	  
regulation	  may	   be	   relevant.	   Studies	   of	   the	   human	   E3	   ligase	   PARKIN	   have	   shown	   that	   the	   in	  
vitro	   removal	   of	   an	   inhibitory	   N-­‐terminal	   fragment	  was	   sufficient	   to	   activate	   the	   auto-­‐poly-­‐
ubiquitination	   activity	   of	   PARKIN	   (Chew	   et	   al.,	   2012).	   Moreover,	   the	   addition	   of	   large	   N-­‐
terminal	   epitope	   tags	   to	   PARKIN	   interfered	  with	   this	   inhibitory	   domain	   and	  de-­‐repressed	   its	  
auto-­‐ubiquitination	   activity	   (Burchell	   et	   al.,	   2012).	   Interestingly,	   the	   addition	   of	   a	   large	   N-­‐
terminal	  epitope	  tag	   to	  EOD1,	   (together	  with	  a	  small	  C-­‐terminal	   tag)	  appeared	  to	   repress	  E3	  
activity	  (Fig.	  5.6b),	  suggesting	  that	  modification	  of	  EOD1	  tertiary	  structure	  may	  also	  influence	  
EOD1	  activity.	  
The	  observation	  that	  EOD1	  and	  DA2	  are	  able	  to	  auto-­‐ubiquitinate	  and	  ubiquitinate	  DA1	  prior	  
to	  their	  cleavage,	  suggested	  that	  DA1-­‐mediated	  cleavage	  may	  alter	  their	  specificity	  rather	  than	  
their	  activity.	   This	  distinction	   can	  be	   illustrated	  by	   the	  neddylation	  and	   rubylation	  of	  CRL	  E3	  
ligases	   (see	   section	   5.1.2),	   an	   event	   that	   changes	   CRL	   quaternary	   structure	   to	   create	   novel	  
catalytic	  geometries,	  which	  alter	  the	  specificity	  of	  the	  enzymes	  (Duda	  et	  al.,	  2008,	  Merlet	  et	  al.,	  
2009).	  EOD1	  and	  DA2	  are	  both	  cleaved	  at	  the	  opposite	  end	  of	  the	  protein	  to	  the	  RING	  domain,	  
and,	   as	   the	  RING	  domain	  mediates	   E2-­‐binding,	   it	   is	   possible	   that	   the	  RING-­‐distal	   ‘domain’	   is	  
that	   which	   determines	   substrate	   specificity.	   Therefore	   it	   is	   conceivable	   that	   DA1-­‐mediated	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cleavage	  substantially	  alters	  the	  substrate-­‐binding	  domain	  such	  that	  new	  catalytic	  geometries	  
are	   created.	   This	   modification	   could	   enhance	   E3	   activity	   in	   the	   same	   way	   that	   neddylation	  
increases	   the	   activity	   of	   SCFβTRCP	   towards	   Iκbα	   (Read	  et	   al.,	   2000),	   and	   the	   activity	   of	   SCFskp2	  
towards	  p27kip1	  (Morimoto	  et	  al.,	   2000,	  Podust	  et	  al.,	   2000).	  Alternatively,	   it	   could	  affect	   the	  
ubiquitin	   chain	   specificity	   of	   the	   E2-­‐E3	   complex,	   allowing	   it	   to	   alter	   the	   architecture	   of	   the	  
ligated	   chains	   in	   a	   similar	   way	   to	   the	   truncation	   of	   PARKIN	   that	   enables	   it	   to	   form	   poly-­‐
ubiquitin	  chains	  (Chew	  et	  al.,	  2012).	  	  
An	  alternative	  explanation	  for	  the	  predicted	  enhancing/activating	  effects	  of	  DA1-­‐ub	  mediated	  
cleavage	   of	   EOD1	   and	   DA2	   may	   be	   the	   disruption	   or	   revelation	   of	   a	   signal	   peptide	   that	  
determines	  the	   location	  of	  the	  E3	  enzymes.	  For	  example,	  cleavage	  of	  the	  membrane	  integral	  
E3	  ligase	  RNF13	  revealed	  a	  putative	  nuclear	  localisation	  signal	  (Bocock	  et	  al.,	  2010)	  thought	  to	  
be	   responsible	   for	   previously	   observed	   nuclear	   localisation	   (Tranque	   et	   al.,	   1996).	   If	   RNF13	  
substrates	   are	   in	   the	   nucleus,	   a	   relocation	   event	   might	   lead	   to	   greater	   E3	   activity	   without	  
modifying	  the	  enzyme	  biochemistry.	  
5.6.3	  –	  DA1	  cooperates	  with	  EOD1	  and	  DA2	  to	  influence	  final	  organ	  size	  
The	   experiments	   described	   in	   this	   chapter	   demonstrated	   genetic,	   physical	   and	   biochemical	  
interactions	   between	  DA1,	   EOD1	   and	  DA2	   in	   the	   regulation	   organ	   growth.	   They	   identified	   a	  
novel	  feed-­‐forward	  loop	  involving	  the	  ubiquitin-­‐activated,	  peptidase-­‐mediated	  modification	  of	  
E3	  ligases	  by	  a	  cognate	  peptidase.	  
Analysis	   of	   the	   growth	   responses	   of	   individual	   and	   combined	   mutants	   (see	   section	   5.2.1)	  
provided	  clear	  evidence	  that	  in	  addition	  to	  their	  mechanistic	  interactions,	  DA1,	  EOD1	  and	  DA2	  
also	   have	   functions	   that	   appear	   to	   be	   independent	   of	   each	   other.	   In	  da1ko1	   plants,	   where	  
DA1-­‐mediated	  controls	  do	  not	  function,	  EOD1	  and	  DA2	  were	  still	  able	  to	  partially	  supress	  the	  
double	   knockout	   petal	   phenotypes	   (da1ko1/eod1-­‐2	   or	   da1ko1/da2-­‐1	   respectively).	   This	  
suggests	   that	   they	   have	   also	   a	   DA1-­‐independent	   role	   in	   setting	   organ	   size.	   This	   could	   be	  
through	  a	  basal	  activity	  of	   the	   full-­‐length	  RING	  E3	   ligases,	  or	   through	  modifications	  by	  other	  
activating	  peptidases.	  Similarly,	  in	  eod1-­‐2	  and	  da2-­‐1	   lines,	  the	  presence	  of	  DA1	  was	  sufficient	  
to	   partially	   supress	   the	   large	   double	   knockout	   petal	   phenotypes;	   revealing	   that,	   despite	   the	  
absence	  of	  EOD1	  and	  DA2,	  DA1	  still	  influences	  growth,	  perhaps	  through	  activation	  by	  another	  
as-­‐yet-­‐unidentified	  ubiquitin	  ligase.	  	  
Taken	  together,	  these	  experiments	  and	  interpretations	  suggested	  that	  DA1,	  EOD1	  and	  DA2	  do	  
not	  function	  in	  simple	  linear	  pathways	  that	  converge	  to	  influence	  growth	  (Fig.	  5.14a).	  A	  more	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realistic	  model	   involves	   the	  coordinated	  activation	  of	  DA1	  by	  a	   set	  of	  E3	   ligases	   that	   control	  
linked	  cellular	  activities	  during	  cell	  proliferation	   (Fig.	  5.14b).	  The	   identification	  of	   these	  DA1-­‐	  
regulated	  E3	  ligases,	  and	  other	  proteins,	  will	  be	  facilitated	  by	  identifying	  and	  assessing	  the	  DA1	  











Chapter	  6	  -­‐	  Genetic	  linkage	  and	  association	  screens	  for	  
regulators	  of	  petal	  and	  seed	  growth	  
	  
6.1	  –	  General	  introduction	  
This	   chapter	   was	   initiated	   as	   a	   complementary	   project	   to	   run	   alongside	   the	   DA1	   functional	  
characterisation	  reported	  in	  Chapters	  3	  to	  5.	  It	  was	  designed	  to	  identify	  novel	  genes	  involved	  
in	   the	  setting	  of	  seed	  and	  petal	  size,	  and	  through	  doing	  so,	   to	  develop	  our	  understanding	  of	  
the	   processes	   involved	   in	   organ	   growth	   and	   development,	   and	   their	   contribution	   to	   natural	  
variation	  in	  organ	  size	  in	  populations	  of	  Arabidopsis.	  	  
Mutant	   screens,	   such	   as	   those	   used	   to	   identify	  DA1	   and	   EOD1	   (Li	   et	   al.,	   2008,	   Disch	   et	   al.,	  
2006),	  are	  powerful	   tools	   for	   identifying	  genes	  of	   interest.	  However	  they	  use	  heavy	  doses	  of	  
mutagens	   that	   cause	   a	   narrow	   range	   of	   severe	   effects,	   such	   as	   the	   complete	   loss	   of	   gene	  
function.	  Natural	  genetic	  variation	   includes	  a	  wide	  variety	  of	  different	  alleles	   that	  have	  been	  
selected	  over	  millions	  of	   generations	  and	  provide	  both	  a	  different	   spectrum	  of	  mutants	  and	  
evidence	   for	   the	   biological	   role	   of	   the	   genetic	   variation	   in	   fitness	   and	   adaptation	   at	   the	  
population	   level.	   Such	  analyses	   can	   identify	   key	   regulatory	  nodes	   and	  genes	   that	  have	  been	  
selected	  by	  evolution.	  Therefore	  to	  complement	  and	  extend	  the	  analyses	  of	  induced	  mutations,	  
an	  investigation	  of	  natural	  variation	  in	  organ-­‐size	  was	  undertaken.	  Natural	  variation	  allows	  you	  
to	  exploit	  a	   larger	  pool	  of	  variation	  not	  available	   in	  common	   laboratory	   strains.	  Because	   the	  
lines	   are	   genotyped	   and	   inbred	   you	   can	   also	   phenotype	   them	   repeatedly	   to	   see	   how	   the	  
environment	  interacts	  with	  your	  trait.	  
Two	   different	   strategies	   for	   investigating	   complex-­‐traits	   such	   as	   final	   organ	   size	   exist	   in	  
Arabidopsis:	   population-­‐based	   association	   studies,	   and	   family-­‐based	   QTL	   mapping	   studies	  
(Mitchell-­‐Olds,	  2010).	  Population-­‐based	  association	  studies	  take	  advantage	  of	  genetic	  variation	  
amongst	  natural	  populations	  of	  Arabidopsis,	  seeking	  out	  associations	  between	  phenotypes	  of	  
interest	   and	   genomic	   markers	   (Atwell	   et	   al.,	   2010).	   Alternatively,	   family-­‐based	   linkage-­‐
mapping	   studies	   look	   for	   genotype-­‐phenotype	   associations	   amongst	   artificial	   inbred	  
populations	  originating	  from	  a	  small	  number	  of	   founding	  parent	   lines.	  Both	  strategies	  search	  
for	   statistically	   significant	   associations	   between	   phenotypes	   of	   interest	   and	   SNP	   genomic	  
markers.	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Both	   techniques	   seek	   to	   uncover	   the	   genetic	   elements	   that	   underlie	   natural	   phenotypic	  
variation.	   This	   is	   done	   through	   the	   identification	   of	   statistical	   associations	   between	   a	  
phenotype	   of	   interest	   and	   an	   array	   of	   genomic	   SNP	   markers.	   The	   most	   highly	   associated	  
markers	   are	   then	   used	   to	   identify	   the	   causal	   genes	   based	   on	   their	   genetic	   linkage	   to	   the	  
marker.	   As	   such,	   the	   predictive	   power	   of	   these	   techniques	   is	   dependent	   on	   the	   linkage	  
disequilibrium	  (LD)	  within	  each	  mapping	  population.	  LD	  is	  the	  phenomenon	  that	  certain	  alleles	  
are	  non-­‐randomly	  associated	  due	  to	  limited	  recombination	  events	  occurring	  between	  their	  loci	  
(Jorde,	  2000).	  At	  linked	  loci,	  instead	  of	  finding	  a	  random	  combination	  of	  the	  constituent	  alleles,	  
there	   are	   linked	   “haplotype	  blocks”	   (Weigel,	   2012).	   The	   amount	   of	   linkage	   disequilibrium	   in	  
the	  population	  –	  the	  length	  of	  these	  haplotype	  blocks	  –	  defines	  the	  maximal	  resolution	  of	  the	  
association	   analysis.	   If	   linkage	   disequilibrium	   is	   large,	   e.g.	   10	   Mb,	   then	   one	   can	   only	   be	  
confident	  that	  the	  causal	  variation	   is	  within	  10	  Mb	  of	   the	  associated	  marker	  SNP,	  whereas	   if	  
linkage	  disequilibrium	  is	  only	  10Kb,	  then	  there	  is	  confidence	  that	  the	  causal	  variation	  is	  within	  
one	  of	  two	  genes	  of	  the	  marker	  SNP.	  Amongst	  other	  factors,	  linkage	  disequilibrium	  is	  affected	  
by	  the	  rate	  of	  recombination,	  and	  therefore	  the	  degree	  of	  intermixing	  within	  a	  population	  will	  
determine	  the	  resolution	  of	  an	  association	  analysis	  (Jorde,	  2000).	  
Population-­‐based	   association	   studies	   utilise	   highly	   recombined	   natural	   populations,	   and	   the	  
resulting	   short	   LD	   allows	   the	   identification	   of	   high-­‐resolution	   QTLs	   (Mitchell-­‐Olds,	   2010,	  
Bergelson	  and	  Roux,	  2010,	  Weigel,	  2012,	  Kover	  and	  Mott,	  2012).	  This	  is	  in	  contrast	  to	  family-­‐
based	  mapping	  studies,	  which	  are	  often	  carried	  out	  with	  F5	  or	  F6	  progeny	  and	  therefore	  often	  
result	   in	   much	   broader	   QTLs	   (Mitchell-­‐Olds,	   2010,	   Bergelson	   and	   Roux,	   2010,	   Kover	   et	   al.,	  
2009).	   Nonetheless,	   despite	   the	   greater	  mapping	   resolution	   achievable	   in	   population-­‐based	  
studies,	  their	  predictive	  power	  can	  be	  reduced	  by	  population	  structure	  effects	  (Mitchell-­‐Olds,	  
2010,	   Bergelson	   and	   Roux,	   2010,	   Weigel,	   2012,	   Kover	   and	   Mott,	   2012).	   In	   this	   context,	  
population	  structure	  refers	  to	  genomic	  variation	  that	  is	  immortalised	  in	  accessions	  and	  yet	  has	  
no	   true	   linkage	   to	   the	   phenotypic	   variation	   being	   investigated	   (Mitchell-­‐Olds,	   2010).	   For	  
example	  -­‐	  distantly	  related,	  phenotypically	  divergent	  accessions	  will	  have	  significant	  genotypic	  
differences	  in	  many	  genomic	  locations;	  only	  some	  of	  which	  will	  contribute	  to	  the	  phenotype	  of	  
interest.	   This	   means	   that	   association	   analyses	   are	   likely	   to	   identify	   multiple	   false-­‐positives.	  
Different	   strategies	   have	   been	   developed	   to	   reduce	   the	   effect	   of	   population	   structure;	  
including	   using	   mixed-­‐model	   analyses	   (Kang	   et	   al.,	   2008)	   and	   the	   use	   of	   less-­‐structured,	  
geographically	  confined	  population	  samples	  (Filiault	  and	  Maloof,	  2012)	  that	  are	  likely	  to	  have	  a	  
limited	   number	   of	   founder	   types.	   Importantly,	   these	   corrective	  methods	   trade-­‐off	   with	   the	  
power	   of	   the	   association	   study;	   with	   mixed-­‐model	   analysis	   increasing	   the	   rate	   of	   false-­‐
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negatives	   (Mitchell-­‐Olds,	  2010),	  and	  the	  use	  of	  geographically	  confined	  populations	   reducing	  
the	  amount	  of	  genetic	  variation	  included	  in	  the	  study.	  
Despite	  this,	  population-­‐based	  studies	  typically	  contain	  significantly	  more	  genotypic	  variation	  
than	   artificial	  mapping	   families,	   whose	   diversity	   is	   limited	   by	   the	   relatively	   small	   gene	   pool	  
held	   by	   the	   founding	   parental	   lines.	   Nonetheless,	   the	   genetic	   diversity	   found	   in	   artificial	  
mapping	   families	   can	   vary	   significantly	   depending	   on	   the	   number	   and	   diversity	   of	   parents	  
(Bergelson	   and	   Roux,	   2010).	   Conventional	   bi-­‐parental	   RIL	   populations,	   such	   as	   that	   which	  
recently	  identified	  ERECTA	  as	  a	  regulator	  of	  petal	  growth	  (Abraham	  et	  al.,	  2013),	  contain	  only	  
the	  genetic	  variation	  present	  in	  the	  two	  founding	  parents.	  In	  contrast,	  the	  multi-­‐parental	  RIL-­‐
type	   MAGIC	   population	   incorporates	   the	   genetic	   variation	   of	   19	   parent	   lines	   (Kover	   et	   al.,	  
2009).	  	  
The	  complementary	  strengths	  and	  weaknesses	  of	  both	  population-­‐	  and	  family-­‐	  based	  mapping	  
approaches	  enables	  powerful	  analyses	   to	  be	  achieved	   through	  a	  combinational	  approach;	  as	  
evidenced	   by	   recent	   work	   identifying	   regulators	   of	   flowering	   time	   (Brachi	   et	   al.,	   2010).	  
Following	   from	   these	   data,	   and	   in	   light	   of	   the	   general	   consensus	   that	   a	   combinational	  
approach	   is	   superior	   (Mitchell-­‐Olds,	  2010,	  Kover	  and	  Mott,	  2012,	  Bergelson	  and	  Roux,	  2010,	  
Weigel,	   2012),	   studies	   described	   in	   this	   thesis	   have	   taken	   a	   dual	   approach	   to	   search	   for	  
regulators	   of	   seed	   and	  petal	   growth:	   a	  Genome	  Wide	  Association	   Study	   (GWAS),	   and	   a	  QTL	  
analysis	   of	   the	   MAGIC	   RIL-­‐type	   population.	   Both	   strategies	   used	   large	   populations	   of	  
Arabidopsis	   (272	   lines	   for	   the	   GWAS,	   443	   lines	   for	   the	   MAGIC	   analysis).	   The	   two	   test	  
populations	  did	  not	  overlap,	  and	  the	  study	  did	  not	  expect	  to	  find	  the	  same	  causal	  variation	  in	  
both	   populations.	   Instead,	   it	   aimed	   to	   maximise	   gene	   discovery	   through	   a	   combinatorial	  
approach,	  and	  to	  look	  for	  functional	  similarities	  amongst	  candidate	  genes	  from	  both	  screens.	  
This	   chapter	   describes	   the	   genes	   that	   have	  been	   identified	   as	   candidate	   regulators	   of	   organ	  
size.	   The	   details	   of	   the	   individual	   genetic	   analyses	   will	   be	   discussed	   in	   section	   6.3	   and	   6.4	  
respectively.	  
6.2	  –	  Seed	  and	  petal	  phenotypes	  were	  investigated	  	  
In	  line	  with	  the	  overall	  direction	  of	  this	  thesis,	  rather	  than	  focusing	  on	  any	  one	  specific	  organ	  
type,	   this	   chapter	   is	   interested	   in	   elucidating	   the	   mechanisms	   governing	   organ	   growth	   in	  
general.	  As	  a	  consequence,	  the	  genetic	  analyses	  described	  in	  this	  section	  are	  focused	  on	  two	  
key	  phenotypic	  areas:	  petal	  growth	  and	  seed	  growth.	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Significant	  developmental	  differences	  between	  petals	  and	  seeds	  (reviewed	  in	  detail	  in	  Chapter	  
1)	  mean	  that	  many	  aspects	  of	  their	  development	  are	  regulated	  through	  independent	  pathways.	  
An	   extreme	   example	   of	   this	   is	   the	   maternal	   regulation	   of	   seed	   size	   through	   the	   ttg2	  	  
(transparent	   testa	  glabra2)	  mutation	   (see	  section	  1.4),	  which	  relies	  on	  the	   interaction	  of	   the	  
integument	  and	  endosperm,	  tissues	  that	  are	  specific	  to	  seeds	  (Garcia	  et	  al.,	  2005).	  In	  addition	  
to	  these	  organ-­‐specific	  growth	  pathways,	  genes	  that	   regulate	  core	  growth	  functions,	  such	  as	  
cell	  proliferation	  and	  cell	   expansion,	  are	  often	   involved	   in	   the	   setting	   the	   size	  of	  both	  organ	  
types.	  For	  example,	  DA1	  and	  KLUH	  influence	  seed	  and	  petal	  growth,	  through	  manipulating	  the	  
duration	  of	  cell	  proliferation	  (Li	  et	  al.,	  2008,	  Adamski	  et	  al.,	  2009,	  Anastasiou	  et	  al.,	  2007).	  This	  
study	   uses	   two	   organ-­‐types	   in	   order	   to	   broaden	   its	   scope;	   exploiting	   two	   distinct	  
developmental	   systems	   to	   maximise	   the	   identification	   of	   common	   and	   organ-­‐specific	  
regulators.	  
The	   following	   sections	   describe	   the	   logic	   behind	   the	   selection	   of,	   and	   the	  methods	   used	   to	  
record	  the	  phenotypes	  chosen	  for	  this	  study.	  
6.2.1	  –	  Petal	  and	  seed	  area	  
The	   manipulation	   of	   core	   developmental	   processes	   that	   drive	   organ	   growth,	   such	   as	   cell	  
proliferation	   and	   cell	   expansion	   (see	   section	   1.3),	   will	   often	   result	   in	   organs	   of	   a	   wild-­‐type	  
morphology,	   but	   an	   altered	   overall	   size.	   For	   example,	   regulators	   of	   cell	   proliferation	   –	  DA1,	  
KLU	   and	   EOD1	   –	   all	   affect	   overall	   petal	   area	   without	   altering	   the	   shape	   of	   the	   organ	  
(Anastasiou	  et	  al.,	  2007,	  Disch	  et	  al.,	  2006,	  Li	  et	  al.,	  2008,	  Adamski	  et	  al.,	  2009).	  In	  addition,	  an	  
increase	  in	  organ	  size	  can	  be	  achieved	  in	  concert	  with	  significant	  morphological	  changes.	  This	  
is	  illustrated	  by	  the	  larger	  and	  rounder	  leaves	  found	  on	  da1-­‐1	  plants	  (Li	  et	  al.,	  2008),	  and	  the	  
larger	  more	   serrated	   leaves	   found	   in	   the	   rpt2a	   mutant,	   which	   has	   increased	   cell	   expansion	  
(Sonoda	  et	  al.,	  2009).	  In	  order	  to	  identify	  elements	  in	  core	  developmental	  pathways,	  involved	  
in	   the	  manipulation	   of	  overall	   organ	   size,	   plants	  were	   phenotyped	   for	  mean	   petal	   area	   and	  
mean	  seed	  area.	  
For	   each	   line,	   ten	   petals	  were	   collected	   from	  5	   individual	   plants	   (two	  per	   plant).	   The	   petals	  
were	  harvested	   from	  the	   first	   flowers	  per	  plant,	   to	  ensure	  developmental	  equivalence;	  once	  
harvested	  they	  were	  placed	  intact,	  on	  transparent	  adhesive	  tape	  and	  attached	  to	  a	  clean	  black	  
background.	   Petal	   area	   was	   recorded	   using	   a	   high-­‐resolution	   scanning	   method	   following	   a	  
protocol	   adapted	   from	   (Herridge	   et	   al.,	   2011).	   Images	   were	   scanned,	   and	   areas	   were	  
calculated	  using	  the	  ImageJ	  image	  analysis	  software	  (see	  section	  2.3.5.1),	  which	  allowed	  for	  a	  
high-­‐throughput	  data	  input	  pipeline.	  To	  identify	  general	  growth	  regulators	  and	  cell-­‐cycle	  genes	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(instead	  of	  only	  petal-­‐specific	  genes)	  petal	  area	  was	  not	  normalised	  to	  sepal	  area	  (Abraham	  et	  
al.,	  2013).	  
Seed	  areas	  were	  calculated	  using	  a	   similar	  method.	  Due	   to	   their	   smaller	   size	   (relative	   to	   the	  
fixed	  resolution	  of	  the	  scanner),	   the	  number	  of	  seeds	   in	  the	  sample	  were	   increased	  to	  n>60,	  
and	  instead	  of	  adhering	  to	  tape,	  the	  seeds	  were	  scattered	  in	  a	  petri	  dish	  prior	  to	  scanning.	  
For	   seed	  analysis,	   the	   ImageJ	   software	  was	   set	   to	  exclude	  aggregations	  of	   seed	   in	   the	  petri-­‐
dish;	   such	   that	   only	   individual	   seed	   areas	   were	   recorded.	   As	   a	   fail-­‐safe,	   and	   to	   ensure	   the	  
accuracy	  of	  the	  data,	  after	  each	  ImageJ	  measurement,	  a	  manual	  check	  of	  the	  scans	  was	  made	  
to	  ensure	  no	  seed	  aggregates	  had	  been	  measured.	  
6.2.2	  –	  Petal	  shape	  
Organ	  size	  is	  intricately	  linked	  to	  organ	  shape	  (see	  section	  1.2.2),	  and	  an	  increasing	  number	  of	  
genes,	  primarily	  characterised	  in	  Antirrhinum	  and	  Arabidopsis,	  have	  been	  identified	  that	  play	  a	  
significant	  role	  in	  influencing	  organ	  shape.	  Prolonged	  cell	  division	  in	  leaf	  meristemoid	  cells	  of	  
the	   Arabidopsis	   PEAPOD	   (PPD)	   mutant	   (White,	   2006),	   and	   mis-­‐regulation	   of	   the	   cell-­‐cycle	  
arrest	  front	  in	  the	  Antirrhinum	  CINCINNATA	  (CIN)	  mutant	  (2003),	  both	  result	  in	  an	  increase	  in	  
leaf	  size	  and	  curvature;	  illustrating	  the	  intimate	  relationship	  between	  size	  and	  shape.	  Despite	  
this	   inter-­‐relatedness,	   many	   genes	   appear	   to	   coordinate	   organ	   shape	   without	   affecting	   the	  
overall	  organ	  area.	  For	  example,	  although	  tcp14	  and	  tcp15	  mutants	  do	  not	  affect	  overall	   leaf	  
size,	  principle	  component	  analysis	  reveals	  that	  they	  cause	  significant	  changes	  to	  leaf	  shape	  and	  
aspect	  ratio	  (Kieffer	  et	  al.,	  2011).	  	  
Cell	  proliferation	  and	  cell	  expansion	  are	  the	  driving	  forces	  behind	  organ	  growth,	  however	  it	  is	  
the	  spatial	   coordination	  of	   these	   forces	   that	  determines	   final	  organ	  shape.	  Many	   factors	  are	  
thought	   to	   be	   involved	   in	   the	   setting	   of	   shape,	   including	   mobile	   morphogens	   such	   as	   the	  
proposed	  KLUH-­‐dependent	  mobile	  growth	   factor	   (Adamski	  et	  al.,	  2009,	  Eriksson	  et	  al.,	  2010,	  
Kazama	  et	  al.,	  2010)	  and	  genes	  that	  exert	  biophysical	  constraints	  on	  the	  developing	  organ.	  For	  
example,	   ttg2	   biophysically	   constrains	   the	   developing	   endosperm	   through	   the	   seed-­‐coat	  
(Garcia	  et	  al.,	  2005),	  and	  angustifolia	  (an)	  mutants	  have	  a	  long	  and	  narrow	  leaf	  phenotype	  as	  a	  
result	   of	   altered	   cortical	   microtubule	   arrangements,	   which	   promote	   cell-­‐expansion	   in	   the	  
apical-­‐basal	  axis	  (Kim	  et	  al.,	  2002).	  These	  topics	  are	  reviewed	  in	  detail	  in	  Chapter	  1.	  	  
This	   genetic	   analysis	   of	   petal	   shape	   is	   designed	   to	   identify	   any	   genes	   involved	   in	   the	  
coordination	  of	  petal	  growth.	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In	   this	   analysis,	   three	   petal	   shape	   parameters	  were	   recorded:	   petal	   length,	   petal	  width	   and	  
petal	   shape	   (length/width).	   The	   primary	   measurements	   (length	   and	   width)	   were	   recorded	  
using	   the	   ImageJ	   software	   directly	   from	   the	   high-­‐resolution	   petal	   scans	   described	   in	   section	  
6.2.1.	  Petal	  shape	  was	  calculated	  as	  a	  secondary	  measurement	  from	  the	  ratio	  of	  length/width	  
according	  to	  recent	  published	  work	  (Abraham	  et	  al.,	  2013).	  
6.2.3	  –	  Variation	  in	  seed	  and	  petal	  size	  
Despite	  the	  indeterminate	  nature	  of	  vegetative	  plant	  growth,	  organs	  such	  as	  seeds,	  petals	  and	  
leaves	  display	  determinate	  growth	   (see	  section	  1.2.1).	  The	  uniformity	  of	   final	  organ	  size	  and	  
morphology	   within	   species,	   compared	   to	   between	   species,	   demonstrates	   a	   high	   level	   of	  
developmental	   regulation.	   This	   regulation	   can	   be	   seen	   clearly	   in	   the	   ‘compensation’	  
mechanism	  that	  ensures	  uniformity	   in	  organ	  size	   in	   spite	  of	  changes	   in	  cell	  proliferation	  and	  
expansion	  (Dewitte	  et	  al.,	  2007,	  Ferjani	  et	  al.,	  2007,	  Jones	  et	  al.,	  1998).	  This	  not	  only	   implies	  
that	   the	   developing	   organ	   possesses	   an	   intrinsic	   knowledge	   of	   its	   pre-­‐determined	   final	   size,	  
but	  that	  there	  are	  regulatory	  networks	  in	  place	  to	  buffer	  against	  aberrations	  in	  development.	  
Variation	  in	  the	  degree	  of	  uniformity	  of	  final	  organ	  size	  is	  likely	  to	  reflect	  differences	  in	  these	  
‘buffering’	  regulatory	  networks,	  and	  in	  order	  to	  identify	  genes	  in	  these	  ‘buffering’	  networks,	  a	  
genetic	  analysis	  of	  the	  variation	  in	  final	  organ	  size	  was	  carried	  out.	  	  
The	  phenotype	  used	   for	   these	  analyses	  was	   the	   standard	  error	   (SE)	  of	   the	  mean	  organ	  area	  
(for	  petal	  and	  seed	  respectively).	  
	  
6.3	  –	  MAGIC	  analysis	  of	  seed	  size	  
This	  MAGIC	   analysis	  was	  designed	   to	   investigate	   the	   regulation	  of	   seed	   and	  petal	   growth	   in	  
Arabidopsis.	  The	  project	  was	  initiated	  late	  on	  in	  my	  research	  schedule	  as	  a	  means	  to	  screen	  for,	  
and	   identify	   novel	   regulators	   of	   organ	   growth	   that	   could	   be	   subjected	   to	   further	   functional	  
study	  akin	  to	  that	  described	  for	  DA1	  in	  Chapters	  3-­‐5.	  As	  a	  consequence	  of	  the	  late	  start,	  at	  the	  
time	  of	  writing	  only	  the	  seed	  data	  have	  been	  analysed.	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NASC Stock Number Accession Origin 
N6643 Bur-0 Ireland 
N6660 Can-0 Canada 
N6673 Col-0 USA 
N6674 Ct-1 Italy 
N6688 Edi-0 Scotland 
N6736 Hi-0 Netherlands 
N6762 Kn-0 Lithuania 
NW20 Ler-0 Germany 
N1380 Mt-0 Libya 
N6805 No-0 Germany 
N6824 Oy-0 Norway 
N6839 Po-0 Germany 
N6850 Rsch-4 Russia 
N6857 Sf-2 Spain 
N6874 Tsu-0 Japan 
N6889 Wil-2 Russia 
N6891 Ws-0 Russia 
N6897 Wu-0 Germany 
N6902 Zu-0 Germany 
	  
	  
This	  section	  describes	  the	  MAGIC	  mapping	  population	  and	  how	  it	  has	  been	  used	  to	  identify	  a	  
priori	   and	   novel	   candidate	   genes	   predicted	   to	   be	   involved	   in	   the	   regulation	   of	   seed	   area.	   It	  
documents	   the	   identification	   of	   eight	  QTL	   for	  mean	   seed	   area,	   short-­‐lists	  a	   priori	  and	  novel	  
candidate	  gene-­‐lists	  for	  each	  QTL,	  and	  briefly	  interrogates	  the	  sequence	  of	  selected	  candidate	  
genes	   to	   screen	   for	   possible	   causative	   genetic	   variation.	   Importantly,	   this	   section	   aims	   to	  
develop	  a	  platform	  for	  identifying	  the	  causative	  variation	  underlying	  the	  identified	  QTL,	  not	  to	  
prove	  the	  causality	  of	  individual	  genes;	  a	  step	  that	  is	  beyond	  the	  scope	  of	  this	  work.	  
The	  mapping	  population	  used	   in	   this	   study	  was	  The	  Multiparent	  Advanced	  Generation	   Inter-­‐
Cross	  (MAGIC)	  lines;	  a	  collection	  of	  527	  RILs	  generated	  from	  inter-­‐mating	  19	  natural	  accessions	  
Table	  6.1	  –	  MAGIC	  parent	  lines	  	  





(Kover	   et	   al.,	   2009),	   kindly	   provided	   by	   Phil	   Wigge	   at	   the	   Sainsbury	   Laboratory	   Cambridge	  
University,	  Cambridge.	  The	  19	  parents	  (Table	  6.1)	  had	  been	  intercrossed	  for	  four	  generations	  
before	  being	   immortalised	  by	  six	  generations	  of	  backcrossing.	  This	  has	  resulted	   in	  527	  stable	  
homozygous	   lines,	  of	  which	  452	  were	  available	   for	   this	   study.	  Compared	   to	   conventional	  bi-­‐
parental	   RIL	   populations,	   the	   presence	   of	   19	   parents	   incorporates	   increased	   allelic	   diversity	  
into	   the	   mapping	   population	   (Kover	   et	   al.,	   2009).	   In	   addition,	   the	   increased	   number	   of	  
recombination	  steps	  involved,	  improves	  the	  mapping	  resolution	  of	  the	  MAGIC	  population	  to	  as	  
little	  as	  300Kb	  (Kover	  et	  al.,	  2009).	  
The	  final	  immortalised	  lines	  are	  unique	  mosaics	  of	  the	  19	  founder	  genomes,	  formed	  of	  a	  series	  
of	  haplotype	  blocks,	  each	  descended	  from	  one	  of	   the	  19	  parents.	  The	   location	  and	  ancestral	  
origin	  of	   these	  haplotype	  blocks	   can	  be	  mapped	  using	   genotype	  data	   available	   for	   each	   line	  
(Kover	  et	  al.,	  2009).	  The	  ability	  to	  probabilistically	  infer	  the	  mosaic	  structure	  of	  each	  ML	  allows	  
the	   prediction	   of	   parental	   contribution	   to	   each	   QTL.	   In	   addition,	   all	   19	   parental	   lines	   have	  
publicly	   available	   genome	   sequences	   (Gan	   et	   al.,	   2011),	   which	   allows	   the	   targeted	  
interrogation	  of	  parent-­‐specific	  genome	  sequence	  data	  at	  predicted	  QTL	  loci.	  	  
The	  MAGIC	  analysis	  was	  performed	  in	  collaboration	  Mathew	  Box	  at	  the	  Sainsbury	  Laboratory	  
Cambridge	  University,	  Cambridge.	  The	  QTLs	  were	  identified	  using	  HAPPY:	  ‘a	  software	  package	  
for	  multipoint	   QTL	  mapping	   in	   genetically	   heterogeneous	   animals’	   (Mott,	   2000,	  Mott	   et	   al.,	  
2000).	   Using	   the	   collected	   phenotype	   values	   and	   pre-­‐existing	   genotype	   data,	   this	   method	  
reconstructs	   ancestral	   haplotypes	   for	   each	  ML	   and	   subsequently	   tests	   for	   QTLs	   using	   linear	  
regression	  analysis	  (Mott	  et	  al.,	  2000).	  For	  this	  investigation,	  the	  genotype	  information	  used	  in	  
the	  HAPPY	  analysis	  was	  from	  1250	  SNPs,	  spaced	  roughly	  100Kb	  apart	  (Kover	  et	  al.,	  2009,	  Mott	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Figure	  6.1	  –	  Variation	  in	  seed	  area	  in	  the	  MAGIC	  population	  	  	  
(A)	  The	  distribution	  of	  seed	  area	  within	  the	  MAGIC	  population,	  data	  is	  presented	  as	  means	  (n=64).	  
(B)	  The	  distribution	  of	  SE	  mean	  seed	  area	   (data	  presented	  as	  SE	  mean	   (n=64))	   representing	   the	  
amount	   of	   variation	  within	   each	   line	   of	   the	  mapping	   population.	   (A-­‐B)	   Black	   crosses	   represent	  
MAGIC	  descendant	  lines	  and	  black	  crosses	  with	  red	  backgrounds	  represent	  MAGIC	  parental	  lines.	  





6.3.1.	  –	  Transgressive	  segregation	  of	  seed	  size	  in	  the	  MAGIC	  lines	  
There	  was	   considerable	   variation	   in	  both	   the	  mean	  and	   standard	  error	   seed	  area	  within	   the	  
MAGIC	  mapping	  population.	  Fig.	  6.1	  shows	  that	  ML	  seeds	  varied	  from	  an	  average	  of	  0.071mm2	  
(line	   51)	   to	   0.208mm2	   (line	   432);	   an	   increase	   of	   291%.	   Seeds	   from	   the	   lines	   with	   the	  most	  
extreme	  seed	  area	  values	  (lines	  51	  and	  432),	  and	  an	  intermediate	  line	  (line	  316)	  are	  shown	  in	  
Fig.	  6.1c,	  illustrating	  the	  variation	  within	  the	  population.	  Interestingly,	  Fig.	  6.1a	  also	  shows	  that	  
the	   range	   of	  mean	   seed-­‐size	   amongst	  ML	   descendants	   (0.071mm2	  to	   0.208	  mm2)	   is	   greater	  
than	   that	   of	   the	   MAGIC	   parental	   lines	   (0.090mm2	   to	   175mm2);	   revealing	   seed	   area	   is	   a	  
transgressive	  phenotype	  amongst	  the	  MAGIC	  population.	  	  
A	  transgressive	  phenotype,	  where	  hybrid	  lineages	  display	  more	  extreme	  phenotypes	  than	  their	  
parental	   lines	   is	  also	  seen	  for	  the	  SE	  mean	  seed	  area	  data	  (Fig.	  6.1a,b).	  For	  this	  data	  set,	  ML	  
hybrids	  range	  from	  1.1x10-­‐3	  mm2	  (line	  216)	  to	  	  4.5x10-­‐3	  mm2	  (line	  432),	  whereas	  parental	  SEs	  
vary	  from	  1.3x10-­‐3	  mm2	  to	  3.2x10-­‐3	  mm2.	  
Transgressive	   segregation	  occurs	  when	  alleles	   at	  multiple	   loci	   in	  parental	   lines	   recombine	   in	  
the	   hybrids.	   This	   results	   from	   the	   interactions	   of	   some	   alleles	   that	   act	   to	   ‘increase’	   the	  
phenotype	  and	  others	   that	   ‘reduce’	   it,	   and	  while	   some	  hybrid	  combinations	  will	   cancel	  each	  
other	  out,	  others	  will	  complement	  each	  other	  and	  generate	  an	  extreme	  effect	  (Bell	  and	  Travis,	  
2005).	   Such	   extreme	   phenotypic	   values	   may	   be	   a	   consequence	   of	   novel	   combinations	   of	  
epistatic	  or	  additive	  parental	   alleles	   (Dittrich-­‐Reed	  and	  Fitzpatrick,	  2012),	  or	   they	  may	   result	  
from	  synergistic	   interactions	  that	  arise	  genes	  from	  working	   in	  a	  common	  mechanism,	  similar	  
to	  that	  seen	  for	  the	  da1-­‐1	  and	  eod1-­‐2	  alleles	  (Li	  et	  al.,	  2008).	  
This	  transgressive	  segregation	  of	  the	  seed	  area	  phenotype	  confirms	  that	  the	  phenotype	  is	  both	  
complex	   and	   quantitative.	   It	   supports	   observations	   in	   the	   literature	   that	   multiple	   genes	  
combine	  to	  regulate	  seed	  growth,	  and,	  as	  is	  demonstrated	  by	  KLUH	  and	  DA1,	  that	  these	  genes	  
have	   antagonistic	   roles	   (Li	   et	   al.,	   2008,	   Adamski	   et	   al.,	   2009,	   Anastasiou	   et	   al.,	   2007).	   This	  
reveals	   that	   within	   the	   parental	   MAGIC	   population	   variation	   is	   likely	   to	   be	   polygenic	   with	  
alleles	  that	  vary	  in	  strength	  both	  positively	  and	  negatively.	  Through	  the	  hybridisation	  of	  these	  
ancestral	   lines,	  and	   the	  subsequent	  disruption	  of	   this	  network,	   the	  QTL	  analysis	  described	   in	  
sections	  6.3.2	  and	  6.3.3	  can	  be	  used	  to	  identify	  constituent	  regulatory	  genes.	  
6.3.2	  –	  No	  significant	  QTLs	  were	  identified	  for	  SE	  seed	  area	  
Despite	   the	   large	   degree	   of	   variation	   in	   the	   SE	   mean	   seed	   area	   dataset,	   no	   QTLs	   were	  
identified	  in	  this	  MAGIC	  analysis.	  Fig.	  6.2	  shows	  the	  QTL	  scan,	  and,	  although	  there	  are	  several	  






6.3.3	  –	  8	  QTLs	  identified	  for	  mean	  seed	  area	  
HAPPY	   analysis	   (Mott,	   2000,	   Mott	   et	   al.,	   2000)	   of	   mean	   seed	   area	   in	   the	   MAGIC	   mapping	  
population	   revealed	   eight	   QTL	   for	   seed	   area,	   which	   had	   peaks	   that	   were	   significantly	  
associated	  with	  the	  phenotype	  to	  the	  95%	  significance	  level.	  There	  is	  one	  QTL	  in	  chromosome	  
1,	  one	  QTL	  in	  chromosome	  2	  and	  six	  smaller	  QTL	  in	  chromosome	  4	  (Fig.	  6.3).	  Table	  6.2	  shows	  
that	  QTL	  1	  and	  2	  (on	  chromosome	  1	  and	  chromosome	  2	  respectively)	  are	  considerably	  broader	  
that	  the	  remaining	  QTL;	  with	  QTL1	  being	  ~5.3Mb	  and	  QTL8	  only	  ~22Kb.	  	  
This	  difference	  in	  QTL	  size	  is	  reflected	  in	  the	  number	  of	  candidate	  genes	  underlying	  each	  QTL.	  
QTL1	  and	  QTL2	  (~5.3Mb	  and	  ~3.0Mb)	  cover	  1410	  and	  742	  genes	  respectively,	  and	  the	  300Kb	  
either	   side	   of	   the	   peak	   SNP	   (Kover	   et	   al.,	   2009)	   for	   each	   QTL	   covers	   172	   and	   150	   genes	  
respectively.	   In	  contrast,	  the	  entirety	  of	  QTL8	  covers	  only	  4	  genes.	  Although	  the	   large	  size	  of	  
QTL1	  and	  QTL2	   is	   not	   abnormal	   (Abraham	  et	   al.,	   2013,	   Kover	   et	   al.,	   2009),	   the	   considerably	  
narrower	  resolution	  of	  QTL	  4,5,7	  and	  8	  may	  be	  an	  artefact	  of	  a	  fragmented	  larger	  QTL.	  
	  
Figure	  6.2	  –	  No	  QTL	  for	  SE	  mean	  seed	  area	  in	  the	  MAGIC	  population	  
Associations	  of	  SE	  mean	  seed	  area	  with	  genome	  position.	  The	  x-­‐axis	  represents	  the	  full	  genome	  
length	  of	  Arabidopsis,	  with	  the	  vertical	  bars	  denoting	  boundaries	  between	  chromosomes.	  The	  y-­‐
axis	  displays	  the	  associations	  of	  genotype	  markers	  at	  different	  positions	  on	  the	  genome	  with	  the	  
phenotype.	   Associations	   are	   presented	   as	   logP	   values	   and	   grey	   bars	   represent	   genome-­‐wide	  
significance	  thresholds	  for	  p=0.5,	  p=0.1	  and	  p=0.05.	  Significant	  associations	  are	  marked	  with	  gold	  
stars.	   This	   genome	   scan	   reveals	   that	   there	   are	   no	   significant	   associations	   between	   genotype	  














1 Chr1 25027501 30348203 5.320702 28136775 MASC00850 6.493990919 0.003 
2 Chr2 10242327 13258513 3.016186 12428271 MN2_12435349 5.656010097 0.011 
3 Chr4 9364976 10777260 1.412284 10045141 PHYE_1561 4.299730069 0.035 
4 Chr4 11001770 11470264 0.468494 11326180 NMSNP4_11326190 4.176744435 0.043 
5 Chr4 11488346 11579827 0.091481 11579827 MN4_11579839 3.709603639 0.077 
6 Chr4 12654216 14379731 1.725515 13576430 MN4_13576438 4.103519746 0.047 
7 Chr4 14379870 14533009 0.153139 14533009 MN4_14533015 3.451684135 0.096 
8 Chr4 14635799 14658631 0.022832 14658631 MASC03154 3.423096522 0.097 
	  
	  
Figure	  6.3	  –	  Eight	  QTL	  for	  mean	  seed	  area	  in	  the	  MAGIC	  population	  
Associations	   of	   mean	   seed	   area	   with	   genome	   position.	   The	   x-­‐axis	   represents	   the	   full	   genome	  
length	  of	  Arabidopsis,	  with	  the	  vertical	  bars	  denoting	  boundaries	  between	  chromosomes.	  The	  y-­‐
axis	  displays	  the	  associations	  of	  genotype	  markers	  at	  different	  positions	  on	  the	  genome	  with	  the	  
phenotype.	   Associations	   are	   presented	   as	   logP	   values	   and	   grey	   bars	   represent	   genome-­‐wide	  
significance	  thresholds	  for	  p=0.5,	  p=0.1	  and	  p=0.05.	  Significant	  associations	  (those	  with	  a	  genome-­‐
wide	  p-­‐value	  of	  p<0.05)	  are	  marked	  with	  gold	  stars.	  This	  genome	  scan	  reveals	  that	  there	  are	  eight	  
significant	  associations	  between	  genotype	  markers	  and	  the	  mean	  seed	  area	  phenotype.	  The	  peak	  
SNPs	  of	   each	  association	  are	   located	  at:	   Chr1-­‐28136775,	  Chr2-­‐12428271,	  Chr4-­‐10045141,	  Chr4-­‐	  
11326180,	  Chr4-­‐11579827,	  Chr4-­‐13576430,	  Chr4-­‐14533009	  and	  Chr4-­‐14658631.	  
	  
Table	  6.2	  –	  Details	  of	  eight	  QTL	  for	  mean	  seed	  area	  
The	   table	   provides	   details	   of	   the	   location	   of	   each	   QTL	   (Chr=chromosome),	   including	   the	  
chromosome	  position	  of	  the	  start,	  the	  end	  and	  the	  peak	  of	  the	  QTL.	  The	  table	  also	  provides	  the	  ID	  
of	  the	  peak	  SNPs	  and	  their	  genome-­‐wide	  p-­‐values.	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6.3.4	  –	  21	  a	  priori	  candidate	  genes	  identified	  in	  QTLs	  	  
Four	  of	  the	  eight	  QTL	  intervals	  (QTL	  1,2,3	  and	  6)	  overlapped	  with	  genes	  known	  to	  be	  involved	  
in	  the	  regulation	  of	  organ	  growth.	  The	  presence	  of	  such	  a	  priori	  candidates	  in	  the	  QTL	  intervals	  
presents	  the	  possibility	  that	  these	  genes	  are	  responsible	  for	  the	  phenotypic	  variation	  observed	  
in	  the	  mapping	  population.	  
The	   a	   priori	   gene	   list	   (Table	   S1)	   is	   populated	   with	   genes	   that	   have	   published	   organ-­‐growth	  
phenotypes,	  and	  is	  designed	  to	  be	  used	  as	  a	  tool	  for	  explaining	  observed	  phenotypic	  variation	  
with	  previously	  characterised	  genes.	  21	  members	  from	  this	  list	  are	  present	  in	  four	  of	  the	  QTL	  
intervals	   identified	   for	   seed	   area	   (Table	   6.3),	   including	   six	   TCP	   transcription	   factors	   (TCPs	  
1,2,10,12,15	  and	  22),	  three	  CLAVATA	  related	  genes	  (CLV1,	  CLE8,	  CLE26)	  and	  the	  E3	  ligase	  DA2.	  
Represented	   in	   these	   QTL	   are	   a	   priori	   genes	   involved	   in	   both	   core	   aspects	   of	   cell	   growth;	  
including	  DA2,	   a	  negative	   regulator	  of	   cell	  proliferation	   (Xia,	   2013),	   and	  RPT2a,	   the	  negative	  
regulator	  of	  cell	  expansion	  (Sonoda	  et	  al.,	  2009).	  	  
The	  QTL	  intervals	  include	  characterised	  seed-­‐specific	  growth	  regulators,	  such	  as	  SHB1	  (SHORT	  
HYPOCOTYL	   UNDER	   BLUE1),	   which	   interacts	   with	  MINISEED3	   and	   HAIKU2	   to	   control	   seed	  
development	   (Zhou	   et	   al.,	   2009).	   However,	   they	   also	   include	   genes	   that	   only	   have	  
characterised	  phenotypes	   in	   leaves	   and	   petals,	   including	   the	  homeobox	   transcription	   factor,	  
ZHD5	  (ZINC-­‐FINGER	  HOMEODOMAIN	  5),	  over-­‐expression	  of	  which	  has	  been	  shown	  to	  increase	  
leaf	  area	  as	  a	  consequence	  of	  increased	  cell	  size	  (Hong	  et	  al.,	  2011).	  In	  addition,	  the	  regulator	  
of	  petal	  size	  and	  shape,	  ERECTA,	  is	  present	  in	  QTL2	  (Abraham	  et	  al.,	  2013,	  Shpak	  et	  al.,	  2003).	  	  	  
The	   QTL	   intervals	   also	   include	   genes	   involved	   in	   phytohormone	   signalling,	   including	   the	  
ethylene	   response	   factor	  ERF6	   (ETHYLENE	  ELEMENT	  BINDING	  FACTOR6),	  which	   is	   a	  negative	  
regulator	   of	   leaf	   growth	   (Dubois	   et	   al.,	   2013)	   and	   a	   positive	   regulator	   of	   jasmonate	   and	  
ethylene	   mediated	   pathogen	   defence	   (Moffat	   et	   al.,	   2012).	   Additionally,	   a	   member	   of	   the	  
gibberellin-­‐signalling	  pathway,	  the	  gibberellic	  acid	  oxidase,	  GA20OX1,	  is	  present	  in	  QTL6.	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QTL	  	   GENE	  ID	   GENE	  NAME	  
QTL1	   AT1G67260	   TCP1	  
QTL1	   AT1G67775	   CLE8	  
QTL1	   AT1G68480	   JAG	  
QTL1	   AT1G68800	   TCP12	  
QTL1	   AT1G69690	   TCP15	  
QTL1	   AT1G69970	  	   CLE26	  
QTL1	   AT1G72010	   TCP22	  
QTL1	   AT1G75240	   ZHD5	  (ZINC	  FINGER	  HOMEODOMAIN5)	  
QTL1	   AT1G75820	   CLV1	  (CLAVATA	  1)	  
QTL1	   AT1G76420	   CUC3	  
QTL1	   AT1G78300	  	   GRF2	  
QTL1	   AT1G78420	   DA2	  
QTL2	   AT2G26330	   ERECTA	  
QTL2	   AT2G31070	   TCP10	  
QTL3	   AT4G17490	  	   ETHYLENE	  RESPONSE	  FACTOR	  6	  
QTL3	   AT4G18390	   TCP2	  
QTL6	   AT4G24900	   TTL	  
QTL6	   AT4G25350	   SHB1	  (SHORT	  HYPOCOTYL	  UNDER	  BLUE	  1)	  
QTL6	   AT4G25420	   GA20OX1	  (GIBBERELLIN	  20-­‐OXIDASE)	  
QTL6	   AT4G28840	   TIE	  
QTL6	   AT4G29040	   RPT2A	  (REGULATORY	  PARTICLE	  AAA-­‐ATPASE	  2A	  
	  
	  
The	  observed	  QTL	  overlap	  with	  a	  priori	  genes	   involved	   in	   all	   aspects	   of	   organ	  development,	  
and	   with	   characterised	   responses	   to	   many	   of	   the	   major	   plant	   hormones,	   is	   encouraging;	  
although	  it	  must	  be	  reiterated	  that	  said	  a	  priori	  genes	  are	  only	  candidates	  and	  not	  necessarily	  
causal.	   Further	   investigation	   –	   which	   is	   beyond	   the	   scope	   of	   this	   study	   –	   is	   underway	   to	  
identify	  causality	  (see	  section	  6.3.7).	  
Of	  particular	  interest	  to	  this	  thesis	  is	  the	  presence	  of	  DA2,	  TCP15	  and	  TCP22	  in	  QTL1.	  Although	  
it	  is	  impossible	  to	  confirm	  causality	  at	  this	  stage,	  data	  from	  Chapters	  4	  and	  5	  strongly	  support	  a	  
role	   for	   these	   genes	   in	   regulating	   seed	   area.	   Section	   5.2.1.2	   and	   recent	   work	   with	   our	  
collaborators	   at	   the	   Chinese	   Academy	   of	   Sciences	   (Xia,	   2013),	   demonstrates	   that	   DA2	   –	   in	  
certain	   genetic	   backgrounds	   –	   has	   a	   significant	   negative	   influence	   on	   seed	   area.	   Although	  
Table	  6.3	  –	  The	  QTL	  for	  mean	  seed	  area	  include	  21	  a	  priori	  regulators	  of	  organ	  growth	  
The	  table	  provides	  the	  details	  of	  21	  a	  priori	  regulators	  of	  organ	  growth	  and	  development	  that	  are	  
present	  within	   the	   eight	  QTL	   identified	   for	  mean	   seed	   area.	  Genes	   listed	   are	   a	   subset	   of	   those	  
presented	  in	  Table	  S1.	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section	  5.2.1.2	  indicates	  that	  a	  da1	  null	  allele	  is	  required	  for	  da2-­‐1	  to	  influence	  seed	  area,	  it	  is	  
possible	   that	   the	   genetic	   background	   of	   the	   MAGIC	   population	   is	   conducive	   to	   da2	   acting	  
independently	  of	  a	  da1	  null	  allele.	  
In	  addition,	  Chapter	  4	  has	  described	   in	  detail	   the	   role	  of	  TCP15	   in	  growth	  and	  development,	  
and	  it	  is	  therefore	  particularly	  interesting	  to	  identify	  this	  gene	  in	  QTL1.	  However,	  TCP22	  is	  also	  
of	   interest	   due	   recent	   work	   which	   has	   shown	   that,	   based	   on	   sequence	   analysis	   of	   the	   TCP	  
domain,	  TCP22	  (and	  TCP14)	  are	  the	  most	  closely	  related	  family	  members	  to	  TCP15	  (Aggarwal	  
et	  al.,	  2010).	  And	  as	  Fig.	  S3	  documents,	  previous	  studies	  in	  the	  lab	  have	  characterised	  TCP22	  as	  
a	  regulator	  of	  organ	  growth	  and	  development.	  
	  
6.3.5	  –	  Bur-­‐0	  haplotype	  predicted	  to	  contribute	  to	  increase	  in	  seed	  area	  
Fig.	  6.4	  shows	  boxplots	  of	  each	  parental	  line,	  representing	  the	  estimated	  contribution	  of	  their	  
haplotype	   to	   each	   QTL	   phenotype	   and	   the	   predicted	   direction	   of	   their	   contribution.	   One	  
particular	  parental	  haplotype	  –	  Bur-­‐0	  –	  is	  predicted	  contribute	  the	  largest	  increase	  in	  seed	  area	  
across	  all	  eight	  QTL.	  In	  some	  instances,	  such	  as	  QTL2	  (Fig.	  6.4b),	  other	  parental	  lines	  including	  
Edi-­‐0,	  Kn-­‐0	  and	  Oy-­‐0	  also	  have	  a	  strong	  predicted	  contribution.	  However,	   for	  others,	  such	  as	  
QTL6	  (Fig.	  6.4f),	  the	  estimated	  Bur-­‐0	  haplotype	  influence	  is	  considerably	   larger	  than	  all	  other	  
parental	  lines.	  
Inspection	  of	  the	  variation	  in	  seed	  area	  amongst	  the	  parental	  lines	  (Fig.	  6.7)	  reveals	  that	  Bur-­‐0	  
has	  the	   largest	  seed	  of	  all	  parents.	  This	  strengthens	  the	  predictions	   in	  Fig.	  6.4	  that	  the	  Bur-­‐0	  
haplotype	   is	   responsible	   for	   all	   eight	   QTL	   and	   suggests	   that	   the	   interrogation	   of	   the	   Bur-­‐0	  
genotype	  at	  these	  intervals	  may	  yield	  insights	  as	  to	  the	  true	  causative	  variation.	  This	  genotype	  
interrogation	  is	  made	  possible	  by	  the	  sequencing	  of	  all	  parental	  lines	  (Gan	  et	  al.,	  2011)	  and	  the	  

















































Figure	  6.4	  –	  The	  predicted	  contribution	  of	  ML	  parents	  to	  the	  eight	  observed	  QTL	  	  	  
(A-­‐H)	  The	  predicted	  contribution	  of	  ML	  parental	  lines	  to	  the	  eight	  observed	  QTL;	  figures	  A-­‐H	  
represent	  QTL	  1-­‐8	  respectively.	  The	  x-­‐axis	  shows	  the	  identities	  of	  the	  19	  parent	  lines	  from	  the	  
MAGIC	  population.	  The	  y-­‐axis	  is	  a	  prediction	  of	  the	  parental	  influence	  on	  phenotype	  using	  pixels	  
as	  units	  (1	  pixel	  =	  5x10-­‐5	  mm2);	  in	  all	  QTL	  a	  Bur-­‐0	  allele	  is	  predicted	  to	  positively	  influence	  seed	  
area.	  
Figure	  6.5	  –	  Variation	  in	  petal	  area	  amongst	  the	  19	  MAGIC	  parent	  lines	  	  	  
The	  x-­‐axis	  shows	  the	  identities	  of	  the	  19	  parent	  lines	  of	  the	  MAGIC	  population	  and	  the	  y-­‐axis	  plots	  




Fig.	  6.6	  shows	  the	  location	  of	  Bur-­‐0	  specific	  polymorphisms	  in	  a	  selection	  of	  candidate	  genes.	  	  
Fig.	  6.6a	  reveals	  that	  there	  are	  a	  considerable	  number	  of	  Bur-­‐0	  specific	  SNPs	  in	  the	  promoter	  
region	  of	  TCP15.	  The	  promoter	  of	  TCP15	  is	  considered	  to	  begin	  1.92	  Kb	  upstream	  of	  the	  5’	  UTR	  
(Kieffer	  et	  al.,	  2011),	  and	  as	  illustrated	  in	  Fig.	  6.6a,	  a	  region	  of	  ~500bp	  extending	  to	  up	  to	  2Kb	  
from	   the	   5’UTR	   is	   populated	   with	   SNPs	   unique	   to	   Bur-­‐0.	   Given	   the	   published	   TCP15	  
developmental	  phenotypes	  (Kieffer	  et	  al.,	  2011),	  and	  the	  seed	  size	  phenotypes	  documented	  in	  
section	  4.3.3,	  it	  is	  plausible	  that	  this	  promoter	  variation	  may	  be	  	  that	  which	  underpins	  QTL1.	  	  
Other	  genes	  of	  interest	  include	  ERECTA,	  an	  LRR-­‐RLK	  involved	  in	  the	  regulation	  of	  organ	  shape	  
(Shpak	   et	   al.,	   2003,	   Torii	   et	   al.,	   1996),	   which	   was	   recently	   identified	   in	   a	   bi-­‐parental	   RIL	  
mapping	  population	  as	  a	  regulator	  of	  petal	  shape	  (Abraham	  et	  al.,	  2013).	  There	  were	  two	  Bur-­‐
0	   specific	   amino	   acid	   transitions	   in	   the	   ERECTA	   coding	   sequence,	   four	   Bur-­‐0	   specific	  
insertion/deletion	  events	  in	  the	  promoter	  region	  and	  a	  two	  amino-­‐acid	  deletion	  in	  the	  5’	  UTR	  
(Fig.	  6.6e).	  The	  two	  amino	  acid	  transitions	  (P155L	  and	  T225A)	  are	  both	  in	  the	  ERECTA	  N-­‐terminal	  
leucine	  rich	  repeat	  domains	  -­‐	  LRR4	  and	  LRR7	  respectively.	  Interestingly,	  another	  single	  amino	  
acid	  transition	  in	  LRR9	  (er-­‐103,	  M282I)	  has	  been	  shown	  to	  be	  sufficient	  to	  cause	  a	  reduction	  in	  
plant	  height,	   silique	   length	  and	  width,	  and	  pedicel	   length	   (Torii	  et	  al.,	  1996).	  Suggesting	   that	  
the	   observed	   Bur-­‐0	   specific	   transitions	   in	   LRR4	   and	   LRR7	  may	   indeed	   be	   sufficient	   to	   cause	  
similar	   developmental	   phenotypes.	   Unfortunately	   the	   publication	   describing	   the	   er-­‐103	  
mutation	  (Torii	  et	  al.,	  1996)	  does	  not	  document	  a	  seed	  size	  phenotype.	  However,	  due	  to	  the	  
intimate	  interaction	  between	  maternal	  tissue	  and	  the	  developing	  seed,	  it	  is	  possible	  that	  such	  
severe	  silique	  phenotypes	  may	  affect	  seed	  size.	  This	  phenomenon	  is	   illustrated	  by	  the	  barley	  
seg1,	   3,	   6	   &	   7	   mutants,	   which	   have	   a	   reduced	   seed	   size	   due	  maternal	   impairment	   of	   seed	  
nutrition	  (Felker	  et	  al.,	  1985),	  and	  the	  ttg2	  mutation	  that	  represses	  seed	  development	  through	  
an	  integument-­‐mediated	  mechanism	  (Garcia	  et	  al.,	  2005).	  	  
Finally,	   investigation	   of	   the	   polymorphism	   environment	   of	   SHB1	   –	   the	   only	   seed-­‐specific	   a	  
priori	  candidate	  present	  in	  the	  QTL	  intervals	  –	  reveals	  the	  presence	  of	  a	  Bur-­‐0	  specific	  SNP	  in	  
the	  3’	  end	  of	  the	  coding	  sequence	  (Fig.	  6.6b).	  This	  SNP,	  a	  T1944G	  substitution,	  results	  in	  a	  Ser-­‐
Arg	   transition	   at	   position	   648,	   which	   is	   located	   in	   the	   EXS	   domain	   (InterPro:IPR004342);	   a	  
region	  rich	  in	  trans-­‐membrane	  helices	  with	  a	  possible	  role	  in	  endomembrane	  sorting	  (Wang	  et	  
al.,	   2004).	   The	   exact	   location	   of	   the	   Ser648Arg	   transition	   is	   in	   an	   extracellular	   inter-­‐
transmembrane	   region.	   The	   role	   of	   the	   EXS	   domain	   is	   not	   clear,	   however	   it	   has	   been	  
demonstrated	   that	   over	   expression	   of	   this	   domain	   phenocopies	   the	   shb1	   null	   mutant	   and	  
generates	  a	  short	  hypocotyl	  phenotype	  (Zhou	  and	  Ni,	  2010,	  Kang	  et	  al.,	  2013).	  The	  sufficiency	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of	   the	   EXS	   domain	   to	   cause	   the	   short	   hypocotyl	   phenotype,	   suggests	   that	   it	   may	   also	   be	  
intimately	  involved	  in	  the	  generation	  of	  the	  seed	  size	  phenotype	  reported	  in	  Zhou	  et	  al	  (2009).	  
If	  this	  is	  the	  case	  then	  it	  is	  possible	  that	  the	  Ser648Arg	  transition	  could	  influence	  the	  seed	  size.	  	  
These	  observations	  are	  not	  yet	  sufficient	  to	  establish	  the	  identity	  of	  genes	  causal	  to	  the	  QTL,	  
however	   they	   strengthen	   the	   arguments	   for	   the	   involvement	   of	   these	   genes,	   and	   allow	   the	  
formulation	   of	   hypotheses	   that	   can	   be	   tested	   to	   develop	   our	   understanding	   further.	   For	  
example,	   the	   identification	  of	  significant	  Bur-­‐0	  polymorphisms	   in	  the	  promoter	  of	  TCP15	  and	  
coding	  sequence	  of	  SHB1	  allows	  the	  initiation	  of	  quantitative	  complementation	  experiments.	  A	  
strategy	  that	  involves	  crossing	  the	  allele	  of	  interest	  into	  a	  knock-­‐out	  background	  and	  assaying	  
its	  ability	  to	  complement	  the	  knock-­‐out.	  This	  is	  then	  compared	  to	  the	  effect	  of	  the	  crossing	  the	  
allele	  of	  interest	  into	  the	  wild	  type	  background,	  to	  control	  for	  the	  genome-­‐wide	  heterozygosity	  
of	  the	  F1.	  	  
This	  section	  has	  discussed	  the	   identification	  of	  a	  priori	   candidate	  genes	   in	  QTL	   intervals,	  and	  
subsequent	   interrogation	   of	   their	   parent-­‐specific	   genotypes.	   However,	   in	   addition	   to	   known	  
regulators	  of	  seed	  size,	  the	  MAGIC	  analysis	  has	  the	  potential	  to	  identify	  novel	  regulators.	  	  
6.3.6	  –	  Candidate	  novel	  regulators	  of	  organ	  size	  
In	  order	  to	   identify	  novel	  regulators	  of	  seed	  size	  from	  all	  eight	  QTL,	  a	  short-­‐list	  of	  genes	  was	  
created	  by	  mining	  all	  genes	  mapping	  to	  QTLs	  for	  the	  keywords:	  expansion,	  proliferation,	  cell-­‐
cycle,	   embryo,	   and	   endosperm,	   as	   well	   as	   manual	   analysis	   of	   all	   the	   published	   gene	  
descriptions.	  The	  resulting	  list	  of	  candidate	  genes	  is	  shown	  in	  Table	  S5	  and	  includes	  many	  cell-­‐
cycle	   genes	   including	  APC6	   (ANAPHASE	  PROMOTING	  COMPLEX	  6),	  CYCLIN	  A1;2,	  CYCLIN	  B2;4	  
and	   CDKB2;1.	   It	   also	   identified	   members	   of	   the	   brassinosteroid	   signalling	   pathway:	   BZR1	  
(BRASSINAZOLE-­‐RESISTANT	  1)	  and	  BIN2	  (BRASSINOSTEROID	  INSENSITIVE	  2),	  both	  of	  which	  are	  
involved	  in	  regulating	  the	  brassinosteroid	  growth	  response	  (He	  et	  al.,	  2005,	  He	  et	  al.,	  2002).	  	  
The	  list	  also	  identified	  many	  apparent	  seed-­‐specific	  candidates;	  in	  all	  QTL	  there	  were	  30	  EMB	  
genes,	  a	  subset	  of	  which	  are	  displayed	  in	  Table	  S5	  and	  all	  of	  which	  are	  shown	  to	  be	  defective	  in	  
embryo	  development	   (Tzafrir	  et	  al.,	  2004).	  Of	   these,	  EMB1417	   and	  EMB1989	  both	  sit	  within	  
41Kb	   of	   the	   peaks	   of	  QTL	   4	   and	   5	   respectively;	   and	  EMB1417	   -­‐	   a	   pentatricopeptide	   repeat-­‐
containing	  protein	  -­‐	  has	  a	  Bur-­‐0	  specific	  amino-­‐acid	  transition	  (L68Q)	  in	  its	  N-­‐terminal	  region.	  In	  
addition,	   in	   QTL	   6	   there	   is	   a	   cluster	   of	   four	   SEED	   STORAGE	   ALBUMIN	   genes	   (SESA1-­‐4)	   that	  
encode	  members	  of	  one	  of	  the	  three	  major	  seed	  storage	  protein	  families	  (Shewry	  et	  al.,	  1995).	  





















Figure	  6.6	  –	  Bur-­‐0	  specific	  polymorphisms	  in	  candidate	  genes	  
(A-­‐F)	  Bur-­‐0	  specific	  SNPs	  (‘*’)	  and	  insertion/deletion	  events	  (‘|’)	  in	  a	  priori	  candidate	  genes	  for	  the	  
eight	  identified	  seed	  area	  QTL.	  The	  figure	  highlights	  only	  mis-­‐sense	  polymorphisms	  in	  transcribed	  
sequence	  and	  polymorphisms	  in	  promoter	  regions.	  (A)	  TCP15	  has	  a	  large	  amount	  of	  Bur-­‐0	  specific	  
polymorphisms	   in	   a	   500bp	   region	   of	   its	   promoter;	   these	   polymorphisms	   include	   SNPs	   and	  
insertion/deletion	  events.	  (B)	  SHB1	  has	  a	  single	  T-­‐G	  transition	  in	  the	  ninth	  exon.	  (C,D)	  SESA1	  and	  
SESA3	  both	   have	   SNPs	   in	   their	   promoter	   regions	   (<400bp	   from	   their	   ATG).	   (E)	  ERECTA	   has	   two	  
SNPs	  in	  its	  coding	  sequence:	  a	  C-­‐T	  transition	  in	  exon	  6	  and	  a	  T-­‐C	  transition	  in	  exon	  9.	  (F)	  ATUBA1	  
has	   a	   single	   A-­‐G	   transition	   in	   exon	   6.	   SNP	   locations	   were	   identified	   using,	   and	   images	   were	  
adapted	   from	   the	   Rätsch	   lab	   GBrowse	   (http://gbrowse.cbio.mskcc.org/gb/gbrowse/thaliana-­‐
19magic/).	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of	  single	  Bur-­‐0	  specific	  SNPs	   in	  the	  promoter	  regions	  of	  SESA1	  and	  SESA3	   (Fig.	  6.6c,d),	  which	  
are	  31.25Kb	  and	  35.75Kb	  from	  the	  peak	  SNP	  in	  QTL	  6	  respectively.	  
An	  ubiquitin	  pathway	  gene	  with	  a	  direct	  link	  to	  DA1	  is	  also	  present	  in	  this	  list	  of	  potential	  novel	  
regulators.	  ATUBA1,	  one	  of	   the	  two	  Arabidopsis	  E1	  activating	  enzymes,	  and	  a	  Y2H	  interactor	  
with	  DA1	   (Chapter	   4),	   is	   present	   in	  QTL2.	   This	   gene	   has	   been	   shown	   to	   play	   a	   role	   in	   plant	  
innate	   immunity	   and	   to	   have	   an	   organ	   size	   phenotype	   in	   certain	   genetic	   backgrounds	  
(Goritschnig	  et	  al.,	  2007).	  ATUBA1	  has	  one	  Bur-­‐0	  specific	  SNP	  in	  the	  coding	  sequence,	  an	  A2656G	  
substitution,	  which	  results	   in	  a	  T886A	   transition	   in	  C-­‐terminal	   region	  of	   the	  protein	   (Fig.	  6.6f).	  
Interestingly,	   this	   amino-­‐acid	   transition	   is	   within	   the	   ATUBA1	   C-­‐terminal	   fragment	   that	   was	  
pulled	  out	  by	  DA1	  in	  the	  Y2H	  described	  in	  Chapter	  4,	  and	  is	  146	  amino	  acids	  from	  the	  deletion	  
responsible	  for	  the	  mos5	  phenotype	  described	  in	  (Goritschnig	  et	  al.,	  2007).	  	  Furthermore,	  the	  
transition	   is	   in	   position	   eight	   of	   the	   second	   ubiquitin-­‐activating	   enzyme	   repeat	   (Interpro:	  
IPR000127,	   Pfam:	   PF02134),	   suggesting	   that	   the	   mutation	   could	   alter	   catalytic	   activity.	  
Modification	  of	  ATUBA1	   function,	  as	  shown	  in	  the	  mos5	  deletion,	  can	  have	  relatively	  specific	  
phenotypic	   effects.	   In	   the	   case	   of	  mos5,	   the	   mutation	   appears	   to	   effect	   only	   plant	   innate	  
immunity	   (including	   a	   growth	   response);	   suggesting	   a	   specific	   relationship	   with	   a	   subset	   of	  
Arabidopsis	   E2s.	   If	   this	   is	   indeed	   the	   case,	   then	   the	   Bur-­‐0	   specific	   T886A	   transition	  may	   also	  
specifically	   affect	   growth	  and	  development	  pathways,	   and	   is	   therefore	  a	   good	   candidate	   for	  
the	  causative	  genetic	  variation	  in	  QTL2.	  
6.3.7	  –	  Future	  work	  
As	  discussed	  in	  section	  6.3,	  this	  work	  was	  initiated	  with	  the	  intention	  of	  identifying	  shortlists	  of	  
a	  priori	  and	  de	  novo	  candidate	  genes,	  which	  could	  be	  tested	  in	  the	  future	  to	  determine	  their	  
role	   in	   the	   identified	  QTL.	  The	  MAGIC	  analysis	  has	   successfully	   identified	  a	   list	  of	  21	  a	  priori	  
candidates	   and	   75	  de	   novo	   candidates.	   Interrogation	   of	   the	   sequence	   of	   these	   genes	   in	   the	  
parental	   haplotypes	   predicted	   to	   underlie	   each	   QTL,	   has	   offered	   additional	   insight	   into	   the	  
likelihood	  of	  these	  genes	  being	  causal.	  	  
This	  not	  only	  provides	  a	  rich	  resource	  of	  candidate	  genes	  for	  further	  investigation,	  but	  the	  SNP	  
interrogation	   of	   parental	   haplotypes,	   and	   subsequent	   focus	   on	   genes	   with	   Bur-­‐0	   specific	  
polymorphisms	   allows	   the	   further	   refining	   of	   the	   candidate	   list.	   Unfortunately,	   due	   to	   time	  
constraints,	   and	   the	  nature	  of	   this	  work	   as	   a	   side-­‐project,	   complete	   SNP	   interrogation	  of	   all	  
candidate	  genes	  has	  not	  been	  completed	  and	  an	  ultimate	  short-­‐list	  of	  candidates	  has	  not	  yet	  
been	   populated.	   Nonetheless,	   sections	   6.3.4	   to	   6.3.6	   provide	   good	   support	   for	   the	   further	  
study	  of	  genes	  including:	  DA2,	  TCP15,	  TCP22,	  ERECTA,	  ATUBA1,	  SESA1,	  SESA3	  and	  EMB1417.	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Knockout	  lines	  will	  be	  acquired	  for	  these	  genes,	  and	  if	  knockout	  phenotypes	  exist,	  a	  strategy	  of	  
quantitative	   complementation	  will	   be	  undertaken	   to	  determine	   their	   role	   in	   their	   respective	  
QTL.	  
6.4	  –	  Genome	  wide	  association	  analysis	  of	  petal	  and	  seed	  growth	  
This	   genome	  wide	   association	   (GWA)	   analysis	  was	   designed	   to	   investigate	   the	   regulation	   of	  
seed	  and	  petal	   growth	   in	  Arabidopsis.	  As	  with	   the	  MAGIC	  analysis,	   this	  project	  was	   initiated	  
late	  on	  in	  my	  research	  schedule	  as	  a	  means	  to	  screen	  for	  and	  identify	  novel	  regulators	  of	  organ	  
growth	  that	  could	  be	  subjected	  to	  further	  functional	  study.	  At	  the	  time	  of	  writing,	  the	  mapping	  
population	  had	  been	  genotyped,	  the	  genotype-­‐phenotype	  associations	  had	  been	  analysed	  and	  
candidate	  genes	  had	  been	   identified.	  This	  chapter	  focuses	  on	  two	  putative	  associations	  only,	  
one	  for	  mean	  petal	  length	  and	  one	  for	  SE	  mean	  petal	  area	  (see	  section	  6.2.3	  for	  explanation).	  
It	  briefly	  documents	  the	  identification	  of	  these	  loci	  and	  the	  candidate	  genes	  therein,	  but	  does	  
not	   investigate	   the	   associations	   any	   further.	  Work	   to	  prove	   the	   causality	   of	   these	   candidate	  
genes	  is	  on-­‐going	  and	  is	  not	  reported	  in	  this	  chapter.	  	  
The	   mapping	   population	   used	   in	   this	   investigation	   was	   made	   up	   of	   a	   subset	   of	   the	   1001	  
genomes	   project	   (Weigel	   and	   Mott,	   2009)	   consisting	   of	   272	   Swedish	   accessions	   kindly	  
provided	  by	  Caroline	  Dean	  at	  the	  John	  Innes	  Centre,	  Norwich	  (Table	  S2).	  This	  population	  was	  
being	  used	  at	  the	  John	  Innes	  Centre	  by	  Caroline	  Dean	  and	  Mathew	  Box	  to	  map	  genes	  involved	  
in	  the	  vernalisation	  response.	  During	  this	  work,	  variation	  in	  petal	  size	  was	  observed	  within	  the	  
population	  and	   therefore	   it	  was	   selected	   for	   this	   study	  of	  organ	  growth.	  Due	   to	   its	   confined	  
geographical	   distribution,	   this	   population	   is	   thought	   to	   have	   reduced	   population	   structure	  
effects	   and,	   as	   a	   consequence,	   a	   reduced	   frequency	   of	   false	   positives	   (Filiault	   and	  Maloof,	  
2012).	  Despite	  this	  mitigating	  measure,	  genetic	  diversity	  in	  Eurasian	  accessions	  of	  Arabidopsis	  
has	  been	  shown	  to	  follow	  a	  broad	  trend	  of	  “isolation	  by	  distance”	  (Platt	  et	  al.,	  2010).	  In	  order	  
to	   determine	   whether	   this	   isolation	   by	   distance	   might	   lead	   to	   population-­‐structure	   effects	  
within	  this	  Swedish	  population,	   the	  effect	  of	   latitude	  on	  phenotype	  was	   investigated	  (Filiault	  
and	  Maloof,	  2012).	  Figure	  6.7	   shows	   that	   there	  were	  negative	  correlations	  between	   latitude	  
and	   both	   mean	   petal	   area	   and	   mean	   petal	   length	   (Pearson’s	   r,	   p=0.006	   and	   p=0.044,	  
respectively),	   and	   a	   positive	   correlation	   between	   latitude	   and	  mean	   seed	   area	   (Pearson’s	   r,	  
p<0.0001).	  For	  these	  reasons	  it	  was	  decided	  that	  a	  further	  corrective	  approach	  would	  be	  used	  
in	  this	  analysis	  (Cheng	  et	  al.,	  unpublished).	  
The	   genome	   wide	   association	   analysis	   was	   kindly	   performed	   in	   collaboration	   with	   Caroline	  
Dean	  at	  the	  John	  Innes	  Centre,	  Norwich;	  Mathew	  Box	  at	  the	  Sainsbury	  Laboratory	  Cambridge	  
194	  
University,	   Cambridge;	   and	   Justin	   Borevitz	   and	   Riyan	   Cheng	   at	   the	   Australian	   National	  
University,	  Canberra,	  Australia.	  The	  analysis	  was	  carried	  out	  using	  the	  QTLRel	  package	  (Cheng	  
et	   al.,	   2011)	   and	   call_method_75_	   TAIR9	   SNP	   data	   (Horton	   et	   al.,	   2012).	   Alleles	   with	   a	  







J    
Phenotype Pearson's r t-statistic p-value 
Mean Petal Area	   -0.17486 2.79682 0.00557 
SE Petal Area	   -0.10869 1.72183 0.08635 
Mean Petal Width	   -0.12408 1.96931 0.05003 
SE Petal Width	   0.07125 1.12489 0.26172 
Mean Petal Length	   -0.12750 2.02435 0.04401 
SE Petal Length	   -0.04855 0.76553 0.44469 
Mean Seed Area	   0.33643 5.78264 <0.0001 
SE Mean Seed Area	   0.09716 1.58018 0.11527 





Figure	  6.7	  –	  Phenotype-­‐latitude	  correlations	  
(A-­‐I)	   Scatterplots	  display	  mean	  values	   for	   the	  phenotypes	  used	   in	   the	  GWA,	  plotted	  against	   the	  
latitude	   at	   which	   the	   accessions	   were	   collected.	   (J)	   A	   table	   displaying	   the	   significance	   of	   the	  
phenotype-­‐latitude	   correlations.	   Mean	   petal	   area,	   mean	   petal	   length	   and	   mean	   seed	   area	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Figure	  6.8	  –	  Phenotype	  distributions	  in	  the	  GWA	  mapping	  population	  	  	  
Mean	  values	  for	  petal	  area	  (A),	  petal	  length	  (C),	  petal	  width	  (E)	  and	  seed	  area	  (G);	  and	  SE	  of	  the	  
mean	  values	  for	  petal	  area	  (B),	  petal	  length	  (D),	  petal	  width	  (F)	  and	  seed	  area	  (H).	  (I)	  Aspect	  ratio	  
plotted	  as	  (mean	  petal	  length	  /	  mean	  petal	  width).	  (Petal	  data,	  n=10;	  seed	  data	  n=100)	  
	  
	  
Figure	  6.9	  –	  Petal	  and	  seed	  phenotypes	  	  	  




6.4.1	  –	  Natural	  variation	  in	  seed	  and	  petal	  phenotypes	  	  
Phenotypic	   analysis	   revealed	   that	   petal	   area,	   petal	   length,	   petal	   width	   and	   seed	   area	  
phenotypes	  varied	  widely	  within	  the	  sample	  population.	  Petals	  varied	  in	  mean	  area	  from	  0.915	  
mm2	   (Död	   1)	   to	   4.92mm2	   (Vår2-­‐6),	   an	   increase	   of	   537%.	   Seed	   area	   varied	   from	   0.073mm2	  
(T1080)	  to	  0.183mm2	  (Fri	  2),	  an	  increase	  of	  250%.	  Fig.	  6.11a	  shows	  petals	  from	  Död	  1,	  Vår2-­‐6	  
and	   an	   intermediate	   petal,	   Hov1-­‐10;	   Fig.	   6.11b	   shows	   seeds	   from	   T1080,	   Fri	   1	   and	   in	  
intermediate	  seed,	  Rev-­‐3.	  
The	   results	   of	   the	   GWA	   analysis	   are	   presented	   as	   whole-­‐genome	   Manhattan	   plots,	   with	  
genomic	   position	   plotted	   against	   association	   significance	   (Fig.	   6.10).	   Associations	   were	  
presented	   as	   LOD	   scores	   and	   thresholds	   were	   estimated	   by	   the	   permutation	   test	   (2500	  
permutations)(Cheng	   and	   Palmer,	   2013).	   SNPs	   with	   LOD	   scores	   greater	   than	   the	   respective	  
genome-­‐wide	  significance	  thresholds	  were	  considered	  for	  further	  analysis.	  
The	  trade-­‐off	  between	  stringency	  and	  call	  rate	  has	  resulted	  in	  the	  somewhat	  nominal	  setting	  
of	  significance	  thresholds	  in	  GWAs	  studies	  (McCarthy	  et	  al.,	  2008,	  Atwell	  et	  al.,	  2010).	  For	  this	  
reason,	  the	  significance	  threshold	  in	  this	  study	  is	  used	  as	  a	  mechanism	  to	  guide	  the	  discovery	  
of	   causal	   variation.	   SNPs	   that	   fall	   above	   the	   significance	   threshold	  will	   be	   followed	  with	   the	  
aim	   of	   identifying	   de	   novo	   regulatory	   genes.	   However,	   non-­‐significant	   SNPs	   close	   to	   the	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Phenotype Significance Chr1 Chr2 Chr3 Chr4 Chr5 Genome 
Mean Petal Area 0.1 4.76632 4.43997 4.67473 4.60904 4.68857 5.38634 
Mean Petal Area 0.05 5.06718 4.78796 5.01636 5.03478 5.10523 5.78109 
Mean Petal Area 0.01 5.82572 5.52993 5.84721 5.81530 6.00708 6.45741 
Mean Petal Width 0.1 4.85770 4.55815 4.77427 4.70212 4.82212 5.49773 
Mean Petal Width 0.05 5.25696 4.94375 5.11562 5.09641 5.16713 5.91964 
Mean Petal Width 0.01 6.08508 5.82206 5.86884 5.99104 6.06160 6.64984 
Mean Petal Length 0.1 4.67971 4.34684 4.59511 4.52073 4.62106 5.27263 
Mean Petal Length 0.05 4.99840 4.64120 4.91601 4.82940 4.98345 5.57528 
Mean Petal Length 0.01 5.67693 5.29947 5.75778 5.55072 5.81650 6.31547 
Mean Seed Area  0.1 4.61988 4.39584 4.55730 4.46356 4.65790 5.21451 
Mean Seed Area  0.05 4.92639 4.69700 4.84001 4.79474 5.02598 5.75572 
Mean Seed Area  0.01 5.76458 5.44659 5.52112 5.41619 5.81205 6.31792 
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Figure	  6.10	  –	  Genome-­‐wide	  association	  of	  phenotype	  with	  SNP	  markers	  
(A-­‐G)	  Manhattan	  plots	  of	  genotype-­‐phenotype	  associations.	  The	  x-­‐axis	  represents	  the	  full	  genome	  
length	  of	  Arabidopsis;	  different	  colours	  denote	  the	  boundaries	  between	  chromosomes.	  The	  y-­‐axis	  
displays	   the	   associations	   of	   genotype	   markers	   at	   different	   positions	   on	   the	   genome	   (with	   the	  
respective	   phenotype).	   Associations	   are	   presented	   as	   LOD	   scores.	   (I)	   Table	   of	   significance	  
thresholds;	  for	  each	  of	  four	  phenotypes	  (mean	  petal	  area,	  mean	  petal	   length,	  mean	  petal	  width	  
and	  mean	  seed	  area).	  LOD	  scores	  for	  p<0.1,	  0.05	  and	  0.01	  significance	  thresholds	  are	  given	  as	  per-­‐
chromosome	   (Chr	   =	   chromosome)	   and	   per-­‐genome	   values.	   SNPs	  with	   LOD	   scores	   greater	   than	  
these	   thresholds	   are	   considered	   to	   be	   significantly	   associated	   with	   the	   phenotype	   to	   the	  
confidence	  level	  expressed	  by	  the	  respective	  p-­‐value.	  	  (B,C)	  The	  ‘*’	  marks	  the	  position	  of	  strongly	  
associated	  SNPs	  of	  particular	  interest	  to	  this	  study.	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6.4.2	  –	  A	  SNP	  at	  Ch4-­‐9471419	  associates	  with	  mean	  petal	  length	  
As	   Fig.	   6.10b	   reveals,	   the	   SNPs;	   Ch4-­‐9471419	   and	   Chr4-­‐10183417	   associate	   with	   the	   mean	  
petal	  length	  phenotype,	  with	  LOD	  scores	  of	  5.85	  and	  4.89	  respectively	  (SNP	  position	  indicated	  
by	  ‘*’)	  .	  The	  per-­‐genome	  and	  per-­‐chromosome	  p<0.1	  significance	  thresholds	  are	  LOD=5.27	  and	  
LOD=4.60	   respectively	   revealing	   that	   both	   SNPs	   are	   significant	   using	   the	   p<0.1	   per-­‐
chromosome	   threshold.	   Moreover,	   the	   per-­‐chromosome	   p<0.01	   significance	   threshold	   for	  
chromosome	  4	  is	  LOD=	  5.55,	  revealing	  that	  the	  association	  of	  the	  peak	  SNP	  (Ch4-­‐9471419)	  is	  
significant	   to	   p<0.01.	   This	   SNP	   alone	   is	   predicted	   to	   contribute	   a	   0.26%	   decrease	   in	   petal	  
length.	  However,	  at	  the	  time	  of	  writing,	  the	  contribution	  of	  the	  underlying	  haplotype	  was	  still	  
being	  calculated.	  
The	   association	   interval	   for	   a	   significant	   SNP	   is	   determined	   by	   the	   LD	   of	   the	   region	   of	   the	  
genome	  in	  which	  the	  SNP	  is	  located.	  Due	  to	  the	  preliminary	  state	  of	  this	  analysis,	  at	  the	  time	  of	  
writing	  the	  specific	  LD	  for	  this	  region	  of	  had	  not	  been	  calculated.	  However,	  based	  on	  genome-­‐
wide	   analysis	   of	   LD	   in	  Arabidopsis,	   this	   investigation	   assumes	   a	   genome-­‐wide	   average	   LD	  of	  
10Kb,	  (Kim	  et	  al.,	  2007).	  Table	  6.4	  shows	  the	  genes	  present	  within	  20Kb	  of	  the	  peak	  SNP	  (Ch4-­‐
9471419)	  and	  highlights	  those	  within	  10Kb.	  The	  peak	  SNP	  for	  this	  association	  is	  located	  in	  the	  
third	   intron	  of	  AT4G16830,	   a	  Hyaluronan	   /	  mRNA	  binding	   family	   gene,	  which	  has	  no	   known	  
organ	  size	  phenotypes.	  	  
Within	  the	  preliminary	  10Kb	  association	  interval	  is	  the	  REDUCED	  VERNALIZATION	  RESPONSE	  2	  
(VRN2)	   gene,	   encoding	   a	   zinc	   finger	   protein	  with	   similarity	   to	   the	   Polycomb	   group	   (PcG)	   of	  
proteins	   (Gendall	   et	   al.,	   2001).	  VRN2	   is	   characterised	   as	   being	   part	   of	   polycomb	   repressive	  
complex	  2	   (PRC2),	   involved	   in	  the	  epigenetic	  regulation	  of	   the	  vernalisation	  response,	  and	   in	  
particular	   in	   the	  maintenance	  of	  FLC	   (FLOWERING	   LOCUS	  C)	   repression	   after	   cold	   treatment	  
(Gendall	  et	  al.,	  2001,	  De	  Lucia	  et	  al.,	  2008).	   In	  addition	  to	  VRN2,	  the	  PRC2	  includes	  two	  PHD-­‐
finger	  proteins	  VERNALIZATION	  5	   (VRN5)	  and	  VERNALIZATION	   INSENSITIVE	  3	   (VIN3)	   (Greb	  et	  
al.,	  2007,	  De	  Lucia	  et	  al.,	  2008,	  Wood	  et	  al.,	  2006).	  Whereas	  VRN2	  is	  constitutively	  associated	  
with	  the	  FLC	   locus,	  VRN5	  associates	  (in	  a	  VIN3-­‐dependent	  manner)	  with	  intron	  1	  of	  FLC	  upon	  
cold-­‐treatment,	   before	   re-­‐distributing	   to	   a	   more	   FLC-­‐wide	   pattern	   after	   a	   return	   to	   warm	  
conditions	  (De	  Lucia	  et	  al.,	  2008).	  
Interestingly,	  VRN5	  has	  been	   reported	   to	  be	   involved	   in	   leaf,	  petal	  and	  silique	  development,	  
with	   vrn5	  mutants	   shown	   to	   have	   curled	   leaves,	   an	   increase	   in	   petal	   number	   and	   distorted	  
siliques	  (Greb	  et	  al.,	  2007).	   It	  has	  also	  been	  reported	  that	  vrn2	  plants	  exhibit	   increased	  petal	  
210	  
area	   and	   an	   increase	   in	   petal	   number	   compared	   to	   the	   wild-­‐type	   (Caroline	   Dean,	   personal	  
communication).	  Both	  VRN2	  and	  VRN5	  are	  members	  of	  a	  polycomb	  group	  complex	  involved	  in	  
the	  epigenetic	  regulation	  of	  gene	  expression	  (Wood	  et	  al.,	  2006,	  Gendall	  et	  al.,	  2001,	  De	  Lucia	  
et	   al.,	   2008),	   and	   it	   is	   therefore	   possible	   that	   their	   influence	  on	   gene	   expression	   extends	   to	  




Peak	  SNP	  (Kb)	   Gene	  Name	  
	   	   	  
AT4G16780	   -­‐21491	   ARABIDOPSIS	  THALIANA	  HOMEOBOX	  PROTEIN	  2,	  	  ATHB-­‐2	  
AT4G16790	   -­‐19000	   Hydroxyproline-­‐rich	  glycoprotein	  family	  protein	  
AT4G16800	   -­‐15492	   ATP-­‐dependent	  caseinolytic	  (Clp)	  protease/crotonase	  family	  protein	  
AT4G16807	   -­‐13064	   Unknown	  protein	  
AT4G16810	   -­‐10358	   VEFS-­‐Box	  of	  polycomb	  protein	  
AT4G16820	   -­‐3080	   PHOSPHOLIPASE	  A	  I	  BETA	  2,	  	  PLA-­‐I{BETA]2	  
AT4G16830	   70	   Hyaluronan	  /	  mRNA	  binding	  family	  protein	  
AT4G16835	   2364	   Tetratricopeptide	  repeat	  (TPR)-­‐like	  superfamily	  protein	  
AT4G16840	   3785	   Unknown	  protein	  
AT4G16845	   6591	   REDUCED	  VERNALIZATION	  RESPONSE	  2,	  VRN2	  
AT4G16850	   9488	   Unknown	  protein	  
AT4G16855	   11019	   Unknown	  protein	  
AT4G16860	   20722	   RECOGNITION	  OF	  PERONOSPORA	  PARASITICA	  4,	  	  RPP4	  
	  
	  
In	   addition	   to	   regulating	   the	   vernalisation	   response,	   PcG	   proteins	   have	   been	   shown	   be	  
involved	   in	   seed	   development.	   They	   are	   known	   to	   play	   a	   role	   in	   the	   repression	   of	   genes	  
involved	   in	   promoting	   precocious	   endosperm	   proliferation	   and	   genes	   involved	   in	   the	  
promotion	   of	   proliferation	   of	   the	   embryo	   and	   endosperm	   after	   fertilisation	   (Bemer	   and	  
Table	  6.4–	  Association	  interval	  around	  Chr4-­‐9471419	  
List	  of	  genes	  within	  20Kb	  of	  peak	  SNP	  Chr4-­‐9471419;	  genes	  within	  10Kb	  are	  in	  bold.	  Distances	  are	  
calculated	  from	  middle	  of	  gene	  to	  peak	  SNP	  
	  
211	  
Grossniklaus,	  2012,	  Köhler	  and	  Makarevich,	  2006,	  Grossniklaus	  et	  al.,	  2001).	  The	  PcG	  complex	  
involved	   in	   regulating	   seed	   growth	   consists	   of	   at	   least	   four	   proteins:	   MEDEA	   (MEA),	  
FERTILIZATION	   INDEPENDENT	   ENDOSPERM	   2	   (FIE),	   FERTILIZATION	   SEEDS	   2	   (FIS2)	   and	  
MULTICOPY	   SUPPRESSOR	   OF	   IRA	   1-­‐5	   (MSI1-­‐5)	   (Bemer	   and	   Grossniklaus,	   2012,	   Köhler	   and	  
Makarevich,	  2006,	  Luo	  et	  al.,	  1999,	  Ohad	  et	  al.,	  1999,	  Grossniklaus	  et	  al.,	  1998,	  Köhler	  et	  al.,	  
2003);	   with	  MEA	   and	   FIS2	   also	   serving	   as	   subunits	   in	   the	   VRN2-­‐PRC2	   complex	   (Bemer	   and	  
Grossniklaus,	  2012).	   In	  addition,	  MEA	  and	  FIS2	  also	   form	  part	  of	  a	  PcG	  complex	  with	  CURLY-­‐
LEAF	  (CLF)/SWINGER	  (SWN)	  and	  EMBRYONIC	  FLOWER	  2	  (EMF2)	  (Katz	  et	  al.,	  2004,	  Bemer	  and	  
Grossniklaus,	   2012,	   Chanvivattana	   et	   al.,	   2004).	   Interestingly,	  CLF	   promotes	   the	   rates	   of	   cell	  
proliferation	  and	  cell	  expansion	  in	  in	  the	  developing	  leaf,	  with	  clf	  mutants	  exhibiting	  a	  curled-­‐
leaf	  phenotype	  and	  a	  reduction	  in	  petal	  size	  in	  the	  second	  whorl	  (Kim	  et	  al.,	  1998a,	  Krizek	  et	  al.,	  
2006).	  CLF	  is	  also	  involved	  in	  the	  AGAMOUS-­‐dependent	  repression	  of	  WUSCHEL	  (WUS)	  (Liu	  et	  
al.,	  2011),	  suggesting	  that	  it	  may	  be	  involved	  in	  the	  regulation	  of	  meristem	  size	  (Schoof	  et	  al.,	  
2000,	  Bleckmann	  et	  al.,	  2010),	  and	  as	  a	  consequence	  floral	  organ	  number	  (Schoof	  et	  al.,	  2000).	  
Interestingly,	  yeast-­‐2-­‐hybrid	  data	  reveals	  a	  physical	  interaction	  between	  the	  C5	  domain	  of	  CLF	  
and	  the	  VEFS	  domain	  of	  VRN2	  (Chanvivattana	  et	  al.,	  2004),	  suggesting	  that	  the	  VRN2	  may	  be	  
able	  to	  influence	  petal	  number	  and	  size	  via	  interactions	  with	  CLF.	  	  
Further	   than	  10Kb	   from	  the	  peak	  SNP	   (Ch4-­‐9471419)	  are	  additional	  genes	   that	  have	   links	   to	  
organ	   growth	   and	   development,	   including	   ARABIDOPSIS	   THALIANA	   HOMEOBOX	   PROTEIN	   2	  
(ATHB2),	   a	   Class	   II	   homeodomain-­‐leucine	   zipper	   gene	   that	   is	   regulated	   by	   far-­‐red	   light	  
(Carabelli	  et	  al.,	  1993,	  Morelli	  and	  Ruberti,	  2002).	  Over-­‐expression	  of	  ATHB2	  results	   in	  longer	  
hypocotyls,	  smaller	  cotyledons	  and	  fewer,	  smaller	  leaves	  (Steindler	  et	  al.,	  1999,	  Schena	  et	  al.,	  
1993).	   The	   reduced	   cotyledon	   size	   is	   due	   to	   a	   reduction	   in	   cell	   expansion,	   whereas	   the	  
elongation	  of	  hypocotyls	  is	  due	  to	  increased	  cell	  expansion	  (Steindler	  et	  al.,	  1999).	  ATHB2	  also	  
negatively	  regulates	  cell	  proliferation	   in	  the	  root	  (Steindler	  et	  al.,	  1999),	  revealing	  that	   it	  can	  
influence	  both	  cell	  expansion	  and	  cell	  proliferation.	  More	  recently,	  ATHB2	  has	  been	  shown	  to	  
influence	  adaxial-­‐abaxial	  polarity	  in	  the	  developing	  leaf	  (Bou-­‐Torrent	  et	  al.,	  2012,	  Turchi	  et	  al.,	  
2013).	  Taken	  together,	   these	  data	  show	  that	  ATHB2	  controls	   the	  development	  of	   leaves	  and	  
the	  setting	  of	  final	  leaf	  size	  in	  Arabidopsis.	  Due	  to	  the	  similarities	  that	  exist	  between	  leaf	  and	  
petal	  development	  (see	  Chapter	  1),	  it	  is	  possible	  that	  ATHB2	  may	  also	  influence	  petal	  size	  and	  
therefore	  be	  causal	  for	  the	  variation	  observed	  in	  this	  GWAs	  for	  petal	  length.	  
Additional	  candidate	  genes	  include	  the	  RPP5	  (RECOGNITION	  OF	  PERONOSPORA	  PARASITICA	  5)	  
cluster	   of	   seven	   (Toll	   Interleukin1	   receptor-­‐nucleotide	   binding-­‐Leucine-­‐rich-­‐repeat)	   TIR-­‐NBS-­‐
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LRR	  class	  resistance	  (R)	  genes	  (Yi	  and	  Richards,	  2007)	  that	  are	  located	  20Kb	  downstream	  of	  the	  
peak	  SNP.	  The	  closest	  of	  these	  genes	  to	  the	  peak	  SNP	  is	  RPP4,	  which	  like	  its	  ortholog,	  RPP5,	  is	  
essential	   for	   resistance	   to	  Peronospora	   parasitica	   (Van	  Der	  Biezen	  et	   al.,	   2002,	   Parker	   et	   al.,	  
1993).	   Also	   in	   the	   RPP5	   cluster	   and	   within	   30Kb	   of	   Ch4-­‐9471419	   is	   SUPRESSOR	   OF	   NPR1-­‐1	  
(SNC1),	  a	  TIR-­‐NBS-­‐LRR	  R	  gene	  that	  promotes	  the	  expression	  of	  pathogenesis-­‐related	  genes	  and	  
whose	  gain	  of	  function	  mutant	  has	  a	  dwarfed	  phenotype	  (Li	  et	  al.,	  2001,	  Zhang	  et	  al.,	  2003).	  	  
6.4.3	  –	  A	  SNP	  at	  Chr1:6666179	  associates	  with	  SE	  mean	  petal	  area.	  
The	  following	  section	  briefly	  describes	  data	  that	  suggest	  that	  an	  allele	  of	  DA1	  might	  associate	  
with	   the	   phenotype	   –	   SE	   mean	   petal	   area.	   This	   section	   of	   the	   GWA	   study	   is	   still	   on-­‐going,	  
therefore	  these	  data	  must	  be	  considered	  preliminary.	  Nonetheless,	  the	  data	  appear	  to	  confirm	  
predictions	  made	   in	  Chapter	  1	  that	  genetic	  variation	  at	  the	  DA1	   locus	  might	  be	   involved	   in	  a	  
size-­‐sensing	  mechanism	  during	  petal	  growth.	  
Fig.	  6.10f	  shows	  a	  large	  peak	  in	  chromosome	  1	  (indicated	  by	  ‘*’	  and	  the	  second	  largest	  peak	  in	  
the	  whole	  study),	  indicating	  a	  strong	  association	  between	  a	  region	  of	  chromosome	  1	  and	  the	  
SE	  mean	  petal	  area	  phenotype.	  The	  peak	  SNP	  (Chr1:6666179)	  has	  a	  LOD	  score	  of	  5.23.	  At	  the	  
time	   of	   writing,	   the	   significance	   thresholds	   had	   not	   been	   calculated	   for	   this	   phenotype,	  
however	   the	   average	   per-­‐chromosome	   p<0.10	   and	   p<0.05	   significance	   thresholds	   for	  
chromosome	  1	  for	  the	  four	  tested	  phenotypes	  are	  LOD=4.73	  and	  LOD=5.06	  respectively.	  These	  
values	  are	  encouraging	  as	  they	  suggest	  that	  the	  peak	  SNP	  (Chr1:6666179)	  associates	  with	  the	  
SE	  mean	  petal	   area	  phenotype	  with	   a	   significance	  of	   p<0.05.	   Currently,	   the	   influence	  of	   the	  
associating	  haplotype	  on	  this	  phenotype	  is	  unknown.	  	  
The	   peak	   SNP	   (Chr1:6666179)	   is	   located	   150bp	   downstream	   of	   the	   3’	   UTR	   of	   DA1.	   Genes	  
within	  20Kb	  of	  this	  SNP	  are	  shown	  in	  Table	  6.5.	  Within	  10Kb	  of	  the	  peak	  SNP	  are	  two	  genes	  of	  
interest:	  DA1	   and	  ATGATL1	   (GALACTURONOSYLTRANSFERASE-­‐LIKE	  1).	  AGATL1	   is	   located	  5Kb	  
from	   the	   peak	   SNP	   and	   encodes	   a	   galacturonosyltransferase	   involved	   in	   carbohydrate	  
metabolism	   (Shao	  et	  al.,	   2004).	   Loss	  of	   function	  of	  ATGATL1	   results	   in	  a	  dwarfed	  phenotype	  
with	  smaller	  leaves	  and	  smaller	  floral	  organs,	  which	  is	  thought	  to	  be	  a	  consequence	  of	  cell	  wall	  





Peak	  SNP	  (Kb)	   Gene	  Name	  
AT1G19230	   -­‐19474	   Riboflavin	  synthase-­‐like	  superfamily	  protein	  
AT1G19240	   -­‐16348	   Unknown	  protein	  
AT1G19250	   -­‐14376	   FLAVIN-­‐DEPENDENT	  MONOOXYGENASE	  1,	  FMO1	  
AT1G19260	   -­‐7765	   TTF-­‐type	  zinc	  finger	  protein	  
At1G19270	   -­‐1915	   DA1	  
At1g19290	   1427	   Pentatricopeptide	  repeat	  (PPR)	  superfamily	  protein	  
AT1G19300	   5716	   ATGATL1,	  GALACTURONOSYLTRANSFERASE-­‐LIKE	  1	  
AT1G19310	   10775	   RING/U-­‐box	  superfamily	  protein	  
AT1G19320	   13588	   Pathogenesis-­‐related	  thaumatin	  superfamily	  protein	  
AT1G19330	   15869	   unknown	  protein;	  
AT1G19340	   19755	   Methyltransferase	  MT-­‐A70	  family	  protein;	  
	  
	  
The	  SE	  phenotypes	  included	  in	  this	  assay	  were	  intended	  to	  map	  genes	  with	  roles	  in	  ‘buffering’	  
the	  variation	  in	  organ	  size	  (see	  section	  6.2.3),	  such	  that	  altered	  function	  would	  lead	  to	  altered	  
variation	  in	  organ	  size.	  Screening	  for	  mean	  organ	  size	  is	  likely	  to	  identify	  genes	  involved	  in	  all	  
aspects	  of	  growth	  control,	  including	  genes	  involved	  in	  sensing	  mechanisms	  and	  genes	  involved	  
in	   core	   growth	   processes,	   such	   as	   cell	   division	   and	   cell	   expansion.	   Conversely,	   screening	   for	  
genes	   involved	   in	   determining	   the	   regularity	   of	   organ	   size	   could	   tend	   to	   identify	   genes	   that	  
play	  a	  role	  in	  sensing	  organ	  size.	  The	  phenotypes	  of	  the	  da1-­‐1	  and	  da1ko1	  mutants	  have	  been	  
well	   described	   in	   this	   thesis	   as	   well	   as	   in	   recent	   publications	   (Xia,	   2013,	   Li	   et	   al.,	   2008),	  
confirming	   that	   knockout	  of	   the	  DA1	   gene	   is	   sufficient	   to	   interfere	  with	  organ	  development	  
and	   the	   setting	   of	   organ	   size.	   It	   is	   also	   possible	   to	   speculate	   that,	   because	   da1-­‐1	   and	  
da1ko1/dar1-­‐1	  mutations	   are	  unable	   to	  be	   compensated	   (Li	   et	   al.,	   2008),	  DA1	   is	   involved	   in	  
some	  way	  in	  a	  size	  sensing	  pathway	  in	  developing	  organs	  (discussed	  in	  section	  1.5.4).	  The	  data	  
Table	  6.5	  –	  Association	  interval	  around	  Chr1-­‐6666179	  
List	  of	  genes	  within	  20Kb	  of	  peak	  SNP	  Chr1-­‐6666179;	  genes	  within	  10Kb	  are	  in	  bold.	  Distances	  are	  
calculated	  from	  middle	  of	  gene	  to	  peak	  SNP	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described	   in	   this	   section,	   which	   suggest	   that	   DA1	   might	   be	   involved	   in	   controlling	   the	  
regularity	  of	  organ	  size	  in	  natural	  populations	  of	  Arabidopsis,	  supports	  these	  predictions.	  
Moreover,	  if	  indeed	  a	  DA1	  allele	  is	  casual	  in	  this	  association,	  interrogation	  of	  the	  genomes	  of	  
the	  relevant	  accessions	  may	  uncover	  novel	  allelic	  variation	  in	  DA1.	  Such	  variation	  would	  permit	  
further	  genetic	  and	  biochemical	  investigation	  of	  DA1,	  and	  potentially	  yield	  new	  insights	  into	  
DA1	  enzymology	  and	  interactomics.	  For	  these	  reasons,	  pursuing	  this	  line	  of	  research	  is	  a	  
priority.	  
6.4.4	  –	  Future	  work	  
So	   far,	   this	   chapter	   documents	   the	   growth	   and	   phenotyping	   of	   a	   mapping	   population,	   the	  
investigation	   of	   phenotype-­‐genotype	   associations,	   the	   identification	   of	   associations,	   and	   the	  
subsequent	  identification	  of	  possible	  candidate	  genes.	  This	  work	  will	  be	  immediately	  followed	  
by	   the	   analysis	   of	   knock-­‐out	   mutations	   in	   candidate	   genes,	   as	   well	   as	   quantitative	  
complementation	  crosses	  of	  these	  alleles.	  Candidate	  genes	  include	  VRN2.	  
6.5	  –	  Future	  perspectives	  
As	   set	   out	   in	   section	   6.1,	   this	   chapter	   is	   a	   parallel,	   complementary	   project	   to	   the	   DA1	  
functional	   analysis	   reported	   in	  Chapters	  3-­‐5.	   The	  work	   in	   this	   chapter	  was	   commenced	   later	  
during	   my	   research	   programme	   and	   consequently	   some	   analyses	   are	   still	   underway.	   As	  
discussed	   in	   sections	   6.3	   and	   6.4,	   the	   MAGIC	   and	   GWA	   analyses	   have	   generated	   several	  
promising	  leads	  around	  which	  future	  research	  efforts	  can	  be	  built.	  
The	  MAGIC	  analysis	  of	  seed	  phenotypes	  has	  identified	  8	  QTL	  for	  mean	  seed	  area,	  identifying	  a	  
list	  of	  candidate	  genes	  which	  include	  a	  priori	  growth	  regulators	  including	  DA2	  and	  TCP15;	  both	  
of	  which	   are	   of	  wider	   relevance	   to	   this	   thesis	   (Chapters	   4	   and	   5	   respectively).	   The	  QTL	   also	  
include	  potential	  de	  novo	  candidates	  involved	  in	  many	  aspects	  of	  organ	  size	  control,	  including	  
the	  brassinosteroid	  response,	  the	  cell	  cycle	  and	  the	  regulation	  of	  seed	  development.	  	  
The	   GWA	   analysis	   has	   identified	   a	   genomic	   region	   in	   chromosome	   4	   that	   associates	   with	  
phenotypic	   variation	   in	   petal	   length	   and	   a	   region	   of	   chromosome	   1	   that	   associates	  with	   SE	  
petal	   area.	   The	   former	   region	   includes	   pathogen	   response	   and	   shade	   avoidance	   response	  
genes,	  both	  with	   links	  to	  the	  regulation	  of	  growth	  and	  development.	  Of	  particular	   interest	   is	  
the	   identification	   of	  VRN2	   as	   a	   promising	   candidate	   and	   the	   observation	   that	   mutations	   in	  
other	  members	   of	   PRC2	   can	   result	   in	   petal	   and	   seed	   growth	  phenotypes	   (Greb	   et	   al.,	   2007,	  
Chanvivattana	  et	  al.,	  2004,	  Kim	  et	  al.,	  1998a,	  Katz	  et	  al.,	  2004).	  The	  region	  of	  chromosome	  1	  
that	   associates	   with	   SE	   petal	   area	   includes	   two	   genes	   with	   organ	   size	   phenotypes,	  AGATL1	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(Shao	  et	  al.,	  2004)	  and	  DA1	  (Li	  et	  al.,	  2008).	  The	  inability	  of	  cell	  expansion	  rates	  to	  compensate	  
for	  an	  increased	  duration	  of	  cell	  proliferation	  during	  organ	  growth	  in	  da1-­‐1	  mutants	  suggests	  
that	   DA1	   may	   be	   involved	   in	   a	   size	   sensing	   mechanism	   in	   the	   developing	   organ.	   The	  
identification	  of	  DA1	  as	  a	  candidate	  in	  the	  association	  with	  SE	  petal	  area,	  suggests	  that	  natural	  
variation	  at	  the	  DA1	  locus	  has	  a	  role	   in	  regulating	  the	  uniformity	  of	  organ	  size	   in	  Arabidopsis	  
populations.	  
Future	   work	   will	   involve,	   as	   outlined	   in	   sections	   6.3	   and	   6.4,	   determining	   the	   genotype	  
contribution	  to	  the	  phenotypic	  variation,	  which	  will	  help	  to	  understand	  the	  relative	  influence	  
of	   the	   variation	   at	   that	   particular	   locus.	   Future	   work	   will	   also	   test	   the	   influence	   of	   the	  
identified	   candidate	   genes	   (and	   their	   constituent	   SNPs)	   on	   the	   phenotypes	   in	   question.	  
Currently,	   work	   is	   underway	   to	   perform	   quantitative	   complementation	   crosses	   with	   the	  
candidate	  genes	  identified	  in	  this	  thesis.	  
The	  work	  in	  this	  chapter	  has	  established	  a	  platform	  for	  future	  gene	  discovery	  and	  provides	  lists	  









The	  work	  documented	  in	  this	  thesis	  has	  shed	  light	  on	  two	  key	  areas	  of	  DA1	  biology.	  Firstly,	  a	  
biochemical	   study	   of	   the	   DA1	   protein	   has	   demonstrated	   that	   it	   is	   an	   ubiquitin-­‐dependent	  
metallopeptidase,	  with	  a	  potentially	  enhancing	  activity	  towards	  the	  two	  E3	  ligases,	  EOD1	  and	  
DA2.	   Secondly,	   an	   investigation	   of	   DA1	   interacting	   partners	   has	   revealed	   that	   DA1	   has	   the	  
potential	   to	   function	   in	   several	   growth	   control	   pathways,	   which	   overlap	   both	   organ	  
development	  and	  pathogen	  response.	  
The	   biochemical	   analyses	   have	   revealed	   a	   novel	   regulatory	   feed-­‐forward	   loop	   between	   two	  
RING	  E3	   ligases	  and	  an	   interacting	  peptidase.	  This	  would	  be	   the	   first	   time	   that	  an	  ubiquitin-­‐
activated	   peptidase	   has	   been	   shown	   to	   regulate	   the	   activity	   of	   an	   E3	   ligase,	   and	   presents	   a	  
novel	  regulatory	  mechanism	  whose	  significance	  may	  extend	  as	  far	  as	  the	  field	  of	  human	  cancer	  
biology.	  In	  terms	  of	  higher	  plants	  however,	  the	  interactomic	  analysis	  in	  Chapter	  4	  suggests	  that	  
peptidase-­‐mediated	   regulation	   by	   members	   of	   the	   DA1	   family	   may	   play	   a	   role	   in	   both	  
pathogen-­‐related	  and	  developmental	  growth	  regulation.	  
Finally,	   the	   identification	  of	  DA1	   in	   a	   genome	  wide	  association	  analysis	   for	   variation	   in	   seed	  
and	  organ	  size	  has	  demonstrated	  that	  natural	  allelic	  variation	  in	  DA1	  may	  contribute	  to	  fitness	  
and	  adaptation	  of	  populations	  in	  the	  natural	  landscape.	  	  
7.1	  –	  DA1,	  EOD1	  and	  DA2:	  molecular	  characterisation	  
7.1.1	  –	  DA1:	  a	  ubiquitin	  activated	  peptidase	  
The	   biochemical	   analyses	   documented	   in	   Chapter	   5	   revealed	   that	   the	   predicted	  
metallopeptidase	   domain	   in	   DA1	   is	   active	   towards	   EOD1	   and	   DA2.	   Importantly,	   it	   also	  
demonstrates	   that	   its	   activity	   is	   dependent	   on	   the	   ubiquitination	   of	  DA1.	   This	   suggests	   that	  
native,	  full-­‐length	  DA1	  exists	  in	  an	  auto-­‐repressive	  state,	  which	  is	  disrupted	  by	  the	  addition	  of	  

















Evidence	  that	  DA1	  UIM2	  binds	  mono-­‐ubiquitin	   in	  vitro	  suggests	  that	  the	  ubiquitin-­‐dependent	  
activation	  of	  DA1	  could	  occur	  through	  interaction	  between	  the	  DA1	  UIMs	  and	  cis-­‐ubiquitin,	  in	  
a	  mechanism	   similar	   to	   that	   observed	   for	   coupled	  mono-­‐ubiquitination	   (Woelk	   et	   al.,	   2006,	  
Haglund	  and	  Stenmark,	  2006,	  Hoeller	  et	  al.,	  2006).	   Indeed,	  ubiquitination	  of	   the	  mammalian	  
UBD-­‐containing	  proteins,	  STS1,	  STS2,	  EPS15	  and	  HRS	  results	  in	  UBD-­‐cis-­‐ubiquitin	  interactions,	  
which	   generate	   a	   change	   in	   protein	   confirmation	   (Hoeller	   et	   al.,	   2006).	   Based	   on	   this	  
observation,	   it	   is	   reasonable	   to	   suggest	   that	   the	   ubiquitination	   of	   DA1	   might	   trigger	   an	  
interaction	  between	   the	  DA1	  UIMs	  and	  cis-­‐ubiquitin,	   the	   result	  of	  which	  would	  cause	  a	  DA1	  
conformational	  change	  and	  thereby	  de-­‐repress	  metallopeptidase	  activity.	  	  
In	   support	   of	   this	   is	   the	   observation	   that	   the	   UIM	   of	   the	   yeast	   transcription	   factor	   MET4	  
interacts	  with	  cis-­‐ubiquitin,	  such	  that	  the	  interaction	  limits	  the	  cis-­‐ubiquitin	  chain	  to	  only	  four	  
Figure	  7.1	  –	  A	  model	  for	  the	  activation	  of	  the	  DA1	  peptidase	  by	  coupled	  ubiquitination	  
Native	  DA1	  exists	  in	  an	  auto-­‐inhibited	  conformation	  (A),	  possibly	  due	  to	  an	  interaction	  between	  
the	  LIM	  domain	  and	  the	  C-­‐terminal	  peptidase.	  Ligation	  of	  a	  short	  ubiquitin	  chain	  to	  an	  as	  yet	  
unknown	  region	  of	  the	  protein	  might	  cause	  an	  interaction	  between	  the	  DA1	  UIM	  domains	  and	  
this	  cis-­‐ubiquitin	  chain	  (B).	  This	  interaction	  might	  result	  in	  a	  conformational	  change	  that	  releases	  




ubiquitin	  molecules	  (Flick	  et	  al.,	  2006).	  Thus	  the	  observation	  that	  EOD1	  and	  DA2	  are	  only	  able	  
to	  ligate	  short	  chains	  onto	  DA1,	  in	  spite	  of	  their	  ability	  to	  auto-­‐poly-­‐ubiquitinate,	  suggests	  that	  
the	  DA1	  UIM	  may	  interact	  with,	  and	  cap	  cis-­‐ubiquitin	  chain	  elongation.	  
Interestingly,	   in	   some	  proteins	   the	  presence	  of	   a	  UBD	  has	  been	   shown	   to	  be	  necessary	  and	  
sufficient	  for	  their	  coupled	  mono-­‐ubiquitination	  (Woelk	  et	  al.,	  2006).	  In	  addition	  to	  interacting	  
with	   cis-­‐ubiquitin,	   the	   UIM	   of	   EPS15	   interacts	  with	   an	   ubiquitin	  molecule	   on	   its	   cognate	   E3	  
ligase;	  an	  event	  that	  is	  necessary	  for	  EPS15	  ubiquitination	  (Woelk	  et	  al.,	  2006).	  This	  is	  thought	  
to	  represent	  EPS15	  recruiting	  its	  cognate	  E3	  ligase	  such	  that	  an	  interaction	  can	  occur	  (Woelk	  et	  
al.,	  2006).	  It	  is	  therefore	  possible	  that	  as	  well	  as	  acting	  as	  a	  cis-­‐regulatory	  domain,	  the	  UIM	  in	  
DA1	  may	  act	  to	  mediate	  the	  interaction	  between	  DA1	  and	  its	  cognate	  E3	  ligases.	  	  
Although	  the	  UIM	  domain	  is	  a	  good	  candidate	  for	  regulating	  DA1	  peptidase	  activity	  through	  a	  
coupled	   mono-­‐ubiquitination-­‐like	   mechanism,	   the	   LIM	   domain	   is	   a	   good	   candidate	   for	   a	  
putative	   peptidase	   interaction	   domain.	   Although	   LIM	   domains	   have	   been	   characterised	   as	  
general	   protein-­‐protein	   interacting	   interfaces	   (Maul	   et	   al.,	   2003,	   Shirasaki	   and	   Pfaff,	   2002,	  
Moes	  et	  al.,	  2012),	  it	  is	  possible	  that	  the	  DA1	  LIM	  domain	  regulates	  peptidase	  activity	  through	  
a	  similar	  mechanism	  to	  that	  of	  the	  LIM	  domain	  of	  LIM	  KINASE-­‐1	  (LIMK-­‐1)	  (Nagata	  et	  al.,	  1999).	  
LIMK-­‐1	  auto-­‐regulates	   its	  kinase	  activity	  through	  a	  direct	   interaction	  between	  its	  LIM	  domain	  
and	   its	   kinase	   domain	   (Nagata	   et	   al.,	   1999).	   The	   identification	   of	   a	   LIM-­‐like	   domain	   in	   DA1	  
family	   members	   (section	   3.2.5)	   presents	   the	   possibility	   that	   the	   LIM-­‐like	   domain	   may	   also	  
regulate	  peptidase	  activity.	  Evidence	  for	  this	  comes	  from	  the	  observation	  that	  mutation	  of	  the	  
DAR4/CHS3	   LIM-­‐like	   domain	   is	   sufficient	   to	   constitutively	   ‘activate’	   the	   resistance	   responses	  
(Bi	   et	   al.,	   2011).	   DAR4/CHS3	   is	   involved	   in	   disease	   responses,	   and	   a	   single	   mutation	   in	   a	  
conserved	   cysteine	   residue	   in	   its	   LIM-­‐like	   domain	   is	   sufficient	   to	   constitutively	   activate	  
immune	  responses	  (Bi	  et	  al.,	  2011).	  Assuming	  that	  (as	  with	  DA1)	  the	  DAR4	  peptidase	  domain	  is	  
functional	  and	  responsible	  for	  the	  activation	  of	  defence	  responses,	  then	  constitutive	  activation	  
of	  an	  immune	  response	  may	  be	  a	  consequence	  of	  its	  constitutive	  peptidase	  activity.	  It	  follows	  
therefore	  that	  mutation	  of	  the	  LIM-­‐like	  domain	  may	  be	  sufficient	  to	  de-­‐repress	  the	  peptidase.	  
These	   observations	   suggest	   a	   model	   that	   explains	   the	   regulation	   of	   DA1	   peptidase	   activity	  
through	  the	  coupled-­‐mono-­‐ubiquitination	  mediated	  de-­‐repression	  of	  LIM-­‐mediated	  repression	  
of	  peptidase	  activity	  (figure	  7.1).	  
The	  model	   in	   Fig.	   7.1	   also	   predicts	   how	   the	   da1-­‐1	   R358K	  mutation	   could	   abrogate	   peptidase	  
function.	   This	   amino	   acid	   change	   is	  within	   the	   highly	   conserved	  C-­‐terminal	   region	   60	   amino	  
acids	   upstream	   of	   the	   peptidase	   active	   site	   (Li	   et	   al.,	   2008).	   In	   vitro	   and	   in	   vivo	   data	   from	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Chapter	   5	   revealed	   that	   mutation	   of	   the	   peptidase	   active	   site	   is	   sufficient	   to	   abolish	   DA1	  
peptidase	  activity	  towards	  EOD1	  and	  DA2.	  It	  is	  therefore	  possible	  that	  the	  da1-­‐1	  mutation	  may	  
also	  reduce	  peptidase	  function.	  This	  can	  be	  readily	  tested	  by	  incorporating	  the	  da1-­‐1	  protein	  
into	  the	  in	  vitro	  and	  in	  vivo	  peptidase	  activity	  assays	  described	  in	  section	  5.3.	  	  
The	   model	   also	   predicts	   that	   abrogation	   of	   LIM	   or	   LIM-­‐like	   function	   may	   be	   sufficient	   to	  
constitutively	   activate	   the	   DA1	   peptidase,	   and	   abrogation	   of	   UIM	   function	   may	   be	   able	   to	  
constitutively	   inactivate	   the	  peptidase.	  This	   could	  be	  directly	   tested	  using	   the	   in	  vitro	   and	   in	  
vivo	  peptidase	  activity	  assays	  (section	  5.3)	  using	  the	  DA1uim12	  mutant	  (full	   length	  DA1,	  with	  
both	  UIMs	  mutated)	  and	  the	  DA1lim8	  mutant	  proteins.	  An	  alternate	  but	  not	  exclusive	  function	  
for	  the	  UIMs	  may	  be	  to	  recognise	  ubiquitinated	  E2	  or	  EOD1,	  or	  both.	  
The	   demonstration	   that	   DA1	   is	   an	   ubiquitin-­‐dependent	   peptidase	   is	   important	   for	  
understanding	   the	   functions	   of	   other	  members	   of	   the	  DA1	   family.	   It	   is	   also	   one	   of	   the	   first	  
examples	  of	  a	  well-­‐characterised	  regulatory	  peptidase	  in	  plants	  and	  emphasises	  the	  significant	  
broader	  roles	  of	  peptidases	   in	  regulating	  diverse	  plant	  processes,	  such	  as	  the	  role	  of	  SOL1	  (a	  
Zn-­‐carboxypeptidase)	  in	  the	  regulation	  of	  meristem	  development	  (Casamitjana-­‐Martınez	  et	  al.,	  
2003).	  All	  DA1	  family	  members	  contain	  a	  LIM	  domain	  and	  a	  highly	  conserved	  C-­‐terminal	  region	  
with	   a	  metallopeptidase	   active	   site	   	   (Fig.	   3.1),	   with	   the	   LIM	   domain	   providing	   a	   postulated	  
auto-­‐regulatory	   function.	   Regardless	   of	   the	   involvement	   of	   the	   LIM	   domain	   in	   peptidase	  
regulation,	  the	  demonstration	  in	  this	  thesis	  that	  the	  DA1	  peptidase	  is	  active,	  suggests	  that	  all	  
other	  DA1	  family	  members	  might	  function	  through	  their	  peptidase	  domains.	  So	  far	  DAR1	  has	  
been	   characterised	  as	   a	   regulator	  of	  organ	   size	   (Li	   et	   al.,	   2008),	  DAR2	  as	   a	   regulator	  of	   root	  
meristem	  size	  (Peng	  et	  al.,	  2013),	  and	  DAR4	  as	  an	  R-­‐protein	  and	  regulator	  of	  freezing	  tolerance	  
(Yang	  et	  al.,	  2010,	  Bi	  et	  al.,	  2011).	  Whether	  or	  not	   these	  proteins	   interact	  with	   their	  own	  E3	  
ligases,	   the	   insight	   developed	   in	   this	   thesis	   is	   likely	   to	   accelerate	   the	   understanding	   of	   the	  
molecular	   basis	   of	   their	   phenotypes	   and	   provide	   further	   information	   on	   a	   novel	   regulatory	  
mechanism.	  
Taking	  DAR4/CHS3	  as	  an	  example,	  recent	  work	  concluded	  that	  the	  LIM	  domain	  may	  act	  as	  an	  
intra-­‐molecular	  repressor	  of	  DAR4/CHS3	  R-­‐protein	  activity	   (Bi	  et	  al.,	  2011,	  Yang	  et	  al.,	  2010).	  
However,	   the	   lack	   of	   information	   regarding	   C-­‐terminal	   peptidase	   function	   led	   to	   the	  
hypothesis	   that	   the	   LIM	   domain	   interacts	   with,	   and	   represses	   some	   aspect	   of	   N-­‐terminal	  
protein	  function	  (Bi	  et	  al.,	  2011).	  Although	  this	  may	  indeed	  be	  the	  case,	  the	  identification	  of	  an	  
active	  peptidase	   in	  the	  C-­‐terminus	  of	  DA1	   leads	  to	  the	  prediction	  that	  the	  DAR4	  peptidase	   is	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also	  active	  and	  therefore	  may	  be	  a	  target	  of	  LIM-­‐repression.	  This	  is	  directly	  testable	  using	  the	  
biochemical	  assays	  developed	  in	  this	  thesis.	  
This	   thesis	  presents,	   to	   the	  best	  of	  my	  knowledge,	   the	   first	   example	  of	  ubiquitin-­‐dependent	  
peptidase	  activation.	  Due	  to	  the	  essentially	   irreversible	  nature	  of	  protein	  cleavage,	  peptidase	  
activity	   must	   be	   very	   stringently	   regulated.	   For	   example,	   caspases,	   proteases	   involved	   in	  
apoptosis	   in	   animal	   systems	   (Thornberry	   and	   Lazebnik,	   1998),	   are	   proteolytically	   activated	  
(Mason	   and	   Joyce,	   2011)	   as	   well	   as	   being	   targets	   of	   phosphorylation-­‐mediated	   regulation	  
(Cardone	   et	   al.,	   1998).	   In	   plants,	   proteolysis	   and	   phosphorylation	   are	   also	   utilised	   as	  
mechanisms	  to	  regulate	  peptidase	  activity.	  For	  example,	  the	  activity	  of	  the	  26S	  proteasome	  is	  
regulated	  by	  phosphorylation	  (Kurepa	  and	  Smalle,	  2008,	  Lee	  et	  al.,	  2003,	  Umeda	  et	  al.,	  1997),	  
and	   the	   Arabidopsis	   CARBOXYPEPTIDASE	   Y	   (AtCPY)	   is	   activated	   through	   cleavage	   by	   the	  
cysteine	   protease	   VPEγ	   (VACUOLAR	   PROCESSING	   ENZYME-­‐γ)	   (Rojo	   et	   al.,	   2004,	   Rojo	   et	   al.,	  
2003).	   	   These	   examples	   highlight	   the	   existence	   of	   both	   phosphorylation-­‐	   and	   peptidase-­‐
mediated	   regulation	   of	   peptidase	   enzymes,	   however	   until	   this	   study	   there	   has	   been	   no	  
evidence	   of	   ubiquitin-­‐mediated	   regulation	   of	   peptidases.	   Nevertheless,	   the	   concept	   of	  
ubiquitin-­‐regulated	  enzyme	  activity	  is	  not	  new;	  for	  example	  poly-­‐ubiquitin	  activation	  of	  the	  E3	  
ligase	  BRCA1	   (Mallery	   et	   al.,	   2002),	   the	  K29/K33-­‐linked	  ubiquitin-­‐mediated	   regulation	  of	   the	  
NUAK1	   kinase	   (Ikeda	   and	   Dikic,	   2008,	   Al-­‐Hakim	   et	   al.,	   2008)	   and	   the	   mono-­‐ubiquitin	  
modification	  of	  the	  endocytic	  protein	  EPS15	  (Woelk	  et	  al.,	  2006,	  Hoeller	  et	  al.,	  2006)	  have	  all	  
been	  reported.	  
7.1.2	  –	  EOD1	  and	  DA2	  are	  peptidase-­‐regulated	  E3	  ubiquitin	  ligases	  
Genetic	   data	   presented	   in	   Chapter	   5,	   revealing	   that	   DA1	   synergistically	   interacts	  with	   EOD1	  
and	  DA2	  to	  influence	  petal	  and	  seed	  size,	  shows	  an	  enhancing	  interaction,	  which	  suggests	  that	  
DA1	  activity	  might	  enhance	  both	  EOD1	  and	  DA2	  functions.	  Biochemical	  data	  in	  Chapter	  5	  also	  
revealed	   that	   DA1	   peptidase	   activity	   cleaves	   EOD1	   and	   DA2.	   Taken	   together,	   these	   data	  
suggest	   that	   DA1	   might	   increase	   the	   growth-­‐repressive	   activities	   of	   these	   two	   E3	   ligases	  



















































Figure	  7.2	  –	  Models	  for	  the	  peptidase-­‐mediated	  activation	  of	  EOD1	  and	  DA2	  
(A)	   The	   E3	   ligase	   exists	   in	   a	   native	   inactive	   state	   and	  peptidase	  mediated	   cleavage	   catalytically	  
activates	   the	  E3,	   such	   that	   its	  activity	   towards	  all	   targets	   (shaded	   squares)	   is	   increased.	   (B)	  The	  
native	   E3	   is	   catalytically	   active	   but	   has	   weak	   substrate	   binding	   affinities.	   Peptidase-­‐mediated	  
cleavage	   enhances	   specific	   substrate	   binding	   affinities,	   and	   thereby	   enhances	   its	   activity	   to	  
specific	  substrates.	  (C)	  The	  native	  E3	  ligase	  is	  active,	  but	  present	  in	  a	  different	  subcellular	  location	  
to	   its	   substrates.	   Peptidase-­‐mediated	   cleavage	   results	   in	   translocation	   of	   the	   E3	   to	   the	   same	  





The	   substrates	   of	   EOD1	   and	  DA2	   E3	   ligase	   activity	   (other	   that	  DA1)	   are	   not	   yet	   known,	   and	  
therefore	   the	  biochemical	   consequences	  of	   their	   cleavage	  are	   currently	  difficult	   to	  predict.	   I	  
propose	  three	  potential	  models	   to	  guide	  experiments	  to	  determine	  how	  DA1	  might	  enhance	  
EOD1	  and	  DA2	  function:	  through	  a	  general	  increase	  in	  E3	  catalytic	  activity,	  through	  an	  increase	  
in	  catalytic	  activity	  towards	  a	  specific	  set	  of	  substrate	  proteins,	  and	  through	  a	  sub-­‐cellular	  re-­‐
localisation	  event	  that	  spatially	  enhances	  enzyme	  activity.	  
The	   importance	   of	   accurate	   spatial	   activation	   of	   enzymes	   can	   be	   seen	   with	   the	   BIN2	  
(BRASSINOSTEROID	   INSENSITIVE	   2)	   serine/threonine	   kinase,	   which	   mediates	   the	  
brassinosteroid	   response	   through	   the	   phosphorylation	   of	   the	   brassinosteroid	   responsive	  
transcription	  factors,	  BZR1	  (BRASSINAZOLE	  RESISTANT	  1)	  and	  BES1	  (BRI1	  EMS	  1)	  (Belkhadir	  and	  
Chory,	  2006,	  Vert	  and	  Chory,	  2006,	  He	  et	  al.,	  2002).	  BIN2	  is	  expressed	  throughout	  the	  cell,	  but	  
because	  BES1	  is	  constitutively	  localised	  to	  the	  nucleus,	  the	  activity	  of	  BIN2	  is	  dependent	  on	  its	  
nuclear	   localisation	   (Vert	   and	   Chory,	   2006).There	   is	   only	  weak,	   indirect	   evidence	   to	   suggest	  
that	   E3	  ubiquitin	   ligases	   are	   regulated	   in	   a	   similar	  way.	   This	   is	   evidence	   that	   the	  membrane	  
localised	  RING	  E3	   ligase	  RNF13	  undergoes	  cleavage	   that	   then	  releases	   the	  RING	  domain	   into	  
the	  cytoplasm	  and	  nucleus	  (Tranque	  et	  al.,	  1996,	  Bocock	  et	  al.,	  2010).	  Despite	  this	  observation,	  
it	   is	   unclear	   whether	   the	   cleavage	   event	   affects	   the	   activity	   of	   RNF13.	   Interestingly	   DA1-­‐
mediated	  cleavage	  of	  EOD1	  and	  DA2	  leaves	  an	  intact	  RING	  domain.	  	  
Although	  spatial	  activation	  EOD1	  and	  DA2	  remains	  a	  possibility	  (Fig.	  7.2c),	  evidence	  presented	  
in	   Chapter	   5	   suggests	   that	   post-­‐translational	   modification	   of	   EOD1	   can	   affect	   its	   catalytic	  
behaviour,	  thereby	  favouring	  other	  models	  of	  activation.	  In	  particular,	  tentative	  evidence	  that	  
EOD1	   activity	   is	   influenced	   by	   the	   addition	   of	   a	   small	   epitope-­‐tag	   to	   its	  N	   terminus	   (section	  
5.3.2)	   reveals	   a	   potential	   role	   for	   post-­‐translational	   modification	   in	   the	   regulation	   of	   EOD1	  
activity.	  This	  is	  similar	  to	  observations	  of	  the	  human	  E3	  ligase	  PARKIN,	  whose	  catalytic	  activity	  
and	   chain	   specificity	   can	   be	   altered	   through	   the	   addition	   of	  N-­‐terminal	   epitope	   tags	   and	  N-­‐
terminal	  truncations	  (Burchell	  et	  al.,	  2012,	  Chew	  et	  al.,	  2012).	  	  
Interestingly,	  as	  in	  PARKIN,	  native	  EOD1	  and	  DA2	  are	  able	  to	  auto-­‐poly-­‐ubiquitinate	  (Chew	  et	  
al.,	  2012,	  Xia,	  2013,	  Disch	  et	  al.,	  2006),	  suggesting	  that	  cleavage	  may	  not	  be	  necessary	  for	  E3	  
activity,	  but	  that	  it	  might	  required	  to	  alter	  their	  catalytic	  properties.	  In	  the	  case	  of	  PARKIN,	  N-­‐
terminal	   truncation	   alters	   the	   enzyme’s	   preference	   for	   mono-­‐ubiquitin	   and	   poly-­‐ubiquitin	  
chains	   (Chew	  et	  al.,	  2012).	  This	   likely	  reflects	  a	  change	   in	  catalytic	  geometries	  resulting	   from	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the	  modification	  of	  the	  N-­‐terminal	  substrate-­‐binding	  domain.	  Both	  PARKIN	  and	  EOD1	  have	  C-­‐


















their	  N-­‐terminal	  regions	  may	  be	   involved	   in	  substrate	  binding.	  Consequently,	  the	  cleavage	  of	  
EOD1	  might	  trigger	  changes	  to	  the	  catalytic	  geometry	  of	   its	  active	  site	  and	  alter	  substrate	  or	  
chain	  specificity	  (Fig.	  7.2b).	  Therefore	  it	  may	  be	  that	  DA1-­‐mediated	  cleavage	  of	  EOD1	  and	  DA2	  
alters	  their	  catalytic	  specificity	  (either	  substrate	  of	  chain-­‐type)	  and	  not	  their	  general	  catalytic	  
activity	  (Fig.	  7.3).	  
The	   observations	   that	   E3	   ligases	   can	   be	   regulated	   by	   post-­‐translational	   modification	   –	  
including	  this	  study	  –	  have	  implications	  across	  the	  field	  of	  biology	  and	  in	  particular	  in	  the	  study	  
of	  cancer	  biology.	  Many	  tumour	  suppressors	  and	  oncogenes	  are	  E3	  ligases.	  These	  include	  the	  
RING	   E3,	  MDM2,	   which	   is	   a	   negative	   regulator	   of	   the	   central	   tumour	   suppressor	   gene	   p53	  
(Fang	  et	  al.,	  2000,	  Gottlieb	  and	  Oren,	  1998),	  and	  the	  RING	  E3,	  BRCA1,	  which	  is	  involved	  in	  DNA	  
damage	  repair	  (Gowen	  et	  al.,	  1998)	  and	  is	  a	  key	  marker	  of	  ovarian	  and	  breast	  cancer	  (Futreal	  
et	   al.,	   1994,	  Miki	   et	   al.,	   1994).	   Other	   examples	   include	   the	   IAP	   (INHIBITOR	   OF	   APOPTOSIS)	  
protein,	   which	   is	   involved	   in	   the	   ubiquitin-­‐dependent	   degradation	   of	   caspases	   (Scott	   et	   al.,	  
2005)	  as	  well	  as	  various	  components	  of	  the	  SCF	  complex,	  such	  as	  SKP2	  and	  FBW7,	  which	  have	  
Figure	  7.3	  –	  A	  Model	  for	  the	  peptidase-­‐mediated	  modification	  of	  EOD1	  substrate	  specificity	  
It	  is	  possible	  that	  in	  EOD1’s	  native	  state,	  the	  C-­‐terminal	  E2-­‐binding	  RING	  domain	  is	  functional	  but	  
the	  N-­‐terminal	  substrate-­‐binding	  domain	  is	  not.	  It	  is	  possible	  that	  peptidase-­‐mediated	  cleavage	  of	  
the	   N-­‐terminus	   of	   EOD1	   alters	   the	   substrate-­‐binding	   domain	   such	   that	   the	   substrate	   can	   be	  
accommodated.	  This	  would	  enable	  the	  E2	  and	  the	  substrate	  to	  interact,	  and	  subsequently	  permit	  




been	   implicated	   in	   lung	  cancer,	  and	  ovarian	  cancer,	  breast	  cancer,	   lymphoma	  and	  colorectal	  
cancer	  respectively	  (Nakayama	  and	  Nakayama,	  2006).	  
Such	  is	  the	  prevalence	  of	  E3	  ligases	  in	  the	  development	  of	  cancers,	  that	  various	  E3s	  have	  been	  
suggested	  as	  therapeutic	  targets	  of	  anti-­‐cancer	  drugs	  (Sun,	  2006,	  Sun,	  2003).	  Identification	  of	  a	  
novel	  mechanism	  for	  the	  regulation	  of	  E3	  ligases	  in	  plants	  may	  guide	  the	  discovery	  of	  a	  similar	  
mechanism	  in	  animal	  systems,	  and	  will	  ensure	  that	  all	  opportunities	  for	  manipulating	  E3	  ligase	  
activity	  are	  understood.	  	  
7.1.3	  –	  DA1,	  EOD1	  and	  DA2:	  a	  novel	  enhancing	  regulatory	  loop	  
Together,	  these	  data	  reveal	  a	  novel	  enhancing	  regulatory	  loop	  involving	  the	  regulation	  of	  an	  E3	  
ligase	  through	   its	   interaction	  with	  an	   interacting	  peptidase	  enzyme.	   If	  both	  the	  E3	   ligase	  and	  
peptidase	  components	  of	  this	  module	  activate	  one-­‐another,	  then	  once	  initiated,	  the	  reciprocal	  
activation	  of	  peptidase	  and	  E3	  would	  be	  likely	  to	  progress	  in	  an	  irreversible	  manner.	  This	  is	  a	  
novel	  switching	  mechanism	  that	  may	  act	  as	  a	  molecular	  ratchet	  that	  drives	  the	  unidirectional,	  
irreversible	  amplification	  of	  a	  signal	  (Fig.	  5.13).	  
Similar	  peptidase-­‐mediated	   reciprocally-­‐activating	  enzyme	   loops,	   such	  as	   those	  proposed	   for	  
the	  DA1-­‐EOD1	  and	  DA1-­‐DA2	  examples	  described	  in	  this	  work,	  have	  been	  described	  in	  studies	  
of	   apoptosis	   in	   animal	   systems.	   Caspase-­‐9,	   a	   member	   of	   the	   caspase	   family	   of	   cysteine	  
proteases	   involved	   in	   the	   apoptotic	   pathway,	   is	   involved	   in	   an	   activating	   feed-­‐forward	   loop	  
with	   its	   sister	   caspase,	   caspase-­‐3	   (Budihardjo	   et	   al.,	   1999).	   Once	   cleaved	   from	   its	   inactive	  
procaspase	   state,	   caspase-­‐9	   cleaves	   procaspase-­‐3,	   which,	   once	   active,	   cleaves	   more	  
procaspase-­‐9	  (Budihardjo	  et	  al.,	  1999).	  This	  cycle	  feeds	  forward	  to	  activate	  the	  entire	  pool	  of	  
caspase-­‐9	   and	   caspase-­‐3,	   thereby	   irreversibly	   committing	   the	   animal	   cell	   towards	   apoptosis	  
(Budihardjo	  et	  al.,	  1999,	  Thornberry	  and	  Lazebnik,	  1998).	  It	  is	  possible	  that	  the	  auto-­‐activating	  
DA1-­‐EOD1	  module	  acts	  in	  a	  similar	  way	  to	  the	  capsase-­‐9-­‐caspase-­‐3	  module.	  This	  would	  predict	  
that	  under	  conditions	  that	  result	  in	  the	  interaction	  of	  EOD1	  and	  DA1,	  an	  irreversible	  EOD1-­‐	  and	  
DA1-­‐dependent	  signalling	  cascade	  is	  initiated.	  
More	   specifically,	   this	   work	   reveals	   a	   novel	   mechanism	   for	   the	   regulation	   of	   E3	   ligases.	  
Previous	   work	   has	   revealed	   the	   regulation	   of	   E3	   activity	   through	   a	   variety	   of	   mechanisms	  
including	   ubiquitination	   (Stevenson	   et	   al.,	   2007,	   Mallery	   et	   al.,	   2002),	   neddylation	   and	  
rubylation	   (Duda	   et	   al.,	   2008,	   Biedermann	   and	   Hellmann,	   2011),	   binding-­‐site	   competition	  
(Zheng	   et	   al.,	   2002),	   dimerization	   (Merlet	   et	   al.,	   2009)	   and	   artificial	   truncation	   (Chew	  et	   al.,	  
2012).	  To	  date,	  to	  my	  knowledge	  no	  one	  has	  demonstrated	  the	  in	  vivo	  cleavage	  of	  an	  E3	  ligase	  
by	  a	  cognate	  peptidase	  enzyme.	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In	  addition	   to	   the	  novelty	  of	   this	   regulatory	  mechanism,	  as	  well	   as	   its	   implications	   for	  other	  
studies	   in	  biology,	   this	   thesis	  has	  advanced	  our	  understanding	  of	   the	   role	  of	  EOD1,	  DA2	  and	  
DA1	   at	   the	   level	   of	   the	   developing	   organ	   (see	   section	   7.2).	   Furthermore	   it	   has	   created	  
significant	  new	  insight	  into	  detailed	  molecular	  mechanisms	  that	  themselves	  provide	  a	  way	  to	  
investigate	  the	  wider	  cellular	  consequences	  of	  EOD1-­‐,	  DA2-­‐	  and	  DA1-­‐	  mediated	  regulation.	  The	  
ability	  to	  constitutively	  activate	  EOD1	  and	  DA2	  enables	  one	  to	  screen	  for	  E3	  substrate	  proteins	  
using	   a	   method	   similar	   to	   that	   used	   in	   (Emanuele	   et	   al.,	   2011).	   A	   promising	   approach	   to	  
identify	   substrates	   of	   E3	   ligases	   by	   converting	   them	   to	   neddylating	   proteins	   (Zhuang	   et	   al.,	  
2012)	  could	  also	  be	  used.	  Furthermore,	  on-­‐going	  work	  (Grant	  BB/K017225/1)	  to	   identify	  the	  
sequence	   specificity	   of	   DA1	   cleavage	   has	   the	   potential	   to	   allow	   in	   silico	   screening	   for	   novel	  
DA1	  targets.	  	  
Breakthroughs	   in	   understanding	   of	   the	  molecular	   relationship	   between	  DA1	   and	   EOD1	   (and	  
DA2)	  will	  also	  enable	  strategies	  for	  the	  improvement	  of	  yield	  in	  commercial	  crop	  varieties.	  The	  
knowledge	   that	  DA1	  acts	   synergistically	  with	  both	  EOD1	  and	  DA2	   in	   the	   regulation	  of	   organ	  
size	  suggests	  that	  a	  combination	  of	  mutations	  will	  increase	  seed	  size	  and	  crop	  yield.	  As	  part	  of	  
this	  project	  a	  patent	  application	  was	  recently	  filed	  for	  the	  protection	  of	  DA1-­‐DA2	  technologies.	  	  
7.2	  –	  DA1:	  regulating	  organ	  growth	  and	  development	  
7.2.1	  –	  DA1:	  A	  role	  in	  organ	  growth	  and	  pathogen	  response	  pathways?	  
Recent	   work	   is	   beginning	   to	   reveal	   considerable	   overlap	   between	   the	   regulation	   of	   plant	  
growth	   and	   development	   and	   pathogen	   responses.	   A	   reduction	   in	   plant	   growth	   is	   a	  
stereotypical	   response	   to	   pathogen	   challenge,	   and	   many	   investigations	   of	   plant	   PAMP	  
(pathogen	   associated	  molecular	   patterns)	   responses	   utilise	   seedling	   growth	   response	   assays	  
(Gómez‐Gómez	  et	  al.,	  1999,	  Gómez-­‐Gómez	  and	  Boller,	  2000,	  Zipfel	  et	  al.,	  2006).	  Indeed	  the	  
challenge	  of	  Arabidopsis	  seedlings	  with	  the	  PAMPs,	  flg22	  (flagellin),	  and	  elf18	  (EF-­‐Tu),	  results	  
in	  an	  inhibition	  of	  growth	  (Gómez‐Gómez	  et	  al.,	  1999,	  Gómez-­‐Gómez	  and	  Boller,	  2000,	  Zipfel	  
et	  al.,	  2006).	  
Further	  cross-­‐talk	  between	  these	  two	  biological	  processes	  have	  been	  revealed	  by	  mutations	  in	  
pathogen-­‐response	   related	   genes	   that	   have	   significantly	   altered	   growth	   and	   development	  
phenotypes.	   For	   example,	   the	   gain-­‐of-­‐function	   mutation	   in	   the	   plant	   resistance	   gene	   SNC1	  
(SUPRESSOR	  OF	  NPR1-­‐1),	  which	  results	  in	  constitutive	  expression	  of	  pathogenesis-­‐related	  (PR)	  
genes,	  also	  has	  a	  dwarfed	  phenotype	  (Li	  et	  al.,	  2001,	  Zhang	  et	  al.,	  2003).	  This	  overlap	  of	  growth	  
responses	   and	   innate	   immunity	   is	   further	   highlighted	   by	   the	   involvement	   of	   BAK1	   (BRI1-­‐
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ASSOCIATED	  RECEPTOR	   KINASE	   1)	   in	   both	   the	   brassinosteroid	   response	   and	   the	   FLS2	   PAMP	  
response.	   bak1	   knockout	   mutants	   have	   a	   reduced	   sensitivity	   to	   brassinosteroids	   and	   flg22	  
treatment,	  and	  have	  a	  semi-­‐dwarfed	  phenotype	  (Chinchilla	  et	  al.,	  2007b,	  Li	  et	  al.,	  2002a).	  BAK1	  
has	  been	  shown	  to	   interact	  with	  both	  BRI1	   (BRASSINOSTEROID	   INSESNITIVE	  1)	  and	  FLS2	  and	  
thereby	  facilitate	  brassinosteroid-­‐	  and	  flg22-­‐responsive	  signalling	  respectively	  (Chinchilla	  et	  al.,	  
2007b,	  Li	  et	  al.,	  2002a,	  Nam	  and	  Li,	  2002).	  	  	  
Whereas	  BAK1	  provides	  an	  example	  of	  a	  gene	  involved	  in	  transducing	  both	  growth-­‐related	  and	  
pathogen-­‐related	  signals,	  the	  TCP	  family	  of	  transcription	  factors	  may	  be	  a	  common	  component	  
of	  growth	  and	  pathogen	  signalling	  pathways.	  As	  described	  in	  Chapter	  4,	  members	  of	  the	  large	  
TCP	   family	   of	   transcription	   factors	   are	   well	   characterised	   regulators	   of	   growth	   and	  
development	  (Martín-­‐Trillo	  and	  Cubas,	  2010),	  with	  evidence	  that	  Class	  I	  TCPs	  bind	  directly	  to	  
the	  promoters	  of	  cell	  cycle	  genes	  (Li	  et	  al.,	  2012).	  However,	  a	  recent	   interactomic	  study	  also	  
identified	   TCP14	   as	   a	   hub	   in	   response	   to	   Pseudomonas	   syringae	   and	   Hyaloperonospora	  
arabidopsidis	   infection	   (Mukhtar	   et	   al.,	   2011).	   In	   addition,	   the	   partial	   correlation	   analysis	   of	  
transcriptome	  data	  (Maclean,	  unpublished)	  documented	  in	  Fig.	  S2	  identified	  DA1	  as	  a	  hub	  in	  a	  
network	  of	  interactions	  in	  response	  to	  flg22,	  with	  TCP15	  being	  a	  downstream	  target	  of	  DA1.	  	  	  
7.2.2	  –	  DA1	  and	  LRR-­‐RLKs:	  regulation	  by	  internalisation?	  
Data	   from	  a	   partial	   correlation	   analysis	   (Maclean,	   unpublished)	   that	   accurately	   predicted	   an	  
interaction	  between	  DA1	   and	  TCP15	   (section	  4.3)	  have	   implicated	  DA1	   in	   the	  FLS2-­‐mediated	  
PAMP	  response.	  Although	  there	  is	  no	  direct	  evidence	  yet	  of	  an	  interaction	  between	  DA1	  and	  
FLS2,	   this	   thesis	   presents	   evidence	   of	   a	   link	   between	  DA1	   and	   two	   LRR-­‐RLKs,	   both	   of	  which	  
have	  connections	  to	  growth	  regulation	  and	  FLS2.	  
First,	   section	   4.4.1.2	   revealed	   that	   da1-­‐1	   seedlings	   have	   a	   reduced	   sensitivity	   to	  
epibrassinolide;	   partially	   phenocopying	   bak1	   knockout	   seedlings.	   bak1	   plants	   have	   a	   semi-­‐
dwarfed	  phenotype	  and	  over-­‐expression	  of	  BAK1	  has	  been	  shown	  to	  increase	  leaf	  elongation	  
(Li	  et	  al.,	  2002a,	  Song	  et	  al.,	  2009),	  which	  demonstrates	  a	  role	  in	  the	  regulation	  of	  final	  organ	  
size.	   Various	   brassinosteroid-­‐related	   genes	   have	   been	   implicated	   in	   the	   regulation	   of	   organ	  
growth,	  and	  in	  particular,	  in	  the	  mis-­‐regulation	  of	  cell	  expansion	  (Azpiroz	  et	  al.,	  1998,	  Clouse	  et	  
al.,	   1996,	  Nakaya	  et	  al.,	   2002,	  Hu	  et	  al.,	   2006)	  and	   indeed	   the	   large	   leaf	  phenotype	  of	  BAK1	  
overexpressing	  plants	  is	  a	  consequence	  of	  enhanced	  cell	  expansion	  (Li	  et	  al.,	  2002a,	  Song	  et	  al.,	  
2009).	  While	  the	  bulk	  of	  these	  brassinosteroid-­‐related	  organ-­‐size	  changes	  are	  largely	  driven	  by	  
altered	  expansion	  rates	   (Azpiroz	  et	  al.,	  1998,	  Clouse	  et	  al.,	  1996,	  Li	  et	  al.,	  2002a,	  Song	  et	  al.,	  
2009),	  it	  has	  been	  reported	  that	  there	  are	  also	  concurrent	  changes	  in	  cell	  proliferation	  (Nakaya	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et	  al.,	  2002).	  These	  data	  make	  it	  difficult	  to	  see	  a	  direct	  developmental	  link	  between	  the	  da1-­‐1	  
phenotype	  and	   the	  brassinosteroid	   response	  because,	  whereas	  DA1	   influences	   the	   timing	  of	  
the	  switch	  from	  cell-­‐proliferation	  to	  cell-­‐expansion	  (Li	  et	  al.,	  2008),	  brassinosteroids	  appear	  to	  
predominantly	   increase	   cell	   expansion	   (Kim	   and	  Wang,	   2010,	   Johnson	   and	   Lenhard,	   2011).	  
However,	  as	  discussed	  in	  Chapter	  1,	  there	  are	  likely	  to	  be	  many	  signals	  acting	  simultaneously	  
on	   cells	   of	   the	   developing	   leaf,	   and	   their	   respective	   influences	   and	   effects	   on	   growth	   will	  
depend	  heavily	  on	  other	  signals	  at	  that	  precise	  time	  during	  organ	  formation.	   It	   is	  relevant	  to	  
note	  that	  CYCD3,	  considered	  to	  be	  a	  negative	  regulator	  of	  the	  switch	  from	  cell-­‐proliferation	  to	  
cell-­‐expansion	   (Dewitte	   et	   al.,	   2007),	   is	   also	   up-­‐regulated	   in	   endoreduplicating	   expanding	  
tomato	  cells	  (Joubes	  and	  Chevalier,	  2000).	  	  
DA1	  has	  also	  been	  shown	  to	  physically	   interact	  with	  the	  cytoplasmic	  domain	  of	  the	  LRR-­‐RLK,	  
TMK4	   in	   a	   yeast-­‐2-­‐hybrid	   and	   an	   in	   vitro	   system.	   TMK4	  was	   recently	   identified	   as	   a	   positive	  
regulator	   of	   growth	   and	   development,	   as	   it	   promotes	   cell	   expansion	   in	   the	   developing	   root	  
and	  cell	  proliferation	  in	  the	  developing	  leaf	  (Dai	  et	  al.,	  2013).	  It	  has	  also	  been	  shown	  to	  enrich	  
with	   FLS2	   in	   lipid	   rafts	   after	   cell	   cultures	   were	   stimulated	   with	   flg22	   (Keinath	   et	   al.,	   2011);	  
possibly	  reflecting	  a	  direct	  or	  indirect	  response	  to	  flg22.	  In	  addition	  to	  this	  tentative	  link	  with	  
flg22-­‐responses,	  mutations	  in	  TMK4	  have	  been	  shown	  to	  reduce	  sensitivity	  to	  auxin	  perception	  
(Dai	   et	   al.,	   2013).	   This	   is	   reminiscent	   of	   the	   reduced	   sensitivity	   of	  bak1	   and	  da1-­‐1	  plants	   to	  
brassinosteroids	  (Li	  et	  al.,	  2002a),	  and	  of	  bak1	  plants	  to	  flg22	  (Chinchilla	  et	  al.,	  2007b).	  
7.2.2.1	  –	  Models	  for	  DA1-­‐dependent	  LRR-­‐RLK	  regulation	  
In	  animal	   systems,	   it	   is	  well	  documented	   that	  RTKs	   (receptor	   tyrosine	  kinases)	   such	  as	  EGFR	  
(EPIDERMAL	  GROWTH	  FACTOR	  RECEPTOR)	  are	  ubiquitinated	  upon	  ligand	  binding,	  and	  that	  this	  
ubiquitination	  is	  sufficient	  for	  receptor	  internalisation	  and	  degradation	  (Haglund	  et	  al.,	  2003).	  
In	  plants,	   there	   is	   good	  evidence	   that	  FLS2,	  and	   tentative	  evidence	   that	  BRI1,	  BAK1	  and	  EFR	  
(EF-­‐Tu	  RECEPTOR)	  are	  ubiquitinated	  (Lu	  et	  al.,	  2011,	  Göhre	  et	  al.,	  2008).	  The	  ubiquitination	  of	  
FLS2	  appears	  to	  negatively	   influence	   its	  stability	  (Göhre	  et	  al.,	  2008,	  Lu	  et	  al.,	  2011),	  but	   it	   is	  
unclear	  whether	   the	   ubiquitin	   ‘smears’	   presented	   in	   Göhre	   et	   al	   (2008)	   and	   Lu	   et	   al	   (2011)	  
represent	   poly-­‐ubiquitin	   chains	   or	  multiple	  mono-­‐ubiquitination	   events,	   as	   was	   observed	   in	  	  
human	  EGFR	  (Haglund	  et	  al.,	  2003).	   If	  FLS2	   is	  mono-­‐ubiquitinated,	   it	   is	  possible	   that,	  as	  with	  
EGFR,	   the	  ubiquitination	   event	   serves	   to	   promote	   internalisation	   and	  either	   recycling	   to	   the	  
plasma	  membrane	   or	   degradation	   in	   the	   lysosome.	   In	   contrast,	   poly-­‐ubiquitination	   suggests	  
ubiquitin-­‐directed	  proteasome-­‐mediated	  degradation.	  There	  is	  evidence	  that	  internalisation	  of	  
the	  BRI1-­‐BAK1	  complex	  is	  essential	  for	  signal	  propagation	  (Geldner	  et	  al.,	  2007,	  Karlova	  and	  de	  
228	  
Vries,	  2006),	  and	  therefore	  it	   is	  possible	  that	  endocytosis	  of	  FLS2	  leads	  to	  signal	  propagation,	  
as	  well	  as	  degradation	  (Robatzek	  et	  al.,	  2006).	  	  
The	   purported	   regulated	   internalisation	   of	   ubiquitinated,	   membrane-­‐bound	   animal	   RTKs	   by	  
UIM-­‐containing	  adaptor	  proteins	   is	  referred	  to	  as	  the	  UIM-­‐cycle	  (Marmor	  and	  Yarden,	  2004),	  
and	  it	  is	  possible	  that	  DA1	  is	  involved	  in	  a	  similar	  cycle	  with	  plant	  LRR-­‐RLKs	  (Fig.	  7.4).	  The	  UIM-­‐
cycle	   predicts	   that	   UIM-­‐containing	   adaptor	   proteins	   bind	   to	   ubiquitinated	   RLKs	   resulting	   in	  
their	   internalisation	   and	   degradation	   or	   recycling	   to	   the	   plasma	   membrane	   (Marmor	   and	  
Yarden,	   2004).	   Evidence	   that	  DA1	  physically	   interacts	  with	   the	   cytoplasmic	  domain	  of	   TMK4	  
suggests	   that	   DA1	   might	   act	   as	   an	   ubiquitin	   dependent	   adaptor	   protein,	   regulating	   this	  
internalisation	  and	  degradation/recycling	  of	  TMK4.	  	  
An	  alternative	  model	  incorporates	  the	  observed	  synergistic/enhancing	  interaction	  of	  DA1	  with	  
EOD1	  and	  DA2	  (Fig.	  7.5).	  This	  models	  predicts	  that	  DA1	  promotes	  the	  EOD1-­‐	  or	  DA2-­‐mediated	  
ubiquitination	   of	   TMK4,	   thereby	   triggering	   its	   internalisation	   and	   degradation,	   and	   the	  
subsequent	   attenuation	   of	   its	   signalling.	   In	   this	   model	   (Fig.	   7.5)	   there	   are	   several	   potential	  
roles	  for	  the	  DA1	  UIM	  domains.	  First,	  as	  with	  the	  UIM-­‐cycle,	  the	  DA1	  UIMs	  may	  recruit	  DA1	  to	  
a	  pre-­‐existing	  ubiquitin	  moiety	  on	  the	  RLK,	  thereby	  recruiting	  its	  cognate	  E3s	  to	  ligate	  a	  further	  
ubiquitin	  signal	  (Fig.	  7.5a).	  This	  would	  be	  similar	  to	  the	  recruitment	  of	  BRCA1	  to	  sites	  of	  DNA	  
damage	   by	   the	   UIM-­‐containing	   protein	   RAP80,	   which	   binds	   pre-­‐existing	   ubiquitin	   chains	   at	  
sites	  of	  DNA	  damage	  (Guzzo	  et	  al.,	  2012,	  Sobhian	  et	  al.,	  2007,	  Wang	  et	  al.,	  2007).	  Alternatively,	  
the	   UIMs	   may	   be	   involved	   in	   a	   coupled	   mono-­‐ubiquitination-­‐like	   mechanism,	   whereby	   the	  
UIMs	  recruit	  the	  cognate	  E3	  to	  DA1,	  and	  also	  regulate	  peptidase	  activity	  via	  interactions	  with	  
cis-­‐ubiquitin	   (Fig.	   7.5b).	  A	   variation	  on	   this	  model	   is	   that,	   instead	  of	  ubiquitination	  of	  TMK4,	  
the	  function	  of	  the	  TMK4-­‐DA1-­‐EOD1	  interaction	  is	  the	  peptidase-­‐mediated	  processing	  of	  TMK4	  
by	  DA1	  (Fig.	  7.6).	  This	  could	  be	  similar	  to	  the	  peptidase-­‐mediated	  cleavage	  of	  the	  membrane-­‐

























Figure	  7.4	  –	  The	  UIM-­‐cycle	  
A	  purported	   regulatory	   cycle	   in	  which	  UIM-­‐containing	   proteins	   regulate	   the	   internalisation	   and	  
endocytosis	   of	   membrane	   localised	   receptor	   molecules.	   	   (A)	   Upon	   binding	   of	   the	   ligand	   (grey	  
circle)	  a	  receptor-­‐like	  kinase	  (black	  ‘T’)	  is	  ubiquitinated	  in	  its	  cytoplasmic	  domain.	  (B)	  The	  ubiquitin	  
moiety	   recruits	   DA1	   (through	   its	   UIM	   domain),	   DA1	   then	   recruits	   the	   endocytotic	   machinery,	  
which	   results	   in	   receptor	   internalisation.	   (C)	   Once	   internalised,	   DA1	   is	   released	   along	  with	   the	  





heparin-­‐binding	   EGF-­‐like	   growth	   factor	   (HB-­‐EGFR)	   (Nanba	   et	   al.,	   2003).	   This	   cleavage	   event	  
results	   in	   the	   translocation	   of	   the	   HB-­‐EGFR	   C-­‐terminal	   fragment	   to	   the	   nucleus	   and	   the	  
subsequent	  export	  of	  the	  transcriptional	  repressor	  PZLF	  (promyelocytic	  leukaemia	  zinc	  finger),	  
which	  is	  a	  negative	  regulator	  of	  the	  cell	  cycle	  (Nanba	  et	  al.,	  2003).	  
This	  model	  also	  incorporates	  the	  observation	  that	  DA1	  physically	  interacts	  with	  TMK4	  as	  well	  
as	   DA2	   and	   EOD1,	   which	   suggests	   that	   DA1	  may	   be	   responsible	   for	  mediating	   an	   RLK	   –	   E3	  
interaction,	   leading	  to	  RLK	  ubiquitination	  by	  the	  E3	   ligase,	  cleavage	  by	  DA1,	  or	  both.	   If	  EOD1	  
and	  DA2	  are	  required	  to	  ubiquitinate	  TMK4,	  then	  DA1-­‐mediated	  co-­‐localisation	  of	  RLK	  and	  the	  
E3	  ligases	  would	  activate	  the	  E3s	  only	  when	  directly	  bound	  to	  their	  substrate	  by	  DA1.	  In	  animal	  
systems	   there	   are	   examples	   of	   E3	  activating	   enzymes,	  which	   localise	   to	   the	   targets	   of	   their	  
respective	  E3s	   in	  a	   similar	  manner.	  The	  RING	  E3,	  MDM2,	  which	  ubiquitinates	  and	  negatively	  
regulates	  the	  tumour	  suppressor	  p53,	  is	  stabilised	  (activated)	  by	  the	  de-­‐ubiquitinating	  enzyme	  
HAUSP,	  which	   itself	   interacts	  with	   p53	   (Stevenson	   et	   al.,	   2007,	   Li	   et	   al.,	   2002b).	   In	   a	   similar	  
system,	  SMAD7	  both	  activates	  the	  human	  HECT	  E3	  ligase,	  SMURF2,	  and	  relocates	  it	  from	  the	  
nucleus	  to	  the	  plasma	  membrane,	  which	  is	  the	  location	  of	  the	  SMURF2	  target	  protein,	  TGF-­‐β	  
(Wiesner	  et	  al.,	  2007,	  Ogunjimi	  et	  al.,	  2005,	  Kavsak	  et	  al.,	  2000).	  
The	   requirement	   for	   the	   suggested	   reciprocal	   activation	   in	   the	  DA1-­‐E3	   ligase	  module	  would	  
ensure	   that	   neither	   component	   could	   be	   active	   without	   interaction	   with	   each	   other.	   This	  
would	  safeguard	  against	  premature	  receptor	   internalisation	  and	   limit	   the	  signalling	   response	  
to	   tissues	   and	   developmental	   stages	   where	   both	   proteins	   are	   expressed.	   Furthermore,	   the	  
feed-­‐forward	   nature	   of	   such	   a	   DA1-­‐E3	   module	   would	   suggest	   that	   subsequent	   E3	   activity	  
would	   be	   all	   or	   nothing;	   preventing	   partial	   ubiquitination	   and	   ensuring	   complete	   receptor	  
internalisation.	   Experiments	   to	   test	   this	   model	   of	   DA1	   function	   are	   possible	   using	   DA1-­‐	  
interacting	  proteins	   identified	  by	  Y2H	  in	  Chapter	  4.	  These	  experiments	  would	   include	   in	  vitro	  
assays	  for	  cleavage	  and	  ubiquitination.	  	  
7.2.2.2	  –	  The	  developmental	  significance	  of	  a	  DA1-­‐RLK	  interaction	  
Both	  models	   discussed	   in	   section	   7.2.2.1	   are	   supported	   by	   preliminary	   data	   that	   show	   that	  
DA1	   and	   TMK4	   antagonistically	   influence	   leaf	   growth.	   Whereas	   TMK4	   has	   been	   shown	   to	  
increase	  leaf	  size	  through	  a	  promotion	  of	  cell	  proliferation	  (Dai	  et	  al.,	  2013),	  DA1	  is	  known	  to	  
negatively	   influence	   the	   duration	   of	   this	   proliferative	   phase	   (Li	   et	   al.,	   2008).	   It	   is	   possible	  
therefore	   that	   DA1	   is	   involved	   in	   the	   attenuation	   of	   TMK4	   dependent	   growth	   promotion,	  


























































Figure	  7.5	  –	  Two	  possible	  models	  for	  the	  DA1-­‐E3	  regulated	  ubiquitin-­‐directed	  internalisation	  of	  
RLKs	  
(A,B)	  Models	  that	  explore	  the	  possible	  role	  of	  DA1	  as	  an	  adaptor	  protein,	   localising	  E3	  ligases	  to	  
the	  cytosolic	  domain	  of	  RLKs,	  such	  that	  the	  RLKs	  are	  ubiquitinated.	  (A)	  DA1	  might	  interact	  with	  an	  
ubiquitin	  moiety	   on	   the	   RLK	   through	   its	   UIMs,	   and	   interact	   with	   its	   cognate	   E3	   ligase	   through	  
another	   domain.	   This	   interaction	   could	   result	   in	   the	   recruitment	   of	   the	   E3	   to	   the	   RLK	   and	   the	  
subsequent	  activation	  of	  the	  E3.	  (B)	  DA1	  could	  interact	  with	  the	  RLK	  through	  an	  unknown	  domain,	  
and	  bind	  E3-­‐isopetide-­‐linked	  ubiquitin	  through	  its	  UIM	  domain.	  This	  interaction	  could	  result	  in	  the	  




Interestingly,	  as	  discussed	   in	  Chapter	  1,	   the	  fact	  that	  the	  da1-­‐1	   large	  organ	  phenotype	   is	  not	  
complemented	   by	   a	   reduction	   in	   cell	   size	   suggests	   that	   DA1	   may	   be	   part	   of	   a	   mechanism	  
involved	   in	  perception	  of	  a	  hypothetical	  diffusible	  growth	  signal	   (section	  1.5.5).	  LRR-­‐RLKs	  are	  
well	   characterised	   as	   signal	   receptor	   molecules	   and	   have	   been	   shown	   to	   transduce	   both	  
steroid	  (Clouse	  et	  al.,	  1996,	  Kinoshita	  et	  al.,	  2005)	  and	  peptide	  signals	  (Chinchilla	  et	  al.,	  2006,	  
Zipfel	  et	  al.,	  2006).	  The	  direct	   interaction	  of	  DA1	  with	  TMK4,	  and	  its	  possible	   indirect	   links	  to	  
BAK1	  and	  FLS2,	  suggest	  that	  DA1	  may	  regulate	  the	  activity	  of	  an	  LRR-­‐RLK	   involved	   in	  sensing	  
such	  a	  diffusible	  signal.	  Furthermore,	  proliferating	  cells	  in	  da1-­‐1	  organs	  appear	  have	  a	  reduced	  
sensitivity	   to	   the	   signals	   promoting	   the	   switch	   from	   proliferation	   to	   expansion.	   This	   is	  
supported	   by	   data	   presented	   in	   section	   4.4.1.2,	   which	   show	   that	   both	   da1-­‐1	   and	   bak1-­‐4	  
seedlings	  have	  reduced	  sensitivity	  to	  brassinosteroid	  perception.	  This	  is	  particularly	  interesting	  
considering	  BAK1	  phosphorylation	  of	  PUB12/13	  has	  been	  shown	  to	  be	  essential	   for	  an	  FLS2-­‐
PUB13/14	   interaction	   (Lu	   et	   al.,	   2011).	   In	   the	   flg22	   response	   at	   least,	   this	   is	   consistent	  with	  
da1-­‐1	   phenocopying	   a	   knockout	   in	   a	   gene	   shown	   to	   be	   responsible	   for	   promoting	   the	  
ubiquitination	  of	  an	  LRR-­‐RLK.	  
7.2.3	  –	  From	  DA1	  to	  the	  cell	  cycle:	  linking	  via	  TCP	  transcription	  factors	  	  
The	  da1-­‐1	  large	  organ	  phenotype	  is	  a	  consequence	  of	  a	  delayed	  exit	  from	  the	  mitotic	  cell-­‐cycle,	  
suggesting	   that	  either	  directly	  or	   indirectly,	  DA1	  may	  regulate	  cell-­‐cycle	  progression.	  Prior	   to	  
the	  work	  documented	   in	   this	   thesis,	   the	   link	   between	  DA1	   and	   the	   cell-­‐cycle	  was	  unknown.	  
However,	  the	  interaction	  between	  DA1	  and	  TCP15	  (section	  4.3)	  provides	  a	  potential	  link	  from	  
the	  da1-­‐1	  phenotype	  to	  the	  regulation	  of	  cell-­‐cycle	  components	  via	  TCP14	  and	  TCP15,	  which	  
are	  involved	  in	  regulating	  cell	  proliferation	  and	  cell	  expansion	  in	  developing	  tissues	  (Kieffer	  et	  
al.,	  2011,	  Li	  et	  al.,	  2012,	  Uberti-­‐Manassero	  et	  al.,	  2012).	  However,	  the	  precise	  role	  of	  TCP15	  in	  
the	  regulation	  of	  cell	  proliferation	  and	  expansion	  remains	  unclear,	  possibly	  due	  to	  its	  apparent	  
tissue-­‐specific	   effects	   and	   the	   coupled	   nature	   of	   cell	   proliferation	   and	   cell	   expansion.	  
Nonetheless,	   the	   observation	   that	   organ	   growth	   is	   affected	   via	   a	   mis-­‐regulation	   of	  
proliferation	   and	   expansion,	   suggests	   that,	   developmentally,	   TCP15	   may	   work	   in	   the	   same	  
pathway	  as	  DA1	   (Kieffer	   et	   al.,	   2011,	   Li	   et	   al.,	   2012,	  Uberti-­‐Manassero	  et	   al.,	   2012).	   Indeed,	  
genetic	  interactions	  presented	  in	  sections	  4.3.3.1	  and	  4.3.3.2	  suggest	  that	  DA1	  and	  TCP14/15	  










































Figure	  7.6	  –	  Possible	  models	  for	  the	  ubiquitin-­‐	  and	  peptidase-­‐	  mediated	  regulation	  of	  RLKs	  by	  a	  
DA1-­‐E3	  module	  
It	  is	  conceivable	  that	  the	  DA1-­‐E3	  module	  might	  regulate	  RLKs	  through	  an	  ubiquitin	  or	  peptidase-­‐
mediated	  mechanism.	  In	  both	  of	  these	  models	  DA1	  would	  behave	  as	  an	  adaptor	  protein,	  targeting	  
the	  E3	  to	  the	  RLK,	  and	  upon	  interaction	  with	  the	  E3,	  DA1	  and	  the	  E3	  would	  reciprocally	  activate.	  
(A)	  DA1	  recruits	  the	  E3	  to	  the	  RLK	  cytoplasmic	  domain.	  The	  E3-­‐DA1	  module	  reciprocally	  activates	  
(not	   shown)	  and	   the	  active	  E3	   ligase	   then	  ubiquitinates	   the	   cytoplasmic	  domain	  of	   the	  RLK.	   (B)	  
DA1	  recruits	  the	  E3	  to	  the	  RLK	  cytoplasmic	  domain.	  The	  E3	  activates	  the	  DA1	  peptidase	  and	  the	  




Recent	  work	  has	  also	  revealed	  several	  direct	  links	  between	  TCP15	  and	  the	  cell	  cycle	  (Kieffer	  et	  
al.,	  2011,	  Li	  et	  al.,	  2012).	  It	  has	  been	  reported	  that	  TCP15	  binds	  directly	  to	  the	  promoter	  of	  the	  
S-­‐phase	   cyclin,	   CYCA2;3;	   as	   well	   as	   to	   the	   promoter	   of	   RBR1,	   which	   is	   a	   regulator	   of	   the	  
transition	   between	   proliferation	   and	   endocycling	   (Li	   et	   al.,	   2012,	   Magyar	   et	   al.,	   2012).	   In	  
addition,	  Li	  et	  al	  (2012)	  and	  Kieffer	  et	  al	  (2011)	   list	  a	  total	  of	  12	  cell-­‐cycle	  regulators	  that	  are	  
differentially	   regulated	   in	   either	   knockout,	   overexpressing	   or	   –EAR	   domain	   fused	   TCP	  
backgrounds.	   Taken	   together	   with	   the	   physical	   and	   genetic	   interactions	   of	   DA1	   and	   TCP15,	  	  
these	  data	  indicate	  the	  DA1	  may	  function	  closely	  with	  the	  cell	  cycle	  machinery	  to	  regulate	  exit	  
from	  the	  mitotic	  cell-­‐cycle.	  	  
Work	  in	  this	  thesis,	  as	  well	  as	  in	  three	  recent	  publications	  (Kieffer	  et	  al.,	  2011,	  Li	  et	  al.,	  2012,	  
Uberti-­‐Manassero	  et	  al.,	  2012)	  has	  demonstrated	  that	  the	  effect	  of	  TCP15	  on	  organ	  growth	  is	  
highly	   tissue	   specific,	   leading	   to	   apparently	   contradictory	   results	   and	   interpretations.	   This	   is	  
highlighted	  by	  data	  from	  Kieffer	  et	  al	  (2011),	  who	  show	  that	  while	  TCP14	  and	  TCP15	  promote	  
cell	  proliferation	  in	  the	  leaf,	  they	  both	  repress	  proliferation	  in	  the	  stem.	  For	  this	  reason	  it	  is	  not	  
easy	  to	  establish	  a	  specific	  developmental	  role	  for	  TCP15,	  and	  it	  is	  therefore	  difficult	  to	  predict	  
a	  directional	  mechanistic	  relationship	  between	  DA1	  and	  TCP15.	  What	  is	  clear	  however	  is	  that	  
DA1	  and	  TCP15	  both	  affect	  the	  balance	  between	  cell	  proliferation	  and	  cell	  expansion,	  and	  that	  
TCP15	  appears	   to	  directly	   regulate	   cell-­‐cycle	   regulators.	   It	   is	   therefore	   reasonable	   to	  predict	  
that	  one	  of	  the	  routes	  by	  which	  DA1	  influences	  the	  persistence	  of	  the	  mitotic	  cell-­‐cycle	  may	  be	  
through	  the	  direct	  regulation	  of	  TCP15	  activity.	  As	  is	  discussed	  in	  section	  7.2.3.1,	  this	  may	  be	  
through	  a	  peptidase	  or	  ubiquitin-­‐mediated	  mechanism,	  which	  can	  be	  directly	  tested.	  
7.2.3.1	  –	  Unifying	  observations	  on	  the	  role	  of	  DA1	  in	  organ	  growth	  	  	  
The	   biochemical	   and	   genetic	   analyses	   described	   in	   this	   thesis	   have	   described	   a	   novel	  
mechanism	  mediated	   by	   DA1	   peptidase	   function	   that	  may	   regulate	   the	   activities	   of	   two	   E3	  
ubiquitin	  ligases	  involved	  in	  organ	  growth	  and	  seed	  size	  control.	  How	  DA1-­‐mediated	  regulation	  
of	  E3	   ligase	  activity	   influences	  organ	  growth	  has	  been	  explored	  using	  examples	  of	   two	  DA1-­‐	  
interacting	   proteins,	   both	   of	   which	   have	   established	   roles	   in	   growth	   control.	   There	   is	  
preliminary	  data	  that	  DA1	  also	  interacts	  with	  several	  other	  proteins	  (see	  Table	  4.1)	  that	  have	  
established	   roles	   in	   growth	   and	   development.	   DA1-­‐mediated	   E3	   ligase	   activity	   may	   also	  
influence	   the	   activity	   of	   these	   proteins,	   perhaps	   suggesting	   a	   broad	   role	   for	   DA1	   in	  
orchestrating	  leaf	  growth.	  	  
The	   identification	   of	   interactions	   between	   DA1	   and	   four	   transcription	   factors	   known	   to	  
regulate	   organ	   development	   (LBD41,	   ASL1,	   TCP15	   and	   ATHB8	   (Prigge	   et	   al.,	   2005,	   Chalfun-­‐
235	  
Junior	  et	  al.,	  2005,	  Uberti-­‐Manassero	  et	  al.,	  2012,	  Li	  et	  al.,	  2012,	  Kieffer	  et	  al.,	  2011,	  Meng	  et	  
al.,	  2010))	  suggests	  that	  DA1	  influences	  organ	  growth	  through	  the	  regulation	  of	  a	  broad	  range	  
of	  transcription	  factors.	  	  
As	  discussed	   in	  section	  5.6.3,	  DA1	  appears	   to	  have	  an	  EOD1-­‐	  and	  DA2-­‐	   independent	  activity,	  
which	  suggests	  that	  the	  DA1	  peptidase	  might	  be	  active	  towards	  some	  substrates	  in	  its	  native	  
state,	  or	  alternatively	  it	  could	  be	  activated	  by	  other	  E3	  ligases.	  PUB12/13/14	  are	  candidate	  E3	  
ligases	  for	  this	  role.	  PUB12	  and	  PUB13	  are	  the	  E3	  ligases	  responsible	  for	  ubiquitination	  of	  FSL2	  
(Lu	  et	  al.,	  2011)	  and	  are	  involved	  influencing	  the	  sensitivity	  of	  flg22	  perception	  (Marino	  et	  al.,	  
2012,	   Lu	   et	   al.,	   2011).	   Because	   there	   are	   indirect	   links	   between	   DA1	   and	   the	   flg22	   PAMP	  
response	  (discussed	   in	  section	  4.4),	  as	  well	  as	  evidence	  that	  DA1	   influences	  the	  sensitivity	  of	  
brassinosteroid	   perception,	   and	   because	   both	   flg22	   and	   brassinosteroids	   are	   perceived	   (in	  
part)	  by	  BAK1	  (Chinchilla	  et	  al.,	  2006,	  Chinchilla	  et	  al.,	  2007a,	  Gómez-­‐Gómez	  and	  Boller,	  2000,	  
Li	  et	  al.,	  2002a,	  Nam	  and	  Li,	  2002),	   it	   is	  possible	   that	  PUB12	  and	  PUB13,	  and	  BAK1	  and	  DA1	  
function	   together	   to	   regulate	   flg22	   and	   brassinosteroid	   perception.	   PUB14	   may	   also	   be	   a	  
candidate	  DA1-­‐activating	  E3	   ligase	  due	  to	   its	  documented	  Y2H	  interaction	  with	  TCP15	  (Dreze	  
et	  al.,	  2011).	  
It	  is	  currently	  an	  exciting	  time	  in	  the	  field	  of	  plant	  developmental	  biology,	  with	  the	  detailed	  
functional	  characterisation	  of	  known	  growth	  regulators	  occurring	  alongside	  the	  discovery	  of	  
new	  regulatory	  genes.	  The	  linkage	  and	  association	  screens	  reported	  in	  Chapter	  6	  aim	  to	  
continue	  this	  progress	  of	  gene	  discovery	  and,	  as	  described,	  have	  so	  far	  identified	  over	  90	  
candidate	  genes	  for	  further	  study	  and	  characterisation.	  	  
In	  addition	  to	  identifying	  novel	  regulators	  of	  organ	  growth	  and	  development,	  these	  screens	  
may	  also	  have	  identified	  potentially	  novel	  allelic	  variation	  in	  a	  priori	  growth	  regulators,	  which	  
may	  be	  related	  to	  fitness	  and	  adaptation	  to	  growth	  in	  different	  environments.	  Of	  particular	  
interest	  to	  this	  work	  is	  the	  identification	  of	  DA1	  as	  a	  candidate	  gene	  in	  a	  GWA	  study	  of	  natural	  
variation	  in	  SE	  mean	  petal	  area.	  It	  is	  hoped	  that	  continued	  investigation	  in	  this	  area	  may	  yield	  
insight	  into	  novel	  DA1	  alleles,	  which	  in	  turn	  may	  feed	  into	  new	  functional	  analyses	  such	  as	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Figure	  S1	  –	  Vector	  maps	  
Maps	  of	  all	  vectors	  used	  in	  this	  thesis,	  with	  the	  exception	  of	  pw1211,	  which	  does	  not	  have	  an	  
annotated	  map.	  Maps	  display	  key	  coding	  regions	  and	  vector	  identities	  are	  located	  in	  the	  
centre	  of	  each	  map.	  All	  maps	  were	  generated	  in	  Vector	  NTI	  (Invitrogen)	  with	  the	  
exception	  of	  the	  maps	  for	  pMDC32	  and	  pEarleyGate201,	  which	  are	  adapted	  from	  
http://botserv1.uzh.ch/home/grossnik/curtisvector/pMDC32.pdf	  and	  
http://sites.bio.indiana.edu/~pikaardlab/pEarleyGate%20plasmid%20vectors%20copy/pl








Figure	  S2	  	  –	  Partial	  correlation	  analysis	  (Dan	  Maclean,	  unpublished)	  
A	  partial	  correlation	  analysis	  of	  expression	  data	  from	  5-­‐week	  old	  Arabidopsis	  leaves	  treated	  with	  
flg22.	  Circles	  represent	  genes,	   lines	  represent	  predicted	   interactions	  between	  genes,	   the	  weight	  
of	  the	  lines	  corresponds	  to	  the	  strength	  of	  the	  predicted	  interaction,	  and	  the	  arrows	  denote	  the	  
direction	   of	   the	   predicted	   interaction.	   (A)	   The	   complete	   network,	   (B)	   the	   nearest-­‐neighbour	  
network	  for	  DA1.	  
This	   analysis	   was	   performed	   by	   Dan	   Maclean	   at	   the	   Sainsbury	   Laboratory,	   Norwich	   using	  












































































































Figure	  S3	  –	  TCP22	  influences	  organ	  growth	  
The	  effect	  of	  the	  tcp22	  mutation	  on	  inflorescence	  stem	  height	  (n=6),	  petal	  area	  (n=10)	  and	  seed	  
area	  (n=600)	  was	  investigating	  by	  crossing	  the	  tcp14/tcp15	  double	  mutant	  with	  tcp22.	  Data	  is	  
presented	  as	  means	  ±	  SE.	  Phenotypes	  that	  were	  significantly	  different	  from	  Col-­‐0	  (Student’s	  T-­‐
test,	  p<0.05)	  are	  marked	  with	  ‘*’,	  and	  phenotypes	  that	  were	  significantly	  different	  from	  
tcp14/tcp15	  were	  marked	  with	  ‘**’.	  (A)	  The	  stems	  of	  tcp14/tcp15/tcp22	  plants	  are	  significantly	  
shorter	  than	  those	  of	  the	  tcp14/tcp15	  double	  mutant,	  indicating	  that	  the	  tcp22	  allele	  acts	  to	  
enhance	  the	  tcp14/tcp15	  phenotype.	  (B)	  Petals	  of	  tcp14/tcp15/tcp22	  plants	  are	  not	  different	  from	  
Col-­‐0,	  whereas	  tcp14/tcp15	  petals	  are	  smaller,	  suggesting	  that	  the	  tcp22	  allele	  antagonises	  the	  
tcp14/tcp15	  allele	  and	  that	  TCP22	  may	  be	  a	  negative	  regulator	  of	  petal	  growth.	  (C)	  Seeds	  of	  
tcp14/tcp15/tcp22	  plants	  are	  larger	  than	  Col-­‐0,	  whereas	  tcp14/tcp15	  seeds	  are	  smaller;	  
suggesting	  that	  the	  tcp22	  allele	  antagonises	  the	  tcp14/tcp15	  allele	  and	  that	  TCP22	  may	  be	  a	  






EOD1     --MNGDNR---------------------------------------------------- 6  
BBR      MPMENDNGPHVGNVVVTAEQATKINETDGRLPENRQTGVVSDTGSGSERGEQGVGESAVA 60  
aaaaaaaaaa   *:.**	  
 
EOD1     ---PVEDAHYTETG-FPYAATGSYMDFYGGAAQGPLNYDHAATMHPQDNLYWTMNTNAYK 62 
BBR     VAVPVEESGSISVGELPAPRSSSARVPFTNLSQIDADLALARTLQEQERAYMMLTMNSEI 120 
aaaaaaaaaaaa***::   ..* :* . :.*    : . :*   :   * *:: *:. *  :. *: 
 
 
EOD1     FGFSGSDNASFYGSYDMNDHLSRMSIGRTNWDYHP------------------------- 97 
BBR      SDYGSWETGSYVYDEDEFDDPENEDEDDDEDEYETDDDPQEDGLDVNVHANEDDQEDDGN 180 
aaaaaaaaaa.:.. :..*:  . *  *. .. . .  : :*.. 
  
 
EOD1     --MVNVADDPENTVARSVQIGDTDEHSE--------AEECIANEHDPDSPQVSWQDDIDP 147 
BBR      SDIEEVAYTDDEAYARALQEAEERDMAARLSALSGLANRVVEDLEDESHTSQDAWDEMDP 240 
aaaaaaaaaaa: :**   ::: **::* .:  : :         *:. : : .* . .. .  *::** 
    
 
EOD1     DTMTYEELVELGEAVGTESRGLSQELIETLPTKKYKFGSIFSRKRAGERCVICQLKYKIG 207 
BBR      DELSYEELLALGDIVGTESRGLSADTIASLPSKRYKEG--DNQNGTNESCVICRLDYEDD 298 
aaaaaaaaa* ::****: **: ********* : * :**:*:** *   .:: :.* ****:*.*: . 
   
 
EOD1     ERQMNLPCKHVYHSECISKWLSINKVCPVCNSEVFGEPSIH------------------- 248 
BBR      EDLILLPCKHSYHSECINNWLKINKVCPVCSAEVSTSTSGQS------------------ 340 
aaaaaaaaa*  : ***** ******.:**.********.:**  ..* : 
	  
	  
Figure	  S4	  –	  The	  E3	  ligase	  BIG	  BROTHER-­‐RELATED	  (BBR)	  (At3g19910)	  is	  similar	  to	  EOD1	  
(A)	   ClustalW	   alignment	   of	   EOD1	   and	   BBR	   protein	   sequence	   (Goujon	   et	   al.,	   2010,	   Larkin	   et	   al.,	  
2007),	   see	   Table	   S3	   for	   key	   to	   colour	   codes.	   (B)	   BBR	   is	   an	   active	   E3	   ligase	   in	   vitro.	   An	   in	   vitro	  
ubiquitination	   assay	   with	   BBR	   as	   the	   E3	   ligase.	   In	   the	   presence	   of	   E1	   (human	   UBE1),	   E2	   (GST-­‐














Figure	  S5	  –	  Ubiquitinated	  DA1	  is	  sufficient	  to	  cleave	  EOD1	  and	  DA2	  in	  vitro	  
(A,B)	  Purified	  FLAG-­‐DA1	  and	  FLAG-­‐DA1-­‐ub	  (ubiquitinated	  DA1)	  was	  added	  to	  a	  reaction	  containing	  
EOD1	  (A)	  or	  DA2	  (B).	  Only	  DA1-­‐ub	  was	  sufficient	  to	  cleave	  EOD1	  (A;	  lane	  1)	  and	  DA2	  (B;	  lane	  1).	  (B)	  
A	   lower	  molecular	  weight	  band	  that	  co-­‐purifies	   from	  E.	  coli	  with	  DA2-­‐HIS	  can	  be	  seen	   in	   lane	  2.	  
This	   is	   thought	   to	  be	  due	   to	  an	  ectopic	   translational	  event	   from	  an	   intragenic	  ATG	   (see	   section	  






S2	  -­‐	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Gene	  name	   Gene	  ID	   Reference	  
ABAP1	  (ARMADILLO	  BTB	  PROTEIN1)	   AT5G13060	   (Masuda	  et	  al.,	  2008)	  
ABA2	  (ABA	  DEFICIENT2)	   AT1G52340	   (Horiguchi	  et	  al.,	  2006b)	  
ABA3	  (ABA	  DEFICIENT3)	   AT1G16540	   (Horiguchi	  et	  al.,	  2006b)	  
ABP1	  (AUXIN	  BINDING	  PROTEIN1)	   AT4G02980	   (Chen	  et	  al.,	  2001)	  
ACD6	  (ACCELERATED	  CELL	  DEATH6)	   AT4G14400	  	   (Lu	  et	  al.,	  2009)	  
AGG3	  (ARABIDOPSIS	  G	  PROTEIN	  GAMMA	  SUBUNIT3)	   AT5G20635	   (Chakravorty	  et	  al.,	  2011)	  
AHK1	  (ARABIDOPSIS	  THALIANA	  	  HISTIDINE	  KINASE1)	   AT2G17820	   (Nishimura	  et	  al.,	  2004)	  
AHK2	  (ARABIDOPSIS	  THALIANA	  	  HISTIDINE	  KINASE2)	   AT5G35750	   (Nishimura	  et	  al.,	  2004)	  
AHK3	  (ARABIDOPSIS	  THALIANA	  	  HISTIDINE	  KINASE3)	   AT1G27320	   (Nishimura	  et	  al.,	  2004)	  
ANT	  (AINTEGUMENTA)	   AT4G37750	  
(Mizukami	  and	  Fischer,	  
2000)	  
AN	  (ANGUSTOFOLIA)	   AT1G01510	   (Kim	  et	  al.,	  2002)	  
AP2	  (APETALA	  2)	   AT4G36920	   (Bowman	  et	  al.,	  1991)	  
APC10	  (ANAPHASE	  PROMOTING	  FACTOR10)	   AT2G18290	   (Eloy	  et	  al.,	  2011)	  
ARF2	  (AUXIN	  RESPONSE	  FACTOR2)	   AT5G62000	   	  (Okushima	  et	  al.,	  2005)	  
GRF8	  (GROWTH-­‐REGULATING	  FACTOR	  8)	   AT5G37020	  	   (Okushima	  et	  al.,	  2005)	  
ARF7	  (AUXIN	  RESPONSE	  FACTOR7)	   AT5G20730	   (Wilmoth	  et	  al.,	  2005)	  
ARF8	  (AUXIN	  RESPONSE	  FACTOR8)	   AT1G1920	   (Wilmoth	  et	  al.,	  2005)	  
ARGOS	   AT3G59900	   (Hu	  et	  al.,	  2003)	  
ARL	  (ARGOS-­‐LIKE)	   AT2G44080	   (Hu	  et	  al.,	  2006)	  
ATAF2	   AT5G08790	   (Delessert	  et	  al.,	  2005)	  
ATHB16	  (ARABIDOPSIS	  THALIANA	  HOMEOBOX	  PROTEIN	  
16)	   AT4G40060	  	   (Wang	  et	  al.,	  2003b)	  
AVP1	  (ARABIDOPSIS	  THALIANA	  V-­‐PPASE)	   AT1G15690	  	   (Li	  et	  al.,	  2005b)	  
AXR1	  (AUXIN	  RESISTANT1)	   AT1G05180	   (Horiguchi	  et	  al.,	  2006b)	  
AXR3	  (AUXIN	  RESISTANT3)	   AT1G04250	  	   (Pérez-­‐Pérez	  et	  al.,	  2010)	  
BB/EOD1	  (BIG	  BROTHER/ENHANCER	  OF	  DA1	  1)	   AT3G63530	   (Disch	  et	  al.,	  2006)	  
BEN1	   AT2G45400	   (Yuan	  et	  al.,	  2007)	  
BIG	   AT3G02260	  	   (Guo	  et	  al.,	  2013)	  
BPEp	  (BIG	  PETAL	  P)	   AT1G59640	   (Szécsi	  et	  al.,	  2006)	  
BRI1	  (BRASSINOSTEROID	  INSENSITIVE1)	   AT4G39400	  	   (Clouse	  et	  al.,	  1996)	  
CDC27A	   AT3G16320	   (Rojas	  et	  al.,	  2009).	  	  
CKX3	  (CYTOKININ	  OXIDASE3)	   AT2G41510	   (Bartrina	  et	  al.,	  2011)	  
CKX5(CYTOKININ	  OXIDASE5)	   AT1G75450	   (Bartrina	  et	  al.,	  2011)	  
CLE26	  (CLAVATA3/ESR-­‐RELATED	  26)	   AT1G69970	  	   (Strabala	  et	  al.,	  2006)	  
CLE8	  (CLAVATA3/ESR-­‐RELATED	  8)	   AT1G67775	   (Fiume	  and	  Fletcher,	  2012)	  
CLV1	  (CLAVATA1)	   AT1G75820	   (Clark	  et	  al.,	  1997)	  
CTR1	  (CONSTITUTIVE	  TRIPLE	  RESPONSE)	   AT5G03730	   (Kieber	  et	  al.,	  1993)	  
CUC1	  (CUP-­‐SHAPED	  COTELYDON1)	   AT5G53950	   (Aida	  et	  al.,	  1997)	  
CUC2	  (CUP-­‐SHAPED	  COTELYDON2)	   AT5G53950	  	   (Hibara	  et	  al.,	  2006)	  
Table	  S1	  	   	   	  
251	  
	   	   	  
CUC3	  (CUP-­‐SHAPED	  COTELYDON3)	   AT1G76420	   (Hibara	  et	  al.,	  2006)	  
CYCLIND3;1	   AT4G34160	   (Dewitte	  et	  al.,	  2007)	  
CYCLIND3;2	   AT5G67260	  	   (Dewitte	  et	  al.,	  2007)	  
CYCLIND3;3	   AT3G50070	   (Dewitte	  et	  al.,	  2007)	  
DA1	   AT1G19270	   (Li	  et	  al.,	  2008)	  
DA2	   AT1G78420	   (Xia,	  2013)	  
DAR1	  (DA1-­‐RELATED1)	   AT4G36860	   (Li	  et	  al.,	  2008)	  
DHS	  (	  DEOXYHYPUSINE	  SYNTHASE)	   AT5G05920	  	   (Wang	  et	  al.,	  2003a)	  
DWF4	  (DWARF4)	   AT3G50660	  	   (Choe	  et	  al.,	  2001)	  
E2F3	  (E2F	  TRANSCRIPTION	  FACTOR3)	   AT2G36010	  	   (Magyar	  et	  al.,	  2012)	  
EBP1	  (ERBB-­‐3	  BINDING	  PROTEIN1)	   AT3G51800	   (Horvath	  et	  al.,	  2006)	  
EIN2	  (ETHYLENE-­‐INSENSITIVE2)	   AT5G03280	   (Alonso	  et	  al.,	  1999),	  
EIN3	  (ETHYLENE-­‐INSENSITIVE3)	   AT3G20770	   (Horiguchi	  et	  al.,	  2006b)	  
EOD3	  (ENHANCER	  OF	  DA1	  3)	   AT2G46660	   (Fang	  et	  al.,	  2012)	  
ER	  (ERECTA)	   AT2G26330	   (Shpak	  et	  al.,	  2003)	  
ERF6	  (ETHYLENE	  RESPONSIVE	  ELEMENT	  BINDING	  FACTOR	  
6)	   AT4G17490	  	   (Dubois	  et	  al.,	  2013)	  
ETO1	  (ETHYLENE-­‐OVERPRODUCTION1)	   AT3G51770	   (Ecker,	  1995)	  
EIN1	  (ETHYLENE-­‐INSENSITIVE1)	   AT1G66340	   (Horiguchi	  et	  al.,	  2006b)	  
EXO	  (EXORDIUM)	   AT4G08950	  	   (Coll-­‐Garcia	  et	  al.,	  2004)	  
EXP10	  (EXPANSIN10)	   AT1G26770	   (Cho	  and	  Cosgrove,	  2000)	  
EXP3	  (EXPANSIN3)	   AT2G37640	  	   (Kwon	  et	  al.,	  2008)	  
FIE	  (FERTILISATION	  INDEPENDNENT	  ENDOSPERM)	   AT3G20740	   (Ohad	  et	  al.,	  1999)	  
FRL1	  (FRILL1)	   AT1G20330	   (Hase	  et	  al.,	  2000)	  
FUS3	  (FUSCA	  3)	   AT3G26790	   (Raz	  et	  al.,	  2001)	  
FUGU2	   AT1G65470	   (Ferjani	  et	  al.,	  2007)	  
FZR2	  (FIZZY-­‐RELATED2)	   AT4G22910	  	   (Larson-­‐Rabin	  et	  al.,	  2009)	  
GA1	  (GA	  REQUIRING1)	   AT4G02780	   (Ubeda-­‐Tomás	  et	  al.,	  2009)	  
GA20OX1	  (GIBBERELLIN	  20-­‐OXIDASE)	   AT4G25420	   (Huang	  et	  al.,	  1998)	  
GASA14	  (G	  A-­‐STIMULATED	  IN	  ARABIDOPSIS14)	   AT5G14920	  	   (Sun	  et	  al.,	  2013)	  
GIF1	  (GRF-­‐INTERACTING	  FACTOR1)	   AT5G28640	   (Lee	  et	  al.,	  2009)	  
GIF2	  (GRF-­‐INTERACTING	  FACTOR2)	   AT1G01160	  	   (Lee	  et	  al.,	  2009)	  
GIF3	  (GRF-­‐INTERACTING	  FACTOR3)	   AT4G00850	  	   (Lee	  et	  al.,	  2009)	  
GOA	  (GORDITA)	   AT1G31140	   (Prasad	  et	  al.,	  2010)	  
GRF1	  (GROWTH	  REGULATING	  FACTOR1)	   AT2G22840	   (Kim	  et	  al.,	  2003)	  
GRF2	  (GROWTH	  REGULATING	  FACTOR2)	   AT1G78300	  	   (Kim	  et	  al.,	  2003)	  
GRF5	  (GROWTH	  REGULATING	  FACTOR5)	   AT3G13960	  	   (Horiguchi	  et	  al.,	  2005)	  
HOG1	  (	  HOMOLOGY-­‐DEPENDENT	  GENE	  SILENCING1)	   AT4G13940	   (Godge	  et	  al.,	  2008)	  
HRC1	  (HERCULES1)	   AT1G45233	  	  
(Century	  et	  al.,	  2008,	  Jiang,	  
2004)	  
JAR1	  (JASMONATE	  RESISTANT1)	   AT2G46370	   (Horiguchi	  et	  al.,	  2006b)	  
KRP1	  (KIP-­‐RELATED	  PROTEIN1)	   AT2G23430	   (Malinowski	  et	  al.,	  2011)	  
KRP7	  (KIP-­‐RELATED	  PROTEIN7)	   AT1G49620	   (Cheng	  et	  al.,	  2013a)	  
KRP4	  (KIP-­‐RELATED	  PROTEIN4)	   AT2G32710	  	   (Cheng	  et	  al.,	  2013a)	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IKU	  (HAIKU)	   AT2G35230	   (Zhou	  et	  al.,	  2009)	  
INO	  (INNER	  NO	  OUTER)	   AT1G23420	   (Villanueva	  et	  al.,	  1999)	  
JAG	  (JAGGED)	   AT1G68480	   	  (Ohno	  et	  al.,	  2004)	  
KAT2	  (3-­‐KETOACYL-­‐COA	  THIOLASE2)	   AT2G33150	  	   (Footitt	  et	  al.,	  2007)	  
KLU	  (KLUH)	   AT1G13710	   (Anastasiou	  et	  al.,	  2007)	  
KRP2	  (KIP-­‐RELATED	  PROTEIN2)	   AT3G50630	   (Cheng	  et	  al.,	  2013a)	  
KRP3	  (KIP-­‐RELATED	  PROTEIN3)	   AT5G48820	  	   (Cheng	  et	  al.,	  2013a)	  
LUG	  (LEUNIG)	   AT4G32551	   (Liu	  and	  Meyerowitz,	  1995)	  
LOB	  (LATERAL	  ORGAN	  BOUNDARIES)	   AT5G63090	  	   (Lin	  et	  al.,	  2003)	  
MED25	  (MEDIATOR	  SUBUNIT	  25)	   AT1G25540	   (Xu	  and	  Li,	  2011)	  
MED8	  (MEDIATOR	  SUBUNIT	  8)	   AT2G03070	   (Xu	  and	  Li,	  2012)	  
MINI3	  (MINISEED	  3)	   AT1G55600	   (Zhou	  et	  al.,	  2009)	  
miR319a	   AT4G23713	   (Palatnik	  et	  al.,	  2003)	  
miR396a	   AT2G10606	  	   (Rodriguez	  et	  al.,	  2010)	  
miR396b	   AT5G35407	  	  	  	   (Rodriguez	  et	  al.,	  2010)	  
MSI1	  (MULTICPOY	  SUPPRESSOR	  OF	  IRA1)	   AT5G58230	   (Köhler	  et	  al.,	  2003)	  
NAC1	  (NAC	  DOMAIN	  CONTAINING	  PROTEIN1)	   AT1G56010	  	   (Xie	  et	  al.,	  2000)	  
NGA1	  (NGATHA1)	   At2G46870	   (Alvarez	  et	  al.,	  2009)	  
NUB	  (NUBBIN)	   AT1G13400	   (Dinneny	  et	  al.,	  2006)	  
OBP2	   AT1G07640	   (Skirycz	  et	  al.,	  2006)	  
ORS1	  (ORGAN	  SIZE	  RELATED1)	   AT2G41230	  	   (Feng	  et	  al.,	  2011)	  
PPD	  (PEAPOD)	   AT4G14713	   (White,	  2006)	  
RBR1	  (RETINOBLASTOMA-­‐RELATED1)	   AT3G12280	   (Magyar	  et	  al.,	  2012)	  
ROT3	  (ROTUNDIFOLIA3)	   AT4G36380	   (Kim	  et	  al.,	  1998b)	  
ROXY1	   AT3G02000	   (Xing	  et	  al.,	  2005)	  
ROXY2	   AT5G14070	   (Xing	  and	  Zachgo,	  2008)	  
RPT2A	  (REGULATORY	  PARTICLE	  AAA-­‐ATPASE	  2a)	   AT4G29040	   (Sonoda	  et	  al.,	  2009)	  
RSW1	  (RADIAL	  SWELLING	  1)	   AT4G32410	   (Hématy	  et	  al.,	  2007)	  
SHB1	  (SHORT	  HYPOCOTYL	  UNDER	  BLUE1)	   AT4G25350	   (Zhou	  et	  al.,	  2009)	  
SHR	  (SHORT-­‐ROOT)	   AT4G37650	   (Nakajima	  et	  al.,	  2001)	  
SLY1	  (SLEEPY1)	   AT4G24210	   (Dill	  et	  al.,	  2004)	  
SPT	  (SPATULA)	   AT4G36930	  	   (Ichihashi	  et	  al.,	  2010)	  
SRF4	  (STRUBBELIG-­‐RECEPTOR	  FAMILY4)	   AT3G13065	   (Eyüboglu	  et	  al.,	  2007)	  
STY1	  (STYLISH1)	   AT3G51060	  	   (Sohlberg	  et	  al.,	  2006)	  
SWP	  (STUWWELPETER)	   AT3G04740	   (Autran	  et	  al.,	  2002)	  
TCP1	   At1G67260	   (Koyama	  et	  al.,	  2010b))	  	  
TCP10	   At2G31070	   (Palatnik	  et	  al.,	  2003)	  
TCP12	   At1G68800	  
	  (Aguilar-­‐Martínez	  et	  al.,	  
2007)	  
TCP13	   At3G02150	   (Koyama	  et	  al.,	  2007)	  
TCP14	   At3G47620	   (Kieffer	  et	  al.,	  2011)	  
TCP15	   At1G69690	   (Kieffer	  et	  al.,	  2011)	  
TCP17	   At5G08070	   (Koyama	  et	  al.,	  2007)	  











	   	   	  
TCP2	   At4G18390	   	  (Palatnik	  et	  al.,	  2003)	  
TCP20	   At3G27010	   (Li	  et	  al.,	  2005a)	  
TCP11	   At5G08330	   (Viola	  et	  al.,	  2011)	  
TCP22	   At1G72010	   See	  Fig.	  S3	  
TCP23	   At1G35560	  
(Balsemão-­‐Pires	  et	  al.,	  
2013)	  
TCP24	   At1G30210	   (Palatnik	  et	  al.,	  2003)	  
TCP3	   At1G53230	   (Palatnik	  et	  al.,	  2003)	  
TCP4	   At3G15030	   (Palatnik	  et	  al.,	  2003)	  
TCP5	   At5G60970	   (Koyama	  et	  al.,	  2007)	  
TCP8	   At1G58100	   (Patel,	  2012)	  
TCP9	   At2G45680	  
(Balsemão-­‐Pires	  et	  al.,	  
2013)	  
TIE	  (TCP	  INTERACTOR	  CONTAINING	  EAR	  MOTIF	  PROTEIN)	   AT4G28840	   (Tao	  et	  al.,	  2013)	  
TOR	  (TARGET	  OF	  RAPAMYCIN)	   AT1G50030	   (Deprost	  et	  al.,	  2007)	  
TTG2	  (TRANSPARENT	  TESTA	  GLABRA2)	   AT2G37260	   (Garcia	  et	  al.,	  2005)	  
TTL	  (TITAN-­‐LIKE)	   AT4G24900	   (Nam	  and	  Li,	  2004)	  
UBP15	  (UBIQUITIN-­‐SPECIFIC	  PROTEASE15)	   AT1G17110	  	   (Horiguchi	  et	  al.,	  2006a)	  
ZHD5	  (ZINC	  FINGER	  HOMEODOMAIN5)	   AT1G75240	   (Hong	  et	  al.,	  2011)	  
Table	  S1	  –	  List	  of	  a	  priori	  growth	  regulators	  	  	  
The	  table	  lists	  genes	  that	  have	  been	  characterized	  as	  regulators	  of	  leaf	  growth,	  petal	  growth	  and	  
seed	  growth.	  It	  is	  based	  on	  tables	  from	  Gonzalez	  et	  al	  (2008)	  and	  Breuninger	  &	  Lenhard	  (2010).	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AccessionName	   AccessionID	  
T910	   6143	  
Ådal	  3	   9323	  
Öde	  2	   9434	  
Öde	  3	   9435	  
Ale1-­‐2	   5829	  
AleA	  1	   9325	  
Aledal-­‐11-­‐63	   1163	  
Aledal-­‐1-­‐34	   1153	  
Aledal-­‐14-­‐73	   1166	  
Aledal-­‐17-­‐82	   1169	  
Aledal-­‐6-­‐49	   1158	  
Ale-­‐Ster-­‐41-­‐1	   991	  
Ale-­‐Ster-­‐44-­‐4	   992	  
Ale-­‐Ster-­‐50-­‐11	   996	  
Ale-­‐Ster-­‐56-­‐14	   997	  
Ale-­‐Ster-­‐57-­‐16	   998	  
Ale-­‐Ster-­‐59-­‐18	   999	  
Ale-­‐Ster-­‐64-­‐24	   1002	  
Ale-­‐Ster-­‐77-­‐31	   1006	  
ÖMö1-­‐7	   6073	  
Ängsö-­‐12-­‐402	   1303	  
Ängsö-­‐57-­‐419	   1312	  
Ängsö-­‐59-­‐422	   1313	  
Ängsö-­‐74-­‐430	   1317	  
Ängsö-­‐80-­‐432	   1318	  
App1-­‐12	   5830	  
App1-­‐14	   5831	  
App1-­‐16	   5832	  
Bag	  1	   9330	  
Bar	  1	   9332	  
Bil-­‐3	   5835	  
Bön	  1	   9336	  
Boo2-­‐3	   5836	  
Böt	  1	   9339	  
Böt	  4	   9342	  
Brösarp-­‐11-­‐135	   1061	  
Brösarp-­‐11-­‐138	   1062	  
Brösarp-­‐21-­‐140	   1063	  
Brösarp-­‐25-­‐142	   1064	  
Brösarp-­‐34-­‐145	   1066	  
Brösarp-­‐37-­‐149	   1068	  
Brösarp-­‐43-­‐152	   1069	  
Brösarp-­‐45-­‐153	   1070	  
Brösarp-­‐51-­‐157	   1072	  
Brösarp-­‐53-­‐159	   1073	  
Brösarp-­‐61-­‐162	   1074	  
Brösarp-­‐63-­‐163	   1075	  
Dja	  1	   9343	  
Dja	  2	   9344	  
Table	  S2	  	  	   	  
	   	  
AccessionName	   AccessionID	  
Död	  1	   9351	  
Djk	  3	   9349	  
Död	  2	   9352	  
Död	  3	   9353	  
Dör-­‐10	   5856	  
Dra1-­‐4	   5865	  
Dra2-­‐1	   5867	  
Dra-­‐3	   5860	  
Dra3-­‐9	   5870	  
Eden	  15	   9354	  
Eden	  16	   9355	  
Eden	  17	   9356	  
Eden-­‐1	   6009	  
Eden-­‐4	   8218	  
Eden-­‐5	   6010	  
Eden-­‐6	   6011	  
Eden-­‐7	   6012	  
Eden-­‐9	   6013	  
EdJ	  2	   9363	  
Eds-­‐9	   6017	  
EkN	  3	   9367	  
EkS	  2	   9369	  
EkS	  3	   9370	  
FäL	  1	   9371	  
Fjä1-­‐2	   6019	  
Fjä1-­‐5	   6020	  
Fjä2-­‐4	   6021	  
Fjä2-­‐6	   6022	  
Fly2-­‐1	   6023	  
FlyA	  3	   9380	  
Fri	  1	   9381	  
Fri	  2	   9382	  
Fri	  3	   9383	  
Frö	  1	   9384	  
Frö	  3	   9385	  
Gårdby-­‐17-­‐198	   1132	  
Gårdby-­‐22-­‐213	   1137	  
Gro-­‐3	   6025	  
Grön	  12	   9386	  
Grön	  14	   9388	  
Grön-­‐5	   6030	  
Had	  1	   9390	  
Had	  2	   9391	  
Had	  3	   9392	  
Hag	  2	   9394	  
Hal	  1	   9395	  
Ham	  1	   9399	  
Ham-­‐10-­‐239	   1366	  
Ham-­‐13-­‐241	   1367	  
	   	  
255	  
	   	  
AccessionName	   AccessionID	  
Ham-­‐2-­‐2	   1360	  
Ham-­‐27-­‐256	   1374	  
Ham-­‐6-­‐232	   1362	  
Ham-­‐7-­‐233	   1363	  
Hel	  3	   9402	  
Hen-­‐16-­‐268	   1585	  
HolA1	  1	   9404	  
HolA1	  2	   9405	  
HolA2	  2	   9407	  
Hov1-­‐10	   6035	  
Hov1-­‐7	   6034	  
Hov3-­‐2	   6036	  
Hov3-­‐5	   6038	  
Kal	  2	   9408	  
Kia	  1	   9409	  
Kor	  1	   9410	  
Kor	  2	   9411	  
Kor	  3	   9412	  
Kor	  4	   9413	  
Kru	  3	   9416	  
Kva	  2	   9418	  
Lag	  1	   9419	  
Lan	  1	   9421	  
Lis-­‐3	   6041	  
Löv-­‐1	   6043	  
Näs	  2	   9427	  
Nyl	  13	   9433	  
Nyl-­‐7	   6069	  
Omn-­‐1	   6070	  
Omn-­‐5	   6071	  
Ost-­‐0	   8351	  
Puk	  1	   9436	  
Puk	  2	   9437	  
Rev-­‐2	   6076	  
Rev-­‐3	   6077	  
Röd-­‐17-­‐319	   1435	  
Sim	  1	   9442	  
Sku-­‐30	   1552	  
Sparta-­‐1	   6085	  
Spro	  1	   9450	  
Spro	  2	   9451	  
Spro	  3	   9452	  
Sr:3	   6086	  
Stabby-­‐13	   1391	  
Stabby-­‐26	   1404	  
Ste	  2	   9453	  
Ste	  3	   9454	  
Ste	  4	   9455	  
Stu-­‐2	   6087	  
T1000	   6090	  
T1010	   6091	  
Table	  S2	   	  
	   	  
AccessionName	   AccessionID	  
T1020	   6092	  
T1030	   6093	  
T1040	   6094	  
T1050	   6095	  
T1060	   6096	  
T1070	   6097	  
T1080	   6098	  
T1090	   6099	  
T1110	   6100	  
T1120	   6101	  
T1130	   6102	  
T1150	   6103	  
T1160	   6104	  
T450	   6105	  
T460	   6106	  
T470	   6107	  
T480	   6108	  
T510	   6109	  
T520	   6110	  
T530	   6111	  
T540	   6112	  
T550	   6113	  
T570	   6114	  
T580	   6115	  
T590	   6116	  
T610	   6118	  
T620	   6119	  
T630	   6120	  
T640	   6121	  
T670	   6122	  
T680	   6123	  
T690	   6124	  
T710	   6125	  
T720	   6126	  
T730	   6127	  
T740	   6128	  
T750	   6129	  
T760	   8225	  
T780	   6131	  
T790	   6132	  
T800	   6133	  
T810	   6134	  
T840	   6136	  
T850	   6137	  
T860	   6138	  
T880	   6140	  
T890	   6141	  
T900	   6142	  
T920	   6144	  
T930	   6145	  
T940	   6146	  
	   	  
256	  
	   	  
AccessionName	   AccessionID	  
T950	   6147	  
T960	   6148	  
T970	   6149	  
T980	   6150	  
T990	   6151	  
TÄL	  07	   6180	  
TÅD	  01	   6169	  
TÅD	  02	   6170	  
TÅD	  03	   6171	  
TÅD	  04	   6172	  
TÅD	  05	   6173	  
TÅD	  06	   6174	  
TAA	  03	   6153	  
TAA	  04	   6154	  
TAA	  14	   6163	  
TAA	  17	   6166	  
TBÖ	  01	   6184	  
TDr-­‐1	   6188	  
TDr-­‐11	   6197	  
TDr-­‐13	   6198	  
TDr-­‐14	   6199	  
TDr-­‐15	   6200	  
TDr-­‐16	   6201	  
TDr-­‐17	   6202	  
TDr-­‐18	   6203	  
TDr-­‐2	   6189	  
TDr-­‐22	   6207	  
TDr-­‐3	   6190	  
TDr-­‐4	   6191	  
TDr-­‐5	   6192	  
TDr-­‐7	   6193	  
TDr-­‐8	   6194	  
TDr-­‐9	   6195	  
TEDEN	  02	   6209	  
TEDEN	  03	   6210	  
TFÄ	  04	   6214	  
TFÄ	  02	   6212	  
TFÄ	  05	   6215	  
TFÄ	  06	   6216	  
TFÄ	  07	   6217	  
TFÄ	  08	   6218	  
TGR	  01	   6220	  
TGR	  02	   6221	  
THÖ	  03	   8227	  
THÖ	  08	   6226	  
TNY	  04	   6231	  
TOM	  01	   6235	  
TOM	  02	   6236	  
TOM	  03	   6237	  
TOM	  04	   6238	  
Table	  S2	   	  
	   	  
AccessionName	   AccessionID	  
TOM	  06	   6240	  
TOM	  07	   6241	  
Tomegap-­‐2	   6242	  
Tos-­‐31-­‐374	   1247	  
Tos-­‐75-­‐384	   1252	  
Tos-­‐82-­‐387	   1254	  
Tos-­‐93-­‐391	   1256	  
Tos-­‐95-­‐393	   1257	  
TRÄ	  01	   6244	  
Tur	  3	   9469	  
Tur	  4	   9470	  
TV-­‐10	   6258	  
TV-­‐22	   6268	  
TV-­‐30	   6276	  
TV-­‐38	   6284	  
TV-­‐4	   6252	  
TV-­‐7	   6255	  
UII2-­‐13	   8427	  
UII3-­‐4	   6413	  
UIIA	  1	   9471	  
UIIA	  2	   9472	  
Ull2-­‐5	   6974	  
Vår2-­‐6	   7517	  
VårA	  1	   9476	  
Yst	  1	   9481	  
Yst	  2	   9482	  
Fly2-­‐2	   6024	  
Stu1-­‐1	   6088	  
Vår2-­‐1	   7516	  
Hovdala-­‐2	   6039	  
TGR	  02	   6221	  
Hovdala-­‐6	   8307	  
Bå1-­‐2	   8256	  
ÖMö2-­‐1	   7518	  
Brö1-­‐6	   8231	  
St-­‐0	   8387	  
Eden-­‐2	   6913	  
Ör-­‐1	   6074	  
Fjä1-­‐1	   8422	  
Algutstrum	   8230	  
Gul1-­‐2	   8234	  







Residue	   Colour	   Property	  
AVFPMILW	   RED	   Small	  (small+	  hydrophobic	  (incl.aromatic	  -­‐Y))	  
DE	   BLUE	   Acidic	  
RK	   MAGENTA	   Basic	  -­‐	  H	  
STYHCNGQ	   GREEN	   Hydroxyl	  +	  sulfhydryl	  +	  amine	  +	  G	  




Table	  S2	  –	  List	  of	  accessions	  used	  in	  GWA	  studies	  
Accession	  names	  and	  accession	  IDs	  for	  the	  Arabidopsis	  lines	  used	  in	  the	  GWA	  analysis	  of	  organ	  
size	  (Chapter	  6).	  All	  accessions	  are	  from	  Sweden	  and	  are	  a	  subset	  of	  the	  1001	  genomes	  project	  
(Weigel	  and	  Mott,	  2009).	  The	  accessions	  were	  kindly	  provided	  by	  Caroline	  Dean	  at	  the	  John	  Innes	  
Centre,	  Norwich.	  
Table	  S3	  –	  ClustalW	  colour	  codes	  
Explanation	  of	  colour	  codes	  used	  for	  ClustalW	  alignments	  from	  






Group	  name	   Amino	  acids	   Displayed	  as	  
Default	   X	   .	  
Single	   X	   -­‐	  
Alanine	   A	   A	  
Cysteine	   C	   C	  
Aspartic	  Acid	   D	   D	  
Glutamic	  Acid	   E	   E	  
Phenylalanine	   F	   F	  
Glycine	   G	   G	  
Histidine	   H	   H	  
Isoleucine	   I	   I	  
Lysine	   K	   K	  
Leucine	   L	   L	  
Methionine	   M	   M	  
Asparagine	   N	   N	  
Proline	   P	   P	  
Glutamine	   Q	   Q	  
Arginine	   R	   R	  
Serine	   S	   S	  
Threonine	   T	   T	  
Valine	   V	   V	  
Tryptophan	   W	   W	  
Tyrosine	   Y	   Y	  
Negative	   D,E	   -­‐	  
Ser/Thr	   S,T	   *	  
Aliphatic	   I,L,V	   l	  
Positive	   H,K,R	   +	  
Tiny	   A,G,S	   t	  
Aromatic	   F,H,W,Y	   a	  
Charged	   D,E,H,K,R	   c	  
Small	   A,C,D,G,N,P,S,T,V	   s	  
Polar	   C,D,E,H,K,N,Q,R,S,T	   p	  
Big	   E,F,H,I,K,L,M,Q,R,W,Y	   b	  
Hydrophobic	   A,C,F,G,H,I,L,M,T,V,W,Y	   h	  
	  
	  
Table	  S4	  –	  Chroma	  colour	  codes	  





QTL	   Gene	   Distance	  from	  
Peak	  (Kb)	  
Gene	  Names	  
	  1	   AT1G80370	   -­‐2078.508	   CYCA2;4,	  	  CYCLIN	  A2;4	  
	  1	   AT1G79840	   -­‐1902.423	   GL2,	  	  GLABRA	  2	  
	  1	   AT1G79350	   -­‐1712.248	   EMB1135,	  	  EMBRYO	  DEFECTIVE	  1135	  
	  1	   AT1G78770	   -­‐1482.408	   ANAPHASE	  PROMOTING	  COMPLEX	  6,	  	  APC6	  
	  1	   AT1G77390	   -­‐946.319	   CYCA1,	  	  CYCA1;2,	  	  CYCLIN	  A1,	  	  	  
	  1	   AT1G76540	   -­‐584.649	   CDKB2;1,	  	  CYCLIN-­‐DEPENDENT	  KINASE	  B2;1	  
	  1	   AT1G76310	   -­‐492.445	   CYCB2;4,	  	  CYCLIN	  B2;4	  
	  1	   AT1G75500	   -­‐202.238	   WALLS	  ARE	  THIN	  1,	  	  WAT1	  
	  1	   AT1G75080	   -­‐49.682	   BRASSINAZOLE-­‐RESISTANT	  1,	  	  BZR1	  
	  1	   AT1G73965	   320.643	   CLAVATA3/ESR-­‐RELATED	  13,	  	  CLE13	  
	  1	   AT1G73165	   627.938	   CLAVATA3/ESR-­‐RELATED	  1,	  	  CLE1	  
	  1	   AT1G72980	   680.317	   LBD7,	  	  LOB	  DOMAIN-­‐CONTAINING	  PROTEIN	  7	  
	  1	   AT1G72970	   682.41	   EDA17,	  	  EMBRYO	  SAC	  DEVELOPMENT	  ARREST	  17	  
	  1	   AT1G72300	   917.475	   PSY1	  RECEPTOR,	  PSY1R	  
	  1	   AT1G71440	   1214.052	   TFC	  E,	  	  TUBULIN-­‐FOLDING	  COFACTOR	  E	  
	  1	   AT1G71220	   1290.001	   EBS1,	  	  EMS-­‐MUTAGENIZED	  BRI1	  SUPPRESSOR	  1,	  	  
	  1	   AT1G71190	   1302.556	   SAG18,	  	  SENESCENCE	  ASSOCIATED	  GENE	  18	  
	  1	   AT1G70910	   1402.378	   DEP,	  	  DESPIERTO	  
	  1	   AT1G70540	   1542.475	   EDA24,	  	  EMBRYO	  SAC	  DEVELOPMENT	  ARREST	  24	  
	  1	   AT1G70520	   1550.701	   ALTERED	  SEED	  GERMINATION	  6,	  	  ASG6,	  	  	  
	  1	   AT1G70490	   1571.908	   ARFA1D,	  	  ATARFA1D	  
	  1	   AT1G70210	   1695.429	   ATCYCD1;1,	  	  CYCD1;1,	  	  CYCLIN	  D1;1	  
	  1	   AT1G69588	   1958.292	   CLAVATA3/ESR-­‐RELATED	  45,	  	  CLE45	  
	  1	   AT1G69270	   2095.08	   RECEPTOR-­‐LIKE	  PROTEIN	  KINASE	  1,	  	  RPK1	  
	  1	   AT1G69230	   2109.745	   SP1L2,	  	  SPIRAL1-­‐LIKE2	  
	  1	   AT1G68840	   2255.744	   EDF2,	  	  ETHYLENE	  RESPONSE	  DNA	  BINDING	  FACTOR	  2	  
	  1	   AT1G68795	   2295.522	   CLAVATA3/ESR-­‐RELATED	  12,	  	  CLE12	  
	  1	   AT1G68510	   2429.207	   LBD42,	  	  LOB	  DOMAIN-­‐CONTAINING	  PROTEIN	  42	  
	  1	   AT1G68310	   2536.298	   AE7,	  	  AS1/2	  ENHANCER7	  
	  1	   AT1G67775	   2725.271	   CLAVATA3/ESR-­‐RELATED	  8,	  	  CLE8	  
	  1	   AT1G67100	   3082.485	   LBD40,	  	  LOB	  DOMAIN-­‐CONTAINING	  PROTEIN	  40	  
	  2	   AT2G25660	   1506.475	   EMB2410,	  	  EMBRYO	  DEFECTIVE	  2410	  
	  2	   AT2G26760	   1025.893	   CYCB1;4,	  	  CYCLIN	  B1;4	  
	  2	   AT2G26830	   982.905	   EMB1187,	  	  EMBRYO	  DEFECTIVE	  1187	  
	  2	   AT2G27170	   814.993	   TITAN7,	  	  TTN7	  
	  2	   AT2G27250	   762.894	   ATCLV3,	  	  CLAVATA3,	  	  CLV3	  
	  2	   AT2G27960	   517.067	   CKS1,	  CYCLIN-­‐DEPENDENT	  KINASE-­‐SUBUNIT	  1	  
	  2	   AT2G27970	   515.517	   CDK-­‐SUBUNIT	  2,	  	  CKS2	  
	  2	   AT2G28830	   59.555	   ATPUB12,	  	  PLANT	  U-­‐BOX	  12,	  	  PUB12	  
	  2	   AT2G29680	   -­‐262.955	   ATCDC6,	  	  CDC6,	  	  CELL	  DIVISION	  CONTROL	  6	  
	  2	   AT2G30110	   -­‐426.723	   ATUBA1,	  UBIQUITIN-­‐ACTIVATING	  ENZYME	  1	  
	  2	   AT2G30410	   -­‐531.778	   KIESEL,	  	  KIS,	  	  TFCA,	  	  TUBULIN	  FOLDING	  FACTOR	  A	  
	  2	   AT2G31060	   -­‐787.641	   EMB2785,	  	  EMBRYO	  DEFECTIVE	  2785	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  2	   AT2G31081	   -­‐810.052	   CLAVATA3/ESR-­‐RELATED	  4,	  	  CLE4	  
	  2	   AT2G31082	   -­‐813.299	   CLAVATA3/ESR-­‐RELATED	  7,	  	  CLE7	  
	  2	   AT2G31083	   -­‐824.221	   ATCLE5,	  	  CLAVATA3/ESR-­‐RELATED	  5,	  	  CLE5	  
	  2	   AT2G31085	   -­‐826.171	   ATCLE6,	  	  CLAVATA3/ESR-­‐RELATED	  6,	  	  CLE6	  
	  3	   AT4G17300	   361.884	   ATNS1,	  	  NS1,	  	  OVA8,	  	  OVULE	  ABORTION	  8	  
	  3	   AT4G17695	   195.773	   KAN3,	  	  KANADI	  3	  
	  3	   AT4G18510	   -­‐167.004	   CLAVATA3/ESR-­‐RELATED	  2,	  	  CLE2	  
	  3	   AT4G18710	   -­‐252.676	   	  BIN2,	  	  BRASSINOSTEROID-­‐INSENSITIVE	  2,	  	  
	  3	   AT4G19350	   -­‐517.749	   EMB3006,	  	  EMBRYO	  DEFECTIVE	  3006	  
	  3	   AT4G19560	   -­‐617.931	   CYCT1;2	  
	  3	   AT4G19600	   -­‐629.609	   CYCT1;4	  
	  3	   AT4G16780	   595.213	   ARABIDOPSIS	  THALIANA	  HOMEOBOX	  PROTEIN	  2,	  	  ATHB-­‐2,	  	  	  
	  4	   AT4G20740	   198.938	   EMB3131,	  	  EMBRYO	  DEFECTIVE	  3131	  
	  4	   AT4G21070	   75.779	   BREAST	  CANCER	  SUSCEPTIBILITY1,	  	  ATBRCA1,	  	  	  
	  4	   AT4G21130	   50.883	   EMB2271,	  	  EMBRYO	  DEFECTIVE	  2271	  
	  4	   AT4G21190	   33.08	   EMB1417,	  	  EMBRYO	  DEFECTIVE	  1417	  
	  5	   AT4G21800	   5.86	   QQT2,	  	  QUATRE-­‐QUART2	  
	  5	   AT4G21710	   40.931	   EMB1989,	  	  EMBRYO	  DEFECTIVE	  1989,	  	  NRPB2,	  	  RPB2	  
	  6	   AT4G24560	   894.356	   UBIQUITIN-­‐SPECIFIC	  PROTEASE	  16,	  	  UBP16	  
	  6	   AT4G24680	   840.066	   MODIFIER	  OF	  SNC1,	  	  MOS1	  
	  6	   AT4G25640	   498.684	   ATDTX35,	  	  DETOXIFYING	  EFFLUX	  CARRIER	  35,	  	  
	  6	   AT4G26080	   355.308	   ABA	  INSENSITIVE	  1,	  	  ABI1,	  	  ATABI1	  
	  6	   AT4G26300	   265.887	   EMB1027,	  	  EMBRYO	  DEFECTIVE	  1027	  
	  6	   AT4G26330	   254.496	   ATSBT3.18,	  	  UNE17,	  	  UNFERTILIZED	  EMBRYO	  SAC	  17	  
	  6	   AT4G26420	   224.748	   GAMT1	  
	  6	   AT4G27140	   -­‐31.25	   AT2S1,	  	  SEED	  STORAGE	  ALBUMIN	  1,	  	  SESA1	  
	  6	   AT4G27150	   -­‐33.278	   AT2S3,	  	  SEED	  STORAGE	  ALBUMIN	  3,	  	  SESA2	  
	  6	   AT4G27160	   -­‐35.749	   AT2S3,	  	  SEED	  STORAGE	  ALBUMIN	  3,	  	  SESA3	  
	  6	   AT4G27170	   -­‐37.509	   AT2S4,	  	  SEED	  STORAGE	  ALBUMIN	  4,	  	  SESA4	  
	  6	   AT4G28110	   -­‐392.276	   ATMYB41,	  	  MYB	  DOMAIN	  PROTEIN	  41,	  	  MYB41	  
	  6	   AT4G28210	   -­‐414.917	   EMB1923,	  	  EMBRYO	  DEFECTIVE	  1923	  
	  6	   AT4G28980	   -­‐713.139	   CDKF;1,	  	  CYCLIN-­‐DEPENDENT	  KINASE	  F;1	  
	  6	   AT4G29060	   -­‐742.981	   EMB2726,	  	  EMBRYO	  DEFECTIVE	  2726	  
	  
	  
Table	  S5	  –	  De	  novo	  candidate	  gene	  list	  for	  MAGIC	  analysis	  
Names	  and	   IDs	  of	  genes	   identified	   from	  the	  8	  MAGIC	  QTL	   for	   seed	  area.	  Genes	  were	   identified	  
from	   the	   QTL	   gene	   list	   by	  mining	   the	   list	   for	   the	   keywords:	   expansion,	   proliferation,	   cell-­‐cycle,	  
embryo,	   and	   endosperm,	   as	   well	   as	   manual	   analysis	   of	   all	   the	   published	   gene	   descriptions.	  
Distance	  from	  peak	  SNP	  values	  are	  given	  from	  the	  midpoint	  of	  the	  respective	  genes.	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Abbreviations	  
3’	   3	  prime	  
5’	   5	  prime	  
ATP	   adenoside	  triphosphate	  
BSA	   bovine	  serum	  albumin	  
cDNA	   complementary	  deoxyribonucleic	  acid	  
dATP	   deoxyadenosine	  triphosphate	  
dCTP	   deoxycytidine	  triphosphate	  
dGTP	   deoxyguanosine	  triphosphate	  
DNA	   deoxyribonucleic	  acid	  
dNTP	   deoxyribonucleotide	  triphosphate	  
DO	   drop	  out	  
dpi	   dots	  per	  inch	  
DTT	   dithiothreitol	  
dTTP	   thymidine	  triphosphate	  	  
EDTA	   ethylenediaminetetraacetic	  acid	  
EGTA	   ethylene	  glycol-­‐bis(2-­‐aminoethylether)-­‐N,N,Nʹ′,Nʹ′-­‐tetraacetic	  acid	  
GST	   glutatione	  S-­‐transferase	  
HEPES	   4-­‐(2-­‐hydroxyethyl)piperazine-­‐1-­‐ethanesulfonic	  acid	  
HIS	   histidine	  
HRP	   horseradish	  peroxidase	  
IPTG	   isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  
LB	   Luria	  broth	  
LiAc	   lithium	  acetate	  
MES	   2-­‐(N-­‐morpholino)ethanesulfonic	  acid	  
Ø	   empty	  
PBS	   phosphate	  buffered	  saline	  
PBST	   phosphate	  buffered	  saline	  with	  tween-­‐20	  
PCR	   polymerase	  chain	  reaction	  
PEG	   polyethylene	  glycol	  
PVDF	   polyvinylidene	  fluoride	  
QTL	   quantitative	  trait	  locus/loci	  
RIL	   recombinant	  inbred	  line	  
RNA	   ribonucleic	  acid	  
RNase	   ribonuclease	  
SC	   synthetic	  complete	  
SDS	   sodium	  dodecyl	  sulphate	  
SNP	   single	  nucleotide	  polymorphism	  
T-­‐DNA	   transfer	  deoxyribonucleic	  acid	  
TE	   tris-­‐EDTA	  
Tris	   tris(hydroxymethyl)aminomethane	  
v/v	   volume	  per	  volume	  
w/v	   weight	  per	  volume	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